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If you want something in life,
just reach out and grab it−
Intoe Wild

Preface
At the very beginning of my PhD, I regarded the research world as one of the
last standing pillars of communism: a community in which every one happily
shared his/her work, striving to create a new, brave world in which evil diseases
would no longer stand any chance against the almighty knowledge of medicine.
And remarkably, not all of that naivety has been robbed o aer 4.5 years. I still
believe that many of the things we do are extremely valuable, and feel proud
if this dissertation may have contributed just a little to that. But contrary to
what many people seem to think, that doesn’t imply that I spent each and ev-
ery working day in solitude, sitting at my desk, watching a computer screen,
thinking about aneurysms. I did so for many hours, I admit, but in fact many
- if not all - of the important achievements have been obtained in co-operation
with other people. And I would like to take the opportunity to acknowledge
each of them for their contribution to this dissertation, and to my personal and
professional development in general. So, let the namedropping begin!
First and foremost I should mention Patrick. In the 4.5 years that have gone
by since the memorable train conversation that started o our collaboration
(and this PhD), I have grown an immense respect for him, both from a per-
sonal and a technical point of view. In a good organization no one should be
irreplaceable, but I’m convinced that the day Patrick would decide to quit pro-
fessoring, the lab would be facing a huge problem. It’s not just that his research
expertise covers the eld of at least 2 professors, he also has that rare quality to
lead a group of over twenty individuals - who all have dierent projects, ambi-
tions and desires - without any struggles and without ever losing the ‘let’s grab a
beer aer work’mentality. Duringmy PhD I’vemetmany other researchers and
PhD students - both inside our university and around the world - but I’ve never
met anyone I would want to switch research lab with. And that has a lot to do
with that unique setting that the boss is just one of the guys - and still makes all
the decisions in good conscience. I must have popped into his oce hundreds
of times to discuss some research (or private) topic, but never felt unwelcome
and always le with greater insight and condence than when I entered. And
that’s pretty exceptional. Patrick, motivational speeches and condence boosts
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between us have been going pretty unidirectional in the last 4 years, as they usu-
ally do in a professor-student relationship, but for once I would like to reverse
the ow to express my sincere and utmost gratitude for all the opportunities
you have created for me, and for every one else in the lab.anks!
But while Patrick has outstanding people management qualities, it is only
fair to mention that his job is and always has been greatly facilitated by the
amazing people that make up our lab. A journey is best measured in friends,
rather than miles, and this PhD has been a very fruitful journey. ere were
the two brothers of the 1st oor: Jan, with whom I spent many highly appre-
ciated therapeutic running sessions, and Seba, master of eloquence and timing
who deserves a special thank you for spending one week of his life on design-
ing the template that was used for this dissertation. Koen was my partner in
fun for craing last-minute PhD-defense presents, and Peter introduced me to
his friends’ biking competition. I also had a lot of (usually conference and/or
football-related) aer-work fun with Matthieu,omas, Sander and Joris. And
then there is the inevitable Italian connection, (not accidentally) mentioned a
little later: Michele (with whom I never had any conversation that didn’t in-
volve at least 2 jokes), Gianluca (who taught me the Italian way of life while
slowly adapting to the Belgian one himself), and Francesco (cazzo!). Finally I
really appreciated the many interesting oce and lunch discussions with Abi-
gail, Charlotte, Tom, Benjamin, Francisco, Nic, Benedict, Tomas, Soe, Fred-
eric, Dieter, Liesbeth, David, Luis, Daniel, Ayfer, Saskia and Jurgen.
Apart from these great colleagues, one of the things I valuedmost about my
research was the combination of so many dierent backgrounds: I’ve worked
with and learned from specialists in engineering, medicine, imaging and even
veterinary sciences. My co-promotor Bart Loeys always provided feedback on
conceptual ideas and advice for their practical implementations. A lot of credit
and a sincere thank you go to Marjolijn Renard, who introduced me to the
wonderful world of genetics and was oen there to lend a helping hand, even
in weekends or aer regular working hours. Christophe Casteleyn played an
important role by teaching me the ins and outs of vascular casting, and Bert
Vandeghinste is not to be forgotten either, as his master thesis was an impor-
tant step in the development of the PhD. A special thanks goes out to Godelieve
Devroe and Joeri Vermeiren, who took care of my mice while I was working,
and to Philippe Joye and especially Scharon Bruneel from the Innity imag-
ing lab, whose assistance during the numerous in vivo micro-CT scans was
indispensable. I know I’ve caused you guys some hard times, asking you to
inject some very expensive stu into an invisible tail vein under a lot of time
pressure, but it was truly appreciated! Finally I would like to acknowledge ev-
ery one I’ve worked with (on many dierent projects) for sharing their time
and ideas: Steven Deleye, Steven Staelens, Stefaan Vandenberghe, Filip Devos,
Philippe Reymond, Nikos Stergiopulos, DanDevos, Denis van Loo, Christophe
Vansteenkiste, Filip Claes, An Berges, Julie De Backer, Laurence Campens, Yike
Kang, Christian Van Hove, Benedicte Descamps, Guido De Meyer and Carole
Van der Donckt.
e opportunity to work with such enthusiastic, motivated people and the
feeling of doing something useful for society have always been the most im-
portant reasons why I’ve never felt reluctant to go to work. But the real nice
part of doing a PhD is the traveling that comes along with it. Like missionaries,
we are sent around the world to convey our message to those who are willing
to listen (usually always the same people though, when you come to think of
it). I have some vivid memories of great (post-)conference times spent in Nor-
way (although I still regret not winning that sleighing competition), California
(spotting bears and scaring Japanese tourists in Yosemite park) and the amaz-
ing NYC: city of hope, freedom and opportunities (and Rudy’s bar). And I am
very grateful to Lord Patrick for sending me out to go win new souls in places
like Lake Tahoe, Singapore, Sao Paulo, Rio, Munich, Paris, Trondheim, Copen-
hagen, London, Rotterdam, Cambridge and Verona. But there is nothing to
traveling without a home to return to. I would like to thank all my friends, who
were always there when I was in for a beer, and in particular my house mates
Lien, Tine and Tim, who had to put up with me while I was writing this disser-
tation.
e reason why I liked the conference part so much is probably related to
the traveling spirit I was raised with. And that really is the key: education. We
all live our lives on a day to day basis, worrying about small, negligible prob-
lems while usually taking the real important things in life for granted. It is only
at occasions like these you reect about what really matters, and who you owe
it to. I started o by thanking Patrick for all the opportunities he’s given me
in the last 4 years, and I’d like to nish by thanking my family for all the op-
portunities they’ve given me in the last 27. Unlike your job or friends, family is
not something you can choose freely, but I couldn’t imagine any better family
to have been born into. anks Jan en Elien, for always being there and never
taking me too seriously, and Liezelot, for always being there and still taking me
seriously (from time to time). Mom, dad, thanks for your patience, for your
everlasting time and love, for letting me go when I needed to and simply for
making me into who I am. En opa, als ik ergens spijt van heb dan is het wel dat
je dit nooit meer zal kunnen lezen, maar toch: bedankt voor alles!
Bram Trachet
Ghent, February 2012
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Inleiding
Een aorta-aneurysma is een cardiovasculaire pathologie die het best omschreven
kanworden als een plaatselijke verbreding of verwijding vande aorta, het bloed-
vat dat zuurstofrijk bloed van het hart naar de organen transporteert. Deze
dilatatie wordt veroorzaakt door een degradatieproces in de aortawand, groeit
langzaam (vaak over een tijdspanne van enkele tientallen jaren) en veroorza-
akt meestal weinig of geen symptomen bij de patiënt. Als het aneurysma te
groot wordt neemt het risico toe dat de gedegradeerde aortawand de interne
bloeddruk niet langer kan weerstaan, wat tot een breuk kan leiden. Zo’n breuk
veroorzaakt inwendige bloedingen die (indien ze niet meteen geopereerd wor-
den) tot een snelle dood kunnen leiden. Aorta-aneurysma komt steeds meer
voor in onze vergrijzende bevolking, en is goed voor 1-2 % van alle sterfgevallen
in de geïndustrialiseerde landen. Terwijl de verschillende processen die ervoor
zorgen dat de aortawand degradeert vrij goed gekend zijn, is er nog steeds een
gebrek aan kennis over de eerste stadia van de ziekte. In dit opzicht is het in-
teressant op te merken dat aorta-aneurysma veel vaker voorkomt in de abdo-
minale aorta (ter hoogte van de nieren) of de ascenderende aorta (net na het
hart) dan in andere delen van de aorta, ondanks het feit dat alle bekende risico-
factoren (bijvoorbeeld roken, mannelijk geslacht, verhoogde bloeddruk) niet
inwerken op één specieke locatie. Een van de bestaande hypotheses om dit
fenomeen te verklaren, is dat de lokale bloedstroming verstoord is op deze spec-
ieke locaties. Het onderzoek dat werd uitgevoerd in het kader van dit proef-
schri hee tot doel een antwoord te vinden op de volgende onderzoeksvraag:
Waarom treden aorta-aneurysma’s selectief op op een aantal zeer specieke
aorta-locaties, en wat is de rol van de lokale hemodynamica hierin?
Het is belangrijk om in gedachten te houden dat de specieke, lokaal ver-
stoorde hemodynamica waarin wij geinteresseerd zijn niet simpelweg kan op-
gemeten worden in vivo of op post-mortem weefsel. Computersimulaties met
behulp van specieke soware (Computational Fluid Dynamics of CFD) zijn
noodzakelijk, en opdat deze simulaties betrouwbaar zouden zijn worden ze bij
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voorkeur doorgerekend op basis van patiënt-speciekemetingen. Zulkemetin-
gen omvatten zowel de geometrie van de aorta (nodig om een 3D-model van de
aorta op te stellen) en bloedsnelheden en/of -drukken (nodig om zogenaamde
randvoorwaarden op te leggen aan de in-en uitlaten van het model). Om de
rol van hemodynamica in aneurysmavorming te bestuderen, zou men idealiter
patiënt-specieke CFD simulaties moeten uitvoeren voordat er een aneurysma
aanwezig is, wachten tot zich een aneurysma ontwikkelt, en vervolgens de lo-
catie van het aneurysma relateren aan de regio’s waarin verstoorde stroming
optreedt in de eerste (baseline) simulatie. Dit is echter quasi onmogelijk voor
humane toepassingen omdat men bijna nooit data ter beschikking hee van de
stadia die aneurysmavorming voorafgaan (aangezien patiënten meestal slechts
een dokter zien als het al te laat is) en het aneurysma een zeer langzame groei
kent. Door met muismodellen voor aneurysmavorming te werken kan men
deze beperking omzeilen: verschillende technieken laten toe om aneurysma’s te
induceren in deze dieren, waardoor men toegang houdt tot de basisgegevens.
Bovendien kan de progressie van de ziekte beter opgevolgd worden aangezien
de periode van inductie tot volledig ontwikkeld aneurysma slechts 30 dagen
beslaat (afhankelijk van het gebruikte diermodel). Er zijn echter een aantal
belangrijke beperkingen bij het doorrekenen van CFD-simulaties in muizen.
Door hun kleine formaat en verhoogde hartslag, moeten de aorta geometrie en
bloedsnelheden opgemeten worden met een veel hogere temporele en ruim-
telijke resolutie dan het geval is voor de mens. Specieke beeldvormingstech-
nieken voor kleine proefdieren zijn dan ook vereist als input voor dergelijke
simulaties.
Dit proefschri bestaat uit vier verschillende onderdelen. Het eerste deel
bevat geen nieuw onderzoek, maar hee tot doel achtergrondinformatie te ver-
schaen over de basisconcepten die worden gebruikt in de latere delen. Het
eerste hoofdstuk gaat dieper in op de cardiovasculaire anatomie vanmensen en
muizen, en bespreekt de voor het ogenblik bekende aspecten van aneurysma-
vorming, zowel bij muizen als bij mensen. Het tweede hoofdstuk gee meer
informatie over de theoretische en praktische overwegingen waarmee rekening
moet worden gehouden bij het uitvoeren van CFD-simulaties in het arteriële
systeem van de muis. In het derde inleidende hoofdstuk worden de theoretis-
che achtergrond, de praktische toepassing en de meest voorkomende valkuilen
van zowelmicro-CT als hoogfrequent ultrageluid besproken. Dit zijn specieke
beeldvormingstechnieken voor kleine proefdieren die werden gebruikt in (het
derde deel van) dit proefschri om muis-specieke geometrieën en bloedsnel-
heden op te meten.
Het tweede deel van dit proefschri bundelt drie studies die werden uit-
gevoerd tijdens de eerste jaren van het onderzoek. Deze initiële fase van CFD
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onderzoek in kleine proefdieren werd gehinderd door een gebrek aan adequate
in vivo beeldvormingstechnieken. Aangezien veel van de hypothesen die wor-
den vooropgesteld in de volgende hoofdstukken afhangen van een goede over-
eenkomst tussen de aorta van de muis en die van de mens, begint hoofdstuk 4
met een puur anatomische studie van de geometrie van de aortaboog, die wordt
vergeleken in muizen en mensen. Deze geometrieën waren gebaseerd op vas-
culaire casts, een techniek waarbij een plastic replica van de aortavasculatuur
wordt gemaakt en ingescand met behulp van in vitro micro-CT. In hoofdstuk
5 worden deze casts gecombineerd met randvoorwaarden uit de literatuur om
CFD-simulaties op te zetten in de muizenaorta, waarbij de invloed van de aor-
tadimensies op de hemodynamica onderzocht werd. De invoering van speciale
micro-CT contraststoen voor muizen liet vervolgens voor het eerst toe om
een 3D model van de cardiovasculaire geometrie in vivo te verkrijgen, zonder
het dier te moeten opoeren. In hoofdstuk 6 worden de geometrische eigen-
schappen endeCFD resultaten verkregenmet behulp vandeze nieuwemethode
vergeleken met die op basis van de eerder gebruikte geometrieën (op basis van
casts).
Het derde deel van dit proefschri bundelt drie studies die werden uitge-
voerd in de laatste jaren van het onderzoek. Tegen die tijd was speciale ap-
paratuur aangeworven binnen de UGent die toeliet om zowel muis-specieke
geometrieën (met behulp van contrastversterkt micro-CT) als bloedsnelheden
(met behulp van hoogfrequent ultrageluid) op te meten in vivo. In hoofdstuk
7 wordt een nieuwe methodiek voorgesteld om deze in vivo-metingen te com-
bineren, met als doel om volledig muis-specieke CFD simulaties te verkrijgen
in de abdominale aorta. Binnen hetzelfde hoofdstuk wordt deze methodiek
toegepast om de hemodynamica in de abdominale aorta bij aanvang van het
onderzoek te relateren aan de locatie van abdominale aneurysma’s. In hoofd-
stuk 8 wordt de ontwikkelde methodiek uitgebreid tot de volledige aorta, en
wordt een dataset gepresenteerd van diameters en debietsverdelingen langs de
gehele aorta van de muis. Vervolgens werd ook in deze dieren een aneurysma
geïnduceerd, en de relatie tussen hemodynamica en aneurysmavorming (zowel
in de ascenderende en de abdominale aorta) wordt besproken in hoofdstuk 9.
In het laatste deel van dit proefschri worden de belangrijkste conclusies
samengevat, de belangrijkste beperkingen besproken en een aantal perspec-
tieven voor toekomstige studies geïntroduceerd.
Deel I: Achtergrond
Hoofdstuk 1. Van muizen en mensen: anatomie en (patho-)fysiologie
Dit hoofdstuk bevat algemene achtergrondinformatie over de anatomie en pa-
thofysiologie van het cardiovasculaire systeem bijmens enmuis. Eerst wordt de
xv
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algemene werking van het humaan (systemisch) arterieel systeem beschreven,
want het is belangrijk om de natuurlijke, fysiologische toestand te begrijpen
alvorens de pathologische toestand te onderzoeken. Daarna wordt de lezer
voorzien van de nodige klinische achtergrond met betrekking tot aneurysma’s.
Een aneurysma kan het best worden omschreven als een lokale verwijding van
de aorta, die vaak leidt tot een plotse dood als ze scheurt. Binnen dit proefschri
richten we ons op twee van de meest voorkomende aneurysmatypes: ascen-
derende en abdominale aorta-aneurysma’s. De belangrijkste factoren waarvan
bekend is dat ze een rol spelen bij het pathofysiologische proces van aneurys-
mavorming worden besproken, evenals het verschil in pathofysiologie tussen
ascenderende en abdominale aneurysma’s. De belangrijkste hypotheses in de li-
teratuurmet betrekking tot de initiële factor(en) die de specieke aanleg van de
aandoening voor deze vasculaire locaties zou kunnen veroorzaken worden be-
sproken, en de potentiële rol van verstoorde hemodynamica hierin wordt geïn-
troduceerd. Zoals eerder aangegeven werd is het zeer moeilijk om de hemody-
namica te bestuderen bij aneurysma’s in mensen. De ziekte kent immers een
zeer traag tijdsverloop bij de mens, en men hee bijna nooit data ter beschik-
king van de stadia die aan aneurysmavorming voorafgaan.
Dit is waar kleine proefdieren van pas komen: aangezien een aneurysma
kan worden geïnduceerd in muizen, vormen ze het perfecte model om gege-
vens te verstrekken over de eerste stadia in aneurysmavorming. Eerst wordt het
gebruik van muizen in onderzoek in het algemeen besproken. Muizen hebben
een korte levensduur die het mogelijk maakt ze in te zetten voor longitudinaal
onderzoek en, nog belangrijker, het genoomvan demuis is volledig beschreven.
Dit laatste laat toe om genetische modicaties te induceren, wat er voor zorgt
dat een brede waaier aan verschillende pathologieën kan onderzocht worden
in deze kleine proefdieren. Bovendien zijn muizen in veel aspecten (waaron-
der het cardiovasculair stelsel) anatomisch zeer gelijkaardig aan hun mense-
lijke tegenhanger. Toch bestaan een aantal belangrijke verschillen , waarvan de
verhoogde hartslag (x10) en kleinere afmeting (/ 10) de belangrijkste zijn. Een
literatuuroverzicht bespreekt alle bestaandemuismodellen voor aneurysmavor-
ming (bekend op het moment van schrijven). Een aneurysma werd reeds geïn-
duceerd in muizen via genetische modicaties, door lokale chemische induc-
tiemethoden en door continue infusie van het peptide hormoon angiotensine
II. De focus van het literatuuroverzicht ligt op dit laatste muismodel, aangezien
dit ook het model is dat werd gebruikt om aneurysmavorming te bestuderen in
de hoofdstukken 7 en 9.
Hoofdstuk 2. Simulatie van de hemodynamica
Dit hoofdstuk gee wat meer achtergrondinformatie over de numerieke me-
thoden die werden gebruikt om de arteriële hemodynamica te simuleren. Eerst
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worden de vergelijkingen van een typisch stromingsprobleem gereduceerd tot
een vereenvoudigde formulering die toelaat de bloedstroom in een slagader te
beschrijven. Voor de meeste toepassingen is het echter vrijwel onmogelijk om
een volledig analytische oplossing voor deze vergelijkingen te bekomen. Com-
putational Fluid Dynamics of CFD zorgt voor een elegante manier om deze be-
perking te omzeilen: een benaderende oplossing wordt verkregen door een dis-
cretisatie van het probleem, die toelaat de vergelijkingen numeriek op te lossen
met behulp van een computer. Binnen dit proefschri werd de eindige volume
methode gebruikt in combinatiemet een gesegregeerde, drukgebaseerde solver,
die geïmplementeerd is in het commerciële soware-pakket Fluent (Ansys).
Enige achtergrondinformatie in verband met de theoretische mechanismen en
veronderstellingen achter deze methode wordt voorzien. Bovendien worden
een aantal praktische overwegingen besproken, die moeten uitgevoerd worden
met grote nauwkeurigheid om betrouwbare resultaten te bekomen bij het uit-
voeren van een CFD-simulatie van de bloedstroming in het arteriële systeem.
Bij de interpretatie van de uitkomst van CFD-simulaties in relatie tot pa-
thologie van het cardiovasculair systeem, zijn drukken noch bloedsnelheden
de parameters die het meest onderzocht worden. Wandschuifspanning (WSS),
de viskeuze spanning die het bloed uitoefent op de endotheelcellen die de bin-
nenste laag van de aortawand vormen, wordt verondersteld om een belang-
rijke signaalfunctie te hebben in de initiële stadia van cardiovasculaire ziektes
zoals atherosclerose of aneurysma’s. AangezienWSS een tijdsafhankelijke vari-
abele is die varieert in de loop een hartcyclus, worden een aantal wandschuifs-
panningsgerelateerde variabelen geïntroduceerd die binnen dit proefschri ge-
bruikt werden om de rol van deze wandschuifspanning in aneurysmavorming
te bestuderen: TAWSS (time-averaged wall shear stress: laat toe zones van hoge
en lage wandschuifspanning te identiceren), OSI (oscillatory shear index: laat
toe zones te identicerenwaar dewandschuifspanning oscilleert, dat wil zeggen
van richting verandert binnen de hartcyclus) en RRT (relative residence time:
combineert de eecten van lage en oscillerende wandschuifspanning).
Het hoofdstuk eindigt met een literatuuroverzicht van CFD studies bij muis
en mens. Humane CFD studies aangaande aorta-aneurysma zijn in bijna alle
gevallen beperkt tot het bestuderen van de doorstroming in een ontwikkeld
aneurysma, door het gebrek aan gegevens in de eerste stadia van de aandoe-
ning. Aangezien we van plan zijn deze beperking te omzeilen door aneurysma’s
te induceren in muizen, wordt ook een overzicht van bestaande CFD studies
in de aorta van de muis besproken. In de beschikbare literatuur bestaan geen
CFD-gebaseerde studies aangaande aorta-aneurysma bij de muis: bijna alle
CFD studies in muizenaorta’s zijn beperkt tot een beschrijving van de hemo-
dynamica an sich. Het literatuuroverzicht focust op het belangrijkste probleem
xvii
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in alle bestaande CFD studies bij kleine proefdieren: het verkrijgen van een re-
alistische arteriële geometrie en realistische randvoorwaarden, bij voorkeur op
basis van in vivo gegevens.
Hoofdstuk 3. Beeldvormingstechnieken voor kleine proefdieren
Het ontbreken van adequate beeldvormingstechnieken voor kleine proefdieren
is al lange tijd het knelpunt voor CFD-simulaties. Dat is ook de reden waarom
dit laatste inleidende hoofdstuk enige achtergrondinformatie verscha over de
twee beeldvormingstechnieken die werden gebruikt om muis-specieke CFD-
simulaties op te zetten binnen (het derde deel van) dit proefschri: micro-CT
en (hoogfrequent) ultrageluid.
Het eerste deel bevat achtergrondinformatie over het algemeen principe
van Computed Tomography (CT), een medische beeldvormingstechniek die
gebaseerd is op de hoeveelheid attenuatie die X-stralen ondervinden wanneer
ze van een bron uitgestuurd worden door het te scannen object naar een de-
tector die aan de andere kant is gepositioneerd. Voor micro-CT zijn enkele
specieke bijkomende vereisten nodig vanwege de geringe omvang van het te
scannen object (i.c. muizen), wat de vereiste resolutie drastisch verhoogt. De
beste resolutie wordt in theorie bereikt in een opstellingwaarin het object draait
en de bron en de detector stil blijven staan (zoals gebruikt werd in de hoofd-
stukken 4 en 5). Voor het in vivo scannen vanmuizen betekent dit echter een te
hoge belasting van de dieren. Voor in-vivo-systemen wordt het dier gewoonlijk
onbeweeglijk gepositioneerd (onder anesthesie), terwijl de bron en de detector
errond draaien. Dit is ook het geval voor de FLEX GE Triumph scanner die
werd gebruikt in hoofdstukken 6, 7, 8 en 9. Enkele veel voorkomende valkuilen
voor micro-CT beeldvorming worden besproken, met speciale nadruk op deze
die van belang zijn voor in vivo beeldvorming van kleine proefdieren, zoals
(o.a.) straling, resolutie, beweging door hart-en ademhaling en, belangrijker
nog, de noodzaak van contrastmiddelen om de aorta te kunnen onderscheiden
van omliggende weefsels.
Het tweede deel van dit hoofdstuk bevat meer achtergrondinformatie over
het algemene principe van ultrageluid, een medische beeldvormingstechniek
die gebaseerd is op de transmissie en reectie van ultrasone akoestische golven
(dat wil zeggen drukgolven met een frequentie boven het hoorbare bereik) via
een medium. Er bestaan veel verschillende ultrageluidsmodaliteiten, maar de-
gene die het meest frequent gebruikt wordt in dit proefschri is Pulsed Doppler.
Het theoretische principe achter deze methode, die toelaat om tijdsafhanke-
lijke snelheden te meten in bloedvaten, wordt uitgelegd. Voor ultrageluid bij
kleine proefdieren is een speciaal systeem nodig, omdat de kleine omvang en
verhoogde hartslag van muizen een veel hogere frequentie van de uitgezonden
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golven vereisen. Binnen dit proefschri werd een Vevo 2100 hoogfrequente ul-
trageluidsscanner gebruikt (VisualSonics). De praktische opstelling van deze
scanner wordt uitgelegd: het dier wordt op een behandelingstafel gepositio-
neerd die draait rond een kogelscharnier, terwijl de transducer gexeerd is. Dit
in tegenstelling tot de klinische echo waarbij de transducer verplaatst wordt
door de operator omeen beeld te bekomen. Enkele veel voorkomende valkuilen
bij ultrageluid worden vervolgens besproken, met de nadruk op degene die van
belang zijn voor ultrageluidsbeeldvorming bij kleine proefdieren in het alge-
meen (zoals (o.a.) anesthesie, lichaamstemperatuur, beeldresolutie) en speciek
voor Pulsed Doppler (zoals hoekcorrectie, aliasing en spectrale verbreding).
Deel II. De muis als model voor de mens: de weg naar muis-specifieke
hemodynamica
De eerste fase van CFD onderzoek in kleine proefdieren werd belemmerd door
een gebrek aan beeldvormingstechnieken om de cardiovasculaire eigenschap-
pen van muizen op te meten in vivo. De specieke beeldvormingstechnieken
voor kleine proefdieren die geïntroduceerd werden in hoofdstuk 3 waren nog
niet (volledig) beschikbaar bij aanvang van het onderzoek. Contrastmiddelen
omdemuizenaorta in vivo te onderscheiden bestonden nog niet, en de arteriële
geometrie was meestal gebaseerd op een vasculaire cast, een plastic replica van
de arteriële vasculatuur die werd gescand in vitro. Literatuurgegevens over op
te leggen randvoorwaarden waren schaars, en muis-specieke cardiovasculaire
CFD-simulaties waren een verre droom. Het tweede deel van dit proefschri
bevat drie verschillende studies diewerdenuitgevoerd binnendeze context. Het
doel van deze studies was om onze bestaande kennis van het arterieel systeem
bij muizen te verhogen.
Hoofdstuk 4. Anatomie van de aortaboog van de muis: validatie van de
muis als model om humane vasculaire ziekten te bestuderen.
Ondanks het feit dat de muis vaak wordt gebruikt als model voor humane (car-
diovasculaire) ziektes, zijn anatomische studies van hun vasculatuur zeldzaam.
Dit hoofdstuk bevat een gedetailleerde vergelijking van de anatomische gege-
vens van 30 muizen (op basis van vasculaire casts gescand met micro-CT) met
twee menselijke datasets van zes jongere en zes oudere mannen (op basis van
een thoracale klinische CT-scan genomen om andere dan cardiovasculaire re-
denen). Aorta diameters (op 6 locaties) en de afstanden tussen de oorsprong
van de verschillende takken worden gerapporteerd voor alle gevallen. We von-
den dat de ventriculaire as van het hart in muizen naar de linker ventrale zijde
van de thorax wijst met een hoek van 39 ○. Deze hoek is iets kleiner bij jongere
mannen en bijna afwezig bij oudere mannen. De overgang tussen de aortaboog
en de ascenderende aorta is meer vloeiend bij muizen aangezien de boog meer
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dwars geplaatst is in de thorax. Verder is er een niet-planaire positie van de
ascenderende en descenderende aorta aanwezig in beide soorten, zij het meer
uitgesproken bij muizen (31 ○) dan bij jongere (13 ○) en oudere mensen (11 ○).
Tenslotte is de muis een van de weinige zoogdieren waarbij het vertakkingspa-
troon in de aortaboog vergelijkbaar is met de mens, met drie slagaders (de bra-
chiocephalicus, de linker halsslagader en de linker subclavia) die aakken on-
der vergelijkbare hoeken als bij de mens. Over het algemeen kunnen we con-
cluderen dat, vanuit een anatomisch oogpunt, de muis een goed model is voor
de mens dat kan dienen als solide basis voor de latere studie van cardiovascu-
laire ziektes.
Hoofdstuk 5. Hemodynamica in de aortaboog van de muis: de invloed van
aortadimensies.
In deze eerste studie naar de hemodynamica bijmuizenwerdenCFD-simulaties
uitgevoerd in de aortaboog, inclusief de drie belangrijkste zijtakken. De geo-
metrie was gebaseerd op een vasculaire cast die werd gescand met behulp van
in vitro micro-CT, terwijl de randvoorwaarden waren gebaseerd op gegevens
afkomstig uit de literatuur. Om de invloed van het lichaamsgewicht van de
muis op de arteriële wandschuifspanning (WSS) te onderzoeken, werd de ini-
tiële geometrie geschaald naar vijf verschillende dimensies die overeenkomen
met laat foetale, neonatale, jonge, jonge volwassen en oude volwassen dieren.
Voor elke geometrie werden CFD-simulaties uitgevoerd in combinatie met een
dimensionale analyse waarin de theoretische, geïdealiseerde WSS waarde werd
gerapporteerd (gebaseerd op de wet van Poiseuille voor volledig ontwikkelde
stroming). De dimensionele analyse toonde aan dat de theoretische WSS af-
neemt bij toenemende grootte van de dieren. Dit werd bevestigd in de CFD-
simulaties waarin de distributie van deWSS over de aortawand berekend werd.
Na vergelijking van de verschillende tijdstippen werd gevonden dat de WSS
snel afneemt in de vroege levensfasen en een plateau-waarde bereikt op vol-
wassen leeijd. Deze gegevens ondersteunen eerdere hypotheses dat WSS een
regulerende rol speelt in de arteriële groei. OSI is anderzijds nagenoeg con-
stant over de verschillende leeijdscategorieën. De gerapporteerde WSS waar-
den waren in het algemeen veel hoger dan de menselijke waarden, wat ook al
eerder werd aangetoond. Deze studie toont duidelijk een inverse relatie tussen
de dimensie van de aorta en het WSS niveau, wat van belang is wanneer gege-
vens van verschillende soorten maar ook van verschillende leeijden binnen
dezelfde soort vergeleken worden. Het is dan ook noodzakelijk om bij het be-
studeren van de arteriële hemodynamica in muizen ten allen tijde rekening te
houden met de leeijd en het type van muizen die werden gebruikt voor het
onderzoek.
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Hoofdstuk 6. Vervangen van vasculaire casts door in vivo,
contrastversterkte micro-CT
In dit hoofdstuk werd een reconstructiemethode gebruik makend van de een
vande eerste contrastmiddelen voormicro-CT inmuizen, FenestraVC-131, ver-
geleken met wat tot dan toe de standaardmethode was om de aorta geometrie
van de muis te bekomen: vasculaire casting. Negen muizen kregen eerst een in
vivo micro-CT scan na injectie van 0.015 ml/g Fenestra VC-131. Sommige die-
ren reageerden niet goed op het (relatief grote geïnjecteerd volume aan) con-
trastmiddel, en moesten om ethische redenen worden gedood kort na de scan.
Een vasculaire cast werd gecreëerd voor alle dieren, die vervolgens werd ges-
cand in vitro. Beelden van vier hoogwaardige casts (zonder luchtbellen) wer-
den behouden en alle datasets werden gesegmenteerd om ze om te zetten in
3D geometrische modellen van de aortaboog. Aortadiameters waren signi-
cant hoger voor de in vivo modellen, met verschillen tot 35 %. Deze verschillen
werden toegeschreven aan een gecombineerd eect van onderschatting van de
cast diameters (omdat van het gebruikte polymeer geweten is dat het krimpt
na de injectie) en overschatting van de in vivo diameters (aangezien een grote
hoeveelheid contrastmiddel werd geïnjecteerd om voldoende contrast te ver-
krijgen). Bifurcatiehoeken waren relatief vergelijkbaar voor beide methoden,
met verschillen kleiner dan 20 % voor alle gevallen.
Ondanks de grote verschillen in numerieke waarden werd een goede cor-
relatie gevonden tussen beide methoden, zowel voor de diameters (R2=0.84)
als voor de bifurcatiehoeken (R2=0.94). Verder werden CFD-simulaties uitge-
voerd in beide datasets. Murray’s wet, die uitgaat van de veronderstelling dat
het debiet in alle takken evenredig is met de derde macht van de diameter van
die tak, werd gebruikt om een schatting te bekomen van de debietsverdeling die
werd opgelegd als randvoorwaarde aan de verschillende uitlaten. De berekende
TAWSS waarden waren lager voor in vivo modellen, als gevolg van het verschil
in aortadimensie tussen beide methoden. De distributie van TAWSS over de
aortawand bleek echter zeer vergelijkbaar in beide gevallen. In het algemeen
werd dus een relatief goede kwalitatieve overeenkomst bereikt tussen de mo-
dellen op basis van in vivomicro-CT enmodellen op basis van de voorheen ge-
bruikte casts. Aangezien het gebruikte contrastmiddel (Fenestra VC-131) echter
niet goed verdragen werd door de dieren en tot een overschatting van de aorta
diameter leidde, werd geconcludeerd dat naar de toekomst toe andere contrast-
middelen (bij voorkeur met een lager geïnjecteerd volume) nodig waren om de
betrouwbaarheid te verhogen.
Deel III. Muis-specifieke hemodynamica en aneurysmavorming
Twee belangrijke gebeurtenissen markeren de overgang tussen de tweede en
derde deel van dit proefschri. De eerste gebeurtenis was de verdere ontwikke-
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ling van contrastmiddelen voor in vivo micro-CT bij muizen. Fenestra VC-131
(het contrastmiddel onderzocht in hoofdstuk 6) werd vervangen door Aurovist,
een alternatief op basis van gouden nanopartikels dat veel lagere ingespoten vo-
lumes vereist en beter wordt verdragen door de dieren. De tweede belangrijke
gebeurtenis was de aankoop van een nieuw, hoogfrequent ultrageluidstoestel
voor beeldvorming bij kleine proefdieren (Vevo 2100, VisualSonics). Het derde
deel van dit proefschri omvat drie verschillende studies waarin (contrastver-
sterkt) micro-CT en hoogfrequente ultrageluidsbeelden werden gecombineerd
om geheelmuis specieke CFD-simulaties op te zetten, met als uiteindelijk doel
om een aantal antwoorden te formuleren wat betre de relatie tussen hemody-
namica en aneurysmavorming bij muizen.
Hoofdstuk 7. Een nieuwe methodiek ommuis-specieke hemodynamica te
relateren aan abdominale aneurysmavorming in angiotensine II -
geïnfuseerde ApoE −/− muizen
In dit hoofdstuk wordt een methodologisch kader gepresenteerd dat toelaat
om muis-specieke hemodynamica op te volgen in longitudinale studies. Na
injectie van het nieuwe contrastmiddel Aurovist (waarbij slechts 0.006 ml/g
vereist is), wordt eerst een in vivo micro-CT-scan uitgevoerd om een 3D geo-
metrisch model van de aorta te verkrijgen. Vervolgens worden hoogfrequente
Pulsed Doppler ultrageluidsmetingen uitgevoerd om muis-specieke tijdsaf-
hankelijke bloedsnelheden te bekomen. Deze laatste worden dan gecombineerd
met diameters van het (gesegmenteerde) 3D-model om debieten te verkrijgen,
aangezien de opgemeten snelhedenniet noodzakelijk compatibel zijnmet elkaar
en daarom niet rechtstreeks kunnen worden opgelegd als randvoorwaarden
in een CFD-simulatie. De fout in de debietsbalans (dat wil zeggen het ver-
schil tussen het inlaatdebiet en de som van de alle uitlaatdebieten) wordt dan
herverdeeld over alle locaties, om ervoor te zorgen dat ten allen tijde aan het
behoud van massa voldaan is. De aldus verkregen tijdsafhankelijke debiets-
golfvormen worden dan opgelegd als randvoorwaarden aan de in-en uitlaten
van het 3D-model onder de vorm van parabolische snelheidsproelen. Deze
methode maakt het mogelijk om volledig muis-specieke CFD simulaties op te
zetten, uitsluitend gebaseerd op in vivo gegevens.
Deze methodiek werd vervolgens toegepast in een longitudinale studie bij
10 angiotensine II-geïnfuseerde, mannelijke ApoE −/− muizen. Eerst werd een
CFD-simulatie doorgerekend om de hemodynamische toestand in de abdo-
minale aorta van deze dieren in te schatten bij aanvang van de studie (base-
line). Vervolgens werd een osmotische pomp - die over een periode van 28 da-
gen doorlopend angiotensine II vrijgaf - geïmplanteerd om abdominale aneu-
rysma’s te induceren. Acht dieren overleefden de volledige procedure, en wer-
den opnieuw gescand 31 dagen na de pomp implantatie (end stage). Vier die-
ren hadden op dat moment een AAA ontwikkeld. Omdat de micro-CT-scans
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genomen bij aanvang en op het einde van de studie nooit perfect met elkaar
overeen komen door de verschillende positie van het dier in de scanner, werd
een nieuwe methodologie ontwikkeld om een zogeheten afstandsverdeling te
berekenen. De locatie van het aneurysma werd aldus gekwanticeerd als de
afstand vanaf de baseline tot de end stage geometrie in elk knooppunt van de
baseline geometrie. De baseline hemodynamica (gekwanticeerd door TAWSS,
OSI en RRT waarden) werd vervolgens vergeleken met de locatie van het aneu-
rysma (gekwanticeerd door de berekende afstandsverdeling).
Zones waarin de bloedstroming verstoord was bij aanvang van de studie
(gekenmerkt door hoge RRT en OSI, lage WSS) kwamen niet overeen met de
zoneswaarAAAontstond. AAA leek eerder te ontstaan proximaal van de zones
die een verstoorde bloedstroming ervaren (meestal ter hoogte van de trifurcatie
waar de mesenterica en rechter nierslagader aakken). Tussentijdse gegevens
die zouden toelaten een eventueel causaal eect te onderzoeken waren echter
niet opgemeten. Hoewel deze eerste resultaten een duidelijke relatie tussen ver-
stoorde hemodynamica en abdominale aneurysmavorming lijken uit te sluiten,
kan de nieuwe methodologie die werd geïntroduceerd in dit hoofdstuk worden
gebruikt in toekomstige longitudinale studies naar de rol van hemodynamica
in muizen met een cardiovasculaire aandoening.
Hoofdstuk 8. De impact van vereenvoudigde randvoorwaarden en inclusie
van de aortaboog op CFD-simulaties in de muizenaorta: een vergelijking
met muis-specieke referentiegegevens
De studie beschreven in hoofdstuk 8 kan worden beschouwd als een uitge-
werkte studie over de basisgegevens van de longitudinale aneurysmastudie in
hoofdstuk 9. De methodiek ontwikkeld in hoofdstuk 7 werd eerst uitgebreid
tot de volledige aorta, waarbij zowel de aortaboog als de abdominale aorta in
het model werden opgenomen, met in totaal zeven zijtakken. Dit resulteerde
in een grote dataset (bestaande uit zowel de diameters en debietsverdelingen
op alle meetlocaties), die als referentie kan dienen voor toekomstige studies. In
de meeste CFD studies bij muizen in de literatuur - evenals in de eerste hoofd-
stukken van dit proefschri - worden aannames gemaakt over de toegepaste
geometrie en randvoorwaarden. Vaak is de geldigheid van deze aannames ech-
ter slecht of niet gevalideerd in muizen door het gebrek aan referentiegegevens.
Aangezien we na bovenstaande metingen zulke referentiegegevens ter be-
schikking hadden, konden we de invloed van deze aannames op de uitkomst
van onze CFD-simulaties nagaan. In eerste instantie werden de resultaten van
CFD simulaties op basis vanmuis-specieke, tijdsafhankelijke metingen verge-
leken met de resultaten van CFD-simulaties in dezelfde geometrie, waarbij in
elke tak de uitgemiddelde debietsverdeling over alle 10 muizen werd opgelegd.
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Op deze manier kan het eect van het opleggen van algemene, niet-specieke
randvoorwaarden uit de literatuur (zoals in hoofdstuk 5) nagegaan worden. De
resultaten werden kwantitatief geanalyseerd met behulp van box plots en een
statistische maat genaamd de Cohen afstand. Voor de gevallen met de beste
(laagste Cohen afstand) en slechtste (hoogste Cohen afstand) overeenkomst
tussen de verschillende methoden werd bovendien ook het kwalitatief verschil
getoond als de distributie van TAWSS, OSI en RRT over de aortawand. Het
gebruik van een uitgemiddelde debietsverdeling resulteerde in een zeer goede
overeenkomst in TAWSS en RRT terwijl OSI lager bleek te zijn, vooral in de dis-
tale aorta. Vervolgens werden muis-specieke CFD simulaties vergeleken met
simulaties waarin Murray’s wet werd gebruikt om de debietsverdeling te schat-
ten op basis van de derde macht van de diameterverhouding van twee takken
(zoals in hoofdstuk 6). In dit geval waren de verschillen meer uitgesproken,
met lokaal verhoogde TAWSS in de thoracale en distale abdominale aorta als
Murray’s wet wordt gebruikt. Deze verschillen variëren bovendien sterk tussen
de dieren, wat tot uiting kwam in hoge standaarddeviaties.
In een derde deel van de studie werden de oorspronkelijke CFD-simulaties
vergeleken met simulaties waarin het geometrische model was beperkt tot de
abdominale aorta (zoals in hoofdstuk 7). Deze aanname bleek de uitkomst
van (het abdominaal deel van) de simulatie niet te beïnvloeden: abdominale
TAWSS, OSI en RRT waren vergelijkbaar voor alle gevallen. We concluderen
dat sommige van de veronderstellingen die in de literatuur vaak toegepast wor-
den (zoals niet-specieke uitlaatrandvoorwaarden, vereenvoudigde aortageo-
metrieën) gerechtvaardigd lijken, terwijl andere (zoals Murray’s wet) de uit-
komst van de CFD simulaties sterk kunnen beïnvloeden.
Hoofdstuk 9. Locatie en evolutie van aneurysma’s: de rol van verstoorde
hemodynamica
In dit laatste hoofdstukwerd de ervaring diewas opgebouwd in de vorige hoofd-
stukken toegepast om de rol van hemodynamica in aneurysmavorming te be-
studeren. De opzet van de studie was dezelfde als in hoofdstuk 7: tien ApoE−/− muizen werden gescand bij aanvang van de studie als input voor muis-
specieke CFD-simulaties, en kregen daarna een osmotische pomp met an-
giotensine II ingeplant om aneurysma’s uit te lokken. Het meetprotocol werd
echter uitgebreid: de volledige aorta werd nu opgenomen in het model, tus-
sentijdse ultrageluid en micro-CT scans werden uitgevoerd 2, 7 en 14 dagen na
pompimplantatie en moleculaire beeldvorming (PET) werd uitgevoerd op de
laatste twee tijdstippen om een vroege indicatie voor inammatie te verkrijgen.
Van de zes dieren die de volledige procedure overleefden ontwikkelden er twee
geen enkel aneurysma. Eén dier ontwikkelde enkel een aneurysma in de as-
cenderende aorta, en drie dieren ontwikkelden zowel een ascenderend als een
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abdominaal aneurysma. Hoewel deze gegevens beperkt zijn, laten ze toch toe
om enerzijds de twee verschillende soorten aneurysma’s te vergelijken, en an-
derzijds aneurysmatische met niet-aneurysmatische dieren te vergelijken.
Beide aneurysmatypes bleken anders te evolueren: het abdominal aneu-
rysma verscheen plots tussen twee scans in, terwijl het ascenderende aneu-
rysma langzaam toenam in grootte. PET kon aneurysmavorming niet voor-
spellen op dag 7, maar bevestigde de aanwezigheid van een aneurysma wel op
dag 14, met een hoge speciciteit. We besluiten dat inammatie betrokken is in
het ontwikkelingsproces van aneurysma’s op beide locaties. Uit Pulsed Doppler
bloedsnelheidsmetingen bleek dat er vanaf dag 7 tijdens diastole terugstroming
plaats vindt doorheen de aortaklep in muizen met aneurysma’s in de ascen-
derende aorta. Omdat het ascenderende aneurysma langzaam evolueert er en
geen scans werden genomen tussen dag 7 en 14, konden we niet bepalen of
de waargenomen diastolische terugstroming in de ascenderende aorta oorzaak
dan wel gevolg is van de aortadilatatie.
Tenslotte werd de rol van hemodynamica in aneurysmavorming onder-
zocht. We vonden dat RRT in de abdominale aorta bij aanvang van de studie
niet verschilde van andere aortazones. Een focale toename van de RRT kon
worden waargenomen in de buurt van zijtakken, maar dit was niet meer uit-
gesproken dan in de buurt van zijtakken in bijvoorbeeld de aortaboog. Het
(lumen van het) abdominaal aneurysma was niet altijd zichtbaar op de micro-
CT-scans, en het aantal gelukte tussentijdse scans was beperkt. Bijgevolg kon-
den we niet verder onderzoeken of het AAA ontstaat ter hoogte van de regio’s
waar de bloedstroming lokaal verstoord is, zoals eerder werd gesuggereerd in
hoofdstuk 7. In de ascenderende aorta, de zone waar een aneurysma ontstond
in 4 van de 6 dieren, werd wel een sterk verhoogde RRT vastgesteld bij aanvang
van de studie. RRT was echter ook verhoogd bij dieren die geen aneurysma
ontwikkelen in de ascenderende aorta. Bovendien was de locatie binnen de as-
cenderende aorta die de hoogste RRT ervoer niet de locatie waar de aorta het
meest uitgezet was op het eind van de studie. Een relatie tussen hemodynamica
en aneurysma lijkt dus te bestaan, vooral in de ascenderende aorta, maar deze
relatie is zeker niet eenduidig.
Deel IV. Conclusies
Hoofdstuk 10. Conclusies en toekomstperspectieven
In dit nale hoofdstuk worden de belangrijkste boodschappen uit de verschil-
lende studies herhaald, en wordt een antwoord op de onderzoeksvraag gefor-
muleerd. We besluiten dat verder onderzoek nodig is om de rol van verstoorde
stromingspatronen in de initiële stadia van abdominale zowel als ascenderende
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aneurysma’s dieper uit te spitten en dat - zoals voor demeeste reizen het geval is
- de weg naar ons doel even leerrijk was als het bereiken van het doel zelf. Ver-
volgens worden de belangrijkste beperkingen van het werk besproken. Het is
onduidelijk in welke mate de resultaten met het gebruikte muismodel kunnen
geëxtrapoleerd worden naar mensen. Bovendien was het aantal bestudeerde
dieren te klein om statistisch signicante conclusies te kunnen trekken. De
vereenvoudigde randvoorwaarde en geometrie aande inlaat vanhetmodel kun-
nen de uitkomst van de CFD simulaties in de ascenderende aorta beïnvloed
hebben. In de abdominal aorta zit de voornaamste beperking in het hard op-
leggen van de golfvormen naar alle takken. Verder laten de starre wanden van
ons model niet toe de buercapaciteit van de aorta in rekening te brengen. In
de nabije toekomst plannen we de ontwikkelde methodiek toe te passen in ver-
schillende muismodellen voor aneurysmavorming en andere cardiovasculaire
aandoeningen. De huidige CFD aanpak zal worden uitgebreid naar FSI (uid-
structure interaction), wat zal toelaten om de wand - en de mechanica ervan -
op te nemen in hetmodel. Materiaaleigenschappen van de aortawand en bloed-
drukken zijn echter nodig om randvoorwaarden op te leggen in deze modellen.
Muis-specieke FSI simulaties wordenmomenteel gelimiteerd door een gebrek
aan beeldvormingstechnieken die toelaten omdeze eigenschappen in vivo op te
meten. De uitdagingen die voor ons liggen zijn dus op vele manieren vergelijk-
baar met degene die eerder aangepakt werden, al kan er met veel meer ervaring
aan begonnen worden.
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Summary
Introduction
Aortic aneurysm is a cardiovascular pathology that can best be described as a
local widening or dilatation of the aorta, the main blood vessel.is dilatation
is caused by a degradation process in the aortic wall, occurs slowly (oen over a
time span of several decades) and usually causes no symptoms in the patient. If
the aneurysm gets too large the risk for the degraded wall to no longer be able
to withstand the internal blood pressure increases, which can lead to rupture.
Such a rupture provokes internal bleeding that (if not operated upon immedi-
ately) will cause the patient to die soon aer. Aortic aneurysm is increasingly
prevalent in our aging population, accounting for 1-2% of all deaths in indus-
trialized countries. While the dierent processes that cause the aortic wall to
degrade are fairly well known, there is still a lack of knowledge on the initial
phases of the disease. Interestingly, aortic aneurysm is much more prevalent
in the abdominal aorta (distal to the kidneys) or the ascending aorta (just dis-
tal to the heart) than in other parts of the main vessel, despite the fact that all
known risk factors (e.g. smoking, male gender, elevated blood pressure) aect
the entire aorta. One of the hypotheses that have been proposed to explain this
predisposition for distinct aortic sites is that the onset of aortic aneurysm may
be related to locally disturbed hemodynamics in these aortic regions. e re-
search performed within this dissertation therefore aims to answer one specic
research question:
Why do aortic aneurysms have a predisposition to develop at some very dis-
tinct aortic locations, and what is the role of local hemodynamics herein?
It is important to keep in mind that the specic locally disturbed hemo-
dynamics in which we are interested cannot simply be measured in vivo or on
post-mortem tissue.ey need to be simulated using dedicated computational
techniques such as Computational Fluid Dynamics (CFD), and for these simu-
lations to be trustworthy, they are preferentially based on patient-specic mea-
surements. ese measurements include both the aortic geometry (to create
a 3D model of the aorta) and blood velocities and/or pressures (to prescribe
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so called boundary conditions at the in-and outlets of the model). In order
to study the role of hemodynamics in aneurysm formation, one would ideally
have to perform such image-based CFD simulations before any aneurysm is
present, wait until an aneurysm develops, and subsequently link the location
of the aneurysm to the regions of disturbed ow in the baseline simulation.
However, this is quasi impossible in humans since pre-diseased data are almost
never available (as patients only show up in the clinic when it’s too late) and it
takes decades for the aneurysm to develop. Mouse models for aneurysm for-
mation can be used to circumvent this limitation: as dierent techniques exist
to induce aneurysms in these animals, one keeps access to the baseline data.
Moreover disease progression can be followed up more closely as the period
from induction to fully developed aneurysm only takes 30 days (depending on
the used model). ere are, however, some important limitations when per-
forming CFD simulations in mice. Due to their small size and increased heart
rate, their aortic geometry and blood velocities should be obtained with amuch
higher temporal and spatial resolution than is the case for humans. Dedicated
small animal imaging technologies are therefore required as an input for such
simulations.
is dissertation consists of four dierent parts. e rst part contains no
new research, but aims to provide some background on the basic concepts that
are frequently used within the subsequent parts. e rst chapter elaborates
on human and murine cardiovascular anatomy, and discusses the currently
known aspects of aneurysm formation, both in mice and men. e second
chapter provides more information on the theoretical and practical considera-
tions that need to be taken into account when performing CFD simulations in
the (murine) arterial system. In the third introductory chapter the theoretical
background, practical setup and common pitfalls of both micro-CT and high-
frequency ultrasound are discussed.ese are dedicated small animal imaging
techniques that were used within (the third part of) this dissertation tomeasure
mouse-specic geometries and blood velocities, respectively.
e second part bundles three studies that were performed during the ini-
tial years of the PhD.is initial phase of small animal CFD was hampered by
a lack of in vivo imaging technologies. Since many of the hypotheses that are
proposed in the following chapters rely on a good agreement between murine
and human geometries, chapter 4 starts owith a purely anatomical study com-
paring the aortic arch geometry in mice and humans. ese geometries were
based on vascular casts, a technique where a plastic replica of the aortic vascu-
lature is created and scanned using in vitro micro-CT. In chapter 5 these casts
are combined with boundary conditions from literature to set up murine CFD
simulations, investigating the inuence of aortic size on aortic arch hemody-
namics. e subsequent introduction of dedicated micro-CT contrast agents
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for mice allowed to obtain a 3D model of the murine cardiovascular geometry
in vivo, without having to sacrice the animal. In chapter 6 geometrical prop-
erties and CFD results obtained using this new method are compared to those
based on the previously used, casted geometries.
e third part of this dissertation bundles three studies that were performed
in the nal years of the PhD. By this time, dedicated equipment had been ac-
quired at Ghent University to measure both mouse-specic geometries (using
contrast-enhancedmicro-CT) and blood velocities (using high frequency ultra-
sound) in vivo. In chapter 7 a novel methodology is proposed to combine these
in vivo measurements in order to obtain entirely mouse-specic CFD simu-
lations in the abdominal aorta. Within the same chapter, this methodology
is applied to investigate the relationship between abdominal aortic hemody-
namics (at baseline) and abdominal aortic aneurysm formation (at endstage) in
aneurysm-developing mice. In chapter 8 the methodology developed in chap-
ter 7 is extended to the complete aorta, and a reference dataset of diameters
and ow ratios along the complete murine aorta is presented. Subsequently,
aneurysm was induced in these animals as well, and the relationship between
hemodynamics and aneurysm formation (both in the ascending and the ab-
dominal aorta) is discussed in chapter 9.
In the last part of this dissertation the main conclusions are summarized,
the main limitations are discussed and some perspectives for future work are
introduced.
Part I: Background
Chapter 1. Of mice and men: anatomy and (patho)-physiology
is chapter provides some general background on the anatomy and patho-
physiology of the cardiovascular system, both in a human and amurine setting.
First the general functioning of the human systemic arterial system is described,
as it is important to understand the natural, physiological state before starting
research on the diseased state. Aerwards the reader is provided with the nec-
essary clinical background on the cardiovascular disease that is the topic of this
dissertation: aortic aneurysm. An aneurysm can best be described as a local
dilatation of the aorta, that oen leads to sudden death upon rupture. Within
this dissertation we focus on two of the most abundant aneurysm locations:
ascending and abdominal aortic aneurysms.e main aspects that are known
to be involved in the pathophysiological process of aneurysm formation are
discussed, as well as the dierence in pathophysiology between ascending and
abdominal aneurysms. e most important existing hypotheses in literature
regarding the initial trigger that might cause the predisposition of the disease
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for those specic vascular sites are discussed, and the potential role of disturbed
hemodynamics herein is introduced. As was pointed out in the introduction,
it is very dicult to study these hemodynamics in human aneurysm as the dis-
ease has a very slow timecourse in humans, and access to pre-disease data is
rare.
At that point small animal research comes in: as aortic aneurysm can be
induced in mice, they are the perfect model to provide data on the rst steps
in aneurysm formation. First the use of mice in general research is dicusssed.
Mice have a short lifespan that allows for longitudinal research and, more im-
portantly, the murine genome has been described completely.e latter allows
to induce geneticmodications and awide range of diseases can thus be studied
in these small animals. Moreover mice are in many aspects (including the car-
diovascular system) anatomically very similar to humans. Nevertheless some
important dierences exist, of which the increased heart rate (x10) and smaller
dimension (/10) are the most important ones in a cardiovascular setting. A lit-
erature overview discusses all existing mouse models for aneurysm formation
(known at the time of writing): aneurysm has been induced in mice via genetic
modications, by localized chemical induction methods and by continuous in-
fusion of the peptide hormone angiotensin II.e focus of the literature review
is on the latter mouse model as it was used to study aneurysm formation in
chapters 7 and 9.
Chapter 2. Computing aortic hemodynamics
is chapter provides some background on the numerical methods that were
used to calculate arterial hemodynamics. First, the governing equations of a
typical owproblem are reduced to a simplied formulation representing blood
ow in an artery. In most engineering applications it is, however, virtually im-
possible to obtain a closed form analytical solution for these equations. Com-
putational Fluid Dynamics or CFD provide an elegant way to circumvent this
limitation: an approximate solution is obtained by a discretization of the prob-
lem, allowing to solve the equations numerically with the aid of a computer.
Within this dissertation, the nite volume method is used in combination with
a segregated pressure-based solver, implemented in the commercial soware
package Fluent (Ansys). Some background on the theoretical mechanisms and
assumptions behind thismethod is provided. Furthermore, some practical con-
siderations are discussed, that need to be executed with great accuracy in order
to end up with trustworthy results when performing a CFD simulation of the
arterial system.
When interpreting the outcome of a cardiovascular CFD simulation related
to the onset of cardiovascular disease, neither pressures or ows are the vari-
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ables that one is generally most interested in. Wall shear stress (WSS), the vis-
cous stress that a uid exerts on the endothelial cells that form the inner layer of
the aortic wall, is believed to play an important role in the initial steps of cardio-
vascular diseases such as atherosclerosis or aneurysm, as it has been shown to
have a signaling function. Since WSS is an instantaneous variable that changes
over a cardiac cycle, a number of shear stress - based descriptors are introduced
that are used within this dissertation to study the role of shear-related hemo-
dynamics in aneurysm formation: TAWSS (time-averaged wall shear stress: in-
dicates zones of high and low shear), OSI (oscillatory shear index: indicates
zones in which shear oscillates, i.e. changes direction within the cardiac cycle)
andRRT (relative residence time: combines eects of low and oscillatory shear).
e chapter ends with a literature overview of CFD studies in both a hu-
man (aneurysm) andmurine context. Human CFD studies on aortic aneurysm
are in almost all cases limited to studying the ow in a developed aneurysm,
as there is a lack of follow-up data on the initial stages of the disease. Since we
intend to induce aneurysms in mice to circumvent this limitation, an overview
of existing CFD studies in the murine aorta is also discussed. No CFD-based
studies on murine aortic aneurysm exist in literature, as almost all studies are
limited to a description of the hemodynamics in the murine aorta as such.e
literature overview focuses on the main problem in all existing small animal
CFD studies: to obtain a realistic arterial geometry and realistic boundary con-
ditions, preferentially based on in vivo data.
Chapter 3. Small animal imaging techniques
e lack of small animal imaging techniques has long been the bottleneck for
small animal CFD simulations, which is why this last introductory chapter pro-
vides some background on the two small animal imaging techniques that were
used within (the third part of) this dissertation to set up mouse-specic CFD
simulations: micro-CT and (high-frequency) ultrasound.
First some background is provided on the general principle of Computed
Tomography (CT), a medical imaging technique that is based on the amount of
attenuation of X-rays traveling from a source through the imaged subject to a
detector that is located at the opposite side. For micro-CT some special consid-
erations are necessary due to the small size of the imaged subjects, increasing
the demands on the required resolution. e best resolution is theoretically
achieved in a setup in which the subject rotates and the source and detector
remain stationary (as was used in chapters 4 and 5). However, for in vivo scan-
ning this puts a high constraint on the scanned animals, which is why for in
vivo systems the animal is usually xated on the animal bed (under anesthesia)
while source and detector rotate around it.is is also the case for the FLEXGE
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Triumph scanner that was used in chapters 6, 7, 8 and 9. Some common pitfalls
for micro-CT imaging are discussed, with special emphasis on those that are of
importance for in vivo small animal imaging such as (among others) radiation,
resolution, cardiac and respiratory movement and, most importantly, the need
for a dedicated contrast agent to discriminate the aorta from surrounding tis-
sues.
e second part of this chapter rst provides more background on the gen-
eral principle of ultrasound, a medical imaging technique that is based on the
transmission and reection of ultrasonic acoustic waves (i.e. pressure waves
with a frequency beyond the audible range) through a medium. Many dif-
ferent ultrasound modalities exist, but the one that was used most frequently
within this dissertation is Pulsed Doppler.e theoretical principle behind this
method, allowing to measure time-dependent velocities in blood vessels, is ex-
plained. For small animal ultrasound a dedicated system is needed, since the
small size and increased heart rate of mice require a much higher frequency
of the emitted waves. Within this dissertation a Vevo 2100 high-frequency ul-
trasound scanner was used (VisualSonics).e practical setup of the scanner is
explained: the animal is positioned on a handling table that rotates around a ball
hinge while the transducer position is xed, as opposed to clinical ultrasound
where the operator moves the transducer around to obtain the desired images.
Subsequently some common pitfalls in ultrasound imaging are discussed, with
emphasis on those that are of importance for small animal ultrasound in gen-
eral (such as (among others) anesthesia, body temperature, image resolution)
and Pulsed Doppler specically (such as angle correction, aliasing and spectral
broadening).
Part II. Mice as a model for humans: the road to mouse-specific
hemodynamics
e initial phase of small animal CFD was hampered by a lack of imaging tech-
nologies that allowed tomeasure murine cardiovascular properties in vivo.e
dedicated small animal imaging techniques introduced in chapter 3 were not
yet (fully) available at the onset of the PhD. Contrast agents allowing to dis-
criminate the aorta in vivo in mice did not exist, and the arterial geometry
was usually based on a vascular cast, a plastic replica of the arterial tree that
was scanned in vitro. Literature data on boundary conditions were scarce, and
mouse-specic cardiovascular CFD simulations were very dicult (if not im-
possible) to achieve.e second part of this dissertation contains three dierent
studies that were performed within this context. e aim of these studies was
to increase our existing knowledge of the murine arterial system.
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Chapter 4. Anatomy of the murine aortic arch: validation of the mouse as a
model to study human vascular diseases.
Despite the fact that the mouse is frequently used to model human (cardiovas-
cular) disease, anatomical studies on its vascular system are rare. is chapter
contains a detailed comparison of the anatomical data of 30 mice (based on
micro-CT scanned vascular casts) to two human datasets of 6 younger and 6
older men (based on a thoracic clinical CT scan taken for other than cardio-
vascular reasons). Aortic diameters (at 6 locations) and distances between the
origin of the dierent branches are reported for all cases. We found that inmice
the ventricular axis of the heart manifestly points to the le ventral side of the
thorax with an angle of 39○. is angle is somewhat smaller in younger men
and almost absent in older men.e transition between the aortic arch and the
ascending aorta is more uently in mice as the arch is positioned more trans-
versely in the thorax. Furthermore a non-planar position of ascending and de-
scending aorta is present in both species, albeit more pronounced in mice (31○)
than in younger (13○) and older humans (11○). Finally, the mouse is one of the
fewmammals in which the branching pattern in the aortic arch is similar to the
human case, with three arteries (brachiocephalic trunk, le common carotid
and le subclavian artery) that branch o with similar angles as in the human
case. Overall we conclude that, from an anatomical point of view, the murine
aorta is a good model for the human aorta, that can serve as a solid basis to
study cardiovascular disease later on.
Chapter 5. Hemodynamics in the murine aortic arch: the inuence of
aortic dimensions.
In this rst study onmurine hemodynamics, CFD simulations were performed
in the aortic arch, including the three main side branches. e geometry was
based on a vascular cast thatwas scanned using in vitromicro-CT,while bound-
ary conditions were based on literature data. In order to investigate the inu-
ence of mouse body mass on arterial WSS, the initial geometry was scaled to
5 dierent dimensions representing intra-species variations of aortic size that
correspond to late fetal, neonatal, juvenile, young adult and old adult animals.
For each geometry CFD simulations were performed in combination with a
dimensional analysis reporting the theoretical, idealized WSS value (based on
Poiseuille’s law for fully developed ow in a duct). e dimensional analysis
showed theoretical WSS to decrease with increasing size of the animals. is
was conrmed in the CFD simulations for the spatially varying computedWSS
values. Comparing the dierent timepoints, we found that murine WSS tends
to decrease rapidly in early life stages and reaches a plateau value in adulthood.
ese data support a mediating role for WSS in arterial growth. OSI values
did not vary markedly between dierent age categories. Reported WSS values
were in general much higher than human values, conrming results obtained
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in previous studies. is study thus clearly shows an inverse relation between
aortic size and WSS levels, which is an important factor when comparing data
between dierent species and for dierent ages within the same species. It is
therefore necessary to keep the age and strain of the used animals in mind at all
times when studying arterial hemodynamics in mice.
Chapter 6. Replacing vascular casts by in vivo contrast-enhancedmicro-CT
In this chapter a reconstruction method using one of the rst contrast agents
for micro-CT in mice that was introduced on the market, Fenestra VC-131, was
compared to what had thus far been the golden standard method to obtain the
murine aortic geometry: vascular casting. Nine mice rst got an in vivo micro-
CT scan aer injection of 0.015 ml/g Fenestra VC-131. Some animals did not
respond well to the (relatively large injected volume of ) contrast agent, and
had to be euthanized soon aer the scan for ethical reasons. A vascular cast
was created for all animals, that was subsequently scanned in vitro. Images of
four high-quality casts (not containing any air bubbles) were retained and all
datasets were segmented to convert them into 3D geometrical models of the
aortic arch. Aortic diameters were signicantly higher for in vivo models, with
dierences up to 35%.ese dierences were attributed to a combined eect of
underestimation of casted diameters (as the used polymer is known to shrink
aer injection) and overestimation of in vivo diameters (as a large volume of
contrast agent was injected to obtain sucient contrast). Bifurcation angles
agreed relatively well between bothmethods, with dierences smaller than 20%
for all cases.
Despite the large dierences in numerical values a good correlation was
found between bothmethods, both for diameters (R2=0.84) and bifurcation an-
gles (R2=0.94). Furthermore, CFD simulationswere performed in both datasets.
Murray’s law was used to estimate xed ow splits that were imposed as outlet
boundary conditions, assuming that ow is in all branches proportional to the
third power of the diameter. Calculated spatially averaged TAWSS values were
lower for in vivo models, due to the dierence in size. e spatial distribution
of TAWSS over the surface was found to be very similar in both cases. In gen-
eral a relatively good qualitative agreement was thus achieved between models
based on in vivo micro-CT and models based on the previously used in vitro
method. However, since the used contrast agent (Fenestra VC-131) was not well
tolerated by the animals and resulted in an overestimation of aortic diameters,
other contrast agents (preferably needing less injected volume) are needed to
increase the reliability.
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Part III. Mouse-specific hemodynamics and aortic aneurysm
formation
Two important events mark the transition between the second and third part
of this dissertation. e rst event was the further development of dedicated
contrast agents for in vivo micro-CT in mice. Fenestra VC-131 (the contrast
agent investigated in chapter 6) was replaced by Aurovist, an alternative based
on gold nanoparticles that requires much smaller injected volumes and is bet-
ter tolerated by the animals. e second important event was the purchase of
a novel high-frequency ultrasound device dedicated for small animal imaging
(Vevo 2100, VisualSonics). e third part of this dissertation contains three
dierent studies in which (contrast-enhanced) micro-CT and high-frequency
ultrasound images were combined to set up entirely mouse specic CFD sim-
ulations, with the nal aim to provide some answers regarding the relationship
between hemodynamics and aneurysm formation in mice.
Chapter 7. A novel methodology to link mouse-specic hemodynamics to
abdominal aneurysm formation in angiotensin II - infused ApoE −/− mice
In this chapter a methodological framework is presented that allows to follow-
up onmouse-specic hemodynamics in longitudinal studies. Aer injection of
the novel contrast agent Aurovist (injecting only 0.006ml/g), an in vivomicro-
CT scan is rst performed to obtain a 3D geometrical model of the aorta. Sub-
sequently high-frequency ultrasound Pulsed Doppler measurements are per-
formed to obtain mouse-specic time-dependent blood velocity waveforms.
e latter are then combined with diameters from the (segmented) 3D model
to obtain volumetric ow waveforms, since measured velocities are not neces-
sarily compatible with each other and can therefore not be imposed directly as
boundary conditions in aCFD simulation.e error in the owbalance (i.e. the
dierence between the volumetric ow at inlet and the sum of all outlets ows)
is then redistributed over all ow waveforms, to ensure that conservation of
mass is obeyed at all times. e thus obtained volumetric ow waveforms are
then imposed as boundary conditions at the in-and outlets of the 3D model as
parabolic velocity proles. is methodology allows to set up entirely mouse-
specic CFD simulations solely based on in vivo data.
emethodologywas then applied in a longitudinal study in 10 angiotensin
II-infused, male ApoE −/−mice. First a CFD simulation was performed at base-
line to assess the hemodynamic condition in the abdominal aorta of these an-
imals. en an osmotic pump - continuously releasing angiotensin II over a
period of 28 days - was implanted to induce abdominal aneurysms. Eight ani-
mals survived the complete procedure, and were scanned again at the endstage,
31 days aer pump implantation. Four animals were found to have developed
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an AAA. Since baseline and end stage micro-CT scans did not match one-on-
one (since the animal is positioned slightly dierent in the scanner at dierent
time points), a novel methodology was developed to calculate a distance map.
is allowed to quantify aneurysm location as the distance from baseline to end
stage geometry in every node of the baseline geometry. Baseline hemodynamics
(represented by TAWSS, OSI and RRT values) were compared to AAA location
(represented by the obtained distance map).
Zones of disturbed ow at baseline (characterized by high RRT and OSI,
low WSS) did not match with zones that developed AAA at end stage. How-
ever, AAA seemed to develop proximal to those zones experiencing disturbed
ow (usually located at the trifurcation where mesenteric and right renal ar-
teries branch o). Intermediate data that would have allowed to investigate if
there was a causal eect were lacking. While these initial results seem to exclude
an overt relationship between disturbed hemodynamics and AAA formation,
the novel methodology that was introduced in this chapter can be used in fu-
ture longitudinal studies to investigate the role of hemodynamics in disease-
developing mice.
Chapter 8.e impact of simplied boundary conditions and aortic arch
inclusion on CFD simulations in the murine aorta: a comparison with
mouse-specic reference data
e study presented in chapter 8 can be considered as an elaborated study on
the baseline data of the longitudinal aneurysm study presented in chapter 9.e
methodology developed in chapter 7 was rst extended to the complete aorta,
thus including both the aortic arch and the abdominal aorta with in total 7 side
branches.is resulted in a large dataset (consisting of both diameters and ow
ratios at all measurement locations) that may serve as a reference for future stu-
dies. In most murine CFD studies in literature - as well as in the rst chapters
of this dissertation - assumptions are made regarding the applied geometry and
boundary conditions. In most cases, the validity of these assumptions is poorly
validated in mice due to a lack of reference data.
As we had obtained such reference data aer performing themeasurements
described above, we could assess some of the assumptions made in literature.
e outcome of CFD simulations based on mouse-specic, time-dependent
measurements was rst compared to the outcome of CFD simulations in the
same geometries, in which at each branch the average ow ratio to that branch
over all 10 mice was imposed. is allowed to simulate the eect of imposing
general, non-specic boundary conditions taken from literature (as in chapter
5). e results were analyzed both quantitavely - using boxplots and a statis-
tical measure called the Cohen’s distance to compare between methods - and
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qualitatively - showing the spatial distribution of TAWSS, OSI and RRT for the
cases with best (lowest Cohen distance) and worst (highest Cohen distance)
agreement between dierent methods. e use of average ow ratios resulted
in a very good agreement in TAWSS and RRT while OSI was found to be lower,
especially in the distal aorta. Next, mouse-specic CFD simulations were com-
pared to simulations in which Murray’s law was used to estimate the ow splits
from the third power of the diameter ratio (as in chapter 6). In this case, dif-
ferences were more pronounced, with locally increased TAWSS in the thoracic
and distal abdominal aorta when Murray’s law is used. ese dierences vary
strongly between animals, which was reected in high standard deviations.
In a third part of the study the original CFD simulations were compared
to simulations in which the geometrical model was restricted to the abdomi-
nal aorta (as in chapter 7). is restriction did not aect the outcome of (the
abdominal part of) the simulation: abdominal TAWSS, OSI and RRTwere sim-
ilar in all cases. We conclude that some of the assumptions that are oen made
in literature (e.g. non-specic outlet boundary conditions, restricted aortic ge-
ometries) seem to be justied, while others (e.g. Murray’s law) inuence the
outcome of the CFD calculations signicantly.
Chapter 9. Location and evolution of aortic aneurysm: the role of
disturbed hemodynamics
In this nal chapter the experience that had been built up in previous chapters
was applied to study the location and evolution of aortic aneurysm.e setup
of the study was the same as in chapter 7: ten ApoE −/− mice were scanned
at baseline to performmouse-specic CFD simulations, and got an angiotensin
II-releasing osmotic pump implanted to provoke aneurysm. However, themea-
surement protocol was extended: the entire aorta was now included into the
model, additional intermediate ultrasound and micro-CT scans were taken 2,
7 and 14 days aer pump implantation and molecular imaging (PET) was per-
formed at the latter two time points to obtain an earlymarker for inammation.
Of the six animals that survived the complete procedure two animals did not
develop any aneurysm, one animal only developed ascending aortic aneurysm,
and three animals developed both ascending and abdominal aortic aneurysm.
ese data are limited, but they did allow to make a comparison between two
dierent aneurysm types, and between aneurysmatic and non-aneurysmatic
animals.
Both aneurysm types were found to evolve dierently over time: the ab-
dominal aneurysm appears abruptly in between scans while the ascending an-
eurysm grows gradually.PET could not predict aneurysm formation at day 7 but
conrmed aneurysm presence at day 14 with a high specicity. We conclude
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that inammation is involved in aneurysm development at both aneurysm lo-
cations. Pulsed Doppler blood velocity measurements revealed that diastolic
backow occurs (in various degrees of severity) from day 7 on in the ascending
aorta of aneurysmatic mice. As the ascending aortic aneurysm develops slowly
over time and nomeasurements were obtained between days 7 and 14, we could
not determine whether the observed diastolic backow in the ascending aorta
precedes aneurysm formation or if it rather is a consequence of the aortic di-
latation.
Finally, the role of hemodynamics in aneurysm formation was investigated.
We found that baseline RRT in the abdominal aorta was not dierent from
the other aortic zones. A focal increase in RRT could be observed near side
branches, but this was not more outspoken than near side branches in e.g. the
aortic arch. Abdominal aneurysm could not always be detected from the aor-
tic lumen (i.e. micro-CT scans) alone and the number of obtained intermediate
scanswas limited. Consequently, we could not further investigate if AAAdevel-
ops proximal to the regions of disturbed ow, as hypothesized in chapter 7. In
the ascending aorta, however, baseline RRTwas increased in all animals, which
is also the zone where an aneurysm developed in 4 out of 6 animals. However,
baseline ascending aortic RRT was also increased in animals that did not de-
velop any ascending aortic aneurysm. Moreover, those local patches within the
ascending aorta that experienced the highest baseline RRT did not develop into
the most dilated patches at end stage. We conclude that a relationship between
hemodynamics and aneurysm seems to exist in the ascending aorta, albeit not
an unambiguous one.
Part IV. Conclusions
Chapter 10. Conclusions and future prospects
In this nal chapter themain take homemessages are summarized for each part,
and an answer to the research question is formulated. We conclude that further
research is needed to fully elucidate the role of disturbed ow patterns in the
initial stages of ascending as well as abdominal aneurysm, and that - as formost
journeys - the road towards our goal has been as instructive as reaching the goal
itself. e most important limitations of our work are discussed. It is unclear
to what extent the used mouse model can be extrapolated to a human setting.
Furthermore, the sample size of our studies was too low to reach statistically
signicant conclusions. Simplied inlet boundary conditions and geometrical
simplicationsmay have aected the outcome of the ascending aortic CFD sim-
ulations. In the abdominal aorta, the main CFD limitation is in the hard-coded
waveform towards the outlets. Furthermore, the rigid walls do not allow to
take into account the buer capacity of the aorta. In the near future we plan to
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apply the methodology in dierent mouse models of aneurysm formation and
other cardiovascular diseases. We will extend the current CFD approach to FSI
(uid-structure interaction), which will allow to include the wall - as well as its
mechanical behavior - into the model. However, aortic wall material properties
as well as aortic blood pressures are needed to dene boundary conditions for
these models. Mouse-specic FSI simulations of the murine aorta are currently
hampered by a lack of dedicated imaging technologies that would allow tomea-
sure these properties in vivo.e challenges that we are facing are thus inmany
ways similar to the ones that were previously tackled, although there is much
more experience to start from.
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Introduction
Clinical Rationale
Cardiovascular disease is a general term comprising all diseases aecting the
cardiovascular system, usually the heart or the arteries that supply blood from
the heart to the dierent organs. Cardiovascular disease is the main reason
of death in the Western world, and manifests itself in many dierent ways.
Atherosclerotic plaque is e.g. characterized by the accumulation of lipids in
the arterial wall. When such a lipid plaque ruptures its content forms a clot
that ends up in the blood trajectory and can cause cerebral stroke (when blood
ow towards the brain is obstructed) or a heart attack (when blood ow to-
wards the heart is obstructed). Aneurysm, the cardiovascular pathology that is
studied within this dissertation, is also characterized by a local change in aor-
tic wall properties. In this case, however, the artery lumen does not narrow,
but on the contrary undergoes a local increase in diameter.is local widening
or dilatation is caused by a degradation process in the aortic wall that occurs
slowly, oen over a time span of several decades, and in most cases causes no
symptoms in the patient. However, the aneurysm will rupture as soon as its de-
graded wall can no longer withstand the internal blood pressure.is provokes
internal bleeding that (if not operated upon immediately) will cause the patient
to die soon aer. Aneurysm is increasingly prevalent in our aging population,
accounting for 1-2% of all deaths in industrialized countries.
Over the course of time, much research has been performed on aneurysm
formation, both from a clinical and from an engineering point of view. Most
studies focus on preventing rupture in existing aneurysms, as there is a direct
benecial eect for the patient. While the dierent processes that cause the aor-
tic wall to degrade are fairly well known, there is still a lack of knowledge on the
initial phases of the disease. Interestingly, the disease is much more prevalent
in the abdominal aorta (distal to the kidneys) or the ascending aorta (just distal
to the heart) than in other parts of the main vessel. As there is no consensus in
literature as to why this is the case, several hypotheses have been proposed to
explain this predisposition of the disease for distinct aortic sites. One of these
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hypotheses is that the rst stages of aneurysm formation may be related to lo-
cally disturbed hemodynamics in the mentioned aortic regions. ese hemo-
dynamics are oen quantied via the so-called wall shear stress, the stress that
is exerted by blood on the inner layer of the vessel wall. is shear stress is
much smaller than the normal stress on the wall that is caused by the internal
blood pressure. However shear stress is believed to have a signaling function:
deviating shear stress values are believed to be picked up by so-called shear-
responsive genes and may activate a cascade of adverse events that eventually
result in a local onset of aortic disease. For atherosclerosis, this link between
shear stress and disease has been demonstrated in several studies, with an in-
creased prevalence of atherosclerosis in aortic zones experiencing low and or
oscillatory shear stress. For aortic aneurysm however, such evidence is lacking.
Aim and technical challenges
e nal aim of the research performed within this dissertation is to answer
one specic research question:
Why do aortic aneurysms have a predisposition to develop at some very dis-
tinct aortic locations, and what is the role of local hemodynamics herein?
It is important to realize that hemodynamic properties such as shear stress
cannot simply be measured on post-mortem tissue.ey need to be simulated
using dedicated computational techniques such as Computational Fluid Dy-
namics (CFD), and for these simulations to be trustworthy, they should prefer-
entially be based on patient-specic measurements.ese should include both
the geometry of the aortic vessels (to create a 3Dmodel of the aorta) and blood
velocities or pressures (to prescribe so-called boundary conditions at the in-and
outlets of the model). In order to study the role of hemodynamics in aneurysm
formation, one would ideally perform such image-based CFD simulations in
the aorta of a patient before any aneurysm is present, wait until aneurysm de-
velops, and subsequently link the location of aneurysm to regions of disturbed
ow in the baseline simulation. However, this is quasi impossible in humans
since pre-diseased data are almost never available (as patients only show up in
the clinic when it’s too late) and it takes decades for the aneurysm to develop.
For this reason no studies exist in which human aneurysmhas been followed up
from its pre-diseased to its endstage state. Mousemodels can be used to circum-
vent this limitation: as dierent techniques exist to induce aneurysm in these
animals, one keeps access to the baseline data. Moreover disease progression
can be followed up more closely as the period from induction to fully devel-
oped aneurysm only takes 30 days (depending on the used model). Within this
dissertation, the role of hemodynamics in aneurysm formation was therefore
l
investigated in the murine case specically.
Furthermore there are some important limitations when performing CFD
simulations to assess hemodynamics in mice. Due to their small size and in-
creased heart rate, imaging modalities to measure their aortic geometry and
blood velocities require a much higher temporal and spatial resolution than is
the case for humans. If the appropriate imaging modalities to perform such
measurements in small animals are lacking, the only way to obtain a mouse-
specic aortic geometry is to sacrice them, while CFD boundary conditions
should be estimated (e.g. from literature). However, in order to set up longitudi-
nal studies that allow to link hemodynamics to aneurysm formation in dierent
timepoints for the same subjects, dedicated small animal imaging technologies
are indispensable.
Structure
is dissertation is divided into four dierent parts. A rst part aims to provide
some background on the basic (patho-)physiological, computational hemody-
namic and imaging concepts that are applied within this dissertation.e sec-
ond part contains three studies that were set up in the initial phase of the PhD.
As follow-up studies were not yet possible, the goal of these rst studies was
to increase the existing knowledge of the murine arterial system, both from
an anatomical and a hemodynamic point of view. In the third part contrast-
enhancedmicro-CT and high-frequency ultrasound had become available, and
the acquired knowledge from previous studies was applied to develope a novel
methodology to set up mouse-specic CFD simulations in the mouse aorta.
ese simulations were performed in a mouse model of abdominal as well as
ascending aortic aneurysm formation, allowing to provide some answers re-
garding our research question. Each part starts with a brief outline that sum-
marizes its content and positions its role within the global story. In the last part
the main conclusions are repeated and some perspectives for future work are
introduced.
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Ofmice andmen: anatomy and
(patho-)physiology
1.1 The human cardiovascular system
1.1.1 e circulatory system
e human body is a complex organism with dierent (sub)systems that are all
interdependent on each other. Each of these systems is indispensable for our
functioning: we need (among others) the digestive system to process the food
we consume into the energywe use, themusculoskeletal system tomove around
and the nervous system to interact with our surroundings while we do so.e
cardiovascular system regulates the body’s functioning by distributing blood
to all of the body’s (approximately) 50 - 100 trillion cells. Blood not only car-
ries vital gases (oxygen and carbon dioxide), it also transports (among others)
nutrients, hormones, antibodies and even heat (regulating the body’s temper-
ature). Blood transportation is driven by a single, centrally placed engine: the
heart, pumping the blood around in a continuous sequence of contraction and
relaxation, thus reaching (on average) 2.5 billion beats in a lifetime. e heart
is ejecting blood into 2 dierent trajectories: the systemic and the pulmonary
circuit. Both circuits form a closed loop and together they comprise the cardio-
vascular system. A schematic overview is shown in Figure 1.1.
In the systemic circuit, oxygenated blood leaves the heart from the le ven-
tricle into the arterial system, where it is carried into a number of parallel net-
works of increasingly smaller arteries and arterioles until it nally reaches the
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Figure 1.1: Schematic overview of the circulatory system.e systemic circuit consists of arteries
(in light red) providing oxygenated blood to the organs and veins (in light blue) that transport
oxygen-depleted blood back to the heart.e smaller, pulmonary circuit consists of veins (dark
blue) transporting the oxygen-depleted blood to the lungs, and arteries (dark red) taking the
oxygen-replenished blood back to the heart. LA = Le Atrium, RA = Right Atrium. Reproduced
from [1].
capillaries. Within the ramied capillary network oxygen, nutrients and other
substances are supplied to the dierent organ cells while carbon dioxide and
waste products are picked up. Aerwards blood enters the venous system: ini-
tially collected in small venules, it is transported into increasingly larger veins
until it nally reaches the heart again via the right atrium. It then enters into
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another, much shorter circuit : the pulmonary circuit. Passing on from the right
atrium to the right ventricle, oxygen-depleted blood is ejected out of the heart
into the pulmonary arteries. At the lungs, oxygen is replenished, carbon diox-
ide is released, and via the pulmonary veins the oxygenated blood is returned
to the le atrium of the heart, which passes it on to the le ventricle for redis-
tribution via the systemic circuit. Each and every day, an average human heart
thus pumps about 7500 liters of blood around the body [1, 2].
1.1.2 e systemic arterial system
General anatomy
In order to reach all cells, the central aorta (the main systemic artery) continu-
ously branches into a ramied network of arteries. A simplied scheme of the
dierent branches of the aorta is depicted in Figure 1.2.e part of the aorta that
Figure 1.2:e human aorta and its main branches. Adapted from [1].
is connected to the aortic valve of the le ventricle is called the ascending aorta.
At its very base, the le and right coronaries branch o to supply the heart itself
with blood. Aer leaving the heart, the aorta immediately makes a distinct turn
of 180○, referred to as the aortic arch. In (most) humans, three arteries branch
o the aortic arch: the brachiocephalic trunk, the le common carotid artery
and the le subclavian artery.ese arteries deliver blood to the brain and the
upper limbs. e part of the aorta that lies distal to the aortic arch is termed
the descending aorta. It contains a number of small branches that supply the
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area between the ribs: the intercostal arteries. e descending aorta (termed
thoracic aorta from the 5th vertebra (T5) on) penetrates the diaphragm at the
level of vertebra T12, aer which it is called the abdominal aorta. e abdom-
inal aorta delivers blood to all the abdominal organs and structures, and does
so via a number of branches. e celiac trunk divides into 3 major branches
(the le gastric, splenic and common hepatic arteries) delivering blood to the
stomach, spleen, pancreas, gallbladder, duodenum and the liver. e superior
mesenteric artery arises distal to the celiac trunk and supplies dierent smaller
arteries to the pancreas, duodenum, small and large intestines. Le and right
renal arteries branch o symmetrically just distal to the superior mesenteric
artery, and head straight to the kidneys. Furthermore, several smaller abdomi-
nal arteries exist: the inferior phrenic arteries (supplying the inferior part of the
diaphragm), suprarenal arteries (supplying the adrenal glands), gonadal arter-
ies (supplying the reproductive organs), small lumbar arteries (supplying the
vertebrae and spinal cord) and the inferior mesenteric artery (supplying the
colon and rectum). At the level of vertebra L4, the abdominal aorta splits into
two major arteries supplying the lower limbs: the le and right common iliac
arteries [1, 3].
Large elastic arteries and the Windkessel function
Figure 1.3:e windkessel eect on pressure curves throughout the aorta. Mean arterial pres-
sure decreases from the aorta towards the periphery. e pulse pressure experienced by large
arteries is eliminated in the arterioles, allowing for a relatively constant, low pressure in the cap-
illaries. Reproduced from[1].
6
1.1. e human cardiovascular system
As one can see in Figure 1.2, the size of the arteries drops with every branch-
ing, while the consecutive branching pattern causes an exponential increase in
the number of arteries. erefore the further downstream, the more the total
cross-sectional area of all arteries increases and the more the individual ves-
sel diameter decreases. To make the exchange of nutrients and oxygen actually
function on a capillary level the downstream blood ow should be continuous,
under a low and constant pressure. An important aspect of the systemic arterial
system is therefore its so-called windkessel function: the aorta and its large cen-
tral branches act as a buer to cushion the rapid, high-pressure, pulsatile blood
ow that is ejected from the heart into a slower, low-pressure, continuous blood
ow downstream (Figure 1.3)[4, 5]. In order to understand how this transition
is regulated, it is important to know the internal structure of the arterial wall,
discussed in the next section.
1.1.3 Structure of the arterial wall
e arterial wall is composed of a number of dierent constituents of which
endothelial cells, vascular smooth muscle cells (VSMCs), elastin and collagen
proteins are the most important ones.
Endothelial cells act as a selective barrier, controlling the passage of substances
and the transit of white blood cells into and out of the bloodstream. ey do
not bear any load, but form an interface between circulating blood in the lumen
and the rest of the vessel wall.
Vascular smooth muscle cells are used to contract the vessels actively. ey are
controlled by the autonomous nervous system to regulate the aortic diameter
by vasoconstriction (reducing the diameter) and vasodilation (increasing the
diameter) and they also produce elastin and collagen bers.
Elastin is a protein of which the production ceases when maturity is reached,
which is why it has a half life of 40-70 years. Elastin bers are load-bearing
constituents of the wall but have no preferential direction: they can bear load
both circumferentially and longitudinally. Elastin is normally found in a cross-
linked form (so-called lamellae) that can be stretched as much as 70% of its
initial length [6].
Collagen, in contrast to elastin, is synthesized on a continual basis throughout
life.erefore the collagen content at a certain moment in time represents the
net eect of synthesis and degradation. Collagen bers are coiled up within
the arterial wall, and are not recruited to bear any load until they have been
stretched completely. Collagen is responsible for tensile strength and high-load
resistance of the arterial wall, and only bears load in a preferential direction
(along the direction of the bers). Dierent types of collagen exist, but type 1
brillar collagen is the one that accounts for aortic wall load bearing capability.
It is able to bear a load that is over 20 times greater than elastin. Structural
damage occurs when collagen is extended beyond 2-4% from its uncoiled form
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[7].
ese dierent constituents are not distributed randomly accros the wall but
are structured in a very organized way, that is similar for all arteries (as well as
veins). At a macroscopic level, the structure consists of three distinct layers: the
tunica intima, tunica media and tunica externa as indicated in Figure 1.4.
Figure 1.4: Detailed view of the three-layered structure of the aortic wall. Intima, media and
adventitia are depicted as well as their main constituents. On the right hand side a 3D view. On
the le hand side a 2D cross-section. Adapted from [1].
Tunica intima
e tunica intima, or tunica interna, is the innermost layer of a blood vessel.
In healthy vessels, this layer consists of a single layer of endothelial cells and an
underlying layer of connective tissue (built of elastic bers) called the internal
elastic membrane.
Tunica media
e tunica media is the middle layer and is separated from the tunica externa
that surrounds it by a thin band of elastic bers called the external elastic mem-
brane. It contains concentric sheets of vascular smooth muscle cells that are
embedded in a framework of loose connective tissue, consisting of collagen and
elastin bers.
Tunica externa
e tunica externa or tunica adventitia is the outermost layer of a blood ves-
sel and contains the blood vessels supplying nutrients to the vessels itself, the
vasa vasorum or ‘vessels of the vessels’. e connective tissue bers of the tu-
nica externa typically blend into those of adjacent tissues, thus stabilizing and
anchoring the blood vessel. e tunica externa contains collagen bers with
scattered bands of elastic bers in between them.
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1.1. e human cardiovascular system
Knowing the general structure of the aortic wall now allows for a better un-
derstanding of the aortic windkessel eect (as described in section 1.1.2). While
the aortic wall always has the same 3-layered structure, the composition of each
layer varies along the length of the aorta. According to these structural dier-
ences, 2 dierent kinds of large arteries exist: elastic andmuscular large arteries
(Figure 1.5).
Figure 1.5: Arterial properties dier along the aorta. Elastic large arteries (top) contain less
smooth muscle cells and more elastic bers, making them more distensible and allowing them
to buer the blood ejected during systole (windkessel eect). Muscular (large) arteries (middle)
contain more vascular smooth muscle cells to allow for (autonomous) blood supply regulation
by active contraction, while arterioles and capillaries (bottom) have almost no load-bearing con-
stituents. Adapted from [1].
Elastic large arteries are large vessels with diameters up to 2.5 cm. ey
are located in the proximal part of the aorta as they transport large volumes of
blood away from the heart. e wall of these elastic large arteries is extremely
resilient since the media contains relatively few smooth muscle cells and a high
density of elastic bers. is permits them to expand and temporarily store
some of the blood ejected during systole, when blood is ejected from the heart
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and pressure rises rapidly. During diastole, pressure drops and the extra stored
blood is delivered to the organs by passive recoil of the elastin bers. As such,
elastic large arteries account for the windkessel capacity of the aorta that is de-
scribed in section 1.1.2. Muscular arteries on the other hand are smaller vessels
that distribute blood to the body’s skeletal muscles and internal organs. Since
they are located more distally from the heart, their autonomous regulation is
more important than their buer capacity, and their tunica media contains a
higher amount of VSMCs and less elastic bers.
1.2 Pathophysiology: human aortic aneurysm
1.2.1 General aortic aneurysm
Figure 1.6: Two abundant aneurysm locations: ascending and abdominal aortic aneurysm. Re-
produced from [8].
e previous section describes the anatomy of the human cardiovascular
system in its natural, physiological state. In the Western world an increasing
number of deaths is related to diseases aecting this cardiovascular system.
Aortic aneurysm is one of these cardiovascular pathologies. On morpholog-
ical grounds, it can be dened as a focal loss of parallelism of the arterial wall,
leading to progressive dilatation and nally to its rupture [9].e consequences
depend on the size of the rupture. A large rupture is most oen followed by a
rapid death caused by internal bleeding, while a small one (sometimes termed a
leak) may produce warning symptoms that allow to seek medical care. A more
pathophysiological denition denes aortic aneurysm as a progressive loss in
the capacity to resist a high intraluminal pressure, related to the degradation of
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the arterial wall [10].
Aortic aneurysm is occurring with increasing frequency in our aging popu-
lation, as it has has been estimated to account for 1-2% of all deaths in industri-
alized countries [11]. It can develop anywhere along the aorta, but occurs more
frequently at some distinct aortic locations such as the cerebral arteries (supply-
ing blood to the brain) and the (infrarenal) abdominal and (ascending) thoracic
aorta. Furthermore, albeit much less frequently, aneurysms can also develop in
the popliteal arteries (supplying blood to the knee joint), in the femoral arter-
ies (supplying blood to the upper part of the lower limbs), the carotid arteries
(supplying blood to the brain ) and the coronary arteries (supplying blood to
the heart). Aneurysms may be saccular (i.e. round, asymmetrical) or fusiform
(i.e. tubular, symmetrical)(Figure 1.7, but the saccular shape is in almost all
cases restricted to cerebral aneurysms.
Figure 1.7: Dierent shapes of aortic aneurysm. Le: saccular aneurysm, usually found in the
cerebral aorta. Right: fusiform aneurysm, usually found in the thoracic or abdominal aorta.
Reproduced from [12].
Both pathophysiology and physical appearance of cerebral aneurysms are
considered to be dierent from other aortic aneurysms [13]. Within this disser-
tation, we will focus on the two most abundant types of (fusiform) aortic an-
eurysm: (ascending) thoracic and abdominal aneurysm. Despite the fact that
many renowned researchers have devoted a substantial amount of their time to
aneurysm research, most research is carried out with the aim to prevent rup-
ture in existing aneurysms. Up to this day it remains unclear why this disease
seems to have a predisposition for both aortic locations [14]. We will rst dis-
cuss the known aspects of prevalence and pathophysiology of both aneurysms
to provide some background, followed by themost important current hypothe-
ses regarding the initial stages of the disease.
1.2.2 Abdominal aortic aneurysm
Prevalence
Abdominal aortic aneurysm (AAA) causes 1-3% of all deaths among men aged
65-85 years in developed countries [9]. Although some patients suer from
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vague symptoms, such as back pain or abdominal pain, most AAAs are asymp-
tomatic until rupture, which causes death in 65% of patients [15]. AAA - as all
other aneurysms - is increasingly prevalent with age, with a peak incidence in
the eighth decade of life [16, 17]. It is associated with numerous nonspecic
risk factors including male gender [18], hypertension [19], smoking [18, 20–22],
Caucasian race [18], coronary artery occlusive disease [18], concurrent periph-
eral aneurysms [23] and a family history of aneurysm disease [16, 18]. AAA is
sometimes termed atherosclerotic aneurysm, as it is oen found in conjunction
with aortic changes that are similar to those found in atherosclerosis [24]. How-
ever, signicant clinical dierences exist between both cardiovascular diseases:
AAAs occur in an older population with a greater gender specicity, are oen
found in a more proximal part of the abdominal aorta and are rarely found in
combination with occlusive plaques [25].
Structure
AnAAA usually takes decades to develop, and during this time period the local
structure of the aortic wall degrades slowly but rmly, until it by no means any
longer resembles the original 3-layered structure as presented in section 1.1.3.
As opposed to atherosclerosis, involving necrotic core formation in the tunica
intima, the structure of AAAs is usually spatially organized from inside to out.
e interface with blood is oen formed by a multilayered intraluminal throm-
bus (ILT), a biologically active neo-tissue that is considered to play an important
role in the disease progression (see below).e AAA wall is further character-
ized by a thin degraded tunica media and a thick remodeled tunica adventitia
(Figure 1.8). Due to the presence of the ILT, there is usually no endothelium or
intima in AAAs [26].
Medial degradation is characterized by a gradual loss of elastin that is ac-
companied by an increase in the collagen content in the adventitia, resulting in
an overall decrease in the elastin to collagen ratio [27]. is suggests a repair
process: as the media attenuates due to loss of elastin, the aortic wall dilates,
thus load bearing increases andmore uncoiled collagen is recruited to bear load
circumferentially [28], leading to adventitial remodeling which nally causes
the arterial wall to thicken and become less distensible [29]. erefore elastin
degradation can be considered as a key step in the development of aneurysms,
but collagen, because of its structural properties, must progressively restructure
for signicant dilatation to occur and must fail for rupture.is has been con-
rmed by experimental studies demonstrating that elastin degradation leads
to arterial dilatation and stiening at physiologic pressures, whereas collagen
degradation leads to arterial rupture without dilatation [30].
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MedialVSMCdensity is also decreased in humanAAA tissues and is associ-
ated with evidence of VSMC apoptosis [31]. VSMC apoptosis has oen been re-
garded as a bystander eect ofwall destruction inAAAs, but addition ofVSMCs
prevents AAA formation [32] and even suspends expansion of already formed
AAAs in mice [33], suggesting that (degradation of) VSMCs does play an im-
portant role in AAA development. In the adventitia angiogenesis occurs: new
small blood vessels (vasa vasorum, see section 1.1.3) are generated in the outer
vessel wall. However, in contrast to what is the case in atherosclerotic plaques,
these neo-vessels do not invade the media or the ILT, probably due to an excess
in local proteolytic activity [34](see below).
Formation and progression of AAA
Figure 1.8: Schematic representation of the role of proteolysis and oxidative stress on medial
degradation and adventitial responses, that can be (among others) inammatory (generation
of mast cells and ATLO), angiogenic (generation of vasa vasorum) or brotic (generation of
collagen bers). ILT = Intraluminalrombus, ATLO = adventitial tertiary lymphoid organ.
Adapted from [10].
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Summarizing the previous section, AAAs do not just result from passive
dilatation of the aortic wall but from a complex remodeling process involving
both the synthesis and degradation of matrix proteins such as elastin and col-
lagen. But what processes drive this aortic degradation? In 2001, the Vascu-
lar Biology Research Program of the National Heart, Lung and Blood Institute
summarized theAAApathogenicmechanism into four broad areas: proteolytic
degradation of the aortic wall connective tissue (termed the extracellularmatrix
or ECM), inammation and immune response, molecular genetics and biome-
chanical wall stress [35]. Wewill shortly discuss each of these pathogenicmech-
anisms hereunder.
1. Proteolysis and oxidative stress
Proteolysis is the direct degradation of proteins (such as elastin and col-
lagen) by cellular enzymes called proteases. In a newly published review
article on AAA pathogenesis, Michel et al. propose AAA to be a partic-
ular form of atherothrombosis, in which the pathogenic role of proteol-
ysis is predominant [10]. Proteases that degrade elastin are called elas-
tases while - not very surprisingly - those degrading collagen are termed
collagenases.e most important proteases identied in excess in AAA
are matrix metalloproteinases (MMPs). Under physiological conditions,
the activation of MMPs and their inhibition (by specic tissue inhibitors
of metalloproteinases termed TIMPs) are precisely regulated at the level
of gene expression. An imbalance between MMP activation and inhibi-
tion has been suggested as a potential mechanism for AAA formation
[36]. e localization of the elastase MMP-12 to residual elastin frag-
ments in the media of human AAAs has provided strong evidence of
ECM-targeting by proteases [37]. e role of proteolysis has been fur-
ther documented by the development of a reproducible animal model of
AAA in which rat aortas were perfused with elastase in vivo [38]. Inhi-
bition of protease expression (by invalidating the corresponding genes)
has demonstrated that MMP-3, MMP-9 and MMP-12 drive AAA for-
mation in this mouse model. Other proteases involved in AAA forma-
tion are (among others) cathepsins, tissue plasminogen activator (tPA),
Urokinase-type Plasminogen Activator (uPA) and plasmin [39]. ese
proteases enter the ECM through various sources: some are secreted by
VSMCs in response to stimulation by the products of elastin degrada-
tion [40], while others originate from inammatory inltrates (see be-
low) [41].
Oxidative stress is another mechanism through which elastin bers de-
grade. It represents an imbalance between the production and mani-
festation of reactive oxygen species such as peroxides and free radicals.
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ese cause toxic eects that damage dierent cell components. Oxida-
tive stress in AAA has been documented by an increased activity of oxi-
dant enzymes as well as a reduced activity of antioxidants found in AAA
tissue [42].
Lately, increasing importance has been assigned to the role of the ILT
in proteolysis and oxidative stress [10]. ILT presence is associated with a
thinner arterial wall, more extensive elastolysis, a lower density ofVSMCs
in the media, and a higher level of inammation in the adventitia [43].
While it develops slowly over the course of years, the ILT is covered by
a thin layer of fresh brin which traps neutrophils, a type of white blood
cells lled with tiny sacs of enzymes that help the cell to kill and digest
microorganisms. ese neutrophils are believed to be major sources of
proteases that are subsequently distributed centrifugally from the throm-
bus surface to the AAAwall, thus making the ILT an important reservoir
of proteases (see Figure 1.8). Furthermore the ILT also plays an impor-
tant role in oxidative stress through the haemagglutination (i.e. clutter-
ing) of red blood cells (RBCs). is process is followed by the release
of free haemoglobin, a molecule that consists of two hazardous compo-
nents: haem/iron is able to engage chemical reactions that result in the
generation of oxidants and free radicals while the globin component un-
dergoes proteolytic degradation and generates specic adverse peptides
[44].
2. Inammation
Inammation is a protective mechanism of the organism to remove in-
jurious pathogens and to initiate the healing process. However, an im-
balance in the generation of inammatory cells can have adverse aects.
e chronic inltration of inammatory cells into the aortic wall is con-
sidered one of the most important pathological features of human AAA.
e inammatory cells involved in AAA pathogenesis consist mainly of
macrophages and T-lymphocytes. Both of them are dierent types of
white blood cells that play a regulatory role in AAA progression through
the release of a cascade of cytokines that eventually evoke an increase
in both proteolysis and oxidative stress [46], causing degradation of the
ECM as described above. Inammation and proteolysis are therefore in-
trinsically connected to each other, and the disease has oen been de-
scribed as a chronic inammatory condition with an associated prote-
olytic imbalance [47]. A detailed description of all the inammatory par-
ticles that are involved is beyond the scope of this dissertation, but the
most important ones are depicted in Figures 1.8 and 1.9.
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Figure 1.9: e role of inammation in AAA formation. AAA is associated with recruitment
of inammatory cells to the aortic media, macrophage activation, and the production of proin-
ammatory molecules.e aortic lumen shows intraluminal thrombus formation and adhesion
of inammatory cells. Within the AAA vessel wall, inammatory cell inltration promotes vas-
cular smooth muscle cell apoptosis, elastin degradation, and collagen turnover either directly
or indirectly (via the production of proinammatory molecules).e AAA vessel wall architec-
ture shows typical changes, including loss of elastin, collagen deposition, depletion of vascular
smooth muscle cells, and neovascularization. Abbreviations: + promotes, - inhibits, APC−PCI= activated protein C−protein C inhibitor complex, CRP = C-reactive protein, EP = elastin pep-
tide, IFN = interferon, IL = interleukin, ILT = intraluminal thrombus, MMP = matrix metallo-
proteinase, PICP = carboxy-terminal propeptide of type I procollagen, PIIINP = amino-terminal
propeptide of type III procollagen, VSMC = vascular smooth muscle cell, TGF = transforming
growth factor, TNF = tumor necrosis factor, VEGFA = vascular endothelial growth factor A.
Adapted from [45].
3. Genetics
AAA can be considered as a complex, multifactorial disorder that inte-
grates the inuence of predisposing genes with lifestyle-associated risk
factors [11]. Despite the fact that the relative risk of developing an AAA
is approximately doubled for individuals with a rst-degree relative with
AAA [48] and the monozygotic twin of an AAA patient has a risk of de-
veloping an AAA that is 71 times higher than the monozygotic twin of
an unaected person [49], not much is known about what genetic deter-
minants inuence AAA formation. Since the rst candidate gene studies
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were published 20 years ago, approximately 100 genetic association stu-
dies using single nucleotide polymorphisms (SNPs) in biologically rele-
vant genes have been reported on AAA [50]. However, very few studies
were large enough to draw strong conclusions and few results could ac-
tually be replicated in another population. Genomewide association stu-
dies have reported two common sequence variants (rs10757278 on chro-
mosome 9p21 and rs7025486 on chromosome 9q33) that were associated
with human AAA in several populations [51, 52]. e two genes with
the strongest supporting evidence of contribution to the genetic risk for
AAA are the CDKN2BAS (also known as ANRIL) and DAB2IP genes
[50]. However, additional functional studies are needed to establish the
mechanisms by which these genes may contribute to AAA pathogenesis.
4. Biomechanics and hemodynamics
e role of structural biomechanics (i.e. mechanics of the vessel wall)
in AAA rupture is clear, since the aneurysm wall - as all other tissues -
is subjected to simple mechanical laws: it will rupture once its strength
can no longer withstand the stress that it experiences. However, uid
hemodynamics (i.e. mechanics of the blood ow) also play a role in the
initiation as well as the progression of AAA.e net stresses exerted by
the blood on the endothelial layer include a component perpendicular
to the wall, caused by the internal pressure, and a component along the
wall, the shear stress. We will not go further into this, as a more detailed
description of these hemodynamic stresses can be found in section 2.1.3.
Endothelial cells sense and respond to dierential hemodynamic stresses
that are exerted upon them [53]. A decrease in shear stress is associated
with an increase in oxidative stress in humans, and an increased ante-
grade (i.e. unidirectional along the ow) shear stress has been reported
to stimulate anti-oxidant, anti-inammatory, and anti-apoptotic aortic
gene expression in rodents [54]. As shear stress increases, the balance
between the reconstruction and destruction of proteins in the aortic wall
is shied: macrophage inltration, MMP-9 and reactive oxygen species
expression are reduced, whereas VSMC density increases [55].
ese processes do not happen directly through a decreased inltration
of inammatory particles, but indirectly through the activation of shear
responsive genes. Proteins that are known to be downstream of shear
responsive genes include inter-cellular adhesion molecule-1 (ICAM-1),
cycloxygenase-2, endothelial nitric oxide synthase (eNOS), Smad6, trans-
forming growth factor −β1 (TGFβ1), copper zinc superoxide dismutase
(SOD2), thrombomodulin and heme-oxygenase-1 (HO-1) [56]. All of
these may ultimately mitigate inammation and proteolysis when shear
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stress is decreased [57–59]. However, the role of shear stress has mostly
been demonstrated in the context of atherosclerosis [60]. In aneurysms
these experimental data are only supported by limited clinical observa-
tions, e.g. a human polymorphism resulting in a lower level of HO-1
expression is associated with a higher prevalence of AAA. A literature
review on computational studies quantifying shear stress in human an-
eurysm is provided in section 2.2.1.
1.2.3 oracic (ascending) aortic aneurysm
Prevalence
oracic aortic aneurysm (TAA) is 3 times less prevalent then its abdominal
counterpart and sixty percent of TAAs involve the ascending aorta [61]. Un-
like AAA, TAA occurs in all age groups and is more highly associated with
hereditary inuences [11].ere is a gradation of severity of the clinical course
of TAA and AAA, with symptoms at younger age, faster aortic dilatation and
higher rupture risk in the latter [9, 62]. Unfortunately, this also implies that
much less research has been devoted to the thoracic variant. Within the re-
mains of this section we will focus on ascending aortic aneurysms as they are
studied in chapter 9. Interestingly, ascending aortic aneurysm is not associated
with atherosclerosis: smoking and atherosclerotic plaque are correlated with
dilatation of the thoracic aorta starting from the arch, but not of the ascending
aorta [37].
Ascending aortic aneurysms should be categorized into 4 dierent types.
Some are directly linked to a genetic defect caused by hereditary connective tis-
sue disorders such as Marfan syndrome (MFS) [63, 64],Loeys-Dietz syndrome
(LDS) [65], Ehlers-Danlos syndrome (EDS) type IV [66] or Turner syndrome
[67]. Others are strongly associated with the presence of a bicuspid aortic valve
(BAV), which means that the valve connecting the le ventricle to the aortic
root only contains 2 leaets instead of 3 [68]. A third group has a defect in the
genes that encode the proteins that build up the contractile apparatus of the
aortic VSMCs [69]. In the majority of patients however, the aneurysm cannot
be related to any specic etiology and is therefore referred to as idiopathic as-
cending aortic aneurysm.
Structure
Much like AAAs, ascending aortic aneurysms are characterized by fragmenta-
tion of the elastic bers, an increase of collagen bers and a loss of VSMCs. No
signicant dierences were observed between specimens taken from patients
with idiopathic ascending aortic aneurysm and those with Marfan syndrome,
while thinner elastic lamellae with greater distances between them have been
observed in patients with BAV-related ascending aortic aneurysm. However,
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macroscopic and histological observations in ascending aortic aneurysms dif-
fer from what is observed in AAAs. First of all, the lumen in the ascending
aorta is essentially free from ILT: no thrombus is formed in ascending aneu-
rysms. Moreover, the density of VSMCs in the media is preserved in the most
dilated portion of aneurysms of the ascending aorta (in patients with noMFS),
while it is decreased in AAAs (see section 1.2.2).is suggests that the media of
aneurysms of the ascending aorta is re-populated by VSMCs, which is clearly
not the case in AAAs. Lastly, the pattern of micro-vessel inltration is dierent
according to the site and cause of the disease. Micro-vessels have been observed
to penetrate into the media of aneurysms in the ascending aorta, whereas those
in the media of AAAs are observed only in ruptured areas [70].
Formation and progression of ascending aortic aneurysm
Most of our knowledge of the pathophysiology of aortic aneurysms is derived
from studies on AAAs. However, extrapolation of these ndings to the tho-
racic aorta, and more particularly to the ascending aorta, is incorrect because
of signicant anatomical, structural, and functional dierences. In contrast to
AAAwhere the interaction between inammatory cell inltration and proteol-
ysis has been shown to drive aneurysm formation (section 1.2.2), things are less
clear in ascending aortic aneurysm formation.
1. Proteolysis
Only few studies have evaluated the presence of proteolysis and inam-
mation in ascending aortic aneurysm, with conicting outcomes. Studies
comparing ascending aortic aneurysm patients to controls have reported
signicantly increased levels of MMP-9 and MMP-1 but no dierences
in MMP-2, TIMP-1 or TIMP-2 [71, 72]. Other studies have, however, re-
ported dierences in the cellular expression of MMP-9 between abdom-
inal and thoracic aortas [73]. In Marfan syndrome MMP-2 and MMP-9
are found to be upregulated [74].
2. Inammation
For inammation, similar ambiguous results are reported as for prote-
olysis. While some studies report clear evidence of macrophages and T-
lymphocytes [75], others nd no signs of inammation at all [73, 76].
oracic aneurysm is characterized by the replacement of degenerated
medial tissuewith so-called cysts, which reects a non-inammatory loss
of medial VSMCs.
3. Genetics
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Figure 1.10: Molecular mechanism of Marfan syndrome. Top le: normal situation. Extra-
cellular microbrils bind the large latent complex of TGFβ, composed of the mature cytokine
(TGFβ), latency-associated peptide (LAP) and one of three latent transforming growth factor-β
binding proteins (LTBPs).is interaction is proposed to suppress the release of free and active
TGFβ (TGFβ activation). In Marfan syndrome, the absence of a sucient quotient of microb-
rils leads to failure ofmatrix sequestration of the large latent complex and promiscuous activation
of TGFβ (bottom le, lightening bolt). Free and active TGFβ (top middle, star burst) interacts
with its cell surface receptor, leading to phosphorylation (P) of the receptor-activated smad pro-
teins (R-Smads 2 and 3), which in turn bind to Smad4 and translocate from the cytoplasm to
the nucleus (bottom middle), where, combined with transcription factors (TFs), they mediate
TGFβ-induced transcriptional responses. Genes downstream of TGFβ induce phenotypic con-
sequences inMarfan syndrome including (amoong others) aortic aneurysm formation. Adapted
from [64].
No defective gene has been identied yet for idiopathic ascending aortic
aneurysms, but genetic factors play an important role in those ascending
aortic aneurysms that are caused by connective tissue diseases such as
MFS, LDS or EDS [77]. Ascending aortic aneurysm inMFS is e.g. caused
by a mutation in the brillin-1 gene [78]. Fibrillin monomers polymerize
into microbrils that (in addition with other proteins) compose elastic
bers. However, MFS pathophysiology is not directly related to a lack
of brillin monomers, as was initially assumed. An important role has
been assigned to a cytokine called transforming growth factor-β (TGF-
β). As indicated in Figure 1.10, this cytokine is normally bound to the
microbrils via a so-called latent complex. In Marfan syndrome the ab-
sence of sucient microbrils causes promiscuous activation of TGF-β
which leads to a cascade of events that culminates in altered gene expres-
sions in the cell nucleus that are eventually responsible for the syndrome’s
phenotypic consequences, including ascending aortic aneurysm forma-
tion [64]. As one can observe in Figure 1.10, TGF-β is also one of the
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cytokines that play a role in the inammatory process of AAA formation
by stimulating VSMCs, and increasing importance is being dedicated to
its mediating role in aneurysm formation.
Furthermore, genetic factors also play an important role in TAAs that
are caused by defects in genes encoding the proteins that build up the
contractile apparatus of aortic VSMCs, such as myosin heavy chain 11
(MYH11) [79], smooth muscle actin alpha 2 (ACTA2) [80] or myosin
light chain kinase (MYLK) [81].
4. Biomechanics and hemodynamics
Not much research has been performed on the role of hemodynamics in
ascending aortic aneurysm specically, as demonstrated in the literature
review in section 2.2.1. e mechanisms described in section 1.2.2 are,
however, valid throughout the arterial system and might therefore also
play a role in thoracic aortic aneurysm formation.
1.2.4 Current hypotheses to explain dierent aneurysm locations
As described in the previous sections, a lot of research has been dedicated to
study the progression and pathophysiology of existing aneurysms. However,
little is known about the initial step, the local trigger causing the cascade of
events that lead to aortic dilatation. Many of the known risk factors described
in section 1.2.2 (including age, smoking and hypertension) are systemic and do
not dier along the arterial wall. Yet, aortic disease seems to be predisposed to
occur most frequently at the abdominal and, to a lesser extent, the ascending
aorta. In this section, we will discuss some of the hypotheses that have been
proposed to explain this phenomenon.
e elastin to collagen ratio
As described in section 1.1.3, the number of elastin bers that is present in the
media is highest in the large elastic arteries of the thoracic aorta and decreases
towards the muscular arteries further downstream. Remarkably, the relative
amount of elastin reaches a local minimum in the infrarenal abdominal aorta,
as depicted in Figure 1.11. e local elastin minimum coincides with the loca-
tion where AAA incidence is highest. Since a minimal number of elastic lamel-
lae needs to be injured for aneurysms to form, the reduced number of elastic
lamellae may explain their abdominal tropism [37]. It might also explain why a
stronger inammatory reaction and medial degradation are reported in AAAs
[47].
e embryonic origin of VSMCs
Another factor that gradually varies along the aorta is the embryonic origin of
VSMCs and how they respond to TGF-β. VSMCs in the proximal end of the
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Figure 1.11: Relative amount of elastin expressed as a percentage of total elastin and collagen in
the dog aorta. Note that elastin predominates in the thoracic aorta, but not in the abdomen.e
relative amount of elastin is minimal in the infrarenal aorta. Adapted from [82].
aorta originate predominantly from the neural crest, whereasmore distally they
are derived from the mesoderm.e VSMC response to TGF-β varies sharply
according to their embryonic origin: TGF-β mediates growth and collagen-I
production in thoracic VSMCs, whereas it inhibits growth and has no eect
on collagen-I synthesis in abdominal VSMCs [83]. Since VSMCs are key de-
terminants of aneurysm formation [32] and expansion [33] through their role
in protein production, dierences in their response to a growth factor such as
TGF-β are expected to modulate the aortic response to inammation and pro-
teolysis and thus determine the topology of aneurysm formation. Moreover,
the embryonic origin of VSMCs might explain why aneurysm inMFS patients,
in which excessive TGF-β signaling plays an important role (section 1.2.3) is
almost always limited to the ascending aorta.
Hemodynamics
Hemodynamic shear stress is a third factor that varies along the aorta. As de-
scribed in section 1.2.2, endothelial cells respond to changes in shear by activat-
ing shear-responsive genes that ultimately mitigate inammation and proteol-
ysis.is suggests that regional dierences in aortic hemodynamic conditions
may account for dierential aneurysm risk. Several studies support this view:
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1. In patients with bicuspid valves, VSMC apoptosis predominates in the
convex part of the ascending aorta, even in the absence of an aneurysm
[84].is suggests that locally altered shear conditions inuence the ini-
tial phases of medial degeneration in ascending aortic aneurysms.
Figure 1.12: AAAs develop in patients with above-knee amputation. Reproduced from[85].
2. A signicantly higher prevalence of AAA has been reported in patients
with one amputated leg: 329 men that lost a leg in World War II were
compared to 702 matched controls (World War veterans).ey were in-
vestigated 43 years aer amputation, and 5.8 % of the amputees had de-
veloped AAA, compared to 1.1 % of the non-amputees [85].is suggests
that local altered hemodynamics play a role in the initial phase of AAA
formation, especially since the location of the aneurysmwas in almost all
cases opposite to the amputated leg (see Figure 1.12).
3. e occurrence of AAA is higher in patients with peripheral vascular
occlusive disease or spinal cord injury (SCI): 89 SCI patients and 223
matched controls were investigated and 20.2 % of SCI had a AAA, com-
pared to 8.9% of controls [86]. Both peripheral occlusive disease and SCI
are conditions in which infrarenal abdominal shear stress is decreased
[87], which suggests that these altered hemodynamic conditionsmay play
a role in AAA formation in these patients.
4. Lower and more oscillatory shear conditions have been reported in the
distal (infrarenal) abdominal aorta compared to the descending thoracic
aorta [88]. e lower prevalence of aneurysms in the thoracic segment
may thus also point to the role shear stress plays in protecting the thoracic
aorta from inammation, proteolysis and VSMC death.
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e nal goal of this dissertation is to increase knowledge on one very specic
research question:
Why do aortic aneurysms have a predisposition to develop at some very dis-
tinct aortic locations, and what is the role of local hemodynamics herein?
One might note that the role of hemodynamics in AAA is mostly a sug-
gestive one, supported by large cohort studies in patients with aberrant aortic
hemodynamics. Despite the fact that the mechanisms through which shear
stress may interfere in proteolytic and inammatory mechanisms are partly
known (section 1.2.2), there is a lack of direct evidence that shear stress is actu-
ally involved in the initial phase of aneurysm formation.e reason is simple:
unlike proteolytic or inammatory particles, shear is not a quantity that is eas-
ily measured on post-mortem tissue. Shear stress needs to be calculated (see
chapter 2) and for these calculations to be trustworthy, in vivo measurements
are indispensable (see chapter 3). In humans, shear stress calculations in the
initial phase of aneurysm formation are hampered by the fact that the disease
is asymptomatic: aneurysm is usually only detected when it is already present,
drastically limiting the available in vivo data on its initial phase. To overcome
this problem, mouse models of aneurysm formation can be used.
1.3 Aneurysm formation in mice
1.3.1 Mice in cardiovascular research
Mice as a model for humans
As the use of human subjects inmedical research is restricted to those examina-
tions that in noway endanger the patient’s health, the human is the onemammal
we cannot use in most of our experiments, while it is the one we are generally
most interested in. e need for laboratory animals is therefore obvious: not
only do they oer tremendous possibilities to investigate dierent disease stages
as they can be sacriced and examined at any time point, they are also indis-
pensable to test newly-developed pharmaceutical treatments. Over the course
of time, mice have become the animal model of choice, not just in the cardio-
vascular eld but in all medical research: a search for the key word ‘mouse’ in
Pubmed, one of the most renowned databases of medical papers, results in an
astonishing 1,147,753 peer-reviewed articles in which - in one way or another -
mouse models are used to increase our knowledge on human pathology.
e reasons why the mouse has become the most-used animal model are
plenty. First of all, mice aremammals andmany of their characteristics (includ-
ing the cardiovascular system: see section 1.3.2) are anatomically very similar
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to the human counterpart. Mice even naturally develop conditions that mimic
human disease, including cardiovascular disease, cancer and diabetes. As ro-
dents they don’t require any specic feeding and due to their small size, they are
easier to keep and oer a low maintenance cost compared to other, larger lab-
oratory animals.eir short lifespan (mice are mature at 2 months and usually
die of old age aer 2 years) allows for longitudinal research and their short ges-
tation (21 days) implies a generation time of only 9 weeks.ey breed through-
out the year, produce relatively large litters (an average ospring of 10-12 an-
imals/litter at optimal production) and are better resistant to inbreeding than
most other mammalian species. Mice have been used in medical experiments
since the 19th century [89], which over the course of time has resulted in a sig-
nicant amount of knowledge that has culminated in a complete description of
the mouse genome in 2002 [90].e latter is extremely important: since most
human genes have a murine counterpart, selective gene modications have in-
creased our understanding of (the genetic component of) many diseases since.
Genetic modication
Dierent techniques exist to aect murine genes. In transgene mice, a piece of
DNA including the structural gene of interest (the ‘transgene’) is extracted and
injected into fertilized mouse eggs, which are then implanted into the uterus of
a surrogatemother.e selected genewill be expressed in some of the ospring.
However, nowadays many researchers rely on a more sophisticated variant: so
called knock-in mice. A knock-in mouse is generated by targeted insertion of
the transgene at a selected locus.e researcher thus obtains complete control
of the genetic environment and it is less likely that the DNA incorporates itself
intomultiple locations. A third technique that is commonly used are knock-out
mice. In this case, genetic information is not added but inactivated or ‘knocked
out’ by replacing or disrupting it with an articial piece ofDNA.e phenotypes
of knock-out mice can be very complex because all tissues are aected, and it is
not uncommon for a knockout mouse to die in the embryonic phase or to show
no phenotype at all.anks to these and other techniques, certain diseases that
aict humans but normally do not strike mice have been induced in the latter,
such as Marfan syndrome [78] or even Alzheimers [91].
1.3.2 e cardiovascular system in mice
e general structure of the murine cardiovascular system is very similar to the
human cardiovascular system described in section 1.1: the systemic arterial cir-
culation delivers oxygenated blood from the heart to the distal tissues and cells,
and the systemic venous circulations transports oxygen-depleted blood back
towards the heart, aer which it enters the pulmonary circulation. However,
the cardiovascular system in mice is in many aspects a smaller, faster version
of the human one. Aortic diameters are at least a factor 10 smaller: the average
25
1. Of mice and men: anatomy and (patho-)physiology
Figure 1.13: Anatomical position of the mouse aorta and its main branches.e le panel shows
the thoracic aorta while the abdominal aorta is depicted on the right. Note the asymmetric loca-
tion of both kidneys and the distally located inferior mesenteric artery, compared to the human
case in Figure 1.2. Adapted from [92].
ascending aorta measures around 1-2 mm, as opposed to 2-3 cm in the human
aorta. Except for size, the most important dierence is in the heart rate: the
average mouse heart beats around 500-600 times per minute, which is 10 times
faster than the average human heart.e anatomy of the arterial system, as de-
scribed into detail in section 1.1.2, is also very similar: the mouse is one of the
fewmammals that has 3 branches branching o the aortic arch, and all abdom-
inal arteries branching o the human abdominal aorta can also be found in the
mouse. However, some subtle dierences exist. Unlike the human counterpart,
le and right kidneys are not positioned symmetrically in the mouse abdomen:
the le renal artery branches o distal to the right renal artery as depicted in
Figure 1.13. Moreover, the inferior mesenteric artery is located far more distally
than in the human case. More details on the comparison of morphological hu-
man and murine arterial properties (in the aortic arch) are provided in chapter
4.
1.3.3 Aneurysm developing mouse models
An extensive overview of the existing mouse models for aneurysm formation-
can be found in Table 1.1.emodels have been subdivided into threemain cat-
egories: genetical induction, chemical induction and angiotensin II-infusion.
Genetically induced models
Using transgenic, knock-in and knock-out techniques as described in section
1.3.1, many researchers have attempted to create mouse models developing an-
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Table 1.1: Literature review on existing mouse models for aneurysm formation.
Mode of aneurysm induction Year Location Characteristics Ref
Genetically induced
Transgene renin/angiotensin 1993 AAA MD [93]
LDL −/− receptor 1994 AAA MD [94]
ApoE −/− 1992 AAA MD A [95, 96]
ApoE −/− x eNOS −/− 2001 AAA MD A T [97]
LDL −/− receptor x LRP −/− 2003 AAA MD A [98]
Col1A1 decient 2004 AAA MD [99]
Blotchy 1988 AAA & TAA MD [100]
Lox decient 1990 AAA & TAA MD [101]
MMP-3 decient 2001 AAA & TAA MD [102]
Timp-1 decient 2002 AAA & TAA MD [103, 104]
PLOD 1 −/− (EDS type VI a) 2007 AAA & TAA MD [105]
FFN-1 −/− (MFS) 1991 TAA MD [78]
Fibulin-4R/R reduced 2007 TAA MD [106]
Transgene S100A12 2010 TAA MD [107]
Chemically induced
Elastase 1990 AAA MD I [38, 108]
Calcium chloride 2001 AAA MD I [109, 110]
Angiotensin II-infused
ApoE −/− 2000 AAA & TAA MD A T I [111, 112]
LDL −/− receptor 2003 AAA MD A T I [113]
C57Bl/6 2003 AAA MD T I [113]
ApoE −/− + cigarette smoke 2010 AAA MD A T I [114]
KLF 15 −/− 2010 AAA & TAA MD [115]
C57Bl/6 treated anti−TGF−β 2010 AAA & TAA MD A T I [116]
AAA=Abdominal aortic aneurysm, TAA=oracic aortic aneurysm, MD=Medial
Degeneration, A=Atherosclerosis, T=rombus formation, I=Inammation
eurysm. Transgenic mice overexpressing renin and angiotensin were reported
to develop AAA aer having been exposed to 10 days of increased salt intake
[93]. Other genetically engineeredmice were decient in receptors for low den-
sity lipoprotein (LDL) [94] and apolipoprotein E (ApoE) [95, 96], commonly
referred to as LDL −/− and ApoE −/− mice.ese mouse models, when put on
a fat, cholesterol-rich diet, develop atherosclerotic plaque and were thus pri-
marily used as a model for atherosclerosis. Suprarenal AAAs were, however,
also frequently reported. ese hyperlipidemic mice have been crossed with
other genetically altered mice in an attempt to increase AAA incidence. First,
micewith a combined deciency forApoE and endothelial nitric oxide synthase
(eNOS) were developed [97], which resulted in a 25% incidence of AAA inmale
mice and, unlike all previous models, thrombus formation. A similar approach
was followed when LDL −/−mice were combined with a mousemodel decient
for low-density lipoprotein receptor-related protein (LRP), a multifunctional
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protein that in this case was depleted specically in the VSMCs. e result-
ing mouse model developed a dilated and thickened aortic wall in both the as-
cending and abdominal aorta, with additional large AAAs formed in the latter
[98]. Finally, mice with a deletion in the rst intron of the Col1A1 gene were
reported to develop abdominal aortic dissection and rupture at adult age [99].
Remarkably, none of the hitherto described genetically induced AAAs present
inammatory signs that are typical of aneurysm progression in humans, and in
only one of them (ApoE −/− x eNOS −/−) AAA thrombus formation has been
reported.
Blotchy [100] and Lysyl oxidase (Lox)-decient [101] mice showed defects
in the extracellular matrix (ECM) that resulted in medial degeneration and an-
eurysm formation, both in the thoracic and the abdominal aorta. However,
these models are associated with generalized health problems that limit their
usefulness. As described in section 1.2.2, MMPs and their inhibitors (TIMPs)
play an important role in proteolysis and the subsequent degeneration of elastin
bers.is has lead to the development of genetically engineeredmice with de-
ciencies inMMP-3 [102] and TIMP-1 [103, 104], also showingmedial degener-
ation in both the thoracic and abdominal aortic segments. Mice with targeted
inactivation of the Plod1 gene for lysyl hydroxylase 1 (LH1) also present aortic
aneurysm in both thoracic and abdominal aorta, causing 15%of these animals to
die of aortic rupture [105].e latter mouse model is representative for Ehlers-
Danlos syndrome type VIa in humans.
Aneurysms restricted to the ascending aorta were found in the brillin-
1 (FBN-1) knock-out mouse model, representative for Marfan syndrome [78].
As humanMFS patients, these animals present ascending aortic aneurysm for-
mation following the TGF-β related pathologic mechanism described in sec-
tion 1.2.3. A particularly interesting mouse model for thoracic aneurysm in-
vestigated the role of Fibulin-4, a protein that is involved in stabilizing the or-
ganization of extracellular matrix structures such as elastic bers. Complete
elimination of Fibulin-4 resulted in embryonic death due to arterial hemor-
rhage [117]. Subsequently, a dose-dependent requirement for Fibulin-4 was
determined [106]: mice with a systemic 4-fold reduced Fibulin-4 expression
level (Fibulin-4R/R mice) show severe dilatation of the ascending aorta as well
as a tortuous aorta, while a modest 2-fold reduction in expression of Fibulin-
4 (Fibulin-4+/R mice) only resulted in clear aberrations in elastin formation
with occasionally small aneurysm formation in the ascending aorta. Finally,
transgenic mice expressing human S100A12 (a small calcium binding protein)
in their VSMCs were also reported to develop thoracic aneurysm [107].
Not all attempts to create aneurysm-developing mice by targeting specic
genes lead to aneurysm formation in adult animals. e destructive nature of
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these techniques oen leads to a phenotype that is not viable (see section 1.3.1),
and embryonic or neonatal death due to aortic rupture has been reported in
several novel mousemodels [118–123].esemodels were not included in Table
1.1.
Chemically induced models
As described in section 1.2.2 elastolysis, the proteolytic degradation of elastic
bers, is a major contributor to AAA pathology. is inspired researchers to
invoke AAAs by infusing elastases into the infrarenal abdominal aorta of rats
[38]: a catheterwas rst introduced at the iliac bifurcation, then a segment of the
abdominal aorta was isolated by sutures, and nally elastase originating from a
porcine pancreas was introduced into the lumen and incubated for 5 minutes
before restoration of ow. is model, leading to infrarenal AAA formation,
was later extended to mice [108]. In a second chemically induced model, AAA
was observed aer the abdominal aorta had been exposed to calcium chloride.
e exposure happened either through placement of a gauze soaked in a cal-
cium chloride solution or through direct placement of a concentrated solution
on the infrarenal aorta [109, 110]. Due to the specic targeting of the abdominal
aorta, no ascending aneurysms have been observed in these chemically induced
mouse models. In contrast with the genetically determined ones, these models
do present inammatory signs related to AAA formation. However, no throm-
bus formation was observed in either model.
Angiotensin II - infusion models
In 2000, genetic and chemical methods were combined when Daugherty et al.
discovered that infusion of the peptide hormone angiotensin II into ApoE −/−
decientmice leads to AAA formation in the suprarenal aorta [111]. AAAs were
also observed when angiotensin II was infused into LDL −/− decient mice and
even in regularC57Bl/6micewithout any genetic defect [113], albeit with amuch
lower incidence in the latter. A small osmotic pump lled with angiotensin
II is implanted subcutaneously, under the mouse skin (see Figure 1.14). ese
pumps continuously deliver angiotensin II for a period of 28 days at a pace of
1000 ng/kg/min.
Within the rst days aer pump implantation macrophage accumulation
is observed in the media, associated with elastin degradation. It is not clear
whether the macrophage accumulation acts as a stimulus for elastin degrada-
tion or vice versa. Between 3 to 10 days aer pump implantation, gross dissec-
tions of the aortas are observed that lead to prominent thrombus formation.
Aer this initial phase, there is a more gradual rate of lumen expansion that is
progressive with continued angiotensin II exposure. ere is extensive aortic
remodeling during this gradual expansion phase, and inammatory responses
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Figure 1.14: Implantation procedure of a subcutaneous osmotic pump for angiotensin II-
infusion in ApoE −/− mice. A.e animal is anesthetized using isourane and a dorsal incision
is made. B.e osmotic pump (model Alzet 2004; Durect Corp, Cupertino, CA ), containing ±
220 µl angiotensin II (Bachem, Bubendorf, Switzerland), is implanted subcutaneously. C.e
wound is sutured. D.e pump continuously delivers angiotensin II for a period of 28 days to
provoke aneurysm formation. Pictures taken in the context of chapter 9.
are observed in the form of inltrating macrophages, B and T lymphocytes. At
later stages of the disease evolution, large atherosclerotic lesions are apparent
[124].
is angiotensin II-infused mouse model is leading to AAAs that corre-
spond very well to the human pathology presented in section 1.2.2: not only do
they present medial degradation and thrombus formation, they are also consis-
tent with an activation of inammatory response that stimulates a proteolytic
cascade. e latter was clearly demonstrated as a broad-spectrum MMP in-
hibitor, doxycycline, signicantly reduced the incidence and severity of An-
giotensin II-induced AAA formation [125]. Another important characteristic
that is in agreementwith clinical (human) observations is the enhanced propen-
sity forAAAs inmalemice: the incidence is approximately twice that of females.
Moreover, the same animal model has recently been reported to present as-
cending aortic aneurysm as well [112]. Interestingly, as in the human case these
ascending aortic aneurysms seem to follow a dierent pathology, without any
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thrombus formation.
Figure 1.15: A. Suprarenal AAA formed in an angiotensin II-infused ApoE −/− mouse. Repro-
duced from[126]. B. Abdominal aorta of a saline-infused ApoE −/− control mouse (le) and an
angiotensin II-infused ApoE −/− mouse developing AAA (right). Reproduced from[111].
Recently, angiotensin II-infusion has been combinedwith other genetic and
chemical techniques to study aneurysm formation. Cigarette smoke inhalation
was found to doubleAAA incidence [114]. Deciency of the transcriptional reg-
ulator Kruppel-like factor 15 (Klf15) was reported to induce both heart failure
and aortic aneurysm formation (72% abdominal, 28% thoracic aorta) in an-
giotensin II-infused mice [115]. Finally, a particularly interesting study showed
that systemic neutralization of TGF-β activity breaks the resistance of normo-
cholesterolemic C57BL/6 mice to angiotensin II−induced AAA formation and
markedly increases their susceptibility to the disease [116]. Amodest but signif-
icant dilatation of the ascending aorta was also reported in these anti−TGF-β
treated mice. ese results are at odds with the pathogenesis of Marfan syn-
drome, where TGF-β signaling is the driving force instead of playing a pro-
tective role. It has therefore been hypothesized that TGF-β may be protective
specically in the setting of acute and intense inammation [11].
Choosing the right mouse model
Within this dissertation, we have opted for the angiotensin II-infused ApoE−/− mouse as the model of choice to study aneurysm formation. e reasons
for this are twofold. First of all, as already discussed, the angiotensin II−infused
ApoE −/− mouse model is (currently) the one that mimics human disease best.
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rombus formation as well as inammatory and proteolytic reactions have
been observed. Most other models either present no inammatory reactions
(e.g. most genetically engineered models) or when they do, no thrombus for-
mation is observed (most chemically induced models). A second reason why
we chose angiotensin II-infused ApoE −/− mice was motivated by the fact that
we are specically interested in the location of aortic aneurysm along the aorta.
In this respect, hyperlipidemicmousemodels such as ApoE −/−mice are partic-
ularly interesting, as they develop abdominal aneurysms in the suprarenal re-
gion and not - as in the human case - in the infrarenal region. Since, unlike the
chemically induced methods, the location of the aneurysm is not determined
by the induction method, this makes ApoE −/− mice a specically well-suited
model to investigate whether altered local hemodynamics play a role in the ini-
tial phase of aneurysm formation. Additionally, angiotensin II-infused ApoE−/− mice present both abdominal and ascending aortic aneurysms, which al-
lows for a comparison between both within the same mouse model.
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Computing aortic hemodynamics
2.1 Computational Fluid Dynamics in blood vessels
Since detailed hemodynamics (by which is meant details of the ow eld, as
pressures are not directly considered in this work) in the human or murine
aorta cannot be measured directly and are too complex to be calculated in an
analytical way, they are computed with Computational Fluid Dynamics (CFD)
techniques. Initially used by (among others) the aviation industry to calculate
ow around an airfoil [127], CFD has become the method of choice to solve
complicated ow problems for a wide scope of engineering purposes. In bio-
medical research CFD has not only been used to simulate the behavior of blood
ow in the cardiovascular system, but also for air ow in the bronchial tubes
[128], or the ow of cerebrospinal uids protecting the brain [129]. Its use has
increased over the last decades, as the computational power of today’s computer
systems allows us to solve ow problems that were simply not possible to solve
not so very long ago. It is, however, important to take into account a number of
theoretical approximations and practical considerations when interpreting the
colorful drawings that are usually the output of a CFD simulation.is section
consists of three parts that aim to provide the reader with the necessary back-
ground information to do so. First, the governing equations of a typical ow
problem are reduced to a simplied formulation representing blood ow in an
artery. en, the theoretical mechanisms that are used to convert these equa-
tions into a CFD environment are claried. A third and nal section explains
the practical settings that are needed to set up and interpret a CFD simulation
of a cardiovascular ow problem.
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2.1.1 Governing equations
e physical laws a uid has to obey are represented by two basic principles:
conservation of mass and conservation of momentum.
Conservation of mass
Consider a general uid owing through a general control volume. e prin-
ciple of conservation of mass states that the net rate of mass ux through the
control surfaces, i.e. the dierence between what goes out and what goes in,
should be equal to the rate of mass accumulation within the control volume:
∫
c.s.
ρ f (v⃗ ⋅ n⃗)dA´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
rate of mass ux
+ ∂
∂t ∫c.v . ρ f dV´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
rate of mass accumulation
= 0 (2.1)
In this equation, ρ f is the uid density, v⃗ is the velocity vector eld and n⃗ is
the normal vector on the control surface c.s., pointing out of the control volume
c.v. In dierential formulation, this equation can be formulated as :
Dρ f
Dt
+ ρ f∇ ⋅ v⃗ = 0 (2.2)
with Dρ fDt the substantial derivative of the density ρ f , which is the sum of a tem-
poral derivative ∂∂t and a convective derivative v ⋅ ∇. Within this dissertation,
blood in the arterial system is modeled as an incompressible uid. is as-
sumption implies that its density is constant, and does not change over time
nor with changes in pressure or temperature. Under this assumption, the sub-
stantial derivation Dρ fDt reduces to zero and the conservation of mass reduces
to:
∇ ⋅ v⃗ = 0 (2.3)
Conservation of momentum
Conservation of momentum is based on Newton’s second law of motion, com-
monly known as F = M ⋅ a. e net force a body experiences is thus directly
proportional to its acceleration and mass. Translated into a uid environment
this results in equation 2.4.e sum of the net rate of momentum ux through
the control surface and the rate of change of momentum inside the control vo-
lume equals all forces working on the system.
∫
c.s.
ρ f v⃗(v⃗ ⋅ n⃗)dA´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
rate of momentum ux
+ ∂
∂t ∫c.v . ρ f v⃗dV´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
rate of momentum accumulation
=∑ F⃗ (2.4)
ese forces can be subdivided into:
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• e surface forces due to stresses acting on the body, represented by the
tensor σ¯ f .
• e body forces due to external forces acting on the body (e.g. gravita-
tional or electromagnetic forces), represented by f⃗ f .
For an incompressible uid the dierential formulation of equation 2.4 comes
down to:
ρ f∇ ⋅ v⃗v⃗ + ρ f ∂v⃗∂t = ∇ ⋅ σ¯ f + f⃗ f (2.5)
e rst term in the le hand part of equation 2.5 can be expanded into two
dierent terms (equation 2.6). Taking into account the conservation of mass
(2.3) the second term can be dismissed and the rst term in the le hand part
of equation 2.5 reduces to:
∇ ⋅ v⃗v⃗ = v⃗ ⋅ ∇v⃗ + (∇ ⋅ v⃗)v⃗ = v⃗ ⋅ ∇v⃗ (2.6)
e right hand part of equation 2.5 can also be simplied when modeling
blood ow in the cardiovascular system of a mouse. Body forces f⃗ f are ne-
glected as in small animals the inuence of gravity is negligible compared to
the stresses σ¯ f acting on the surface of the body, and the latter are subdivided
into two dierent parts:
• normal stresses caused by the internal pressure p f (per unit area) that are
exerted perpendicular to the surface.
• the shear stress tensor τ¯ f caused by viscous forces (per unit area) that are
exerted parallel to the surface.
∇ ⋅ σ¯ f + f⃗ f ≅ ∇ ⋅ σ¯ f = ∇ ⋅ (−p f I¯ + τ¯ f ) (2.7)
Taking into account equations 2.6 and 2.7, equation 2.5 can then be formu-
lated in dierential form as:
ρ f
∂v⃗
∂t
+ ρ f v⃗ ⋅ ∇v⃗ = −∇p f +∇ ⋅ τ¯ f (2.8)
e le hand side can be reformulated using the substantial derivative Dv⃗Dt to
nally obtain the Navier-Stokes equations in dierential form:
ρ f
Dv⃗
Dt
= −∇p f +∇ ⋅ τ¯ f (2.9)
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2.1.2 Computational Fluid Dynamics in theory
General principle
e conservation of mass and the Navier-Stokes equations (equations 2.3 and
2.9) form a system of coupled non-linear partial dierential equations (PDEs).
Closed form analytical solutions for these PDEs are feasible in some distinct
cases in which the non-linear terms can be neglected (e.g. creeping ows) or
naturally drop out due to the nature of the problem (e.g. fully developed ow in
a duct). In most engineering applications however, non-linearities in the gov-
erning PDEs cannot be neglected and it is virtually impossible to obtain a closed
form analytical solution for the problem. Computational Fluid Dynamics or
CFD provides an elegant way to overcome this limitation: an approximate so-
lution is obtained by a so-called discretization of the problem.e continuous
formulation of the governing equations is converted into a discrete formulation
and solved with the aid of a computer. Dierent spatial discretization methods
exist, but within this dissertation the nite volume method is used: the uid
domain is subdivided into a grid of smaller control volumes (as in Figure 2.4)
and the governing equations are converted into a set of algebraic equations and
solved over each control volume.ese equations are generally solved in an it-
erative loop, basing the input for the next step on the output of the previous one,
until the error in the numerical solution is lower than a predened threshold.
e CFD simulations performed within this dissertation were performed using
the commercial CFD soware package Fluent (Ansys, Canonsburg, Pennsyl-
vania). Details about the implementation of the used approximations are de-
scribed in the sections below.
Discretization in space
Figure 2.1: Comparison of the Eulerian and Lagrangian grid approaches. Adapted from [130].
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An Eulerian grid is used to subdivide the uid domain into control volu-
mes. An Eulerian grid is xed in space throughout the computation, as op-
posed to a Lagrangian approach in which the grid is connected to the material,
and is allowed to deform throughout the computation. e latter approach is
the method of choice for structural computations in Computational Solid Me-
chanics (CSM).e dierence between both approaches is claried in Figure
2.1. While solving the equations, Fluent uses a co-located scheme: all quanti-
ties (including pressures and velocities) are stored in the center of the grid cell
(Figure 2.2). However, face values are also needed throughout the computation
(see section 2.1.2). In order to obtain face-centered pressure values - needed
to solve the conservation of momentum - Fluent uses an interpolation scheme.
For the face-centered velocity values however - needed to solve the conserva-
tion of mass - a linear interpolation of the cell-centered velocities would result
in unphysiological checkerboarding of the pressure values [131].is problem is
solved by adding a pressure-dependent term to the mass uxes:
J f = Jˆ f + d f (pc0 − pc1) (2.10)
In this equation, pc0 and pc1 are the pressures within the two cells on either
side of the face f (see Figure 2.2), and J f is the mass ux through the face f.
Jˆ f contains the inuence of cell-centered velocities in c0 and c1, and the term
d f (m/s) is function of the momentum equation coecients for these cells. Fi-
nally, face-centered values are also needed for other scalar quantities ϕ that are
transported during the solution procedure (e.g. momentum coecients, tem-
perature, etc). In this case, a second order upwind scheme is used: face values
of a scalar quantity ϕ are derived from the cell lying upstream or upwind.is
is achieved by taking a Taylor expansion of the cell centered solution about the
cell centroid:
ϕ f = ϕc−up + (∇ϕ)c−up ⋅ r⃗ (2.11)
with ϕc−up and (∇ϕ)c−up the cell-centered value and its gradient in the up-
stream cell, and r⃗ the displacement vector from the upstream cell centroid to
the face centroid.
Discretization in time
For transient (non steady-state) simulations, the governing equations must not
only be discretized in space, but also in time. Within this dissertation, an im-
plicit backward Eulerian scheme has been used to solve the equations over time.
Consider t represents the current time step while t+1 represents the next time
step, in which the ow eld is still unknown, and t-1 the previous time step.
In a backward Euler scheme, the derivative of a scalar quantity ϕ over time is
approximated by the implicit equation 2.12a.e discretization is implicit since
ϕt+1 in a given cell is a function of unknown quantities ϕt+1 in that cell and the
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Figure 2.2: Simplied 2D representation of a control volume. e face center f is connected to
the cell centers c0 and c1 of its neighboring cells by the displacement vectors r⃗0 and r⃗1 .
surrounding cells via the term X(ϕt+1). In a second-order backward scheme,
time discretization is performed as in equation 2.12b. Within this dissertation,
a second order scheme was applied for all simulations.
ϕt+1 − ϕt
∆t
= X(ϕt+1) (2.12a)
3ϕt+1 − 4ϕt + ϕt−1
2∆t
= X(ϕt+1) (2.12b)
Solving the equations
For all simulations performed within this dissertation, a pressure-based segre-
gated solver is used in Fluent. In a segregated solver the governing equations are
solved sequentially, only taking into account one variable eld in each step.e
SIMPLE scheme (Semi-Implicit Method for Pressure-Linked Equations) was
used to do so. A schematic overview of the solution method is given in Fig-
ure 2.3. As the pressures p and mass uxes J f are both unknown, the method
starts o with an initial guess for the pressure eld: p*. is allows us to solve
a matrix of linearized momentum equations in all cells for the unknown mass
uxes J∗f , using a point implicit Gauss-Seidel technique. A detailed description
of this method falls beyond the scope of this work but can be found in the Flu-
ent manual. Taking into account equation 2.10 the resulting face mass uxes J∗f
can then be described in terms of the guessed pressure p∗:
J∗f = Jˆ∗f + d f (p∗c0 − p∗c1) (2.13)
In this equation, p∗c0 and p∗c1 are the (guessed) pressures within the two cells on
either side of the face f, J∗f is the estimated mass ux through the face f, Jˆ∗f is a
term containing the inuence of velocity in surrounding cells and d f is func-
tion of the momentum equation coecients for these cells. However, the thus
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Figure 2.3: Schematic overview of the pressure-based segregated solution method using the
SIMPLE scheme.
obtained mass uxes J∗f will not necessarily satisfy the conservation of mass.
erefore, themass ux is corrected for with an extra, pressure-dependent term
J′f :
J f = J∗f + J′f = J∗f + d f (p′c0 − p′c1) (2.14)
Substitution of equation 2.14 then allows for a description of the equations for
conservation ofmass in terms of the pressure-correction p’.ismatrix of equa-
tions is solved for p’ numerically using the algebraic multigrid method. As for
the Gauss-seidel technique, a detailed description of this method falls beyond
the scope of this work but can be found in the Fluent manual. Once p’ is known
in all cells, it is used to update the value for face-centeredmass ux (J f ) in equa-
tion 2.14 and to update the value for cell-centered pressure p. Pressure is not
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transferred to the next iteration directly as rst under-relaxation is performed:
p = p∗ + αpp′ (2.15)
with α the used under-relaxation factor for pressure, taken as 0.3 in Fluent by
default. Once pressures and face mass uxes are updated, other scalar equa-
tions describing the transportation of energy, species or turbulence are solved
numerically (if necessary). In general, each scalar quantity ϕ that is updated in
between iterations is calculated as a weighted sum of the value that was used in
the previous iteration (ϕi−1), and the value that was calculated from the updated
governing equations (ϕnew):
ϕi = ϕi−1 + α(ϕnew − ϕi−1) (2.16)
Underrelaxation cushions the dierence between consecutive iterations, thus
allowing for a smoother and faster solution process. Once all equations are
solved, the residual of the governing equations is compared to a predened
threshold. As long as this convergence criterium is not met, the updated vari-
ables are used as the input for a new iteration step. e solving procedure is
thus repeated until a converged solution is reached (Figure 2.3).
2.1.3 Computational Fluid Dynamics in practice
Preprocessing the geometry: the segmentation
CFD simulations in the cardiovascular system are set up with a specic goal:
to calculate the ow eld in a geometry of interest, in this work a (pathologi-
cal) aortic vessel.is geometry is in almost all cases based on medical images
obtained fromMagnetic Resonance Imaging (MRI) or Computed Tomography
(CT) scans. Within this dissertation, a micro-CT scanner dedicated for small
animal imagingwas used for all cardiovascular geometries. More detailed back-
ground on small animal imaging can be found in chapter 3. Existing medical
imaging techniques do not scan specic organs but the complete intersection of
(a part of) the body, resulting in a stack of 2D images. A 3D model of the aorta
should be extracted from these images by a technique that is called segmen-
tation (Figure 2.4). Several commercial (e.g. Mimics (Materialise) or Amira
(Visage Imaging)) and open-source (e.g. VTK-snap or 3D-Slicer) packages ex-
ist to perform the segmentation process.
Some packages (e.g. Mimics) use a semi-automatic approach, based on dif-
ferences in image contrast between dierent structures in the body.ese dif-
ferences are expressed inHounseldUnits (HU), ameasure that is proportional
to the density of the material (see section 3.1). resholding (based on the ab-
solute HU values) and morphological (based on erode- and dilate operations)
techniques are then used to segment the aorta. Other packages (e.g. VTK-snap)
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Figure 2.4: Segmentation of a human AAA. A stack of medical images is obtained (2 slices are
depicted). Aer segmentation, dierent 3D structures can be dierentiated, i.c. as the skeletal
structure (in yellow) and the aorta (in red). Courtesy of Materialise (Leuven, Belgium).
oer a more automated approach based on active contours or snakes.e user
places some seeds within the structure that needs to be segmented, and these
actively grow to ll up the desired geometry. Edge intensity (based on the HU
gradient) and statistical probability maps (based on the probability that a cer-
tain pixel belongs to the geometry of interest) techniques are then used to detect
the edges of the geometry of interest [132].
Despite the fact that the latter method provides several adjustable parame-
ters to prevent the snake from ‘leaking’ into neighboring structures, it is di-
cult to automatically separate aortic and venous structures in a murine setting.
Not only are both structures positioned on top of each other (see Figure 1.13
for a schematic representation of the vessels in the murine abdomen), they also
both have the same HU value as they are both lled with (contrast-enhanced)
blood (see Figure 3.6 B for an in vivo micro-CT scan of the murine abdomen).
Since Mimics provides faster and more user-friendly interventional techniques
to separate aortic and venous structures, it was used to segment the aorta in
all simulations performed within this dissertation. Aer segmentation, the ob-
tained 3D surface is smoothed in order to remove articial bulges or dents that
are caused by the segmentation process. During the smoothing operation, care
should be taken not to shrink the structure.
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Figure 2.5: Structured hexadralmeshwith dierent parametrically determined gradations of ac-
curacy (le) and unstructured tetradralmeshwith prismatic boundary layer (right) of a stenosed
artery. Courtesy of [133].
Dening the CFD geometry: the mesh
To set up a CFD simulation the geometry of interest should rst be subdivided
into a grid of control volumes called a mesh (see section 2.1.2). Several types
of meshes are possible. In most biomedical applications, unstructured meshes
are used.ese are characterized by an irregular connectivity, implying that the
neighborhood connectivity of the cells has to be stored explicitly. Tetrahedral
cells (bounded by 4 triangular faces) are used to ll the bulk volume. Since the
velocity near the wall is important within arterial hemodynamics to calculate
wall shear stresses (see section 2.1.3), the mesh density near the wall is oen in-
creased using prismatic cells (bounded by 2 triangular and 3 quadrilateral faces)
since these can be aligned in parallel with the boundary surface. Such hybrid
meshes - consisting of tetrahedral bulk cells with a prismatic boundary layer -
can be generated automatically using the appropriate soware (e.g. TGrid, An-
sys), and were used for the CFD simulations in chapters 5 and 6.
Structured meshes on the other hand have a regular connectivity that can
be expressed as a 3D-array, which allows for detection of the neighborhood re-
lationships between dierent cells just by checking their storage arrangement.
ey are built up on hexahedral cells (bounded by 6 quadrilateral faces), and
reduce the error due to numerical diusion in the CFD simulation since all
cells are aligned with the direction of the ow. However, structural meshes are
more dicult to generate due to the topological constraints of hexahedral cells
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(a tetrahedron has only 4 neighbors, a prism has 6 but a hexahedron has 8). Re-
cently, however, a new method has been developed to create block-structured
hexahedralmeshes for cardiovascular owproblems [134].esemeshes can be
generated in a parametrical way using in house-developed soware PyFormex,
as was done for the CFD simulations in chapters 7, 8 and 9.
Regardless which method is used to mesh the geometry, it is important to
keep in mind that the obtained numerical solution depends on the number of
grid cells that is used. However, the more cells the longer the computation
time. A mesh-independence study should therefore be carried out, gradually
increasing the number of cells until the solution no longer changes upon a fur-
ther increase in cells. It has been shown that for cardiovascular applications
hexahedral meshes converge in a more stable way and require less cells than
tetrahedral and hybrid meshes [135].
Prescribing the CFD ow: the boundary conditions
Having obtained a meshed geometry, solving the linearized governing equa-
tions over all control volumes as in section 2.1.2 will soon lead to a problem.
Each solution depends on the solution in neighboring control volumes, but one
needs correct values to start from. As not all control volumes are surrounded
by neighbors, appropriate boundary conditions are needed at the boundaries,
i.e. at the faces of those control volumes that constitute the geometric borders
of the model. e resulting solution of a CFD simulation depends to a great
extent on the boundary conditions that were applied, so it is important that
they are as realistic as possible, preferentially measured in vivo (e.g. using ded-
icated imaging technology as introduced in chapter 3). In cardiovascular ap-
plications, three dierent types of boundaries usually exist: inlets, outlets and
walls. At the walls, most oen a no-slip condition is imposed, meaning that the
velocity of the blood is the same as the velocity of the wall. As all simulations
in this work are done using rigid stationary walls, the velocity near the wall is
zero. At the in-and outlets of a model, several possibilities exist: one can pre-
scribe ows, pressures or impedances (representing the ratio of pressure over
ow, usually implemented as a pressure boundary condition). As non-invasive
pressure measurements (needed for the latter two options) are very dicult to
obtain in a murine setting, only ow boundary conditions were used within
this dissertation.
At the inlet, the most commonly used boundary condition is a prescribed
velocity prole.is is a so-called Dirichlet boundary condition: for each time
point all values of the variable (i.c. velocity) are specied at all faces of the
boundary ow domain.e prescribed prole can take any form, but the most
commonly applied proles are either a plug prole (i.e. the prescribed values
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are the same for all faces in the inlet plane) or a parabolic prole (i.e. the values
form a paraboloid surface in space with the maximal value at the center of the
inlet plane). Prescribed velocity proles were used as inlet boundary condition
in all simulations performed within this dissertation, and as outlet boundary
condition in chapters 7, 8 and 9.
At the outlets, a ow rate can be imposed when the details of the ow veloc-
ity prole are not known a priori. is outow boundary condition is appro-
priate at outlets where the exit ow is close to a fully developed condition, as it
assumes a zero normal gradient for all ow variables except pressure.e solver
extrapolates the required information from interior. Furthermore, an overall
mass balance correction is applied if the imposed ow fractions towards dif-
ferent outlets do not match. Mass ow outlet rates are prescribed at all outlets
in chapters 5 and 6, and only at the distal abdominal aorta in chapters 7, 8 and 9.
Regardless which method is used to prescribe the boundary conditions, in
a transient simulation it is important to keep in mind that the obtained numer-
ical solution also depends on the size of the time step that is used. However,
the smaller the time step the longer the computation time. One should there-
fore rst ensure that the used time step is suciently small to still capture all
important ow features in a time-step-independence study.
Interpreting CFD results: Wall shear stress
e output of a CFD simulation includes (among others) the complete velocity
and pressure eld in the geometry of interest, with calculated values in every cell
of themesh. An important remark is that the pressure eld is not determined in
absolute terms when modeling incompressible ow: an arbitrary constant can
be added to the pressure eld without aecting the solution, so only relative
pressure dierences are of importance. However, when interpreting the out-
come of a cardiovascular CFD simulation related to the onset of cardiovascular
disease, pressures nor ows are the quantities that are most oen reported. As
described in section 1.2.2, aneurysm pathologymay be related to low and/or os-
cillatory values of shear stress, through the activation of shear-sensitive genes.
Atherosclerosis has also been demonstrated to develop preferentially at loca-
tions experiencing low and/or oscillatory shear [60]. Knowing the local shear
stress distribution that aortic endothelial cells experience is therefore one of the
main reasons to perform CFD simulations in an aortic setting.
As mentioned in section 2.1.1, normal stress is the stress that is exerted by
the blood perpendicular to the wall, and is thus directly related to what is com-
monly referred to as a high or low blood pressure. Wall shear stress (WSS) on
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the other hand is exerted in the direction of the ow, and is a viscous stress that
depends on the blood viscosity, and on the velocity gradient near the wall:
WSS = τ¯ = µ ∂v⃗
∂y y=0 (2.17)
In this equation µ is the dynamic blood viscosity, and y is the direction perpen-
dicular to the direction of the ow and perpendicular to the vessel wall (Figure
2.6). Absolute values of wall shear stress are much lower than those of normal
stress, but the importance of shear is more in its signaling function than in it
actually causing physical damage to the endothelial cells, as explained in sec-
tion 1.2.2. Since the velocity eld is calculated for all control volumes in a CFD
Figure 2.6: Schematic representation of wall shear stress and normal stress in an artery. In fully
developed ow, the velocity prole is parabolic, with maximum velocity vmax in the center of the
vessel.
simulation (section 2.1.2), WSS can be calculated for every control volume that
is positioned near the wall of the geometry of interest.
As indicated by equation 2.17, the modeled value for blood viscosity is an
important parameter that will inuence the computed WSS values. Viscosity
can be considered as a measure for a uid’s resistance to shear deformation. A
Newtonian uid by denition is a uid of which the viscosity is independent
of the shear rate at which it is deformed. In a non-Newtonian uid however,
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viscosity is not constant and the value corresponding to a certain shear rate is
termed the apparent viscosity. To model blood viscosity in a CFD simulation
it is rst important to understand its composition: blood consists of multiple
small particles (red blood cells, white blood cells, platelets, etc) that are diluted
in a medium of proteins and water (blood plasma). While blood plasma is a
Newtonian uid [4], the interaction of the diluted red blood cells causes a Non-
Newtonian eect. When shear rates are low, red blood cells start adhering to
each other (Rouleaux formation) and the apparent viscosity increases [136]. At
higher shear rates these Rouleaux stacks of red blood cells break down and the
apparent viscosity decreases, a process that is termed shear thinning. As blood
viscosity is thus strongly related to the behavior of red blood cells, its value is
also dependent on the blood hematocrit, the ratio of the volume of red blood
cells over the total blood volume. Another important characteristic is the so-
called Fåhræus-Lindqvist eect: the apparent viscosity of blood is not only de-
pendent on the shear rate it experiences, but also on the diameter of the vessel
it passes through (Figure 2.7). When red blood cells pass through the smallest
vessels (capillaries in a human setting) they tend to line up, thus reducing blood
viscosity [137].
Figure 2.7: Non-Newtonian behavior of (human) blood. Le: Shear thinning. Apparent blood
viscosity decreases as shear rate increases, and reaches a plateau value at high shear rates.e ef-
fect is shown for various levels ofHematocrit (H). Adapted from [138]. Right: Fåhræus-Lindqvist
eect. Blood viscosity decreases as it ows through smaller vessels, with a minimum value for
vessels of 6-7 µm [137]. Adapted from [139].
In a murine setting, shear rates are much higher than in the human case
[140] and shear thinning has little eect: viscosity is assumed to remain at a
constant plateau value (as in Figure 2.7). e Fåhræus-Lindqvist eect might
play amore important role sincemurine vessel diameters aremuch smaller than
in the human case (section 1.3.2), but detailed murine viscosity data are (to the
46
2.1. Computational Fluid Dynamics in blood vessels
best of our knowledge) lacking. Within this dissertation, the Fåhræus-Lindqvist
eect is ignored and blood is modeled as a Newtonian uid, implying that its
viscosity remains constant throughout the simulation.
Post-processing CFD results: wall shear stress based descriptors
Even if viscosity is assumed to be constant, the instantaneousWSS distribution
will change over time in a transient CFD simulation as shear stress is depen-
dent of the velocity eld (equation 2.17), which is dierent for every time step
of the cardiac cycle. Dierent WSS-based descriptors have therefore been de-
veloped to summarize the WSS-behavior over time, allowing the operator to
assess which zones are subject to low and/or oscillatory shear conditions within
the glimpse of an eye. In this dissertation, three of these descriptors are used:
time-averaged wall shear stress (TAWSS), the oscillatory shear index (OSI) and
the relative residence time (RRT).
1. Time-averaged wall shear stress or TAWSS
TAWSS simply represents the average of the absolute value of the WSS
over a cardiac cycle:
TAWSS = 1
T ∫ T0 ∣τ∣ dt (2.18)
TAWSS distribution gures thus allows for the assessment of zones of low
and high shear stress over the cardiac cycle.
2. Oscillatory shear index or OSI
OSI represents the amount of oscillation WSS undergoes over a cardiac
cycle. OSI was introduced by Ku et al. [141] and is calculated as:
OSI = 1
2
⎛⎜⎝1 − ∣
1
T ∫ T0 τdt∣
1
T ∫ T0 ∣τ∣ dt
⎞⎟⎠ (2.19)
is equation is exemplied by Figure 2.8. Imagine that shear is always
exerted in the same direction throughout the cardiac cycle, as in panel
A of Figure 2.8. Instantaneous WSS will then vary between two positive
values, which causes the numerator (∣ 1T ∫ T0 τdt∣) and the denominator
( 1T ∫ T0 ∣τ∣ dt) in equation 2.19 to be equal, and thus implies that OSI will
be zero. Imagine on the other hand that shear is varying between pos-
itive and negative values, as in panel B.e numerator in equation 2.19
is then represented by the surface under the (positive) black curve mi-
nus the surface under the (negative) gray curve: to some extent, positive
and negative values cancel each other out.e denominator on the other
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Figure 2.8: Dierent aspects of the oscillatory shear index (OSI). A: WSS is unidirectional
throughout the cardiac cycle, OSI=0. B: WSS changes direction between positive (black) and
negative (gray) values. (∣ 1T ∫ T0 τdt∣) is calculated as the the dierence between the black and
gray surfaces. C:e absolute value of WSS is always positive. ( 1T ∫ T0 ∣τ∣ dt) is calculated as the
sum of black and gray surfaces. Adapted from [142].
hand is represented by the sum of the gray and black surfaces, as in panel
C. Since in this case the absolute value ofWSS is calculated before the in-
tegration, positive and negative values add up. As the value of the numer-
ator will always be smaller than or equal to the value of the denominator
and the numerator will never take a negative value (due to the absolute
value of the entire integral), the fraction in equation 2.19 varies between
0 and 1, corresponding to extreme OSI values of 0.5 and 0 respectively.
e maximal OSI value of 0.5 is reached when positive and negativeWSS
directions (black and gray surfaces in Figure 2.8) cancel each other out
completely. In practice, shear stress acting on the wall is a vector.e nu-
merator is calculated by rst performing a time integration for x, y and
z directions and then taking the absolute value, while the denominator
is calculated by rst taking the absolute value (of the composite shear
vector) and then performing the time integration.
3. Relative Residence Time or RRT
RRT takes into account bothmagnitude and oscillatory behavior ofWSS.
It was introduced by Himburg et al. [143] and is calculated as:
RRT = 1(1 − 2OSI)TAWSS (2.20)
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High RRT values can be caused by low TAWSS and/or highOSI, and thus
represent exactly those regions that might be at hemodynamic risk.
2.2 Hemodynamics and aneurysm formation
2.2.1 Hemodynamics in human aneurysm formation
Literature review
Over the course of time, a number of studies have used computational tech-
niques similar to the ones described in section 2.1 to elucidate the hemodynamic
behavior in human AAAs. An overview of known studies at the time of writing
is given in Table 2.1.
Initially, idealized axisymmetric models were used in which all side branches
were neglected [144–147].ese models allowed for the calculation of ow pat-
terns in the dilated part of the abdominal aorta: vortices were reported, giving
rise to high variation of shear stress values over the aneurysm, with low shear
stress values in the aneurysmal sac and high shear values near the distal part
of the aneurysm. Inducing asymmetry in these idealized models was shown to
increase the obtained WSS levels [148]. ese results were conrmed in more
recent CFDwork based on patient-specic geometries: Biasetti et al. [149] com-
pared the oweld in normal abdominal aortas to saccular and fusiformAAAs,
basing their models on CT images. Much like previous, idealized cases, they re-
ported ow recirculation just distal to the aneurysm neck, giving rise to high
shear at the tip and low WSS values in the aneurysmal sac. e rst CFD stu-
dies in AAAs using patient-specic geometries as well as boundary conditions
(including celiac, mesenteric and renal arteries) were published by the group of
Taylor et al [151].ey tracked the pathway of blood particles within the aneu-
rysm over several cardiac cycles, and found a slow particle clearance in AAAs,
coupled to low shear values.e same group also reported that evenmild levels
of exercise might benecially inuence ow stasis in AAAs, as patient-specic
CFD simulations showed that exercise causes an increase in TAWSS and a de-
crease in OSI and particle clearance time [150, 151].
A more advanced class of computational models are uid-structure inter-
action or FSI models.ese allow for a simulation of the blood ow as well as
the structural displacement of the wall, thus combining the output of both CFD
and CSD simulations. A thorough discussion of dierent FSI techniques can be
found in [158] and falls beyond the scope of this work. While many FSI simula-
tions of AAAs focus on the structural part of the simulation, trying to predict
the risk of rupture [153, 159, 160] or the eect of stent gra treatment [161, 162],
some FSI simulations do report hemodynamic results within AAAs. Fraser et
al. [154] reported dierences in TAWSS of 30 up to 60 % between axially sym-
metric CFD and FSI models. Kelly et al. [155] conrmed earlier CFD results of
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low shear values at the aneurysm sac and high shear at proximal and distal ends
in an idealized FSI geometry, while Xenos et al. [163] parametrically changed
the angles in idealized FSI AAAmodels to assess the inuence on (among oth-
ers) WSS levels.
Many (if not all) of the aforementioned simulations focus on the oweld in
existing AAAs, while the focus of this dissertation is on nding a link between
hemodynamics and initiation and progression of AAAs. However, CFD and
FSI techniques have not just been used to compute the AAA ow eld as such.
Already in 1996, Bluestein et al combined AAA CFD simulations with Particle
Image Velocimetry (PIV) measurements in an idealized AAA model to point
out that recirculation zones may give rise to thrombus formation [156]. Yeung
et al. [87] used CFD to demonstrate dierences in abdominal TAWSS and OSI
between patients with spinal cord injury and control patients. While not com-
puting any AAA ow patterns, this study did provide indirect evidence for a
link between hemodynamics and AAA formation as patients with spinal cord
injury have much higher incidence of AAA than the control group [86]. A new
emerging technique uses CFD computations to study AAA initiation and for-
mation by coupling its outcome to growth and remodeling models [157].ese
analytical models mimic the degradation of the wall over time, taking into ac-
count elastin degradation and collagen turnover as described in section 1.2.2.
e output of the instantaneous, short-term CFD simulations (e.g. TAWSS and
pressure in all nodes) is used as input for the long-term analytical growth and
remodeling model. is results in a remodeled abdominal geometry, which
is then used as the input for a new CFD simulation. Starting from a healthy
abdominal artery without side branches, zones of low TAWSS were found to
cause elastin degradation and AAA formation.ese models are still in an ini-
tial phase, as their outcome largely depends on a thorough understanding of the
modeled interaction between hemodynamics and aortic wall remodeling (sec-
tion 1.2.2). Furthermore, the predicted AAAs were derived from non-diseased
geometries and have not been compared to actual AAAs developing over time.
In the future, coupling of CFD and laws for growth and remodeling might in-
crease our knowledge on AAA formation [13].
Limitations and challenges
Almost all studies focusing on hemodynamics in an aneurysmal setting study
AAAs (Table 2.1) or cerebral aneurysm (Table 2.2). No studies exist (to the best
or our knowledge) to elucidate the ow eld in ascending aortic or thoracic
aneurysms, despite the fact that the presence of the aortic arch might cause in-
teresting hemodynamic eects. Furthermore, as can be observed in Table 2.1,
all studies on AAA hemodynamics focus on end-stage geometries, in which
the aneurysm has already developed. Aer all, the major interest of the clinical
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community is in obtaining a better understanding of these existing AAAs as
they are at risk of rupture. Currently surgical intervention is performed when
the AAA diameter surpasses a critical level of 5.5 cm [9]. However, the rupture
potential of an aneurysm is not only dependent on its size, but on the ratio be-
tween its local strength and the stress it experiences.erefore a lot of research
is performed on the structural aspect of AAAs (and cerebral aneurysms) inCSD
and FSI simulations, trying to provide the medical community with a so-called
rupture potential index (RPI) to assess the risk level in a more trustworthy way
than simply measuring the AAA diameter [173].
A second reason why there are hardly studies focusing on the role of hemo-
dynamics in pre-diseased or intermediate AAA stages, is simply the lack of
data. In a cerebral setting, it is relatively straightforward to digitally remove
the specic saccular shape of the intracranial aneurysm, allowing for a realistic
pre-diseased geometry. Such articially generated ‘baseline’ geometries have
been used to relate CFD-based shear stress descriptors with the onset of cere-
bral aneurysm formation [168, 170]. Human cerebral aneurysm hemodynamics
have also been followed up over time, reporting those areas experiencing low-
est TAWSS to growmost [165].is study is particularly interesting since it was
the rst to conrm the hypothesis that there is a link between disturbed hemo-
dynamics and aneurysm growth. Due to the recirculation of blood the dilated
zone of the aneurysm will experience locally decreased and oscillatory shear
stress that will accelerate the local process of inammation and proteolysis (sec-
tion 1.2.2), thus entering into a vicious circle. However, cerebral aneurysms dif-
fer inmany aspects from their central aortic counterparts [13], and their detailed
study falls beyond the scope of this dissertation. In AAAs it is much more di-
cult to reconstruct the pre-diseased geometry due to their fusiform shape (Fig-
ure 1.7, section 1.2.1). Moreover, as AAAs are asymptomatic and take decades
to develop, it is a huge technical challenge to follow up on dierent stages of
disease progression over a longer period of time, especially if one wants to in-
clude the pre-diseased stage. However, these problems can be circumvented by
performing CFD studies on aneurysm initiation and progression in a murine
setting, as both AAA and ascending aneurysm can be induced in these animals
(section 1.3.3), while still keeping access to the baseline, pre-aneurysmal hemo-
dynamic state.
2.2.2 Hemodynamics in murine aneurysm formation
Background: murine CFD
e principle behindCFD simulations has been explained in section 2.1, and ex-
amples of its application within a human (aneurysmal) setting are given in sec-
tion 2.2.1. Unfortunately, however, one cannot simply transfer this knowledge to
amurine setting. As described in section 1.3.2, themouse cardiovascular system
51
2. Computing aortic hemodynamics
can be considered as a much faster and smaller version of the human cardio-
vascular system.is implies that human imaging modalities, readily available
in the clinic, cannot be used to obtain the geometries and boundary conditions
that are needed as an input for murine CFD simulations. Dedicated small ani-
mal imaging modalities are required, which has hampered the use of small an-
imal CFD simulations for a signicant period of time. A specic problem was
the lack of contrast agents to discriminate the mouse aorta from surrounding
tissues in micro-CT scans (see section 3.1.3). In many studies this problem has
been circumvented by rst creating a so-called vascular cast: a plastic replica of
the aorta that is scanned ex vivo to obtain the aortic geometry. More details on
vascular casts are provided in chapters 4, 5 and 6.
Literature review
An overview of all CFD studies (known at the time of writing) on aortic hemo-
dynamics in small animals is given in Table 2.3. e rst study reporting on
shear stresses in small animal models was performed on New Zealand white
rabbits [174]. Moore et al. found signicant dierences between WSS values
based on a scanned cast of the infrarenal abdominal aorta and those based on
in vivo MRI images obtained on a 1.5 Tesla (human) MRI scanner. However,
rabbits are much larger thanmice, and it took 7 years of technological improve-
ments before Greve et al. [88] were able to compute shear stresses in the in-
frarenal aorta of a mouse, basing their geometry on 4.5 Tesla MRI images and
measuring inlet boundary conditions with Phase-Contrast MRI. ey found
that murine WSS is generally much higher than human WSS, a nding that
was later conrmed from a theoretical point of view using allometric scaling
laws [180]. As micro-MRI (at the time) did not allow for the assessment of the
(smallest) side branches, most authors used micro-CT scanned vascular casts
to dene their geometry, as described above. Moreover, the aortic geometry in
murine CFD was oen restricted to the aortic arch as the main objective usu-
ally was to demonstrate a link between hemodynamics and atherosclerosis, and
plaques oen develop in the arch. Suo et al. [175] performed CFD simulations
in the aortic arch of C57Bl/6 mice to demonstrate a link between zones experi-
encing lowWSS and zones with increased expression of VCAM-1 and ICAM-1
(shear responsive genes, see section 1.2.2), while Zhu et al. demonstrated that
signicant dierences in aortic arch WSS can exist between dierent mouse
strains [176].
Still basing the geometry on a scanned cast, Feintuch et al. were the rst
to implement mouse-specic inlet and outlet boundary conditions into their
CFDmodel.ey reported small dierences between ow ratios obtained from
high-frequency ultrasound and PC-MRI (7 Tesla) in the side branches of the
aortic arch [140]. e most detailed CFD simulation in a murine setting was
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presented by Huo et al. [177]. ey modeled ow in the complete aorta (from
the ascending aorta to the iliac bifurcation), including even the smallest side
branches and 9 pairs of intercostal arteries, and reported much more compli-
cated WSS patterns in the aortic arch compared to other aortic regions. More
recently, Hoi et al. simulated hemodynamics in LDL −/− mice with aortic re-
gurgitation, a mouse model for atherosclerotic plaque [178]. ey found that
locations of high RRT and OSI were consistent with plaque locations (although
plaque data and RRT andOSI were obtained in dierent animals). Finally, Vin-
cent et al. performed a detailed study of hemodynamics in the aortic arch and
descending aorta of New Zealand rabbits, demonstrating the presence of two
Dean vortices in the arch [179].
Most of the murine CFD studies described above focused on technical dif-
culties, and simply describe the small animal ow eld as such [88, 140, 174,
177, 179]. Some have demonstrated a link between murine hemodynamics and
atherosclerosis [175, 178], but none studied the role of hemodynamics in mouse
aneurysm formation. However, recent advances inmouse-specic imaging tech-
nology did enable to follow up on aneurysm development in angiotensin II-
infusedApoE −/−mice, themousemodel of choicewithin this dissertation (sec-
tion 1.3.3). An overview of studies following up AAA formation in this mouse
model is given in Table 2.4 and discussed below.
Barisione et al. [181] measured AAA progression in angiotensin II-infused
ApoE −/− mice at short intermediate timepoints using high-frequency ultra-
sound, while Turner et al. [182] used a 9.4 Tesla micro-MRI scanner to follow
upAAAs on aweekly basis. However, as these are purelymorphological studies,
they did not increase understanding on the underlying phenomena causing the
initial disease stages. Amirbekian et al. reported that ApoE −/− mice (unlike
humans) do not experience reversed ow in the infrarenal aorta, and suggested
a causal eect with the suprarenal location of their AAAs [126]. Using 4.5 Tesla
micro-MRI in the same mouse model, Goergen et al. [183] hypothesized that
the suprarenal location of AAAs might be related to a local increase in ves-
sel curvature. In a follow-up study, the same authors demonstrated that AAAs
correlate with aortic motion in both angiotensin II-induced (suprarenal) and
elastase-induced (infrarenal) AAAs [184].
Limitations and challenges
1. Geometry
As described above, no (small animal) CFD studies in literature have
been performed in a follow-up setting, and vice versa no follow-up stu-
dies on (murine) aneurysm formation have included any CFD simula-
tions. is is a direct consequence of the lack of appropriate imaging
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techniques that existed for a long time: as mice need to be sacriced
to obtain a vascular cast, follow-up studies were not possible. micro-
MRI provides an alternative, but this technique is not always available
and its resolution oen does not allow for inclusion of the (smallest) side
branches into the model. Within this dissertation, micro-CT (both in
vitro using vascular casts and in vivo using dedicated contrast agents) was
used to obtain the murine aortic geometry. More details on the general
principle and pitfalls behind micro-CT imaging are provided in section
3.1.
2. Boundary conditions
Many dierent ways exist to impose boundary conditions (BCs) in a CFD
simulation (section 2.1.3). In almost all murine CFD simulations, a time-
varying velocity prole is imposed at the inlet, which is measured us-
ing micro-MRI [88, 140], (rescaled) ultrasound [140, 175, 176, 178] or
taken from literature [174, 179]. Outlet boundary conditions are usually
to be measured in much smaller vessels than inlet boundary conditions.
is is - combined with the aforementioned limitations in imaging tech-
niques - the main reason why very few publications have applied entirely
mouse-specic outow boundary conditions in their murine CFD sim-
ulations. Huo et al. [177] used invasive carotid pressure measurements
to generate outlet pressures at all branches, taking into account local di-
ameter information. However, carotid pressure is an invasive, single-
performancemeasurement that is not possible in a follow-up study. Non-
invasive methods to measure aortic pressure in vivo do exist, but are lim-
ited to the tail. To the best of our knowledge, the only study imposing
entirelymouse-specic BCs at both in-and outlets was presented by Fein-
tuch et al. [140], who determined ow rates in the aortic arch with PC-
MRI and ultrasound.
Many authors circumvent the problem by assuming constant ow frac-
tions based on (scarce) literature data [88, 174–176]. Others prescribe a
xed volumetric ow rate such that the wall shear stress (based on fully
developed laminar Poiseuille ow) is equal for each outlet [179]. is
method is oen referred to as Murray’s law [185]. Murray proposed al-
ready in 1926 that the arterial system is designed in such a way that the
total energy is minimal at all times. Minimizing the total energy with
respect to the arterial diameter (dE/dr = 0), Murray’s theory implies that
the volumetric ow at a certain aortic location should at all times be pro-
portional to the aortic diameter at that location.is insight can then be
used to calculate the ow ratio going to a specic side branch according
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to the following equation:
Q1
Q2
= r31
r32
(2.21)
with Q1 and r1 the volumetric ow and the lumen radius of the mother
branch (before a bifurcation) whileQ2 and r2 represent ow and radius of
the side branch. Murray’s law thus allows for the dimensions of the spe-
cic studied geometry to be taken into account into the boundary con-
ditions.e eect of imposing approximate outlet boundary conditions
from either literature data or Murray’s law is discussed in depth in chap-
ter 8.
It is important to keep in mind that the appropriate level of detail for
the boundary conditions depends on the desired application. If one only
wants to elucidate what the general ow eld looks like in a particular
geometry or mouse model, BCs can be taken from (relevant) literature
as long as they represent the average situation. Side branches can even
be neglected if their inclusion would not aect the ow eld one wants
to study [178]. However, within the setting of a follow-up study in which
disease is induced, animal-specic BCs are indispensable. As the goal
is to elucidate the inuence of hemodynamics on disease initiation and
progression, dierences in measured BCs between animals as well as dif-
ferences within the same animal over time might aect the outcome of
the study, and one cannot simply impose the same general BCs in all sim-
ulations. Within the second part of this dissertation, ow splits obtained
from Feintuch et al. were imposed in those simulations in which the gen-
eral ow eld was the main interest (chapter 5), while ow splits based
on Murray’s law were imposed to compare hemodynamics in dierent
mouse-specic models of the same aortic geometry (chapter 6). In the
third part of this dissertation, a method to obtain mouse-specic bound-
ary conditions has been introduced (chapter 7) and applied (chapters 7, 8
and 9). ese boundary conditions were based on (high-frequency) ul-
trasound velocity measurements. More details on the general principle
and pitfalls behind ultrasound imaging are provided in section 3.2.
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Small animal imaging techniques
3.1 micro-CT
3.1.1 General CT principle
Figure 3.1: Setup of a typical cone-beam scanner. X-rays are emitted from the focal spot and
collimators shape the beam to match the rectangular shape of the detector, positioned at the
opposite side of the subject. All beams travel through the Field Of Measurement (FOM).e
setup rotates around the z-axis to obtain a set of projections. An X-ray is parameterized by the
rotation angle α and the detector coordinates (u,v). Adapted from [186].
Computed Tomography (CT) is a medical imaging technique based on the
amount of attenuation of X-rays traveling through a medium (i.c. the imaged
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subject). Dening I0 as the photon quanta emitted by the X-ray source, the
resulting number I of photon quanta reaching the X-ray detector (positioned at
the other side of the subject, see Figure 3.1) can be computed as:
I = I0e− ∫ L0 µ(r⃗)dr⃗ (3.1)
with r⃗ the location within the subject and µ the distribution of a so-called atten-
uation coecient that is related to the material properties of the tissue. How-
ever, the amount of information one can obtain from 1 such projection is lim-
ited due to the superposition of dierent tissues within the traveled path of the
X-ray. In (micro-)CT imaging, a large set of dierent projections is therefore
taken over an angular area ≥ 180○ + the fan angle (depicted in Figure 3.1).
Figure 3.2: Micro-CT rotation with moving source and detector. Up to 1000 views per rotation
are acquired.e entire FieldOfMeasurement (FOM) can be reconstructed as long as it has been
viewed by the X-rays under an angular interval of 180 ○ + the fan angle. Adapted from [186].
e dierent projections can be obtained in 2 dierent ways:
• e subject rotates while both X-ray source and detector stay in a station-
ary position.
• Both X-ray source and detector rotate around the subject (Figure 3.2).
e rst option is oen used for in vitro imaging as the amount of moving parts
is limitedwhen both source and detector are stationary, allowing for an increase
in resolution. For in vivo studies, however, the comfort of the imaged subject
is primordial and both source and detector have to rotate around the subject.
ese scanners are much more complicated from a mechanical point of view,
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as the rotation should be very precise not to inuence the image quality. e
set up for a typical cone-beam scanner is depicted in Figure 3.1.e cone shape
of the X-ray bundle is achieved by placing so-called collimators just distal to
the source, to stop X-rays from being emitted into undesired zones. For each
X-ray the so-called projection value p is obtained by summing the energies of
photons detected per pixel. is relates to the line integral of the attenuation
coecient µ (which depends on x,y,z) along the length L of the X-ray:
p(L) = −ln I(L)
I0
= ∫
L
dLµ(x , y, z) (3.2)
e thus obtained projection value p has a value that is dependent on the ro-
tation angle α and the detector coordinates (u,v) (see Figure 3.1). A dedicated
algorithm is then needed to reconstruct the spatial variation of µ(x , y, z) from
the obtained set of projection values p(α, u, v): the so-called reconstruction al-
gorithm. Imagine a simplied parallel beam scanner (as opposed to the cone
beam in Figure 3.1) with 1 detector array, taking 1 slice per projection.e raw
data would be given by setting the longitudinal detector coordinate v to zero:
p(α, u, 0).e goal of the reconstruction algorithm is then to determine µ(x,y)
for each slice along the axial direction z. First a change of variables is performed
to express the projection value p in the parallel-beam geometry: instead of de-
scribing the ray by the source position α and detector position u it can also
be described as a function of θ, the angle between X-ray and coordinate sys-
tem, and ζ , the distance of the X-ray to the center of rotation. e process of
changing the variables to the parallel beam geometry is also known as rebin-
ning. Equation 3.2 then comes down to:
p(ζ , θ) = ∫ ∞−∞ ∫ ∞−∞ µ(x , y)d(xcos(θ) + ysin(θ) − ζ)dxdy (3.3)
e projection-slice theorem then implies that if an innite number of 1D pro-
jections of an object exists from an innite number of angles, the original ob-
ject can always be reconstructed [187]. As an analytical solution for the inverse
problem (the inverse Radon transformation [188]) is very sensitive to noise, a
discretized, stable version is oen applied: the ltered back projection. Detailed
description of themathematical implementation of this reconstructionmethod
falls beyond the scope of this work, but can be found in [189] for parallel beams
and was extended to cone beams by Feldkamp et al. [190]. As a nal step the
reconstructed µ(x,y) for each slice are converted into CT-values, expressed in
Hounseld Units or HU:
CT = µ − µwater
µwater
⋅ 1000HU (3.4)
e HU is calibrated so that air equals -1000HU and water is 0 HU.e CT
value of a specic pixel can thus be interpreted as the relative density of the
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Figure 3.3: An X-ray is represented by ζ=xcosθ + ysinθ with θ the angle between X-ray and the
original (x,y) coordinate system and ζ the distance of the X-ray to the center of rotation.
imaged object (at that pixel location) to the density of water. A stack of 2D
slices can then be converted into a 3D volume using segmentation techniques
as described in section 2.1.3.
3.1.2 Small animal micro-CT in practice: the need for contrast
Summarizing the previous section, micro-CT is an imaging technique that re-
sults in a set of 2D images in which dierent structures can be segmented (sec-
tion 2.1.3) by exploiting the dierence in CT values between pixels. As most
so tissues in the body (including blood) have a similar CT value (expressed
in HU) proper segmentation of the aorta is an impossible task without appro-
priate contrast agents to enhance the CT value of blood. However, traditional
human (iodine-based) contrast agents cannot be used since they are cleared by
the murine renal system before the micro-CT scan has been completed. e
lack of appropriate contrast agents for micro-CT scans has long been the main
limitation in small animal cardiovascular CFD.
In vitro micro-CT
As described in the literature overview in section 2.2.2, many publications in
literature use so-called vascular casts to circumvent the lack of murine contrast
agents: a plastic replica of the murine aorta is scanned in vitro, using a dedi-
cated micro-CT setup with rotating subject (see Figure 3.4). Within this disser-
tation, in vitro scanned vascular casts were used in chapters 4 and 5. Vascular
casts are obtained by injecting a specic polymer solution (Batson’s #17, VWR,
Haasrode, Belgium) into the abdominal aorta of a euthanized animal.e poly-
mer is liquid upon injection but solidies inside the arteries within 30 minutes.
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Figure 3.4: Casting procedure and in vitromicro-CT setup. A.e animal is euthanized and the
abdominal cavity is opened. About 2 ml of Batson’s # 17 solution is injected into the abdominal
aorta. B.e polymer is rst le to solidify and aerwards all so tissue is dissolved in 25 %
potassium hydroxide. C. A vascular cast (a plastic replica of all arterial and venous blood vessels)
remains. D.e aortic structure of interest (in this case the aortic arch) is excised and scanned
using a dedicated in vitro micro-CT setup with rotating subject. e depicted setup was also
used for scans in chapters 4 and 5.
Subsequently, the mice bodies are macerated in 25% potassium hydroxide or
KOH (Roth, Karlsruhe, Germany). All so tissues disappear, and the remain-
ing vascular cast is rinsed with water and dried under a vented hood.is cast
represents a replica of the arterial system that allows for a high resolution and
proper contrast when it is scanned, but excludes follow-up in the same animal.
In vivo micro-CT
In vivo micro-CT scans (recently) became possible due to the development of
dedicated contrast agents for murine micro-CT, allowing for in vivo images in
which the aorta could actually be discriminated from surrounding tissues.e
need for contrast agents to visualize themurine aorta is clearly indicated in Fig-
ure 6.1 in chapter 6. Within this dissertation, dierent contrast agents have been
tested. e possibilities of the rst contrast agent that was introduced to the
market, Fenestra VC-131 (Advanced Research Technologies Inc., Saint Laurent,
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Figure 3.5: A.e GE Flex Triumph in vivo micro-CT scanner used within this dissertation
(GammaMedica-Ideas, Northridge, CA, USA).e animal is positioned on the animal bed and
anesthetized using isourane. e animal monitored during the scan via the screen on top. B.
Zoomed view of the animal’s position on the bed.
Canada), were explored in chapter 6. However, mice did not tolerate this con-
trast agent well as high volumes needed to be injected. Another contrast agent,
Exia XL 160 (Binitio inc, Ottawa, Canada) was tested in a proof-of-concept
study but not used within this dissertation since relatively large injected volu-
mes were (still) necessary. Finally, the gold nanoparticle-based contrast agent
Aurovist (Nanoprobes, Yaphank, NY, USA) was found to yield the best results,
and was used to obtain in vivo micro-CT scans in longitudinal studies in chap-
ters 7, 8 and 9.
Within this dissertation, an in vivo micro-CT scanner with rotating source
and detector was used for all in vivo studies.e used scanner was the GE Flex
Triumph (GammaMedica-Ideas, Northridge, CA,USA), depicted in Figure 3.5.
Before the scan, the animal was injected with contrast agent in the lateral tail
vein. During the scan the animal wasmounted on a small animal pad and anes-
thetized with 1.5% isourane.
3.1.3 Pitfalls for (small animal) micro-CT imaging
As described above, the lack of appropriate contrast agents has long been the
most important bottleneck for (in vivo) small animal micro-CT. Some other
important pitfalls are discussed hereunder.
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Radiation
It is important tominimize the amount of radiation in the subject, as X-rays are
known to be carcinogenic [191].e amount of radiation depends on a number
of factors, including (among others) the total scan time, the power of the beams
emitted by the source and the saturation time of the detector.e radiation dose
for a typical in vivo micro-CT scan as obtained in e.g. chapter 6 is estimated to
be in the order of 30-50 mGy ([192]) while the lethal dose LD50/30 (i.e. the
dose causing 50% of the animals to die within 30 days) for mice is assumed
to be around 6.5 - 7 Gy. However, even if there is no direct deterministic risk
to be expected, irradiation may aect other parameters (e.g. tumor growth, cell
proliferation) that are of importance for a study. Especially in the case of follow-
up studies the irradiation should be kept as low as reasonably possible, as the
total dose adds up for dierent scans in the same animal.
Image resolution and noise
e spatial in-slice resolution ∆r of amicro-CT image can be estimated as [193]:
∆r = 1
M
√
D2 + (M − 1)2s2 (3.5)
with M the magnication of the object, D the size of a detector element and
s the width of the focal spot. e main advantage of micro-CT is in the high
resolutions that can be obtained compared to other imaging techniques such as
MRI. As the size of detector and source elements is usually xed for a certain
scanner, the most important parameter to determine the in-slice resolution is
the desired magnication M. Another important parameter to consider is the
image noise:
σ2 ∝ 1
mAse f f ⋅ ∆z ⋅ ∆r3 (3.6)
In this equation, σ is de standard deviation of the distribution of the image
noise, δz is the axial resolution andmAse f f is the product of the source current
and the radiation time of a voxel. Image noise should beminimized to optimize
for segmentation of the structure of interest (section 2.1.3). is implies that
there is a trade-o between spatial resolution, image noise and radiation dose:
a higher resolution implies an increase in noise. However, in order to decrease
noise the mAse f f should be increased, which implies a longer radiation time
and/or an increased source current, both of which have an adverse eect on the
radiation dose experienced by the subject.
Respiratory and cardiac movement
As the reconstruction algorithm (section 3.1.1) is sensitive to movement during
image acquisition, the subject should remain as motionless as possible to op-
timize image quality. Despite the fact that the animals are anesthetized during
the scan, two dierent motion-related sources of error always remain:
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Figure 3.6: A. Axial cross-section of the abdomen of a mouse that was implanted an osmotic
infusion pump with metal ow divider. Beam hardening occurs, due to the high density of the
metal.e image was taken in vivo on a Skyscan 1076 micro-CT scanner, contrast-enhanced via
lateral tail vein injection of Exia (Binitio, Ottawa, Canada).e image was taken in the context of
a proof-of-concept study preceding chapter 7. B. Axial cross-section of the abdomen of a mouse
that was implanted an osmotic infusion pump in which the metal ow divider was replaced by
a PEEK alternative. No beam hardening occurs as the metal component has been removed.e
image was taken in the context of chapter 9 on a Flex Triumph micro-CT scanner depicted in
Figure 3.5, contrast-enhanced via lateral tail vein injection of Aurovist (see chapter 8 for tech-
nical details on the scan). e vena cava and abdominal aorta are located next to each other as
mentioned in section 2.1.3.
• e respiratory cycle, causing the entire thorax to go up and down during
breathing
• e cardiac cycle, causing the heart to contract at a pace that is ten times
faster than the human counterpart (section 1.3.2).
Aorticmovement induced bywall distensibility (section 1.1.2) can be considered
a consequence of the latter and happens at the same frequency. Computational
techniques exist to minimize the eect of motion on image quality: so-called
gating. In prospective gating, images are only obtained during specic time-
points of the cardiac or respiratory cycle (e.g. expiration). However, this im-
plies a signicant increase in scan time and - in a cardiovascular setting - has
an adverse eect on the amount of contrast agent present in the blood at the
end of the scan. If a sucient amount of projections is taken, retrospective gat-
ing can also be performed: only those projections at end-expiration are used
in the reconstruction algorithm and other projections are dismissed. Within
this dissertation, prospective gating was not performed as it was not supported
by the available GE Flex Triumphmicro-CT scanner. Retrospective respiratory
gating has been attempted in chapter 6 but the (small) improvement in image
quality due to motion reduction did not outweigh the reduced image quality
due to the decreased number of projections and non-uniform angles in the re-
construction algorithm (see section 6.4.4). More details on the implemented
gating procedures can be found in chapter 6 and [194].
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Image artifacts
While cardiac and respiratory movement are the main sources of error for in
vivo micro-CT imaging, other image artifacts exist. One possible source of er-
ror is misalignment of the scanner: the position and orientation of source and
detector must be known much more accurately than the actual desired spatial
resolution, and thus have to be aligned with micrometer accuracy for micro-
CT applications. Defective detector pixels can cause ring artifacts if they are
not accurately corrected for, and the fact that the scanner cannot discriminate
between a small amount of dense material (e.g. bone) and a large amount of
less dense material (e.g. cartilage) can induce blurred edges. Another impor-
tant source of error is beam hardening: the generated X-rays are not monoener-
getic, but follow a certain polyenergetic spectrum depending on the materials
used in the X-ray tube. If an X-ray passes a dense object the lower-energy pho-
tons are attenuated more rapidly, leaving behind only the high energy photons.
e beam thus becomes harder since its mean energy increases.e latter eect
can cause streaks between two dense objects in an image because the portion
of the beam that passes through one of the objects at certain tube positions is
hardened less than when it passes through both objects at other tube positions.
It is therefore important to avoid (external) dense materials during a micro-CT
scan (e.g. metal identication chips in mice).is is also the reason why metal
components are removed from osmotic infusion pumps in chapters 7 and 9.
e eect of a metal ow divider inside such a pump on the micro-CT images
is shown in Figure 3.6.
3.2 High-frequency ultrasound
3.2.1 General ultrasound principle
Ultrasound is a medical imaging technique that is based on the transmission
and reection of ultrasonic acoustic waves (i.e. pressure waves with a frequency
beyond the audible range) through a medium. Ultrasound imaging is per-
formed via anultrasound transducer, containing piezoelectricmaterial that con-
verts electrical to acoustical energy and vice versa. Most ultrasound imaging is
performed via the pulse-echo imaging principle. First, the (reverse) piezoelec-
tric eect is used to emit pressure pulses with an ultrasonic frequency. ese
pulses travel through the imagedmedium and are partially reected and/or scat-
tered whenever they meet a change in acoustic impedance. Reections have
a preferential direction (opposite to the incoming direction) and occur when
the acoustic waves encounter a change in impedance on an object that is much
larger than the pulse wavelength (e.g. Z1, Z2 and Z3 in Figure 3.7) while scatter-
ing is omnidirectional and occurs mainly on objects that are smaller than the
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pulsewavelength. Within cardiovascular ultrasound imaging, important reec-
tions are those caused by the tissues constituting the aortic wall, while impor-
tant scatterers are e.g. red blood cells.e reected and backscattered acoustic
waves that reach the transducer are converted into an electric signal and further
processed to visualize and characterize the imaged tissue. Depending on the
Figure 3.7: Ultrasound principle: acoustic waves are rst emitted (A) by the transducer and
partially reect (B + C) when they meet a change in acoustic impedance Z. Reected waves are
received (C) by the transducer to be processed into an ultrasound image.
desired application, the reected ultrasound waves can be processed in many
dierent ways. Some of themost commonly used applications in cardiovascular
imaging are:
• B-Mode imaging, to obtain a 2D view of anatomical structures along all
scanlines
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• M-Mode imaging, to obtain the time-dependent change of an anatomical
structure at a high temporal resolution along a single scanline
• Color Doppler imaging, to obtain a rudimentary 2D view of the 1D ve-
locity eld, with by convention blue color coding denoting ow directed
away from the transducer and red color coding denoting ow towards
the transducer.
• Pulsed Doppler imaging, to obtain the time-dependent change of the ve-
locity eldwithin a specied sample volume at a high temporal resolution
Examples of these imaging techniques are given in Figure 3.8, showing vari-
ousmurine ultrasound images as theywere obtained in the context of chapters 7
(panels A, C) and 9 (panels B,D). A detailed description of themethodology be-
hind all ultrasound modalities would be beyond the scope of this dissertation.
In this introductory chapter, we will therefore focus on the theoretical back-
ground of Pulsed Doppler, the ultrasound application that is used to measure
the time-dependent blood velocity proles thatwere imposed asmouse-specic
boundary conditions in the CFD simulations of chapters 7, 8 and 9.
3.2.2 Velocity imaging with ultrasound
e rst Doppler systems in literature were based on a continuous wave system,
making use of the Doppler eect to detect the frequency shi between contin-
uously emitted and received signals: an observer (the red blood cells) moving
towards the source (the transducer) causes an increase in frequency (positive
Doppler shi)while an observermoving away from the source causes a decrease
in frequency (negative Doppler shi). e velocity of the moving scatterers
in the direction of the transducer could then be estimated from the detected
Doppler shi in frequency. However, this technique did not allow for the de-
tection of the exact depth from which the backscattered signal originated. To
overcome this limitation Pulsed Doppler was developed to estimate local blood
velocities, the method that was also used within this dissertation .
Unlike the continuous wave system, Pulsed Doppler does not rely directly
on the Doppler eect to determine blood velocity. Short bursts of ultrasound
are rst transmitted and then received in well dened time intervals.e depth
from which the signals are gathered is determined by the time delay that is ap-
plied before receiving the signals. is depth is operator-dependent: the ul-
trasound imager chooses the location of a so-called sample volume (see Figure
3.8 D) and only backscattered waves from inside that sample volume are con-
sidered while all other returning ultrasound information is essentially ignored.
In this case, the motion of a scatterer inside the control volume does not only
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Figure 3.8: Dierent ultrasound applications used to image murine aneurysm in vivo, obtained
within the context of chapters 7 (panels A, C) and 9 (panels B, D). A. B-mode: 2D longitudinal
view of the abdominal aorta with a dilated part representing an AAA. B. M-Mode: Distention
of a dilated aortic arch over time along a scanline.e aneurysm is less pronounced as in panel
A.e B-Mode eld of view is depicted on top, and shows the location of the obtained M-Mode
image (dotted yellow line). C. Color Doppler: colored 1D velocity eld in the same AAA of
panel A. Red zones indicate ow towards the transducer, blue zones indicate ow away from
the transducer. Recirculating ow can be observed in the AAA. D. Pulsed Doppler: velocity
prole over time in the same ascending aorta as panel B.e B-Mode eld of view is depicted
on top, with the sample volume (two solid yellow lines) and the direction for angle correction
(dotted yellow line).e image is taken under angular correction of 45 ○. In all applications the
electrocardiogram (green line) and respiratory signal (yellow line) are displayed at the bottom,
while heart rate (green), respiratory rate (yellow) and body temperature (blue) are monitored
continuously.
cause a classical Doppler shi but also an additional time shi due to its motion
in between pulses, as indicated in equation 3.7 for the case of a single scatterer.
r(t) = a ⋅ e( c − vz
c + vz t´udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¸udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod¶
Doppler eect
− 2d0
c + vzdcurly
time delay
) (3.7)
In this equation, r(t) is the signal received by the transducer, a is the amplitude
of the scattered signal, e the amplitude of the emitted signal, c the velocity of
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sound, vz the velocity of the scatterer and d0 the distance between scatterer and
transducer before emission of the pulse. In this case, the Doppler eect is small
compared to the additional time delay of the pulsed waves.e velocity of the
scatterers is determined via a spectral analysis, relying on the fact that a packet
of samples that is received from a certain tissue depth gives rise to a so-called
slow-time waveform. Without going into detail, it can be shown that the center
frequency of the slow-time waveform fslow is related to the velocity v of the
scatterers:
fslow = 2v ⋅ cos(θ)c f0 (3.8)
with c the velocity of sound, f0 the center frequency of the emitted waveform
and θ the angle between the beam direction and the motion of the scatterer. As
the frequency content of the slow time waveform is known, this equation can
be used to obtain an estimate for the velocity v of the red blood cells (i.e. the
scatterers) within the sample volume. A detailed description of the used algo-
rithms to determine the velocity prole is beyond the scope of this work but
can be found in [195]. e result is a typical time-dependent Pulsed Doppler
velocity sonogram as visualized in Figure 3.8 D. It is important to realize that,
in principle, PulsedDoppler can only be used to estimate velocities in the direc-
tion of the transmitted ultrasound beams. To partially overcome this limitation
it is possible to perform angle correction upon measurement: the operator can
indicate the assumed ow direction, and the ultrasound soware will rescale
the obtained velocity values to correct for the angle between the measured and
assumed ow direction.is angle correction is represented by cos(θ) in equa-
tion 3.8. As the cosine of 90 ○ is zero, this implies that no velocities can be
measured in the direction perpendicular to the transducer. In general, angle
correction only yields reliable results if −60○ ≤ θ ≤ 60○. An angle correction of
45 ○ was applied to measure the ascending aortic velocity in Figure 3.8 D, while
an angle correction of 55 ○ was needed to align the beamwith the ow direction
in the abdominal aorta in Figure 3.10 D.
3.2.3 Small animal ultrasound in practice
Dedicated systems have been developed recently to perform ultrasound imag-
ing in small animals (Vevo 770 and 2100, Visual Sonics, Toronto, Canada).
While the general principles as described in section 3.2.1 are the same, trans-
ducer design for small animal imaging is much more challenging. Indeed, the
center frequency of the transducer is much higher for mice (30 - 50 MHz, de-
pending on the application) than for humans (1-18 MHz, depending on the ap-
plication). A dedicated small animal ultrasound system is required, as one can-
not simply attach a high-frequency transducer to a clinical ultrasound device.
e increased transducer frequency is necessary since it is directly related to the
spatial resolution and inversely related to the depth of the image (because of at-
tenuation). A more detailed analysis of the resolution requirements in small
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animal imaging is discussed in section 3.2.4.
Within (the third part of) this dissertation a Vevo 2100 small animal ultra-
sound device was used. As can be seen in Figure 3.9, the mouse is xated on
Figure 3.9: Setup for high-frequency small animal ultrasound. A.e Vevo 2100 (Visual Sonics,
Toronto, Canada), used for all ultrasound imaging within this dissertation. B. e mouse is
xated on the (heated) animal handling table. A rectal probe monitors body temperature, while
the 4 paws are connected to electrodes that are used to monitor the electrocardiogram (ecg) and
respiratory rate.
a handling table and anesthetized by continuous inhalation of 1.5 % isourane.
e handling table is connected to a heating element to keep it on a constant
temperature of 40○C and mouse body temperature is continuously monitored
via a rectal probe.e paws are connected to electrodes that are used to mon-
itor the electrocardiogram (ECG) signal as well as the respiratory rate during
the measurements (green and yellow signals at the bottom in Figure 3.8, re-
spectively). In human ultrasound imaging the ultrasound operator changes the
position of the transducer to obtain the desired image, while the patient lies on
the bed and remains as motionless as possible. In a murine setting however,
the probe position is xed with a clamp (Figure 3.9 B) while the position of the
mouse is changed by the operator, as the handling table is xed on a ball hinge
that enables free rotation in all directions.
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3.2.4 Pitfalls for (small animal) ultrasound imaging
Temporal and spatial resolution in B-Mode imaging
As already explained in section 1.3.2, the murine (cardiovascular) system can
be considered as a smaller and faster version of the human system. is im-
plies that when imaging mice, both temporal and spatial resolution must fulll
much higher requirements in order to obtain similar results as for humans.e
maximal temporal resolution that can be achieved in regular B-mode imaging
is related to the time that ultrasound waves need to travel back and forth from
the transducer to the scatterers in the tissue. As the traveled distance is about
10 times less in a murine setting, the so-called round-trip travel time will also
be 10 times smaller.eoretically, the higher temporal resolution requirements
in mice (due to a 10-fold increase in heart rate) are thus met by the smaller dis-
tances that need to be traveled. e spatial resolution ∆z on the other hand is
determined by:
∆z = cT
2
(3.9)
In this equation c is the speed of sound which depends on the material proper-
ties through which the sound wave travels and is equal to 1540m/s in bothmice
andmen. T is the pulse duration and is inversely related to the center frequency
of the transducer (40 MHz). However, even if the term high-frequency imaging
might suggest otherwise, the central frequency is only about 4 times larger for
the murine transducer than for the human transducer, while the imaged tissues
generally are 10 times smaller (e.g. ascending aortic diameter is around ± 2 cm
in humans, ± 2 mm in mice).e increase in frequency thus doesn’t fully meet
the increased spatial resolution requirements.
Anesthesia and body temperature
Before imaging the animal has to be shaved, since the impedance mismatch of
ultrasonic waves that are reected on the fur would otherwise deteriorate image
quality.e combination of shaving and anesthesia causes body temperature to
drop. As indicated in section 3.2.3, the animals are therefore positioned on a
heated pad during the measurements. Nevertheless body temperature will de-
crease over time, which is why the ultrasound protocol should be restricted in
time.e lowered body temperature might also aect the general homeostasis
of the animal, although it remains to be shown whether there is an inuence
on the measured blood velocities. Anesthesia on the other hand is known to
reduce both cardiac and respiratory rate, and will therefore inuence the mea-
sured velocities as it reduces the cardiac output of the heart. As it is technically
very dicult to perform reliable vascular ultrasound measurements on con-
scious mice [196], anesthesia is an unavoidable confounding factor that should
be taken into account when interpreting resulting ultrasound velocitymeasure-
ments.
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Figure 3.10: Dierent image artifacts in ultrasound images obtained within the context of chap-
ter 9. All artifacts are indicated with a white arrow. A. Shadows: a shadow (probably cast by a
rib) is present in the ascending part of the aortic arch. B. Reverberations: an articial stationary
structure is present in the ascending part of the aortic arch. C. Aliasing: articial blue velocities
(directed towards the heart) are detected in the central part of the ascending aorta due to a PRF
(Pulse Repetition Frequency) that is set too low. D. Spectral broadening: dierences in detected
velocities of the scatterers within the sample volume can cause a broad, not clearly delineated
velocity prole.
Image artifacts in B-Mode imaging
In certain circumstances image artifacts impede proper ultrasound imaging.
Some of the most frequently encountered artifacts are depicted in Figure 3.10.
When the ultrasonic wave passes through dense structures (such as bones) the
wave gets attenuated and no more signal reaches the receiver, which casts a so-
called shadow over the obtained image (Figure 3.10 A).is is particularly a
problem in thoracal (e.g. cardiac or aortic arch) imaging due to the presence
of the sternum and ribs. To overcome this limitation, standardized probe po-
sitions are used for imaging, in an attempt to avoid bony structures as much
as possible. Similarly, proper B-Mode imaging may also be hindered by the
presence of air (e.g. in lungs). Other image artifacts include (among others)
reverberations, caused by stationary structures that cause the ultrasonic wave
to bounce back and forth between skin and structure, thus increasing the travel
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time of thewave and giving rise to an articial (deeper located) stationary struc-
ture in the image (Figure 3.10 B). Except for these general B-mode related image
artifacts, specic sources of error exist for velocity imaging, such as aliasing and
spectral broadening.
Aliasing in Pulsed and Color Doppler imaging
Doppler pulses are transmitted at an operator-dependent sampling frequency
known as the pulse repetition frequency (PRF).e time interval between sam-
pling pulsesmust be such that a pulse canmake the round trip to the transducer.
e maximum frequency fslow (see equation 3.8) that can be measured unam-
biguously with Pulsed Doppler is half the PRF. Low velocities (e.g. venous ow)
are measured at low PRF, as the longer interval between pulses allows for the
identication of slow ow. Aliasing will occur if a too low PRF (regulated by
the operator as the velocity scale) is used while high velocities are encountered
(Figure 3.10 C).is will result in the velocity scale erroneously switching sign.
Conversely, if a high PRF is used to examine high velocities (e.g. ascending
aortic velocity), low velocities may be more challenging to identify.
Spectral broadening in Pulsed Doppler imaging
As explained in section 3.2.1 Pulsed Doppler velocity measurements are ob-
tained by sampling scatterer motion within a sample volume (indicated by two
parallel solid yellow lines in Figure 3.8 D). A clearly delineated velocity prole
is obtained when all red blood cells within the sample volume have a similar
velocity (Figure 3.8 D). However, if dierent scatterers within the sample vo-
lume have dierent velocities, spectral broadening occurs (also dependent on
the used imaging setup).e Pulsed Doppler sonogram shows large variation,
and the local brightness of the signal is related to the number of red blood cells
moving with a certain velocity within the sample volume (Figure 3.10 D).
General operator dependency
Ultrasound is an operator-dependent technique, meaning that 2 operators per-
forming the same measurements on the same animal under comparable cir-
cumstances, might still obtain dierent results.is is in part caused by the fact
that the eld of view is at all times twodimensional (see e.g. the B-mode image
in Figure 3.8A).e operator thus needs to be trained to recognize all cardiovas-
cular structures in standardized 2D views to allow for ecient imaging. More-
over, once the cardiovascular structure of interest is identied, the operator
needs to ensure that all measurements are taken at the correct location within
that structure.is is an important remark as it is not always straightforward to
position the animal in such a way that the obtained 2D B-mode section repre-
sents the central part of the structure of interest. For velocity measurements in
blood vessels, it is important to position the B-mode eld of view perpendicular
77
3. Small animal imaging techniques
to and along the centerline of the (3D) vessel before any pulsed Doppler veloc-
ity measurement is started. is is necessary as - assuming the velocity has a
parabolic prole as in Figure 2.1.3 - the maximal, centrally placed velocity value
is the one that needs to be measured and processed to obtain CFD boundary
conditions (section 2.1.3). Due to the 2Dnature of the image, incorrect (i.e. non-
central) B-mode imaging prior to the Pulsed Doppler measurement will result
in an underestimation of the real velocity. Other operator-dependent sources
of error during Pulsed Doppler imaging are an incorrect placement of the sam-
ple volume (which should be located in the center of the blood vessel) and an
incorrect angle correction within the sample volume (which should be aligned
with the direction of the ow as explained in section 3.2.1).
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Outline
As outlined in the literature overview in section 2.2.2, the initial phase of small
animal CFD was hampered by a lack of imaging technologies that would allow
us to measure murine cardiovascular properties in vivo. e dedicated small
animal imaging techniques presented in chapter 3 were not yet (fully) available
at the onset of the PhD. Contrast agents allowing for in vivo micro-CT mea-
surements in mice did not exist, and the arterial geometry was usually based
on a vascular cast, a plastic replica of the arterial tree that was scanned in vitro.
Literature data on boundary conditions were scarce, and mouse-specic car-
diovascular CFD simulations were very dicult to achieve.
e second part of this dissertation contains three dierent studies that
were performed within this context. e aim of these studies was to increase
our existing knowledge of the murine arterial system. Intra-species dierences
(i.e. dierences between mice) and inter-species dierences (i.e. dierences
between mice and men) in the aortic arch are studied from both an anatomi-
cal (chapter 4) and a hemodynamic (chapter 5) point of view. Furthermore the
inuence of newly developed contrast agents for micro-CT is studied (chapter
6). In a later stage of this dissertation (part 3), the knowledge that was gained
in these rst chapters was applied to study the inuence of hemodynamics on
aneurysm formation.
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Anatomy of themurine aortic arch:
validation of themouse as amodel
to study human vascular diseases
e results of this study were published in:
Christophe Casteleyn, Bram Trachet, Denis Van Loo, Daniel G.H. Devos, Wim
Van Den Broeck, Paul Simoens, Pieter Cornillie . Validation of the murine aor-
tic arch as a model to study human vascular diseases. Journal of Anatomy 2010,
216(5):563-571.
4.1 Introduction
In recent years, several researchers have investigated the hemodynamics in the
murine aortic arch as a model to study human vascular diseases, as described
in the literature overview in section 2.2.2. One of the most intensely studied
hemodynamic factors is wall shear stress (WSS) because it is believed to con-
tribute to the development of atherosclerosis and aneurysms [60, 165]. AsWSS
cannot be measured directly, computational uid dynamics (CFD) simulations
are used to quantify its distribution over the aortic wall [140, 174, 177]. ese
simulations oen base their geometry on vascular casts, plastic replicas which
accurately represent the in vivo geometries and dimensions of the vascular sys-
tem. Although both geometry and boundary conditions are of major impor-
tance for an accurate representation of the hemodynamics, variations in arterial
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geometry are the main cause of the variability in wall shear stress distribution
[197]. As a result, detailed anatomical descriptions of the murine aorta are in-
dispensable. Such descriptions could also be useful for toxicological studies as
numerous chemicals, including drugs, can provide aortic arch malformations
in mice [198].
Notwithstanding the fact that themouse is frequently used tomodel human
vascular diseases, anatomical studies on its vascular system have seldomly been
performed [199]. A solid knowledge of the murine circulatory system is, how-
ever, a prerequisite for the correct interpretation of experimental data and the
validation ofmousemodels. Furthermore, anatomical and physiological analo-
gies between mice and humans are most controversial. For instance, Feintuch
et al. [140] state that the haemodynamic patterns in the murine aorta are sub-
stantially similar to those in humans and larger domestic mammals because of
the similarity in anatomy, blood ow velocity, cardiac output waveform shape
and blood pressure. In contrast Suo et al. [175] hold that, given dierences in
size, heart rate and blood ejection fraction, it is expected that the mouse model
does not scale up to the human and that the hemodynamic parameters could
be quite dierent.
ese literature data clearly demonstrate the need for detailed anatomical
studies in mice. e rst aim of the present chapter was therefore to describe
the anatomy and geometry of themurine heart and thoracic aorta with its main
branches. Vascular corrosion casts, accurate three-dimensional (3D) replicas of
the vascular system, were used for this purpose.e second goal was to validate
the use of the murine heart and thoracic aorta as a model to mimic human
vascular diseases. For this purpose 3D models based on contrast-enhanced CT
scans of six younger and six older male human hearts and thoracic aortas were
compared with the 3D casts of the respective murine structures.
4.2 Materials and methods
4.2.1 Subjects
Mice
irty 2-months-old female mice (species: Mus musculus, strain: C3HeB/FeJ)
with a mean weight of 30.6 g were obtained (e Jackson laboratory, Maine,
USA).eir accommodation and husbandry was conformed to the guidelines
stipulated in Appendix A of the European Convention for the protection of ver-
tebrate animals used for experimental and other scientic purposes [200]. Ap-
proval for this research was obtained by the Ghent University Ethical Commit-
tee on Laboratory Animal Tests (ECD 07/20).
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Men
Contrast-enhanced CT images of the hearts and thoracic aortas of six younger
men, aged 25 to 29 years, and six older men, aged 84 to 85 years, were analyzed.
Patients having had a CT examination of the thorax were selected from our im-
age archive on the basis of their age, the clinical reason for the CT investigation,
and the normal-for-age appearance of the aorta as assessed by a radiologist.e
selected patients had their CT scans for reasons other than aortic pathology.
Approval of the ethical committee of Ghent University Hospital for this retro-
spective study using anonymised CT scans was obtained under the number EC
UZG 2009/648.
4.2.2 Vascular analysis in mice
Vascular corrosion casting
e protocol of vascular corrosion casting was analogous to the one described
by [201], and has been visualized in Figure 3.4.e animals were euthanised by
CO2 inhalation [202]. A large median incision from pubis to xiphoid wasmade
and the abdominal aorta was catheterised with a 26 gauche catheter (Terumo
Europe, Leuven, Belgium). Two ml of Batson’s #17 solution (VWR, Haasrode,
Belgium)was gently injected in retrograde direction by free-hand. Pressure was
not controlled, but complete lling of the vascular system was indicated by the
appearance of red intravascular polymer shining through the skin of the toes
and nose [203]. Subsequently, the mice bodies were macerated in 25% potas-
siumhydroxide (Roth, Karlsruhe, Germany), rinsedwithwater anddried under
a vented hood.e casts were evaluated and photographed with a stereomicro-
scope (Olympus SZX7, Olympus Belgium, Aartselaar, Belgium) equipped with
a charge-coupled device camera (Olympus Colorview, Olympus Belgium). All
measurements on murine blood vessels were made directly on the casts un-
der the stereomicroscope using image analysis soware (Cell*D, Olympus Bel-
gium).
Intrathoracic position of the murine heart and aortic arch
e position of and approach to the murine heart and aortic arch are described
using the adjectives ventral vs. dorsal and cranial vs. caudal according to vet-
erinary anatomical nomenclature [204]. e position of the murine heart and
aortic arch into the thorax was determined on six vascular corrosion casts using
image analysis soware (Cell*D, Olympus Belgium).e deviation of the ven-
tricular axis to the le of the median plane was determined on both a ventral
and a cranial view. On the latter view, the deviation of the aortic arch to the
le of the median plane was also measured. On a lateral view, the deviation of
the ventricular axis to the ventral side of the thorax and the angle between the
ventricular axis and the ascending aorta was calculated. A visual representation
of the angles that were measured is given in Figure 4.1.
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Figure 4.1: Visual representations of the various angles that were measured concerning the in-
trathoracic position of the heart and the geometry of the aortic arch. A:e deviations of the
ventricular axis (1) and the aortic arch (2) to the le of the median plane were measured on an
anterior / ventral view. e same deviations (3 and 4, respectively) were also determined on a
superior / cranial view. On a lateral view the deviation of the ventricular axis to ventral (5) and
the angle between the ventricular axis and the ascending aorta (6) were measured. B:e angles
at which the brachiocephalic trunk (aa-bc), the le common carotid artery (aa-lc) and the le
subclavian artery (aa-ls) branch o from the aortic arch were measured on an anterior / ventral
view. e angles between the ascending aorta and the descending aorta at the level of the aor-
tic bulb (aa-da) and between the ascending aorta and the thoracic aorta aer it had joined the
vertebral column (aa-ta) were determined on a right lateral view.
Geometry of the murine thoracic aorta and its branches
e geometry of the murine aortic arch and its branches was examined in six
animals aer carefully dissecting these structures out of the vascular casts. 3D
computer models of these structures were generated by scanning the casts us-
ing an in house developed in vitro micro-CT system consisting of an open type
X-ray system (Feinfocus, Stamford, Connecticut) with transmission target.e
detector was a VHR (Photonics science, Millham, UK) used in binning 4, re-
sulting in 967 x 644 pixels. A total of 665 projections have been taken with 2
seconds exposure time each.is was done at 80 kV resulting in a spot size of 3
µm.e images were reconstructed with Octopus which is an in house devel-
oped soware package [205]. Aer cropping, 600 slices of 474 x 407 pixels with
a pixel size of 18 µm2 remained. e resulting images were further processed
in Mimics (Materialise, Leuven, Belgium) to produce a realistic 3D computer
model of the aortic arch including its three side branches. For the reconstruc-
tion of the scanned images into a 3D model an operator-dened threshold was
used. In Mimics all superuous parts at inlets and outlets were removed, the
model surface was smoothened to remove occasional bulges and dents and a
triangular surface mesh of the 3D model was created.
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In order to determine the angles at which the aortic branches originate from
the aortic arch as accurately as possible, a centerline was calculated in 3-matics
(Materialise, Leuven, Belgium). e best tting line was calculated through
each branch, tangential to the centerline at that location. en a plane was
dened through the endpoints of the two lines indicating the direction of the
branch and the direction of the aorta directly preceding that branch. Both lines
were projected onto this plane, and the angle between those projections was
calculated. is procedure was repeated for each of the three side branches of
each model. To determine the angle between the ascending and descending or
thoracic aorta, a plane was dened perpendicular to the direction of the ow,
in the middle of the arch. Again, both lines indicating the direction of the as-
cending and descending or thoracic aorta were projected onto this plane, and
the angle between them was determined. As a result, only the angle of interest
was taken into account, and not the total (3D) angle between both lines. Figure
4.1 schematically shows the various angles that were measured.
4.2.3 Vascular analysis in men
e position of and approach to the human heart and aortic arch are described
using the adjectives anterior vs. posterior and superior vs. inferior according to
human anatomical nomenclature [206]. Contrast enhanced CT image datasets
of six younger and six older men were generated using a Siemens Somatom
scanner (Siemens AG, Muenchen, Germany) with Visipaque (Iodixanol, GE
Healthcare Limited, Buckinghamshire, England) as contrast agent. A 3D com-
puter model was reconstructed from these CT images in a similar way as men-
tioned above for the mice. On the 3D models the intrathoracic position of the
human heart and aortic arch as well as the geometry of the thoracic aorta and its
branches were determined in a similar way as in mice (Figure 4.1). For diame-
ter and lengthmeasurement of blood vessels a centerline was rst computed for
each vessel inMimics. Blood vessel diameters were determined from the cross-
sectional surface area orthogonal to this centerline. In case of a non-circular
cross-section the equivalent diameter corresponding to a circular surface area
was calculated instead. Lengths were measured by summing the lengths of the
required centerline segments. Distances between the origins of the branching
vessels were measured along these centerlines.
4.2.4 Statistical analysis
Signicant dierences (when p < 0.05) between the measurements performed
in mice, and younger and older men were detected using one-way analysis of
variance (ANOVA). All pairwise multiple comparisons were performed using
the Bonferroni method.
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4.3 Results
4.3.1 Branching pattern of the aortic arch
Mice
Table 4.1: Mean diameters (mm) ± SE of the various segments of the thoracic aorta and its main
branches of mice and younger and older men.
Vessel Mice Younger Men Older Men
Ascending aorta 0.82±0.01 27.48± 1.37 35.13 ±2.75
Aortic arch 1.06±0.02 22.74±0.97 26.35± 1.00
Descending aorta 1.06±0.02 22.74±0.97 26.35± 1.00
Brachiocephalic trunk 0.54±0.02 11.38±0.31 16.68± 1.52
Le common carotid artery 0.35 ±0.02 7.53±0.34 7.72±0.91
Le subclavian artery 0.38±0.02 10.11 ±0.41 10.91±0.83
Table 4.2: Mean distances (mm) ± SE between the origins of the three branches of the aortic
arch in mice and younger and older men.
Distance Mice Younger Men Older Men
BRT - LCC 0.96±0.06 12.23±0.62 16.62± 3.32
LCC - LSC 1.21 ±0.04 21.20±2.03 21.28± 4.11
BRT=brachiocephalic trunk, LCC=le common carotid artery,
LSC=le subclavian artery.
e brachiocephalic trunk, the le common carotid artery and the le sub-
clavian artery subsequently branched o from the aortic arch in all 30 speci-
mens (Figure 4.2).e mean diameters with standard error of the various seg-
ments of themurine thoracic aorta and itsmain branches are presented in Table
4.1. Table 4.2 shows the distances between the origins of the three branches of
the aortic arch.e length of the brachiocephalic trunk ranged from 0.39 mm
to 2.08 mm with a mean and standard error of 1.20 mm ± 0.17 mm. In most
cases the right internal thoracic artery branched o from the right subclavian
artery. In four cases (13%), however, a long brachiocephalic trunk was present
which resulted in the branching of the right internal thoracic artery from the
brachiocephalic trunk (Figure 4.3).
Men
e branching pattern of the human aortic arch was identical to that of mice
(Figure 4.4).e mean diameters with their standard error of the various seg-
ments of the thoracic aorta and its main branches of the younger and oldermen
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Figure 4.2: Ventral view of a casted (le side of the gure) and schematically drawn (right side
of the gure) murine aortic arch with its originating arteries (R and L = right and le side of
the thorax, respectively). bct = brachiocephalic trunk, rit = right internal thoracic artery, rs =
right subclavian artery, rcc = right common carotid artery, rv = right vertebral artery, rct = right
cervical trunk, rsc = right supercial cervical artery, ra = right axillary artery, rb = right brachial
artery, rtd = right thoracodorsal artery, lcc = le common carotid artery, ls = le subclavian
artery, lit = le internal thoracic artery, lv = le vertebral artery, lct = le cervical trunk, lsc = le
supercial cervical artery, la = le axillary artery, lb = le brachial artery, ltd = le thoracodorsal
artery. Notice that the right internal thoracic artery in this specimen branches o from the long
brachiocephalic trunk.
Figure 4.3: Ventral views of casted murine aortic arches showing the right internal thoracic
artery (rit) either branching o from a long brachiocephalic trunk (bct) (le side of the gure)
or from the right subclavian artery (rs) (right side of the gure) when the brachiocephalic trunk
is very short (R and L = right and le side of the thorax, respectively). rcc = right common carotid
artery, lcc = le common carotid artery, ls = le subclavian artery.
are presented in Table 4.1. Additionally, the distances between the origins of the
three branches of the aortic arch are shown in Table 4.2. In younger men the
length of the brachiocephalic trunk ranged from 36.89 mm to 43.59 mm with a
mean and standard error of 41.61 mm ± 1.1 mm. In older men it ranged from
11.99 mm to 56.50 mmwith a mean and standard error of 36.61 mm ± 6.95 mm.
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Figure 4.4: Computerized 3D reconstructions of the hearts (le ventricles in men) and aortic
arches of mice, younger and older men, allowing for a comparison of the geometry and intratho-
racic position of these structures.
4.3.2 Anatomical topography of the heart and aortic arch
Mice
Figure 4.4 shows the anatomical topography of the murine heart and aortic
arch.e values of the various angles that were measured are presented in Fig-
ure 4.5.e longitudinal axis of the heart was oriented obliquely in the thorax
with the apex of the heart directing towards the lower le thoracic quadrant,
and the basis of the heart together with the ascending aorta directing towards
the upper right thoracic quadrant.e ventricular axis deviated 31○ and 41○ to
the le of the median plane on a ventral and a cranial view, respectively. On a
lateral view an inclination of the ventricular axis towards the ventral side of the
thorax of 39○ was observed.e initial segment of the aorta, comprising the as-
cending aorta, the aortic arch and the cranial part of the descending aorta, was
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sigmoidally curved when looked upon from a cranial view.e ascending aorta
was oriented cranially and situated ventral to the descending aorta at the right
of the median plane. On a cranial view the aortic arch had an inclination of
45○ to the le from the median plane in dorsocaudal direction.e descending
aorta was located dorsally and to the le of the midline and pursued a caudal
course. On a ventral view it was obvious that the aortic arch crossed the thorax
transversely from right to le. e descending aorta was located to the le of
the median plane and pursued its course in caudal direction to join the midline
at the level of the 10th thoracic vertebra.
Men
Figure 4.4 shows that the intrathoracic position of the human heart was quite
similar to that of the murine heart. e mathematical results concerning this
position are presented and statistically compared with the data of the mice in
Figure 4.5. Compared to mice the axis of the human heart was positioned sig-
nicantly less towards the anterior side of the thorax on a lateral view (only 25○
and 1○ in younger and older men, respectively). As in mice, the initial segment
of the human aorta was sigmoidally curved. On the anterior view the origin of
the ascending aorta was positioned in the median plane (= in the center of the
coronal plane). e ascending aorta rst ran in superior direction, slightly to
the right side of the median plane. Subsequently, it deviated to the le of the
median plane at an angle of approximately 15○ in younger men and 29○ in older
men. Such a deviation was not present in mice. On the superior view the aor-
tic arch turned posteriorly and to the le at an angle of approximately 22○ and
31○ with the median plane in younger and older men, respectively. In younger
men the descending aorta ran in a fairly straight course towards the abdomen
in a prevertebral position slightly le of the median plane. In some older men
the descending aorta rst ran back towards the median plane and then again to
the le of the median plane to join the vertebral column at the level of the 11th
thoracic vertebra.
4.3.3 Geometry of the aortic arch and its main branches
Mice
e angles at which the brachiocephalic trunk, the le common carotid artery
and the le subclavian artery branched o from the aortic arch are shown in
Figure 4.5. e angle that is present on a lateral view between the ascending
and descending aorta at the level of the aortic bulb, and between the ascending
aorta and the thoracic aorta aer the latter has joined the vertebral column are
also reported.
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Figure 4.5: Box plots showing the values of the various angles that were measured in mice,
younger and older men as illustrated in Figures 1A and B (part A and B of the present gure,
respectively). Values marked with the same symbol (*, ○ or #) dier signicantly from each other
(p<0.05).emean value is represented by the horizontal bar in the box, the box itself represents
the interquartile range (25% - 75%of the values), and theminimal andmaximal values aremarked
by the horizontal bars at the lower and upper ends of the box, respectively.
Men
Figure 4.5 shows the values for the younger and older men of the same ve
angles that were also measured in mice. Signicant dierences between mice,
younger men and older men are indicated.
92
4.4. Discussion
4.4 Discussion
4.4.1 Branching pattern of the aortic arch
e results of our study show that the variable length of the brachiocephalic
trunk inuences the branching pattern of the arteries that arise from it. Inmost
examined mice the right internal thoracic artery branched o from the right
subclavian artery. In a few animals, however, the right internal thoracic artery
arose from a relatively long brachiocephalic trunk. ese observed variations
seem to be normal individual variations of the vascular system. Although an
animal’s vascular phenotype is mainly determined by its genotype, the environ-
mental conditions to which the animal is exposed to should not be neglected.
Wilson and Warkany [207], for example, found that nutritional deciency of
vitamin K considerably increases the number of vascular varieties in the ar-
teries that branch o from the aortic arch in the rat. Monnereau et al. [198]
found a rat fetus in which the brachiocephalic trunk was absent and the right
subclavian and the right common carotid arteries originated separately from
the aortic arch.is nding is in accordance with the large variation in length
of the brachiocephalic trunk and more specically with the occurrence of very
short brachiocephalic trunks in some mice observed in the present study.
Variation in length of the brachiocephalic trunk is also present in humans.
emean length observed in the 12men examined in our studywas 33mmwith
a range between 12 mm and 57 mm.ese values are similar to those presented
by Shin et al. [208] who found amean length of 33 mmwith a range between 24
mm and 46 mm. In most humans the three major branches originate directly
from the aortic arch [209]. In some individuals the le common carotid artery
branches o from the brachiocephalic trunk. It is also possible that the le
vertebral artery originates from the aortic arch in between the le subclavian
artery and the le common carotid artery [208].
4.4.2 Intrathoracic position of the heart
Figures 4.4 and 4.5 clearly demonstrate that the hearts of bothmice andmen are
positioned obliquely in the thorax with the apex pointing to the le lower tho-
racic quadrant. In older men, however, the position of the heart is much more
horizontal with the apex pointing to the le side of the thorax. In mice the
apex of the heart manifestly points to the le ventral side of the thorax since
an angle of 39○ is present between the ventricular axis and the vertebral col-
umn. is angle is somewhat smaller in younger men and almost absent in
older men.is species dierence could be explained by the latero-lateral at-
tening of the murine thorax. A morphological explanation for the dierence
between younger and older men is, however, not obvious. Although the apex
of the murine heart presents this ventral deviation, there is almost a straight
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course from the ventricle towards the ascending aorta as the latter forms an an-
gle of 31○ with the descending aorta. Such an almost straight course is also seen
in older men.
4.4.3 Geometry of the aortic arch
e ascending and descending aorta of mice are not positioned in a single ver-
tical plane (non-planar aortic geometry). is characteristic conguration is
also present in humans, albeit the least pronounced in younger men. Our mea-
surements of the inclination of the aortic arch to the le of the median plane
are in accordance with the results obtained by Shin et al. [208] who found an
average inclination angle of the aortic arch of 28○ with variation between 0○ and
90○. Only in men amarked inclination between the aortic arch and the ascend-
ing aorta to the le side of the thorax was seen on the anterior view. In mice,
the transition between both aortic segments is smoother and the aortic arch is
positioned more transversely in the thorax.
In contrast to mice and younger men in whom a roman aortic arch with
normal semi-circular morphology was present, the older men had gothic aortic
arches with a triangular morphology [210]. Such a distortion of the aortic arch
is considered as an inuencing factor in the development of atherosclerosis,
rather than an expression of the disease [211]. Since the vascular branching
pattern of the aortic arch and the geometry of the branches are also similar in
mice and humans, the murine model seems valuable to study human vascular
diseases. is conforms with the statement of Feintuch et al. [140] that the
anatomy of the murine and human aortic arches are quite similar. Moreover, a
preliminary study performed by Casteleyn et al. [212] indicated that themurine
model appears to be far more suitable than that of other laboratory animals,
such as the rabbit and the rhesus monkey, or pet animals, including the cat
and the dog. Further research on the geometry of the aortic arches of various
domestic animals should, however, be performed to denitely conclude that the
mouse is the most suitable animal model to study human vascular diseases that
are related with vessel geometry.
4.5 Conclusion
is study revealed that the topology of the murine and human hearts and the
branching patterns of their aortic arches present many analogies. Moreover,
a non-planar geometry of the aortic arch is present in both species. e aor-
tic arches of mice and older men seem, however, to be share most similarities.
erefore, the choice ofmany researchers to use themouse as amodel tomimic
human vascular diseases, which are related to the geometrical characteristics of
the thoracic aorta, seems justied.
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Hemodynamics in themurine aortic
arch: the influence of aortic
dimensions
e results of this study were published in:
Bram Trachet, Abigail Swillens, Denis Van Loo, Christophe Casteleyn, Anne
De Paepe, Bart Loeys, Patrick Segers.e inuence of aortic dimensions on cal-
culated wall shear stress in the mouse aortic arch. Computer Methods in Biome-
chanics and Biomedical Engineering 2009, 12(5):491-499.
5.1 Introduction
Mouse models are oen used for medical research since they can provide very
useful and relatively easily accessible information on the pathology of several
diseases, as indicated in section 1.3.1. In the cardiovascular eld, genetically
modied mice are being used to study genetic disorders such as the Marfan
and Loeys-Dietz syndrome [63, 77, 213], but also for the study of atherosclero-
sis and other vascular diseases [214–216]. However, extrapolation of research
results obtained in mice to the human situation is not always straightforward,
especially when studying aspects related to the biomechanics and hemodynam-
ics. Due to their fast heart rate (10 times faster than in humans) and their small
dimensions, the hemodynamic parameters in the murine vascular system are
of a dierent order of magnitude than those in the human system. One of the
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hemodynamic parameters that play an important role in the regulation of the
vascular system is the arterial wall shear stress (WSS). WSS is considered to be
an important factor in the development and progression of cardiovascular dis-
ease in humans. It is generally believed that WSS is best kept within certain
limits. For example, several studies have shown a connection between low and
oscillatingWSS patterns and atherosclerosis [141, 217, 218]. Computational uid
dynamics (CFD) simulations are oen used to quantify theWSS. Provided with
the correct boundary conditions that prescribe the ow behavior at the in- and
outlets, these numerical models can accurately predict the shear stress that the
blood ow will exert on the aortic wall. Reported data, however, display a rela-
tively broad range of WSS, both in experimental [219–221] and computational
[88, 174, 175, 177, 218] studies, indicating a large variability between dierent
subjects of the same species. It is well known that vessel size is an important
determinant of WSS.is geometrical factor is not only relevant when com-
paring data from species of a dierent size, but it is also a factor that will play
a role during growth and development of the individual animal. Aortic root
diameter is believed to be linked to body weight [222] and since mice grow
faster than men, aortic dimensions may change signicantly over a period of
weeks and months. Published results for WSS in ’adult mice’ might thus de-
pend strongly on the exact age and corresponding aortic diameter of the mice
used for research. e goal of study presented in this chapter is to investigate
the inuence of the mouse body mass and corresponding aortic dimensions on
its aortic WSS, i.e., the dierence in WSS between dierent mice with varying
arterial diameters at the same location in the arterial tree. e aortic arch was
chosen as the location of interest. As the eect of a change in diameter onWSS
can also be addressed in an analytical way, we rst performed a dimensional
analysis. Additionally, a CFD analysis was made to study the WSS distribution
in a more detailed way. A 3Dmodel of the mouse aortic arch was created based
on a geometry obtained by vascular corrosion casting. In order to assess the in-
uence of the change in aortic dimensions onWSS in the aortic arch the model
was rescaled to 5 dierent dimensions, each representing a dierent stage in
the mouse life cycle.e WSS pattern in each model was then computed with
numerical ow simulations.
5.2 Materials and methods
5.2.1 Dimensional analysis
To assess the impact of a change in aortic diameter on the ow eld, a dimen-
sional analysis was performed.is analysis can be done very rapidly and yields
information on the general ow eld. e Reynolds number (Re) is a key di-
mensionless parameter in uid dynamics, expressing the ratio of inertial and
viscous forces. It can be used to assess whether ow is in a laminar, turbulent
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or transitional phase. For steady ow in a circular tube, the transition points
are at Re = 2000 (laminar to transitional phase) and Re = 2500 (transitional to
turbulent phase).
Re = v ⋅ D
ν
(5.1)
Assuming that kinematic blood viscosity (ν) and the inlet velocity (v) are con-
stant for all models while the inlet diameter (D) changes, the Reynolds num-
ber will increase linearly with the diameter. WSS ( τpois) is computed using
Poiseuille’s law [223]
τpois = 8 ⋅ µ ⋅ vD (5.2)
with µ the dynamic blood viscosity ( µ = ν ⋅ ρ, with ρ the density of blood) and
will thus decrease linearly with the diameter. It should, however, be noticed
that equation 5.2 is only valid in laminar steady (Poiseuille) ow conditions in
a straight circular tube, and not in a complex ow eld as present in the aortic
arch. Given the pulsatile nature of blood ow, another dimensionless parame-
ter to consider is the Womersley number, expressing the ratio of unsteady and
viscous forces.
Wo = D
2
⋅√2pi ⋅ f
ν
(5.3)
with f the frequency of the oscillations, i.e. the heart rate. When theWomersley
number is suciently low (< 1) inertial eects are low and ow is dominated by
viscous forces. In case of laminar pulsatile ow, this implies that at all moments
in time, the velocity prole remains parabolic in shape (though with varying
amplitude). A dimensional analysis can be used to reveal trends but does not
yield accurate numerical results. CFD should be used to obtain amore accurate
assessment of the absolute WSS values and to study the temporal and spatial
variation of the shear stress patterns [224].
5.2.2 Geometry of the mouse aorta for CFD simulations
e casting procedure was analogous to the one visualized in Figure 3.4. Fol-
lowing 24 hour food restriction an eight-week-old wild type mouse (Mus mus-
culus, strain: C3HeB/FeJ, obtained frome Jackson Laboratory, Maine, USA)
was euthanized by CO2-inhalation. e abdominal aorta was dissected free
through a ventral midline incision of the abdominal wall and catheterized un-
der a stereomicroscope. Twoml of Batson’s #17 Plastic Replica kit (Polysciences,
Warrington, Pennsylvania) was injected using 1 ml syringes and complete ll-
ing of the vascular system was indicated by the appearance of red intravascular
polymer shining through the skin of the toes and nose [203].e mouse body
was immersed for 30 minutes in tepid water allowing the cast to set.e mouse
was then macerated in 25% KOH, so only the plastic cast remained.e vascu-
lar corrosion cast was rinsed gently for 3 hours with tap water to remove tissue
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remnants. Aer drying, the aortic arch was excised to obtain a plastic replica of
the intended geometry (Figure 5.1 A).e experiment was conducted following
the Guidelines for Animal Care and Treatment set by the Council of European
Communities and was approved by the local Animal Ethics Commission.
5.2.3 Generating a 3D computer model
e plastic cast of the aortic arch was scanned using the in-house developed
in vitro micro-CT system of the Ghent University Center for X-ray Tomog-
raphy (UGCT), consisting of an open type x-ray system (Feinfocus, Stamford,
Connecticut) with transmission target.e detector was a VHR (Photonics sci-
ence, Millham, UK) used in binning 4, resulting in 967x644 pixels. A total of
665 projections have been taken with 2 seconds exposure time each. is was
done with a voltage of 80 kV resulting in a spot size of 3 µm.e images were
reconstructed with Octopus, an in house developed soware package [205] and
aer cropping 600 slices of 474x407 pixels with a pixel size of 18 µm2 remained.
ese resulting images were further processed in Mimics (Materialise, Leuven,
Belgium) to produce a 3D model of the aortic arch including its 3 major side
branches. For the reconstruction of the scanned images an operator-dened
threshold was used. InMimics all superuous parts at inlet and outlets were re-
moved and the surface was smoothened to remove occasional bulges and dents.
A triangular surface mesh of the 3D model was created in Mimics (Figure 5.1
B) and exported to TGrid (Ansys, Canonsburg, Pennsylvania), where a volume
mesh was generated. e volume mesh consisted of 5 layers of prismatic ele-
ments at the boundaries to improve accuracy where it is most needed, and the
bulk of the model was lled with tetrahedral elements (as explained in section
2.1.3). To investigate the inuence of the body mass of the mouse on the WSS,
the original model (with an aortic root diameter of 0.8 mm) was then rescaled
to obtain 4 extra models. e nal models used for this study had aortic inlet
diameters of 0.7, 0.8, 1, 1.3 and 1.5 mm. ese diameters correspond to dier-
ent stages in the mouse life cycle [225]: late fetal (embryonic day 18.5), neonate
(10 days), juvenile (1month), young adult (2 months) and old adult (9 months),
respectively.
5.2.4 CFD simulations
Fluent (Ansys, Canonsburg, Pennsylvania) was used to numerically solve the
Navier-Stokes equations for the ow. Blood density was taken to be 1060 kg/m3
[88] and at the high shear rates appropriate for the murine arterial system the
dynamic blood viscosity was assumed to remain at a constant asymptotic value
of 3.5 mPas [140]. A blunt inlet velocity prole was imposed at the aortic root
and traction free boundary conditions were imposed at all outlets. e ow
split at the side branches of the aortic arch was taken from Doppler ultrasound
measurements by Feintuch et al. [140] as 15% into the brachiocephalic trunk,
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8% into the le common carotid artery and 7% into the le subclavian artery.
For all diameters a time-dependent simulation was performed. A physiological
ow velocity waveform (Figure 5.5) was imposed at the inlet.e time period of
the inlet velocity prole was changed from 1 to 0.1 seconds to match the murine
heart rate.e ow division at the outlets was assumed to be constant through-
out the pulse.e maximal amplitude of the inlet velocity prole was assumed
to remain at a constant value of 1 m/s for all 5 geometries, based on theoretical
[180] and experimental [225–227] data. e amplitude of the time-dependent
ow prole was thus rescaled to obtain a peak velocity of 1 m/s. e mean in-
let velocity corresponding to this velocity prole is 0.18 m/s. For each model
time-averaged WSS distribution (TAWSS, equation 2.18) and oscillatory shear
index (OSI, equation 2.19) were calculated and plotted. If WSS always acts in
the same direction the oscillatory shear index (OSI) is 0, however if WSS is
oscillating between positive and negative values OSI will increase, with 0.5 as a
theoreticalmaximum. Since the endothelial cells are sensitive tomagnitude and
changes in the direction of WSS, extreme TAWSS and OSI values may thus be
an indication for disturbed endothelial function. In order to quantify the dier-
ence in WSS between the models, spatially averaged TAWSS (TAWSSavg) was
computed for each time-averaged model as well as the 95th percentile TAWSS
value (TAWSS95%, only 5 % of TAWSS values are higher then this value) as a
marker of highest WSS values. A mesh-independence study was performed for
the old adult model with a diameter of 1.5 mm.e number of volume elements
was changed from 500,000 to 1,800,000 and analysis showed that the resulting
TAWSS95% and the TAWSSavg remained at a constant value for models con-
taining 1,200,000 elements or more. Since this amount of elements resulted in
sucient accuracy for the largest model, it was used for all models.
5.3 Results
5.3.1 Dimensional analysis
e results from the dimensional analysis are summarized in Table 5.1. e
Reynolds number (assuming a constant velocity of 0.18 m/s) increases from 36
(late fetal) to 77 (old adult). WSS (τpois) decreased with age from 7.82 Pa (late
fetal) to 3.65 Pa (old adult). ese results only indicate a trend for the WSS
values, since idealized Poiseuille ow is assumed in the aorta, and the nature of
the dimensional analysis yields results that are averaged over time and space. Yet
the age-dependence of the computed WSS is already obvious. e Womersley
parameter varies from about 1.5 (late fetal) to 3.2 (old adult).
5.3.2 CFD simulations
e CFD simulations revealedWSS values that aremuch higher than values en-
countered in men, conrming previously published results [140, 175, 177, 180].
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Table 5.1: Dimensional analysis.
Late fetal Neonatal Juvenile Young adult Old adult
(D=0.7 mm) (D=0.8 mm) (D=1.0 mm) (D=1.3 mm) (D=1.5 mm)
Re 37 42 53 69 79
Wo 1.48 1.69 2.12 2.75 3.18
τpois 7.82 6.85 5.48 4.21 3.65
Re=Reynolds number, Wo=Womersley number,τpois =wall shear stress based
on Poiseuille’s law
Additionally, WSS displays a large temporal and spatial variability. e spatial
distribution of the TAWSS in the aortic arch is shown for dierent diameters in
Figure 5.2. e smallest model, representing the mouse in the late fetal stage,
shows relatively high TAWSS values (TAWSS95% = 26.14 Pa; TAWSSavg = 15.1
Pa) compared to the old adult model (TAWSS95% = 16.26 Pa; TAWSSavg = 9.17
Pa). In Figure 5.3 the numerical results from time-averaged simulations are
summarized and it is clear that TAWSS decreases with increasing aortic diam-
eter and thus CFD simulations yield the same trend of lower TAWSS for larger
dimensions as could be derived from the dimensional analysis.e distribution
of OSI was similar for all models and is only plotted for the young adult model
(Figure 5.3). CFD allow us to study the spatial distribution of the TAWSS in
detail. Zones with high TAWSS are mostly localized dorsal to the ow dividers,
at the proximal side wall of the inner curvature of the aortic arch. In all studied
cases, the location with the highest WSS (time-averaged over the cardiac cy-
cle) appears dorsal to the le common carotid artery (P1 in Figure 5.2, bottom
right panel).e locations ventral to the branches (P2, P3, P4 in Figure 5.2, bot-
tom right panel) have low WSS, and might thus be more prone to developing
cardiovascular disease. is counts especially for P4 which also has elevated
oscillating shear stress, as can be observed in Figure 5.4.
Apart from the spatial distribution there is also temporal variation of shear
stress throughout the cardiac cycle, the highest values obviously occurring dur-
ing systole. is temporal variation is shown in Figure 5.5 for the young adult
case (D = 1.3 mm).e temporally averaged values obtained from dimensional
analysis or by averaging CFD simulations over the cardiac cycle can bemislead-
ing andhighWSS values are reachedduring systolic acceleration (WSSavg=27.52
Pa; WSS95%=43.3 Pa), at systole (WSSavg = 59.81 Pa; WSS95% = 112.1 Pa) and
during systolic deceleration (WSSavg = 32.46 Pa; WSS95%= 67.46 Pa). During
diastole the WSS drops to almost zero over the complete surface of the arch
(WSSavg = 0.13 Pa; WSS95% = 0.31 Pa). Since the time period of the cardiac
cycle is 10 times faster in mice than in men, the mouse endothelium thus un-
dergoes very large temporal gradients of WSS during the systolic peak.
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Figure 5.1: A. Ventral view of the vascular corrosion cast of the original aortic arch (D = 0.8
mm), with part of the le heart still visible.R, right; L, le; 1, ascending aorta; 2, aortic arch; 3,
descending aorta; 4, brachiocephalic trunk; 5, le common carotid artery and 6, le subclavian
artery. B. Surface mesh of the 3D-model based on the vascular cast of panel A, created inMimics
(Materialise). C. Velocity proles in the young adult model (D = 1.3 mm) at systole, computed
with Fluent (Ansys). D. Wall shear stress (WSS) distribution corresponding to the velocity pro-
les in panel C, in the young adult model (D = 1.3 mm) at systole.
5.4 Discussion
5.4.1 Factors inuencing calculated wall shear stress
Overall, the results presented in this chapter raise three important issues. First,
as also previously shown in several other studies [88, 180, 219, 220], our data
clearly indicate an inverse relation between aortic size and the level of wall shear
stress.is is an important consideration when comparing WSS data obtained
in mammalian species diering in size. Second, our study draws the attention
to the fact that the size-dependency of WSS is also considerable when calcu-
lating WSS data for a given species, in our case the mouse. Depending on the
specic strain or age of the animal studied, weight and size of the animal can
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Figure 5.2: Inuence of aortic diameter on time-averaged wall shear stress (TAWSS).
substantially dier and lead to signicantly dierent aortic calibers. is vari-
ability in the size of the studied geometry, in combination with the assumption
for the magnitude of the inlet ow (assuming constant velocity independent of
size, or calculating inow conditions based on scaling laws as in [140]), gives
rise to results within a very large range of WSS, explaining some of the vari-
ability encountered in literature. A third issue that implicitly follows from our
work is that at a given anatomical location, WSS eectively does vary through-
out the animal’s life span, with values estimated to decrease by 38% over a life
span of 9 months (Figure 5.3B). As our simulations are based on experimental
observations of Hinton et al. [225] and reasonable assumptions regarding the
growth of the arterial tree with age, we believe that these ndings are more than
a purely speculative extrapolation of our numerical data. Our data support the
ndings ofHuang et al. [228], who calculatedWSS using Poiseuille’s equation in
49 mice at dierent ages from 1- 33 days old (until the juvenile stage) and found
that (i) WSS decreases linearly during development and that (ii) WSS can be
considered a strong stimulus for the remodeling of the lumen of the aorta. In
our numerical study we found that WSS is decreasing linearly until the young
adult age (2 months).is supports a mediating role forWSS in arterial growth
with high WSS in early life being a stimulus for outward arterial remodeling
and arterial growth. Figure 5.3B suggests that this feedback process is stable,
leading to a plateau value of WSS in adulthood.
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Figure 5.3: A. Spatially averaged TAWSS (TAWSSav g) and 95% TAWSS value (TAWSS95%) as
a function of aortic root diameter. B. Spatially averaged TAWSS (TAWSSav g) and 95% TAWSS
value (TAWSS95%) as a function of age.
Figure 5.4: Oscillatory shear stress (OSI) distribution for the young adult model (D = 1.3 mm).
5.4.2 Comparison with literature data
To assess similarities and dierences in WSS patterns between humans and
mice, numerical models of the murine arterial tree have been developed ([88,
140, 174, 175, 177]. When comparing these results with our data, it is important
to do so for similar dimensions and boundary conditions. Since most authors
who have computed WSS distributions for the mouse aortic arch have used a
geometry similar to that of our ‘young adult’ mouse, i.e. with a diameter of the
ascending aorta of approximately 1.3 mm, this model was used to compare our
computational results with literature data. Feintuch et al. [140] have numeri-
cally computed the TAWSS in the mouse aortic arch for a model with an inlet
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Figure 5.5: Wall shear stress (WSS) distribution at dierent time steps for young adult model (D
= 1.3 mm).
diameter of 1.3 mm and reported a value varying from a baseline value of 5.8
Pa at the root of the ascending aorta to a peak value of ± 36 Pa dorsal to the
le common carotid artery. Although their peak value is higher than the 17.42
Pa (95% value) that we obtained in our time-averaged simulation for a similar
diameter, the peak value does occur at the same anatomical location in both
studies.e mice used by Suo et al. [175] had a diameter of the ascending aorta
of 1.17 ± 6 mm (4 aorta’s), and obtained TAWSS values varying between 6 and
22 Pa depending on the location in the arch. Huo et al.[177] used a model with
a diameter of the ascending aorta of 1.3 mm, and found a spatially averaged
TAWSSavg of 7 Pa over the outer curvature and 0.8 Pa over the inner curvature
of the arch in the time-averaged model, which is slightly lower than our value
(11.04 Pa over the total arch, including side branches).ey also reported a peak
WSS value at the aortic arch during systole of 113 Pa which is almost identical to
theWSS95% that we computed during systole at the aortic arch for amodel with
the same inlet diameter. As for the WSS patterns, all mentioned authors have
computed WSS patterns with peaks dorsal to the le common carotid artery
and zones with low WSS at the inner side of the curvature and ventral to the
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side branches.
Huo et al. [177] reported similar OSI distributions in the arch but higher
OSI values at the side branches (in the order of 0.3 over the entire surface of all
brancheswhile we only found elevatedOSI in the order of 0.3 on the ventral side
of the le subclavian artery). We found little dierences in OSI between our 5
studied models. We ascribe this to the relatively low values of the Womersley
parameter for all studied geometries, indicating an almost quasi-static behav-
ior and explaining the fact that the WSS patterns (and derived parameters as
OSI) are similar throughout time, even though the absolute magnitude of WSS
changes signicantly. In general we can conclude that our 1.3 mm model pro-
duces WSS results that are in line with previously published numerical results.
Besides computing WSS in a CFD model, it is also possible to estimate, to
some extent,WSS experimentally from velocity proles recorded noninvasively
by means of MRI or ultrasound. Whole blood viscosity can be estimated from
plasma viscosity, wall shear rate and hematocrit [229], whereaer WSS can be
calculated using Poiseuille’s equation [220]. Cheng et al. [219] published an
excellent review article summarizing a number of experimental WSS measure-
ments from literature. ey found that averaged WSS at the carotid artery in-
creased from 1.16 Pa in humans to 6.48 Pa inmice (mean values over several stu-
dies using both ultrasound and MRI).e authors further reported substantial
dierences in WSS depending on the measurement location, with higher WSS
the more downstream the vessel is located. Based on their data, they claim an
inverse relationship between vessel lumen diameter andWSS between dierent
species in the carotid artery as well as for dierent types of arteries within the
same species.is inverse relation between diameter and WSS was conrmed
by experimental data [220]. Greve et al. [88] estimated WSS in the abdominal
aorta for dierent species using MRI and found thatWSS depends inversely on
bodymass.is hypothesis was supported by theoretical work ofWeinberg and
Ethier [180], who used allometric scaling principles to show that WSS should
be 20 times higher in mice than in men.
We can thus conclude from literature that, both on experimental and theo-
retical bases, (i) WSS at a given anatomical location depends on the species and
its size, and (ii) that for a given species, WSS depends on the anatomical loca-
tion studied. In this work, we have extended these observations, showing that
even though WSS is studied within the same species and at a given anatomi-
cal location, the obtained result is still highly susceptible to the vessel size at
the same anatomical location for dierent animals of the same species (i.c. the
mouse).
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5.4.3 Assumptions and limitations: geometry
All simulations have been performed with a rigid wall, so the inuence of the
pulsating aorta on the WSS behavior has been neglected. Batson’s plastic is
known to shrink inside the arteries [230], resulting in a slight underestima-
tion of the aortic diameter for the vascular casting technique compared to in
vivo imaging with MRI [174]. is will however not aect the general conclu-
sions in this work, since all models are rescaled versions of the same vascular
cast. Linear scaling was applied to obtain models representing dierent stages
in the mouse life cycle. Huang et al.[228] investigated the geometric properties
of the mouse aorta during growth and found that the axial nonuniformity of
the aortic geometry was increased in the rst stages of postnatal growth.ey
investigated mice between 1 and 33 days old and found that both the thoracic
and abdominal aorta grow linearly with age, where the abdominal parts grow
slower than the thoracic part. However, in our study only the proximal part of
the aorta was modeled so we feel that our linear scaling approach is justied.
5.4.4 Assumptions and limitations: boundary conditions
As for all numerical models, our computational model tries to mimic the real-
life situation as closely as possible. As it is known that the imposed boundary
conditions have a major inuence on the resulting values, measurements of the
inlet and outlet conditions should ideally be done on the same animal that is
used to base the geometry of the model upon. It was (at the time of the study)
not feasible to measure pressures or ows on small animals and therefore as-
sumptions had to be made. Fixed ow fractions were applied at the outlets,
based on in vivo measurements by Feintuch et al [140]. ese measurements
were thus not performed on the same animal as the one used for casting. Al-
though the ow split can vary between animals, we assumed that these dier-
ences will only have a minor inuence on the obtained WSS.
At the inlet, a velocity prole used for simulations of human hemodynam-
ics was scaled both in magnitude and in time to match murine physiology, as-
suming that the shape of the velocity prole is similar for both species (qualita-
tive comparison of published ultrasound measurements in the aorta in mouse
and man suggests this to be a most reasonable assumption).e scaling in the
time domain was based on the dierent heart rate of the mouse, resulting in
a ten times shorter time period. Although heart rate is slightly decreasing as
the mouse gets older (data reported in sedated mice show a decrease from 477± 97 bpm at the age of 10 days to 420 ± 66 bpm at the age of 9 months [225])
we believe that this will not inuence our results signicantly, since the magni-
tude and spatial distribution of the calculated WSS distribution will be similar.
e only conditionwhere the actual hemodynamic loadmight diermore from
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the simulations is for the late fetal case, as not only heart rate but also the global
hemodynamics are dierent in the fetus. As such, the data for this diameter are
likely to be more representative for the post-natal stage. e amplitude of the
inlet velocity prole was scaled assuming a constant peak value for all species
of 1 m/s, based on allometric argumentation [180]. Average peak velocities for
the aortic root of 1.04 m/s in mice [227] and 1.03 m/s in men [226] have been
measured using Doppler ultrasound techniques, conrming this allometric ar-
gumentation.
e approach of a constant inlet velocity for all species is, however, contra-
dictory to the inlet conditions applied by Feintuch et al. [140], who calculated
the inlet velocity based on the aortic dimensions. erefore, we performed a
parameter study in which we compared the twomethods to determine the inlet
velocity. Following Feintuch et al. [140], mouse body weight M (in g) is as-
sumed to be linearly related to the aortic root diameter D (in mm) measured
from casts, by D = 0.0284 M + 0.008 (r2 = 0.86). e cardiac output for con-
scious mice as a function of their body weight was measured by Janssen et al.
[196] to be 512 ml/min⋅kg over a range of dierent body masses. Combining
these results allowed for the computation of the mean inlet velocity for dier-
ent diameters, yielding values of mean inlet velocity from 0.48 m/s (late fetal)
to 0.24 m/s (old adult). For reasons of computational cost the comparison was
only performed using steady state simulations, imposing the mean velocity at
the inlet. Numerical simulations based on these inlet velocities showed, as an-
ticipated,much higher TAWSS values (e.g. TAWSS95% = 18.3 Pa for the Feintuch
method vs. TAWSS95% = 10.5 Pa using the constant inlet velocity), demonstrat-
ing that the method used to obtain the inlet velocity will have a signicant in-
uence on the resulting TAWSS values.
Recently published measured peak velocities in mice at dierent ages [224]
showed that our assumption of a constant value for the inlet velocity are likely
to be relevant from a physiological point of view, especially from 1 month on.
Nevertheless, variations in peak velocity up to 20% were reported in younger
animals (fetal and neonate). Imposing these age-dependent values instead of
a constant peak velocity would aect the quantitative outcome of the study, as
shear stress levels are directly dependent on the inlet boundary condition.e
latter should be kept in mind when analyzing the data.
Ideally, the le ventricle should be included in the numerical model, since
the rotation of the ventricle around its longitudinal axis results in a skewed ve-
locity prole at the inlet [231]. Including this changed boundary condition in
our models may aect some of the obtained numerical results. However the
general conclusions of this work would remain the same.
107
5. Hemodynamics in the murine aortic arch
5.5 Conclusion
e inuence of mouse body mass on arterial WSS at the location of the aortic
arch has been investigated for an aortic arch with the same conguration but
with dierent dimensions, representing intra-species variations of aortic size. A
tendency towards lower WSS for larger diameters has been revealed. WSS was
found to decrease rapidly in early life stages and to reach a plateau in adulthood,
supporting a mediating role for WSS in arterial growth. ese results indicate
that it is very important to clearly indicate the age and strain of the mice used
for research in the hemodynamic eld. Additionally, whenever possible, cal-
culation of WSS with CFD is ideally based on real, measured inow boundary
conditions.
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Replacing vascular casts by in vivo
contrast-enhancedmicro-CT
e results of this study were published in: Bert Vandeghinste*, Bram Tra-
chet*1, Marjolijn Renard, Christophe Casteleyn, Steven Staelens, Bart Loeys,
Patrick Segers, Stefaan Vandenberghe. Replacing vascular corrosion casting by
in vivo micro-CT imaging for building 3D cardiovascular models in mice. Mole-
cular Imaging and Biology 2011, 13(1):78-86.
6.1 Introduction
Mouse models are oen used for medical research in the cardiovascular eld,
since they can provide valuable information on the development and progres-
sion of cardiovascular pathologieswithin a reasonable time frame (section 1.3.1).
Genetically modiedmice have been used to study e.g. abdominal aortic aneu-
rysm formation [111] or atherosclerosis [232, 233], but also to studymore specic
genetic disorders such as the Marfan and Loeys-Dietz syndrome [63, 77, 213].
Hemodynamic factors and blood ow patterns have been linked to the gene-
sis and development of atherosclerotic cardiovascular disease [234, 235] and to
the growth and progression of cerebral aneurysms [165]. Computational Fluid
Dynamics (CFD) are oen used to simulate the ow patterns inside the aorta,
both in animal and in human models, in an attempt to elucidate the role of
these biomechanical actors/stimuli in the early disease stages. As introduced
1* both authors contributed equally to this study
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in section 2.1.3, an important parameter in this respect is the tangential shear
force exerted by moving blood along the axis of ow (wall shear stress or WSS,
equation 2.17). In order to study the inuence of shear stress on cardiovascular
disease, it would be very useful to be able to perform realistic CFD simulations
on (genetically modied) animal models.
In order to perform such CFD simulations, reliable 3D computer models of
the arterial system are needed. As described in the literature review in section
2.2.2, most studies that performedCFD simulations inmousemodels in the past
created a geometrical model by in vitro micro-CT scanning of a plastic replica
of the arterial system obtained by vascular corrosion casting [140, 175]. How-
ever, this technique requires sacricing the animals and thus excludes follow-up
studies. If one wants to study the inuence of local hemodynamics on disease
development, it is mandatory to perform follow-up studies in which the hemo-
dynamic situation pre and post disease development can be compared. To per-
form such studies, alternative in vivo imaging techniques permitting scans of
the same animal at multiple time points are indispensable. In vivo imaging with
micro-CT could be such an alternative, but traditional iodine-based contrast
agents used in human medicine (needed to dierentiate the aorta from sur-
rounding tissues) cannot be used for mice since they are cleared through the
murine renal system within one minute, whereas micro-CT scanners typically
have a total acquisition time of at least 5 to 10 minutes for an acceptable level
of image quality. Fenestra VC-131 (Advanced Research Technologies Inc., Saint
Laurent, Canada) is a new contrast agent developed for cardiovascular imaging
in mice that has a slow uptake in the liver, enabling a sucient time period of
contrast-enhanced imaging.
e goal of the present study is to investigate whether reliable and accurate
3D geometrical models of the murine aortic arch could be reconstructed us-
ing in vivo micro-CT with this contrast agent, Fenestra VC-131. We compared
geometrical models obtained using a contrast injection followed by an in vivo
micro-CT scan with models obtained aerwards from the same animals using
vascular corrosion casting followed by an in vitro micro-CT scan.
6.2 Materials and methods
6.2.1 Experimental setup
A total of nine wild-type mice were used in the experiments, with body weights
ranging from 14 to 35 g (Tables 6.1 and 6.2).e animals were anesthetized and
scanned in vivo aer administration of the contrast agent. ey were subse-
quently casted via the abdominal aortawith 2ml of Batson’s#17 casting solution.
e resulting plastic replicas of the arterial system were scanned in vitro using
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micro-CT. Both data sets were segmented and compared.e Ghent University
ethical committee approved all animal experiments (ECD 07/20).
6.2.2 In vivo micro-CT scan: contrast agent
e used contrast agent Fenestra VC-131 binds iodine particles (50 mg/ml) on
lipids, which ensures clearance in the liver, leading to 4 h of contrast-enhanced
visualization time upon injection. Previous research has shown that Fenestra
VC-131 induces no signicant risk on renal toxicity [236]. Nine 5- to 27-week-
old animals were put on a diet of cooked yam 24 h before the experiment and
received an intraperitoneal injection of 100 µl physiological uid 1 h before the
start of the experiment. Anecdotal evidence gathered from small experiments
(not depicted here) has shown that these measures help to prevent dehydra-
tion, which can be caused by the use of Fenestra VC-131. Fieen minutes aer
the administration of 0.015 ml/g Fenestra VC-131 through the tail vein with a
bolus injection, the animals were anesthetized with an 8 µl/g IP injection of
a mixture of 1.05 ml ketamine (Ketamine 1000, CEVA Sante Animale, Brus-
sels, Belgium), 0.3 ml xylazine (Xyl-M 2%, VMD, Arendonk, Belgium), and 3.4
ml physiological uid. e animals were scanned aer 10 min of anesthesia,
as optimal contrast is achieved 25 min aer administering Fenestra [237]. e
25-min total waiting time also reduced the chances on spasms and other irreg-
ularities aecting imaging quality.e mice were then placed on a heated pad
(30○C) and scanned in aGEFLEXTriumphCT scanner (GammaMedica-Ideas,
Northridge, CA, USA) with the following acquisition parameters: 50 µm focal
spot, 2x2 detector binning, 2048 projections over 360○, 3.5 magnication and
70 kVp tube voltage. Using a blank air scan, the ideal tube current was deter-
mined by increasing the current until the detector response saturated.is ideal
tube current was determined at 180 µA for a 70-kVp tube voltage. e gantry
rotated continuously, providing faster acquisition compared to step-and-shoot
mode. is results in a 33.81-mm transverse eld of view, a theoretical spatial
resolution of 46 µm, and a scanning time of 8.53 min. e projections were
reconstructed with proprietary soware (Cobra EXXIM, EXXIM Computing
Corp., Livermore, CA, USA) using a Feldkamp-type algorithm with Parker’s
weighting function [238] in a 512x512x512 matrix with a 50-µm voxel size.
6.2.3 Gating
In addition to standard reconstruction, we also employed a retrospective respi-
ratory gating method. e idea was rst proposed by Ford et al. [239, 240]. A
region of interest (ROI) was selected on the projection images containing both
the diaphragm and the lungs of the animal.is allows us to compute the cen-
ter of mass of the ROI in one projection. Now, the projection can be classied
as in peak expiration or peak inspiration phase according to the location of the
center of mass. Aer classication of all projections, 820 minimal lung volume
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projections (70 kVp,180 µA) were selected and reconstructed while the ungated
images were reconstructed from a dataset of 2048 projections. Reconstruction
of the reduced dataset requires modication of the Feldkamp reconstruction
algorithm by incorporating Parker’s weighting function to account for the non-
uniform angles of the projections.
6.2.4 In vitro micro-CT scan: vascular corrosion casting
For each of the nine animals scanned in vivo, a corrosion cast was created 1
week aer acquiring the micro-CT images. e casting procedure was anal-
ogous to the one visualized in Figure 3.4. When the health of the animal did
not permit waiting for 1 week, the animal was casted as soon as possible. Bat-
son’s #17 (Polysciences, IncWarrington, PA, USA) was used as casting agent.
is agent causes little shrinkage, can still ll the smallest vessels, and delivers
mechanically stable casts. First, the mice were euthanized by an inhaled CO2
overdose. Aer making an abdominal incision, the abdominal aorta was lo-
cated. Special care was taken to prevent rupture to vessels or organs, as this
would greatly reduce the quality of the cast. A catheter was then placed in the
abdominal aorta in retrograde direction and the arterial system was perfused
with a ready-made mixture of Batson’s #17. Pressure was not controlled during
injection: complete lling of the vascular system was indicated by the appear-
ance of red intravascular polymer shining through the skin of the toes and nose
[203]. Aer this perfusion, the animal was placed in a cold water bath to avoid
tissue damage that might occur during the exothermic curing process. Aer 30
min, the preparation was placed for 3 days in a bath containing a macerating
solution of 20% KOH at room temperature. Subsequently, the cast was cleaned
in distilled water and dried. Dierently from the previous chapters, scans of
these casts were taken with the same micro-CT scanner as used in the in vivo
experiments, with the following parameters: 2x2 binning, 2048 projections, 70
kVp (180 µA), and magnication of 3.e casts were placed in an acrylic tube
to prevent the cast from motion due to airow.
6.2.5 Segmentation
Each dataset (one from in vivo experiments, one from casting the same animal)
was segmented manually in Mimics soware (Materialise, Leuven, Belgium).
Each part of the aortic arch (ascending aorta, aortic arch with its branches, and
the descending aorta) was manually thresholded in a rst segmentation step,
using dierent threshold levels for each part. is allows for a more accurate
segmentation, as every part has a distinct CT value on the images. When the
resulting segmentation was judged suciently accurate, a 3D geometric model
was built according to this segmentation mask. is 3D model was smoothed
(1st order Laplacian volume preserving smoothing with 3 iterations and smooth
factor 70 %) in Mimics Remesher (Materialise, Leuven, Belgium) to remove
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unphysiological bulges and dents while care was being taken that no articial
shrinking of the model occurred. is resulted in a suciently smooth 3D
model usable for CFD simulations.
6.2.6 CFD simulations
We performed CFD simulations on all 3D models to assess the inuence of the
imaging techniques on the resulting computed wall shear stress levels. First a
3D volume mesh was created with TGrid (Ansys, Canonsburg, USA) consist-
ing of a boundary layer near the wall lled with prismatic elements to improve
accuracy where it is most needed, and the bulk of the model lled with tetrahe-
dral elements. Fluent (Ansys) was then used to numerically solve the Navier-
Stokes equations for the ow. Blood density was taken to be 1060 kg/m3 [88]
and at the high shear rates appropriate for the murine arterial system the dy-
namic blood viscosity was assumed to remain at a constant asymptotic value
of 3.5 mPas [140]. For all models a time-dependent simulation was performed.
We did not measure animal-specic in vivo measured boundary conditions to
impose at the in - and outlets of our models. However, the goal of this part
of our study was to show the impact of the used imaging technique on WSS
values.erefore the same physiological velocity prole was imposed at the in-
let of all models. is velocity waveform had a maximal amplitude of 1 m/s,
a generally accepted value based on both theoretical [180] and experimental
[225–227] data. At all outlets traction free boundary conditions were imposed,
and the ow fractions assigned to each branch were computed using Murray’s
law (equation 2.21). Flow fractions were thus geometry-specic, since Murray’s
law assumes the ow fraction between a side branch and a mother branch to
be proportional to the (third power) of the diameter ratio between them (as
explained in section 2.2.2).
6.2.7 Comparison
e actual comparison between bothmodalities was computed in four dierent
ways:
1. We determined the diameter of the 3D models at six dierent locations:
ascending aorta, descending aorta, le subclavian artery, le common
carotid artery, brachiocephalic trunk, and the middle of the aortic arch
between the le common carotid artery and the brachiocephalic trunk.
In case of a non-circular cross-section the equivalent diameter corre-
sponding to a circular surface area was calculated instead. Each diameter
was then calculated as the mean over a suciently large aortic section.
2. As secondmetric, we considered the bifurcation angles.ese weremea-
sured in the plane of the bifurcation as the angle between the centerline
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of the side branch and the centerline of the aortic arch.is provides in-
sight in the angle and resistance encountered by the blood ow inmoving
from the aortic arch to a side branch.
3. As a third metric, we considered a general distance metric between co-
registered voxels on the models. First, we coregistered every cast model
with the in vivo data from the same animal, and then we used a color
code dependent on the distance between both 3D models.
4. Finally, computedTAWSS (equation 2.18)was compared formodels based
on both imagingmodalities. In order to quantify the dierence inTAWSS
between the models, spatially averaged TAWSS (TAWSSavg) was com-
puted for each model as well as the 95% TAWSS value (TAWSS95%) as a
marker of highest TAWSS values.
6.3 Results
6.3.1 Natural history
High-quality casts were obtained for four animals, which were scanned using
0.015-ml/g Fenestra (mice 5, 6, 7 and 8 in Table 6.1). A small proof of concept
study has shown that the contrast increase by administering 0.015ml/g Fenestra
VC-131 (Figure 6.1 C, D) leads to an increase of 118 ± 2 gray values in the aortic
arch, compared to a baseline image (Figure 6.1 A, B).e mean image noise
in the baseline image was determined at 24.7 gray values. Casts from mice 1,
2, 3, 4, and 9 were not lled completely and contained air bubbles; these were
thus not further used in the measurements. e time between casting and ac-
quisition diered greatly between mice 7 and 8 and the other mice. Five out of
nine animals were sacriced prematurely due to the declining health of the said
animals and to limit animal suering. While casting the animals, some small
eects were noticed: the liver was colored whiter than usual, some lymph nodes
were opaque white, and we noticed some mice had cornea edema.
6.3.2 Gating
Figure 6.2 shows a comparison between ungated slices (Figure 6.2 A, C) and
retrospective respiratory-gated slices (Figure 6.2 B, D) for mouse 5 (Table 6.1).
All 4 slices are shown in the samewindow level and size.e gated images show
better delineation of the diaphragm and the ribs.e cardiovascular systemwas
visualized by 0.015 ml/gram Fenestra VC-131 and showed no signicant image
quality increase due to respiratory gating. e increase in image noise due to
the low angular sampling decreased the segmentation accuracy.
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Table 6.1: Basal and micro-CT related data for all mice.
Mouse Age Body weight Anaesthetics ∆Tc Cast
ID (weeks) (g) (ml) (mm) quality
1 28 23.0 0.10 1h −
2 14 21.7 0.10 2h −
3 15 27.5 0.10 3h −
4 14 25.5 0.10 5h −
5 28 30.7 0.10 4h +
6 28 35.0 0.10 5h +
7 5 16.8 0.05 6d +
8 5 15.8 0.12 5d +
9 5 14.6 0.12 6h −
ml=milliliter,mm=millimeter, ∆Tc = time between casting and scanning,
h=hours, d=days, - : cast contained air bubbles and was not analyzed,
+ : high quality cast.
6.3.3 Geometric comparison
Measurements obtained from the 3D models generated from the scanned casts
and in vivo images are shown in Tables 6.2 and 6.3 for aortic arch diameters
and bifurcation angles respectively. e diameters show a signicant dier-
ence between in vivo and cast models. Using Fenestra VC-131, this dierence
amounts from 30% up to 40% increase in diameter. e aortic arch diameters
show an overall 31% dierence (31.9 ± 1.8%), while the three bifurcation dia-
meters show a larger dierence variation (35.7 ± 7.4%). e bifurcation angles
show a relatively small dierence (less than 20%) between the casts and the in
vivo models. Figures 6.3 and 6.4 show the regression and Bland-Altman plots
of the (pooled) aortic diameters and the aortic angles.e Pearson correlation
coecient equals 0.91 for the diameters (Standard Error of the Estimate 0.12
mm) and 0.97 for the angles (SEE 11.13 degrees).
Figure 6.5 compares the general geometry in 3 dierent view angles of the
3D model built from mouse 6 using both modalities. Figure 6.6 shows the co-
registered models from Fenestra and the casts aer a rigid, global N-point reg-
istration in 3-Matics (Materialie, Leuven, Belgium).e euclidian distance be-
tween both co-registeredmodels was visualized via a voxel to voxel comparison.
e color scale was normalized over the dierent models and they can thus be
compared to each other. ese results show that the general geometry (aortic
arch) of both the 3D cast and the 3D in vivo model are highly comparable.e
descending aorta region shows the highest dierence.
6.3.4 CFD comparison
Figure 6.7 shows a comparison of theTAWSSdistribution formouse 6 for both a
casted and an in vivomodel.e distribution of TAWSS over themodel surface
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Figure 6.1: Four micro-CT slices showing the dierence between baseline (A and C) and
contrast-enhanced imaging (B and D) aer administration of 0.015 ml/gram Fenestra VC-131.
is leads to an increase of 118 ± 2 gray values in the aortic arch (arrow).
is very similar: zones with high or low absolute values occur in the same region
for both models. However, the in vivo models on average show lower absolute
TAWSS values: the spatially- and time-averaged TAWSSavg is 8.2± 0.8 Pa for in
vivomodels and 10.5± 2.5 Pa for the castmodels.e 95%percentileTAWSS95%
was 16.6 ± 1.6 Pa for the in vivo models and 19.4 ± 3.7 Pa for the cast models.
6.4 Discussion
6.4.1 Geometric comparison: aortic diameters
In this chapter, we proposed amethod to visualize the aortic arch and the aortic
arch bifurcations using micro-CT, providing an alternative for vascular corro-
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Figure 6.2: Comparison between ungated slices (A and C) and retrospective respiratory-gated
slices (B and D) for mouse 5 (Table 6.1). All slices are shown in the same window level and size;
e gated images show better delineation of the diaphragm and the ribs, but no signicant image
quality increase in the cardiovascular system.
sion casting.e resulting 3D geometry models from in vivo scans were com-
pared to models of vascular corrosion casts and were found to be an accurate
representation, although the diameters showed a signicant dierence. A gen-
eral dierence in aortic diameter of 30 to 40% was found between in vivo and
casted models (Table 6.2). However, the correlation plot in Figure 6.3 (right
panel) and the Bland-Altman plot in Figure 6.4 (right panel) show that the dia-
meters of both modalities are well correlated (r=0.91) and there is no bias for
lowor high absolute values of the diameter. In literature vascular corrosion casts
have been reported to shrink 16-20 % [230]. One might hypothesize that our
casts have shrunk more, since the Batson’s solution was injected by free-hand
without manometric control of the injection pressure. However, according to
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Table 6.2: Casted and in vivo diameters aswell as the percentage dierence between both. Values
are reported as mean ± standard deviation.
Aortic Cast In vivo Dierence
location (mm) (mm) (%)
AA 1.08±0.09 1.43±0.07 32.41
BRT 0.55 ±0.06 0.78±0.05 41.82
AoA 0.93±0.05 1.24±0.07 33.33
LCC 0.40±0.07 0.51 ±0.01 27.50
LSC 0.45±0.05 0.62±0.04 37.78
DA 0.87±0.09 1.13 ±0.09 29.89
AA=Ascending Aorta, BRT=Brachiocephalic Trunk, AoA=
Aortic Arch, LCC=Le Common Carotid Artery, LSC=Le
Subclavian Artery, DA=Descending Aorta.
Table 6.3: Casted and in vivo bifurcation angles as well as the percentage dierence between
both. Values are reported as mean ± standard deviation.
Aortic Cast In vivo Dierence
location (○) (○) (%)
BRT 136.24±6.70 127.37±5.58 -6.51
LCC 119.56± 1.64 106.76±2.47 -10.70
LSC 103.07±5.36 87.29±2.80 -18.07
AA-DA 27.98±4.88 34.79±2.63 24.35
BRT=Brachiocephalic Trunk, LCC=Le Common Carotid Artery,
LSC=Le Subclavian Artery, AA=Ascending Aorta, DA=
Descending Aorta.
Hodde et al.[203] this technique gives consistently better results than injection
with an injection apparatus. We therefore hypothesize that the extra 10 to 20%
dierence can be attributed to the increase in arterial pressure due to overlling
the animal during the in vivo scans, given the high contrast volume adminis-
tered. One should also keep in mind that no true single value for the aortic
diameter exists, since the aorta is constantly expanding and relaxing. As we ap-
plied no cardiac gating, we could not determine diastolic dimensions. It makes
sense to state that the diameters obtained in vivo will probably be more repre-
sentative of the systolic state whereas in vitro (casting) diameters will be a better
estimate for the diastolic state.e true time-averaged diameter is most prob-
ably a value in the middle between those two. Segmentation errors also have to
be taken into account, as the aortic arch is inuenced by cardiac motion and is
thus blurred, leading to small errors in the segmentation and the resulting 3D
model.
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Figure 6.3: Regression plots for the aortic arch diameters (le) and the aortic arch angles (right).
Diameter Standard Error of the Estimate (SEE) equals 0.125mm, angle SEE equals 11.130 degrees.
Figure 6.4: Bland-Altman plots for aortic arch diameters (le) and aortic arch angles (right).
Both plots contain the limits of agreement (average ± 1.96 standard deviation of the dierence).
6.4.2 Geometric comparison: aortic angles
e dierence between in vivo and in vitro angles is much smaller compared
to the dierence in diameters: only 5-20% (Table 6.3). is small dierence
indicates that the representation of morphological characteristics of the arterial
geometry does not diermuch between both imaging techniques.is can also
be observed from the good color-coded agreement between in vivo and in vitro
models in Figure 6.6, and from the correlation plot in Figure 6.3 (le panel)
and the Bland-Altman plot in Figure 6.4 (le panel). e angle between the
ascending and descending aorta (AA-DA in Table 6.3) is in good agreement
with previously reported values in chapter 4.
6.4.3 CFD comparison
Both spatially averaged WSSav and 95 percentileWSS95% are lower for in vivo
models. According to Poiseuille’s law theoretical WSS values (in an innitely
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Figure 6.5: General geometry of a 3D model generated from the in vivo dataset for mouse 6. A:
cast model. B: in vivo model.
long straight tube) are proportional to blood velocity and inversely proportional
to diameter. Since the in vivo models are larger than the cast models but the
same velocity is imposed at the inlet, it makes sense that in vivo models result
in lower shear stresses.is is an important aspect that should be kept in mind
when performing CFD simulations of the blood ow in murine vasculature:
even when exactly the same measured velocity prole is imposed at the inlet of
the model, results can be dierent depending on the imaging technique used
to build the 3D model. With the casting technique, diameters will be under-
estimated and WSS will be overestimated. Using in vivo micro-CT (with the
currently needed amount of contrast agent), diameters will be overestimated
and WSS values will be underestimated.
6.4.4 Gating
We found that retrospective respiratory gating is not necessary to get a high 3D
model quality.e ribs and diaphragm are more clearly delineated, but the dif-
ference is not noticeable in the aorta or the aortic arch. Cardiac gating can be
done prospectively, where the ECG signal is used to determine if a projection
should be acquired at that specic moment.is requires a very short integra-
tion time on the detector, and an X-ray tube which can be switched on and o
in the order of milliseconds. Leaving the X-ray tube on for the duration of the
whole gated scan would deliver a radiation overdose to the small animal. is
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Figure 6.6: Comparison between co-registered models from Fenestra VC-131 and the casts for
mice 5 (A), 6 (B), 7 (C) and 8 (D). Both models were rst co-registered using a rigid, global
N-point registration in 3-Matics (Materialise). e color scale was normalized to the maximal
distance of all models. A green color code was used to mark voxels with little distance; red
was used when a large distance was measured. e descending aorta region shows the highest
dierence, due to the dierence in AA-DA angles.
hardware was unavailable to us. e inuence of cardiac gating was thus not
studied in this work, but may be presented in future work.
6.4.5 Comparison with literature
Schambach et al. [241] used both a blood pool contrast agent (Fenestra) and a
bolus technique with a conventional contrast agent (Imeron). eir setup was
dierent from ours, with the probe (and the animal) rotating horizontally in the
course of the beam (see section 3.1.1).is results in a shorter acquisition time,
but also introduces movement artifacts and higher radiation doses (due to the
larger magnication). is study clearly shows the need to address technical
challenges still involved with in vivo micro-CT imaging of the cardiovascular
system inmice. Willekens et al. [237] used Fenestra and Exia 160 XL to enhance
liver and spleen contrast in mice, but did not study the eects on the arterial
system or the dierence between in vivo and ex vivo models. e dierence
between in vivo and in vitro methods to obtain 3D models of murine vascu-
lature has not been studied extensively in literature. Kratky et al. [230] have
demonstrated Batson’s #17 to induce a shrinking factor of 16-20 %, but did not
compare in vitro with in vivo models. In chapter 6 we already showed that the
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Figure 6.7: Comparison of CFD results: TAWSS distribution formouse 6 for both a casting (le)
and an in vivo model (right).
morphology of 3D models of the murine aortic arch (obtained using vascular
corrosion casting) is very similar to the one of the human aortic arch (obtained
in vivo). An alternative method to obtain 3D models of the murine arterial ge-
ometry in vivo is MRI imaging. Moore et al. [174] compared this technique to
vascular corrosion casting and also found casts to have smaller diameters and
bifurcation angles. However, small animal MRI is an expensive technique that
is not widely available yet.
6.4.6 Methodological issues with in vivo micro-CT
e radiation dose for a one-minute y-scan at 2x2 binning, 80 kVp and 1.3x
magnication was reported at 20-25 mGy. As the dose is proportional to the
eective tube current-time product, we can suspect the dose for our protocol to
be in the order of 100-150 mGy, low enough to allow for follow-up studies. For
Fenestra VC-131 the minimal contrast dose needed to obtain sucient contrast
was determined beforehand in a small proof of concept study. A 0.015 ml/gram
contrast dose induces a relatively high strain on the animals, as this accounts
for 25% extra blood volume. e small health eects noticed in the liver and
lymph nodes can with high probability be amounted to the use of Fenestra and
this high contrast volume, causing the high mortality rate.
6.4.7 Future work
Keeping the remarks of previous sections inmind, our results show that contrast-
enhanced micro-CT visualization can be used to build 3D geometrical models
of the aortic arch and the aortic arch bifurcations. Because of the highmortality
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due to the use of Fenestra VC-131, dierent contrast agents will be tested before
proceeding to longitudinal follow-up studies. Exia 160 XL (Binitio Biomedical
Inc., Ottawa, Canada) is a blood pool contrast agent that contains 160mg iodine
/ml, a 3.2 times higher dose than FenestraVC-131. Preliminary results show that
the mortality is much lower than when using Fenestra VC-131 while preserving
image quality.e decreased death ratemay be due to the lower volume needed
(0.0075 ml/gram) being half the dose needed when using Fenestra.e results
of both contrast agents (using their minimal dose) are similar: both can be used
to reconstruct reliable 3D models of the cardiovascular system.
6.5 Conclusion
In conclusion, with Fenestra VC-131 it is possible to build reliable 3D geomet-
rical models of the cardiovascular system in mice and to base CFD simulations
on these models. ese in vivo models have signicantly larger dimensions
than in vitro models based on the same geometry, also resulting in lower WSS
values. However, the total morphology and bifurcation angles show only small
dierences, and the WSS distribution over the model surface is also very simi-
lar. In vivo micro-CT imaging thus provides a valuable alternative for vascular
corrosion casting.
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Outline
Two important events mark the transition between the second and third part
of this dissertation. e rst event was the further development of dedicated
contrast agents for in vivo micro-CT in mice. Fenestra VC-131 (the contrast
agent investigated in chapter 6) was replaced by Aurovist, a gold-particle based
alternative that requiredmuch less injected volumes andwas better tolerated by
the animals.e second important event was the purchase of a high-frequency
ultrasound device for mice (Vevo 2100, Visual Sonics).is allowed us to mea-
sure mouse-specic blood velocity proles that could be processed to serve as
boundary conditions in the CFD simulations. e introduction of these new
imaging techniques required a signicant amount of training to recognize and
circumvent common imaging pitfalls as described in sections 3.2.4 and 3.1.3.
is was especially true for ultrasound, an operator-dependent technique in
which operator experience is an important factor to guarantee reproducible
results. A number of small pilot studies was set up (not reported in this dis-
sertation) to determine the optimal contrast agent dose for in vivo micro-CT
(nding a balance between the needed image contrast and the animal’s wellbe-
ing), and to gain experience with the practicalities of small animal ultrasound
imaging.
e third part of this dissertation contains three dierent studies in which
contrast-enhancedmicro-CTandhigh-frequency ultrasound imageswere com-
bined to set up entirely mouse specic CFD simulations. In rst instance, a
methodology was developed to perform such CFD simulations in the abdomi-
nal aorta, studying the link between hemodynamics and abdominal aneurysm
formation (chapter 7). e methodology was then extended to the complete
aorta (chapter 8) and in chapter 9 it was applied in the complete aorta of mice
developing both ascending and abdominal aortic aneurysm, thus allowing us
to study the original research question of this dissertation:
Why do aortic aneurysms have a predisposition to develop at some very dis-
tinct aortic locations, and what is the role of aortic hemodynamics herein?
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Amouse-specific methodology to
linkmouse-specific hemodynamics
to abdominal aneurysm formation in
angiotensin II - infused ApoE −/−mice
e results of this study were published in: Bram Trachet, Marjolijn Renard,
Gianluca De Santis, Steven Staelens, Julie De Backer, Luca Antiga, Bart Loeys,
Patrick Segers. An integrated framework to quantitatively link mouse-specic
hemodynamics to aneurysm formation in angiotensin II - infused ApoE −/− mice.
Annals of Biomedical Engineering 2011, 39(9):2430-2444.
7.1 Introduction
As described in section 1.2.1, the pathogenesis and natural history of aortic an-
eurysm formation are not fully understood. Despite the fact that known risk
factors such as old age, male gender, smoking, hypertension or genetic predis-
position are of a systemic nature, aneurysms tend to occur at a limited number
of aortic sites. A typical example is the abdominal aortic aneurysm (AAA),
that (in humans) most oen develops in the infrarenal region of the abdominal
aorta. Several theories have been proposed over the years to explain the specic
local nature of this phenomenon [9, 242, 243].e human infrarenal abdominal
aorta is believed to be a region of low mean and oscillatory wall shear stresses
[218], hemodynamic conditions that have been shown to be related to the onset
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of atherosclerosis [60, 141]. Furthermore there is anecdotal evidence for a re-
lationship between disturbed ow and AAA formation in patients with spinal
cord injury (SCI) [86, 87] and patients with one amputated leg [85].erefore,
one theory on the location of AAA formation hypothesizes that biomechanical
factors related to the forces induced by the blood ow on the endothelium (low
shear stress levels and/or oscillatory blood ow patterns) interplay with vascu-
lar biology. However, this theory has never been tested in a longitudinal study
comparing hemodynamic conditions pre - and post AAA.
To assess the aforementioned biomechanical factors related to the blood
ow, one requires detailed information on the 3-dimensional ow eld with a
high resolution both in time and in space. It is feasible to measure ows in the
aorta using either ultrasound or MRI, but neither of these techniques provides
a resolution (in time nor space) that would allow for studying the ow eld in
sucient detail to assess the shear forces directly. To overcome this problem,
Computational Fluid Dynamics (CFD) can be used to resolve the ow eld in
the abdominal aorta. For this purpose one typically needs (i) an accurate 3D
geometrical model and computational mesh of the abdominal aorta and major
side branches; (ii) precise information on the inow and outows (boundary
conditions) in each branch. is information should be patient-specic and
preferentiallymeasured in vivo. Patient-specicCFD results at baseline, if avail-
able, can then be compared to AAA location in the end-stage geometry of the
same patient.
Unfortunately, it is virtually impossible to monitor the genesis and progres-
sion of an aneurysm in humans throughout their life.e main reason for this
is the fact that most AAA are asymptomatic and as such there are no base-
line data in almost all clinical cases. Moreover disease progression oen takes
several decades, another complicating factor in the study of the natural his-
tory [244]. Given these limitations in human research animal models in gen-
eral, and mouse models in particular, are a suitable alternative to unravel the
potential role of these biomechanical factors in aneurysm development. e
most well studiedmousemodel for AAA is probably the ApoE knockoutmouse
model which, when continuously infused with Angiotensin II via an implanted
osmotic pump, leads to development of an abdominal aneurysm [245]. is
mousemodel has beenused in several studies to assess e.g. the dierent stages of
aneurysm formation ex vivo [124] or the morphometric evolution of the aortic
diameter over time in vivo [181]. A remarkable observation is that the AAA in
thismousemodel develops in the suprarenal region in contrast to the infrarenal
region in humans [245]. e debate as to why this is the case is still ongoing.
It has been shown that the suprarenal region has a higher degree of curvature
(bending to the le) that appears to correlate with the direction of vesselmotion
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over the cardiac cycle and direction of average AAA expansion (both of which
also appear leward) [184]. Another study showed that ApoE −/− mice, as op-
posed to humans, don’t experience reversed ow in the infrarenal abdominal
aorta [126]. e latter observation was based on MRI measurements of aor-
tic volumetric blood ow rate, but did not include CFD simulations to study
the local hemodynamics in detail. Until recently, the limiting factor for such
studies was the lack of temporal and spatial resolution in the available imag-
ing modalities. Most CFD simulations working with murine data base their
arterial geometry on a vascular cast (excluding longitudinal studies) and the
applied boundary conditions are oen generic (e.g. applying a xed volumet-
ric ow rate)[175, 177], as in chapter 5. Recent advances in imaging technology
have, however, enabled us to circumvent these limitations, as was demonstrated
in chapter 6.
In this chapter, we present an experimental-computational framework com-
bining information from both contrast-enhanced micro-CT (arterial geome-
try) and high-frequency ultrasound (boundary conditions) to set up mouse-
specicCFD simulations allowing us to study the hemodynamic situation in the
abdominal aorta in a detailed way. For each mouse included in the study a rep-
resentative set of volumetric ow rates (compatible with each other throughout
the cardiac cycle) going to all abdominal branches is presented. Moreover, us-
ing a previously described mouse model of AAA formation [111] we compared
hemodynamics in the abdominal aorta at baseline - i.e. before the aneurysm is
initiated - to the location of the aneurysm in the end-stage geometry.
7.2 Materials and methods
7.2.1 Mice
Ten in-house bred male ApoE −/− mice on a C57Bl6 background (age 12 ± 3
weeks; other data: see table 1) were included in this study.ey were housed in
separate cages and water and regular mouse diet were available ad libitum. As
previously described [111] these mice were implanted an osmotic pump (model
Alzet 2004; Durect Corp, Cupertino, CA ), lled with Angiotensin II (Bachem,
Bubendorf, Switzerland). To avoid interference with the micro-CT images, the
metal ow divider inside the pump was replaced by a PEEK alternative (Durect
Corp, Cupertino, CA).e eect of this removal on image quality of the scans
can be assessed in Figure 3.6. Each pump released its content over a period of
28 days, at an infusion rate of 1000 ng/kg/min. Pumps were implanted subcuta-
neously on the right ank via an incision in the scapular region. Mice were ob-
served daily aer the implantation of pumps. Ultrasound and micro-CT scans
(see below for details) were obtained at baseline (before pump implantation)
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and at end stage (31 days aer pump implantation). Aer the last scan, the ani-
mals were euthanized and the abdominal aorta was dissected. Images of the dis-
sected AAA regionwere taken using anOlympusmicroscope equipped with a 5
MPixel camera. All experiments were in accordance with EC guidelines for an-
imal research and were approved by the animal ethics committee of the Ghent
University.
7.2.2 Contrast-enhanced micro-CT
At each scanning timepoint, animals were anesthetized with 1.5% isourane
and, once anesthetized, injected intravenously in the lateral tail vein with 100
µl/25g of Aurovist (Nanoprobes, Yaphank, NY ). As the contrast is maximal im-
mediately aer injection, the animals were subsequently scanned in supine po-
sition in a GE FLEX Triumph CT scanner (Gamma Medica-Ideas, Northridge,
CA, USA).e acquisition parameters were the following: 50 µm focal spot,
2x2 detector binning, 1024 projections over 360 degrees, 3.5 times magnica-
tion and 70 kVp tube voltage. Using a blank air scan, the ideal tube current
was determined by increasing the current until the detector response saturated.
is ideal tube current was determined at 180 µA for a 70 kVp tube voltage.e
gantry rotated continuously, providing faster acquisition compared to step-and-
shootmode.is results in a 33.81mm transverse eld of view, a theoretical spa-
tial resolution of 46 µm and a scanning time of 4.26 minutes. e projections
were reconstructed with proprietary soware (Cobra EXXIM, EXXIM Com-
puting corp., Livermore, USA) using a Feldkamp-type algorithm with Parker’s
weighting function in a 512x512x512 matrix with a 75 µm voxel size.
7.2.3 High-frequency ultrasound
Aer the micro-CT scan, anesthesia was maintained and mice immediately
underwent an ultrasound scan. Ultrasound data were obtained with a high-
frequency ultrasound apparatus (Vevo 2100, Visualsonics, Toronto, Canada)
equippedwith a linear array probe (MS 550D, frequency 22-55MHz) andmouse
handling table. All measurements were performed by a single operator. e
animal was secured on the table in supine position and ECG and respiratory
rate were monitored via 4 electrodes connected to the paws of the animal while
body temperature was monitored via a rectal probe. e ultrasound protocol
was restricted to 1 hour per mouse. First, B-mode imaging of the abdominal
aorta and side branches was performed followed by Pulsed Doppler to assess
ow velocities at proximal (inow) and distal (outow) abdominal aorta. For
Pulsed Doppler measurements the sample volume size was adapted to the size
of the imaged vessel and was placed in the center of the vessel.e mouse was
positioned in such a way that the imaged vessel was positioned along the ultra-
sound beam as much as possible, and an additional angle correction (up to a
maximum angle of 60 ○) was performed when needed. To enable correlation
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of ow velocity measurements with diameters obtained in micro-CT, the dis-
tance from (i) the location of proximal aortic ow velocity measurement to the
bifurcation of the celiac artery and (ii) the location of distal aortic ow velocity
measurement to the bifurcation of the mesenteric artery were measured along
the aorta. Color Doppler imaging was used to locate celiac, mesenteric and
le and right renal arteries, and Pulsed Doppler was used to assess ow veloci-
ties in these side branches of the abdominal aorta (with angle correction upon
measurement). Each ow velocity measurement in the side branches was per-
formed at 2 locations: the rst one immediately aer branching, and the second
more distally in the branched artery. For each Pulsed Doppler measurement
the distance from the measurement location to its originating bifurcation was
measured along the branch.
7.2.4 Processing micro-CT data
Reconstructed images were converted into DICOM standard format, and im-
ported into the 3D segmentation soware package Mimics (Materialise, Leu-
ven, Belgium). e abdominal aorta and its 4 major branches (celiac, mesen-
teric and le and right renal arteries) were semi-automatically segmented using
the built-in segmentation tools, with as nal result a 3D reconstruction of the
abdominal aorta. All superuous parts at inlet and outlets were removed and
the surface was smoothened to remove occasional artifacts such as bulges and
dents.e luminal surface, represented as triangular grid, was processed in py-
Formex 1 to generate a structured and conformal fully hexahedral mesh inside
the aortic ow domain, which allows for higher accuracy than unstructured
meshes due to a lower numerical diusion error in the CFD calculations [135].
Briey, themeshwas generated using amulti-block approach, in which hexahe-
dral cells were aligned longitudinally along the vessel centerlines and combined
together in a conformal fashion at locations of branching, both for bi- and tri-
furcations. We refer to Figure 7.1 for an example of the mesh used for the ow
computations.
7.2.5 Processing ultrasound data
Doppler ow velocity spectra were automatically traced using the built-in anal-
ysis tools of the Visualsonics soware and subsequently exported for further
analysis in dedicated soware tools (Matlab, Natick, MA).ese time-series,
containing multiple beats, were rst converted into an ensemble averaged ow
velocity waveform. To do so, the R-peak of the ECG-signal was used to mark
the start and ending of a cardiac cycle. Aminimum of 3 cycles was selected, and
one representative average ow velocity waveform was obtained.
1B. Verhegghe, www.pyformex.org
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Figure 7.1: A conformal hexahedral mesh is generated to be used as a geometrical model in the
CFD simulations.
Since ow velocity is not constant throughout an arterial segment (due to
the tapering of the aorta) and as the boundary conditions in the CFD model
were not always applied at the exact same locationwhere ow velocity wasmea-
sured, a conversion to volumetric ow rate was mandatory. For this purpose
the diameter at the location of the ow velocity measurement was measured
in the reconstructed 3D model of the artery (based on the micro-CT scans).
To determine the location of the ow velocity measurement on the 3D model,
the distance along the aorta was used. Volumetric ow rate was then obtained
by multiplying ow velocity with the local cross-sectional area and dividing by
2, assuming that velocity proles are parabolic and that pulsed wave Doppler
measures the peak of the parabolic ow prole. For the four side branches,
in general the average between the proximal and distal measurement was used
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when both were available.
e calculations described above lead to one volumetric ow rate wave-
form (proximal aorta) used as input, and ve volumetric ow rate waveforms
that could potentially be used as output boundary conditions. Since the ow
velocity measurements in dierent branches were not obtained simultaneously,
small dierences in heart rate occurred for all volumetric ow rate waveforms.
erefore the average heart cycle duration over all waveforms was calculated
and all waveforms were resampled and scaled in time to match this heart cycle
duration. Furthermore, as the CFD simulations are performed assuming rigid
walls, it is essential that at any timepoint, the input equals the sum of the output
volumetric ow rates (dotted lines in Figure 7.2C) to balance the conservation
of mass. To ensure that this was eectively the case, the dierence between the
measured volumetric outow rate (dotted line in the bottom panel of Figure
7.2C) and the computed theoretical volumetric outow rate (dashed line in the
bottom panel of Figure 7.2C, obtained by subtracting the measured outow to-
wards all side branches from the measured inow) was redistributed over all
in- and outlets (resulting in the solid lines in Figure 7.2C) at each timepoint.
is redistribution was according to a weighing scheme based on the diameter
of the in- and outlets: it was assumed that the largest branch (usually the prox-
imal aorta) was subject to the largest measurement error.e nal volumetric
ow rate curves were then divided by the cross-sectional area at the respective
in-or outlet of the model, to nally obtain ow velocities that can be imposed
as boundary conditions in the CFD model. Figure 7.2 displays how ultrasound
measurements were processed for an example case.
Allmeasured ultrasounddatawere processed as described above andmouse-
specic redistributed volumetric ow rates going to each branch are presented
in Table 7.1. Dierences between dierent branches in blood supply and aortic
diameter were analyzed using a paired student’s test in which a p-value smaller
than 0.05 was considered statistically signicant.
7.2.6 CFD simulations
All numerical simulations of the ow eld were performedwith Fluent 6.2 (An-
sys, Canonsburg, PA), a commercially availableComputational FluidDynamics
(CFD) soware package. Blood density was taken to be 1060 kg/m3 and at the
high shear rates appropriate for the murine arterial system the dynamic blood
viscosity was assumed to remain at a constant asymptotic value of 3.5 mPas
[140]. As inow boundary condition, a parabolic ow velocity prole derived
from the volumetric ow waveform was imposed in the proximal abdominal
aorta (see above).e time-dependent outow velocity curves as derived above
(Figure 7.2) were imposed as parabolic proles at the outlets of the mesenteric,
celiac and le and right renal arteries. To avoid numerical instabilities via im-
posing ow boundary conditions at all in- and outlets, the distal abdominal
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Figure 7.2: Methodology to obtain realistic CFD boundary conditions from the measured ow
velocitywaveforms, shown formouseAA6. At each outletmicro-CTdiameters (A) are combined
with measured US ow velocities (B) to obtain representative ow proles based on measure-
ments (C, dotted lines). e computed (theoretical) outow (C, bottom panel, dashed line) is
determined subtracting the ow rate to all side branches from the ow rate at the inlet.e er-
ror betweenmeasured and computed (theoretical) ow rates is then calculated and redistributed
over all outlets, and the resulting ow proles (C, solid lines) are imposed as boundary condi-
tions.
aorta was modeled as a traction-free outlet. For each simulation, three cardiac
cycles were simulated and all results were obtained from the third cycle, when
cycle-to-cycle variability had ceased. e hexahedral mesh consisted of about
500,000 cells, and amesh-sensitivity analysis was performed in one typical case,
increasing the number of cells up to 900,000 to ascertain that a further increase
of the number of cells did not inuence the results.
7.2.7 Hemodynamic results vs AAA location
Derived CFD data consisted of time-varying 3-dimensional vector elds of the
ow velocity in the abdominal aorta and side-branches, and these datawere fur-
ther processed using Tecplot (Tecplot Inc., Bellevue, WA). Time-averaged wall
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shear stress (TAWSS, equation 2.18), oscillatory shear index (OSI, equation 2.19)
and relative residence time (RRT, equation 2.20) were calculated, which have
previously been suggested as potential measures of disturbed aortic ow [246]
(see section 2.1.3).
In order to quantify the correlation betweenCFD-based parameters and the
location of the aneurysm, the latter needs to be represented by a quantiable pa-
rameter. However, although both baseline and end-stage geometries were ob-
tained in the same animal they did not match one-on-one due to the dierent
position of the animal on the bed. Also, the aorta expanded both in length and
in diameter since there was a 5 weeks time period between both scans. To ac-
count for these dierences, the Vascular Modeling ToolKit (VMTK 2) was used
to subdivide the end-stage geometry into 5 separate parts, using natural land-
marks such as bifurcations. Each part was then manually co-registered with
the corresponding baseline geometry and a distance map was generated to cal-
culate the closest node-to-surface distance from the baseline geometry to that
part of the end-stage geometry. ese 5 distance maps were merged to obtain
one single distance map which allowed us to pinpoint the exact location of the
(at that stage yet to be developed) aneurysm on the baseline geometry.
VMTK was used to divide the aortic surface into patches [247]. e aorta
was subdivided into longitudinal zones with a nominal length of 1 mm, and
each longitudinal zone was again subdivided into 6 circumferential patches.
is resulted in a batch of 120-150 patches per aorta, and these were used to cal-
culate the average TAWSS, OSI, RRT and distance over each patch (see Figure
7.3). ese patched values were then used aerwards to generate scatter plots
(Figure 7.6), to enable a quantitative analysis of the results. Patches were di-
vided into 3 dierent groups to visualize their longitudinal position along the
abdominal aorta. A rst group included all patches in the proximal abdomi-
nal aorta, while a second group included 3 layers (18 patches) proximal to the
celiac artery as well as all patches between celiac and le renal arties. A third
group included all patches distal from the le renal artery. Dividing the surface
in such a structured way thus allowed us to focus on the region of our interest:
the aneurismal area of the abdominal aorta.
7.3 Results
7.3.1 Natural history
Of the tenmice included in the study (indicated asAA*), eight animals survived
the complete procedure. One animal (AA3) died 7 days aer pump implanta-
tion and was therefore further excluded from the study.is animal was found
2L. Antiga and D.A. Steinman. http://www.vmtk.org
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Figure 7.3: Methodology for generation of distance map and patches in mouse AA2. In each
panel, the aorta is shown from a right lateral view (le part) and a le lateral view (right part).
A: Baseline (black) and end-stage (white) geometries in their original conguration. B:e end-
stage geometry is divided into 5 parts and each part is coregisteredmanually to the corresponding
baseline geometry. C: A displacement map is generated indicating the distance from baseline to
(coregistered) end-stage in each node. D:e surface is divided into patches to enable quanti-
cation of the results. Each patch is coloured with the average distance value of its nodes. E-G:
e patched surface is used to generate patch values of all CFD-based parameters.
to have severe intra-abdominal bleedings, in accordance with Sara et al.[124]
who found that on average 10 % of the animals die from aortic dissection in
the rst week. To facilitate analysis of the results, any aortic region in which
the distance between the geometry at day 31 and the geometry at baseline ex-
panded with more than 0.3 mm was termed ‘AAA region’. One animal (AA6)
was euthanized 18 days aer pump implantation for ethical reasons, since it was
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suering of a necrotic tail.is animal showed a small dilatation of the abdom-
inal aorta on post-mortem inspection, but was not considered a mouse with
developed AAA since the dilatation was smaller than 0.3 mm. In 4 of the 8 re-
maining animals, the abdominal aorta showed local dilation > 0.3 mm, visually
conrmed on post-mortem inspection aer 31 days.is is in agreement with
previous studies, reporting an incidence of around 50 % inmale ApoE −/−mice
[245].e post-mortem diagnosis of AAA was conrmed aerwards based on
segmented micro-CT images.e circumferential location of the AAA region
was not the same in all animals: in three out of four cases the aneurysm was
fusiform (AA1, AA2, AA10), in the fourth animal a saccular aneurysm devel-
oped on the le side of the aorta (AA4).e longitudinal location of the AAA
(lumen) region also varied: in some cases it was limited to the region proximal
to the celiac artery (AA4, AA10), in others it included the trifurcation region
where the mesenteric and right renal arteries branch o the aorta (AA1, AA2).
7.3.2 Flow data
e data presented in Table 7.1 show the average measured diameters and volu-
metric ow rates per branch at baseline for every mouse, as well as the fraction
of the volumetric ow rate going to each side branch. In general, themesenteric
artery is supplied with the largest fraction of the volumetric ow rate (29%), fol-
lowed by the distal aorta (25%), right renal artery (20%), le renal artery (15%)
and celiac artery (10%). Figure 7.4 shows streamlines in an example case (mouse
AA2) at dierent timepoints in the cardiac cycle.ese streamlines reveal a very
ordered laminar ow throughout the cardiac cycle, only showing some complex
laminar ow (recirculation) near the trifurcation immediately aer the systolic
peak.
7.3.3 Hemodynamics vs AAAs
Figures 7.5 and 7.6 respectively show a qualitative and a quantitative analysis of
the results of CFD simulations in the 4 cases in which an AAA region could be
detected.e qualitative plots formouseAA2 (Figure 7.5A) show a distinct zone
of disturbed ow (low TAWSS and high RRT) at the trifurcation, and a similar
but less distinct zone just proximal to the celiac artery. e distance map and
the end-stage geometry reveal that the aneurysm takes its largest dimension in
the aortic region proximal to the celiac artery and extends over the trifurcation
region. e patches containing the AAA region (represented by a large dis-
tance to baseline geometry), however, did not experience more disturbed ow
compared to other patches along the aorta (Figure 7.6A). Also, patches where
RRT was highest at baseline (at the trifurcation) are not the ones where AAA
region is maximal.e situation in mouse AA4 (Figure 7.5B) is similar: there is
a small zone of disturbed ow at both the le and right hand side of the celiac
artery and at the trifurcation. e AAA region is on the le hand side of the
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Figure 7.4: Streamlines at dierent timepoints in the cardiac cycle in mouse AA2.
celiac artery, but in a more proximal part of the aorta. Again, the scatter plots
for mouse AA4 (Figure 7.6B) show that there was no disturbed ow at baseline
in the AAA region. Mouse AA10 does not experience seriously disturbed ow,
the highest values of RRT occurring at the trifurcation and opposite to the le
renal artery (Figure 7.5C).e AAA region on the other hand is to be found just
proximal to the celiac artery, a region in which there was no disturbed ow at
all at baseline. is is also reected in the scatter plots (Figure 7.6C), as there
is a tendency for TAWSS to be higher and RRT to be lower in the AAA region
when compared to other patches.e last mouse in which an AAA region was
detected is mouse AA1. Figure 7.5D shows three regions of disturbed ow at
baseline: one distinct zone at the trifurcation and two smaller zones at the level
of celiac and le renal arteries. In this case, the aneurysm is located proximal to
the celiac artery, extending to the trifurcation region. Again, the scatter plots do
not reveal any trivial relation between the studied ow parameters at baseline
and the size of the AAA at day 31.
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Figure 7.5: Qualitative results. TAWSS, RRT and distance maps at baseline are shown for all
4 animals that developed an aneurysm, as well as the corresponding end-stage geometry as ob-
tained frommicro-CT images (lumen) and dissection (outer wall, including adventitia). A: AA2;
B: AA4; C: AA10D: AA1.
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Figure 7.6: Quantitative results. Scatter plots show the relationship between local hemodynam-
ics at baseline and the distance to the corresponding end-stage geometry. Each point represents
one patch as obtained via the procedure shown in Figure 7.3. Patches were divided into 3 dier-
ent groups according to their longitudinal position along the abdominal aorta. Each group was
allocated a dierent symbol. Note that the second gure in panel A was set to a dierent scale to
include outliers. A: AA2; B: AA4; C: AA10;D: AA1
7.4 Discussion
7.4.1 Disturbed ow vs AAA location
We performed mouse-specic CFD simulations of the abdominal aorta in a
mousemodel ofAAA formation to study the relation between intra-aortic hemo-
dynamics and AAA formation. Streamlines reveal a laminar, very structured
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ow throughout the cardiac cycle except for systolic deceleration, when a com-
plex laminar ow with recirculating streamlines can be observed near the tri-
furcation. is laminar ow can be explained when taking into account the
Reynolds number (Re), a key dimensionless parameter in uid dynamics ex-
pressing the ratio of inertial and viscous forces (equation 5.1). It can be used to
assess whether ow is in a laminar, turbulent or transitional phase. For steady
ow in a circular tube, the transition points are at Re = 2000 (laminar to transi-
tional phase) and Re = 2500 (transitional to turbulent phase) In our simulations
the average Reynolds number at the inlet of the model is 40, whereas a typical
value in a human abdominal aorta would be around 200 [148].
We did not nd a direct, trivial correlation between areas of disturbed ow
(low TAWSS, high OSI, high RRT) and location of aneurysm formation in the
animals developing AAA (AA1, AA2, AA4 and AA10). However, we did ob-
serve some recurring patterns when analyzing the results of CFD simulations:
the most distinct area of disturbed ow oen occurs at the trifurcation, where
mesenteric and right renal artery branch o the aorta (AA2, AA4 and AA1).
is can also be observed in Figure 7.4, where a small recirculation zone is
present in the trifurcation area immediately following the systolic peak. Fur-
thermore, smaller areas of disturbed ow occur in the region of celiac (AA2,
AA4 and AA1) and, to a lesser extent, le renal artery (AA10, AA1). Note, how-
ever, that the absence of correlation between the area of disturbed ow and the
location at which the aorta is dilated most (Figure 7.6), does not necessarily
mean that hemodynamics do not inuence AAA formation. In 3 out of 4 mice
(AA2, AA4, AA10) the zone where the AAA region is maximal and the zone
of disturbed ow are located at the same side of the aorta, and the AAA region
is located proximal to the zone of disturbed ow (Figure 7.5). From a hemo-
dynamic point of view, one might speculate that AAA formation is initiated at
a location that suers from disturbed ow at baseline (the trifurcation in AA2
and AA1, the celiac artery in AA4). Once a (small) dilatation is established, ar-
eas of disturbed owwould arise in the proximal part of this dilatation, as is the
case in an actual aneurysm [147].erefore, if AAA formation does depend on
the local hemodynamics, one would expect the AAA to originate proximally
to the area at which disturbed ow occurs at baseline. Even though the AAA
area is not systematically overlapping with the area of disturbed ow at base-
line, this hypothesis is (partly) conrmed by the current results, although one
would need additional intermediate data to conrm it.
7.4.2 Obtained ow data
Taking a closer look at the average ow ratios going to each branch, there is
a strong trend (p=0.07) towards a dierence in blood supply to the le and
right renal arteries.e dierence between both renal arteries is also reected
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in their size, as the le renal diameter (mean value: 0.43 mm) is signicantly
smaller than the right renal artery (mean value: 0.54 mm; p<0.05).is dier-
ence has not been reported previously and is, to the best of our knowledge, not
present in humans. It is interesting to note that, unlike in humans, the right re-
nal artery (and kidney) is located superior to its le counterpart.us, reduced
ow to the le renal artery may be a simple matter of less ow in the aorta at
that distal location. Further data conrm that ow is not only determined by
the cross-sectional area of a branch, as the le renal shows a tendency to take
on average 50% more ow than the celiac artery (p=0.06), while they have ex-
actly the same average diameter (0.43 mm). Also, ow to the mesenteric artery
is not signicantly dierent from ow to the distal abdominal aorta (p=0.55),
even if its diameter (mean value: 0.65 mm) is signicantly lower than that of
the distal aorta (mean value: 0.73 mm) (p<0.05). e presented ow data also
illustrate the importance ofmouse-specic boundary conditions: simply apply-
ing a constant outow rate based onMurray’s law (equation 2.21) to each branch
would not hold true in this setting. We will not go into this further, as the use of
Murray’s law will be discussed into detail in chapter 8. Noteworthy, a relatively
large spread is observed between dierent animals, especially in the right renal
and mesenteric arteries. It should be mentioned that the animals did not fast
prior to the scans and had ad libitum access to water, which may account for
some of the variability in the data. A large fraction of the variation is caused by
outliers, but the relative distribution of all ow rates is consistent within each
animal. It seems that some animals in general experience much higher ow (in
all branches) than others (e.g. AA8).
7.4.3 Methodological issues on mouse-specic CFD
Until recently, the limiting factor to perform mouse-specic CFD studies was
the lack of temporal and spatial resolution in the available imaging modali-
ties. Some studies have performed CFD simulations of the ow eld in the
mouse aorta basing both geometry and boundary conditions on MRI [88], but
although in recent work an isotropic voxel resolution of up to 117 µm3 has been
reached in mice [183], the resolution is in most cases not sucient to capture
ow in the (smaller) side branches. In literature, most CFD simulations in the
mouse aorta base their arterial geometry on a vascular cast, a plastic replica
of the arterial system which is subsequently scanned in vitro using micro-CT
[140, 175, 177], as in chapter 5. Obviously, this technique excludes longitudinal
studies, since the mouse needs to be sacriced.e recent introduction of con-
trast agents for micro-CT allows us to circumvent this problem (see chapter 6).
Due to these contrast agents the aorta can be dierentiated from surrounding
tissues, and it is no longer necessary to sacrice the animal to obtain a 3D ge-
ometry of its arterial system.
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Apart from the geometry, boundary conditions are indispensable to pre-
scribe the ow rate at the in-and outlets of the model. As described in section
2.2.2, most CFD studies working with murine data impose a xed volumetric
ow rate (throughout the cardiac cycle) to all side branches. ese xed volu-
metric ow rates are in some studies (partially) based on mouse-specic ow
velocity measurements using ultrasound or MRI [140, 177] and in other studies
on literature data obtained in dierentmice [175]. In this paper, a novelmethod-
ology was used to obtain time-dependent volumetric ow rate proles in vivo
in all necessary branches, combining ow velocity measurements (based on
high-frequency ultrasound) and diameter measurements (based on contrast-
enhancedmicro-CT). Over the length of an arterial segment (not including any
side branches), ow velocity can change signicantly due to tapering, whereas
volumetric ow rate remains constant. Moreover, although ultrasound is a re-
liable technique it has some drawbacks: it is operator-dependent and it is not
always possible to obtain good measurements at all locations throughout the
arterial tree (see section 3.2.4).erefore, an important advantage of the inclu-
sion of diameter data from micro-CT is that it allows for the measurement of
ultrasound ow velocities at the location where quality of the pulsed Doppler
signal is optimal.
7.4.4 Methodological issues in processing ultrasound data
Our methodology corrected for a possible mismatch between dierent mea-
surements, and resulted in a set of time-dependent mouse-specic volumet-
ric ow rate proles, compatible with each other throughout the cardiac cycle.
ese data, listed in Table 7.1 (and used for the CFD simulations), provide new
insight into how the ow is distributed to the dierent branches in the mouse
abdominal aorta, and can therefore be used as reference values for future re-
search. e presented data were obtained aer redistributing the error in the
mass balance at the outlet over all branches.e redistribution had some inu-
ence on the nal ow values (Mean Dierences: PAA 0.16 ml/s (11%); CA 0.02
ml/s (15%); MA 0.04 ml/s (13%); RRA 0.03 ml/s (11%); LRA 0.02 ml/s (11%);
DAA 0.06 ml/s (18%)). However, without this redistribution the theoretical
volumetric outow rate showed - in some cases - phases of negative ow which
were not present in the measured outow signal of these animals.
ere are several reasons as towhy an error in themass balance is inevitable:
(i) not all branches between the inlet and the outlet of the model have been
taken into account. Several smaller branches, such as the middle suprarenal
arteries, inferior phrenic artery, gonadal artery and spinal branches were ne-
glected since they were too small to be segmented with sucient accuracy from
the micro-CT images. Also, it would have been dicult to measure ow veloc-
ity to all these side branches within the reasonable timeframe of one hour; (ii)
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the actual aorta has a buer capacity that allows it to distend over time, and
therefore the ow waveform arrives at a later time point in the cardiac cycle
further downstream the aorta.
Our CFD simulation is based on a rigid model, which not only implies that
the computed wall shear stresses are expected to be higher than what would be
the case in a distensible model, but also that at all moments in time the sum
of ows at outlets should equal the ow at the inlet. is is incompatible with
the (minute) time shi that exists between the measurements.erefore mea-
surements of ow in the proximal and distal aorta were not performed at the
physical location of the in-and outlets of the model, but close to the location
of the side branches. Since there were no side branches between the measure-
ment location and the model inlet, the mean value of the volumetric ow rate
is the same, but the time shi between dierent measurements is much smaller.
is allowed us to subtract outlet ows from the inlet ow without losing the
characteristic time-dependent waveform of the ow proles.
7.4.5 Methodological issues on following up AAAs
e in vivo obtained ow proles and geometries were combined to set up
a mouse-specic CFD simulation at baseline. Previously, it has been shown
that low and oscillatory shear can be linked to atherosclerosis, both in humans
[60, 141] and mouse models [248]. No such data exist for aneurysm formation
except for the study of Boussel et al. [165], who have shown in a quantitative
way that a human cerebral aneurysm grows most in the region of lowest time-
averaged wall shear stress (TAWSS). However, in this study the aneurysm was
already present at the start of the study so its results are only relevant for an-
eurysm growth, not for its initial phase. In other studies an existing (cerebral)
aneurysm was digitally removed in order to obtain an articial baseline geom-
etry [168–170], that served as a basis for a CFD simulation to calculate several
hemodynamic parameters that could then be linked to the location of the (re-
moved) aneurysm. e eccentric shape of the cerebral aneurysm makes this
operation more feasible than e.g. for an abdominal aneurysm, but the funda-
mental problem remains: one must always assume the shape (and boundary
conditions) of the original geometry. In our study we could avoid this problem
since we ascertained to the actual baseline data.
e short-time eect of pump implantation on abdominal hemodynamics
is unclear. Although there are no data that would support this theory, we cannot
exclude the possibility that pump implantation itself causes a sudden change in
hemodynamics (e.g. due to geometric deformation of the aorta). It might thus
be benecial to obtain a set of extra ‘baseline’ data just aer pump implantation.
Furthermore, it is an open question why the incidence of AAA aer pump im-
plantation in male ApoE −/− mice is not higher than 50 %. In this paper we
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were mainly interested in the relationship between hemodynamics and AAA
formation in those animals that do develop an AAA and as such we considered
it beyond the scope of this work to hypothesize on this incidence rate.
We calculated a distance map to represent the growth from baseline to end-
stage geometry in the 4 animals that developed an AAA.e main goal of the
distance map was to identify the AAA zone on the baseline geometry, thus en-
abling a comparison with CFD data in a quantitative way. A simple automatic
rigid coregistration of the baseline and end-stage geometries (Figure 7.3A) did
not suce to generate a reliable distance map on the baseline surface. Subdi-
viding the end-stage geometry into 5 subparts allowed us to overcome the eect
of the dierent bending of the aorta in both geometries (Figure 7.3 B). However,
this coregistration is still fairly rigid and therefore in some locations the gen-
erated distance map will still be suboptimal (e.g. the distal abdominal aorta
in Figure 7.3 B). However, we believe that the articial distance caused by this
suboptimal positioning is negligible when compared to the distance at the lo-
cation of the aneurysm. It is in any case impossible to match both geometries
one-on-one since - due to the 5 weeks period between both scans - the aorta
has not only expanded in diameter but also in length, causing an increase in
the distance between dierent landmarks (e.g. celiac bifurcation, mesenteric
and right renal trifurcation) as well. We have chosen to optimize the position
of the part containing the aneurysm itself, which in some cases implies a slight
longitudinal mismatch in proximal and distal parts of the aorta.
e obtained results were subdivided into a structured set of patches to fa-
cilitate a quantitative comparison between hemodynamics and AAA location.
e size of the patches was determined in such a way that contingent local spu-
rious ow features were averaged out, but sucient detail was maintained to
distinguish dierent zones from each other based on their hemodynamic con-
ditions. Patches on the dierent side branches were not taken into account since
we are only interested in locating the region of the aortic wall that is most prone
to AAA development. Since the scans of both geometries in general did not
contain the exact same aortic length, superuous patches at in and/or outlets
were dismissed in the quantitative analysis, as were patches at in-and outlets
that contained articially high WSS values due to the inlet conditions.
Within this chapter, we use the term ‘AAA region’ for all aortic regions in
which the dierence in distance between the end-stage and the baseline lumen
was greater than 0.3 mm. is is a somewhat articial denition not based on
clinical practice (where an aneurysm is dened as a dilatation of at least 1.5 times
the local diameter 1.2.1). However, we believe that it is justied to use this term
even for small dilatations, since we do not use it as the basis for a clinical deci-
sion but aremainly interested inAAA initiation itself.e presence of AAAwas
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initially based on a macroscopic evaluation of the aorta just aer autopsy. All
animals were dissected on the same day the last micro-CT scan was performed,
and in general there is a good agreement in the macroscopic shape of the AAA
between images obtained from autopsy and end-stage micro-CT (Figure 7.5).
One can observe that the AAA region oen looks smaller in the micro-CT im-
ages (e.g. AA1 in Figure 7.5 D).is is mainly due to the fact that the micro-CT
geometry is based on the (segmented) lumen. However, it is known that medial
and adventitial remodeling occur [124] which may in some cases cause signi-
cant dierences between the circumferential shape of interior and exteriorAAA
wall. Consequently, the calculated distance map in these particular cases (e.g.
AA1) may not correspond entirely to the actual aneurysmatic region.
7.4.6 Limitations of the model
We decided to limit our geometrical model to the abdominal aorta and its most
important side branches. Similar to our reasoning about the smallest abdom-
inal side-branches, reduction of scanning time was the main argument not to
include the aortic arch (and the 3 great vessels branching o it) into our model.
is decision was further supported by the fact that the aortic arch is not in-
cluded in most CFD models of the human abdominal aorta found in literature
[87, 149, 150], see also section 2.2.1. We modeled the velocity ow prole enter-
ing the abdominal aorta as a non-skewed, fully developed parabolic prole. In
reality, however, blood enters the descending thoracic aorta as a skewed prole,
due to the particular bending of the arch [249]. Including this rotational part of
the ow into the inlet boundary condition of our model might therefore inu-
ence the distribution over the aorta of several of the calculated hemodynamic
parameters [250]. e inuence of these (current) limitations on the outcome
of the CFD simulations is adressed more thoroughly in chapter 8.
Furthermore, the ApoE −/− mouse model infused with Angiotensin II has
recently been reported to develop thoracic aortic aneurysms in some cases as
well [112].e latter is an important nding if one would perform intermediate
or end-stageCFD simulations as in chapter 9, since the presence of an aneurysm
in the proximal part of the aorta might inuence the ow prole entering the
abdominal aorta.
7.5 Conclusion
We set up an experimental-computational framework combining ow velocity
measurements (based on high-frequency ultrasound) and diameter measure-
ments (based on contrast-enhanced micro-CT) to set up mouse-specic CFD
simulations of the hemodynamic situation in the mouse abdominal aorta, only
based on in vivo data. We applied the methodology in an established mouse
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model of AAA to investigate the relation between the presence of disturbed
hemodynamics at baseline and the formation of abdominal aortic aneurysm
(AAA). We observed signicant inter-individual variability in hemodynamic
characteristics of the abdominal aorta, emphasizing the importance of mouse-
specic analysis. e most distinct area of disturbed ow was in most cases
either at the trifurcation (where mesenteric and right renal artery branch o)
or at the bifurcation where the celiac artery branches o the aorta. Qualita-
tive results showed that for the animals which developed AAA, its dimension is
maximal in areas that are situated proximal to those areas that experience most
disturbed ow in 3 out of 4 mice. Although further detailed analysis did not
reveal any obvious relationship between areas that experience most disturbed
ow and the end-stage AAA dimensions (and therefore excludes a conclusive
message), the results of this study do not exclude that hemodynamics do play a
role in AAA formation. Due to its mouse-specic and in vivo nature, the pre-
sentedmethodology can be used in future research to link detailed and animal-
specic (baseline) hemodynamics to (end-stage) arterial disease in longitudinal
studies in mice.
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The impact of simplified boundary
conditions and aortic arch inclusion
on CFD simulations in themurine
aorta: a comparison with
mouse-specific reference data
e results of this study are accepted for publication in: Bram Trachet, Joris
Bols, Gianluca De Santis, Stefaan Vandenberghe, Bart Loeys, Patrick Segers.
e impact of simplied boundary conditions and aortic arch inclusion on CFD
simulations in the mouse aorta: a comparison with mouse-specic reference data.
Journal for Biomedical Engineering -Transactions of theASME2011, 133(12):121006.
8.1 Introduction
A wide scope of small animal cardiovascular research applications, formerly
hampered by technological limitations, have recently become open for investi-
gation, due to advancements in small animal imaging technology such as high-
frequency in vivo ultrasound and contrast-enhanced in vivo micro-CT (as in-
troduced in chapter 3). ese dedicated techniques allow us to keep the ani-
mals alive while performing high-resolution measurements and can therefore
be used in longitudinal studies with a close follow-up of the animal through-
out disease development. Moreover, measured data can be used as an input for
151
8. The impact of simplified BCs and geometry on CFD simulations
Computational Fluid Dynamics (CFD) simulations, which allow for the calcu-
lation of ow elds in vascular territories into great detail, solely based on in
vivo data. In chapter 7 we used these techniques to follow up on the potential
link between hemodynamics and AAA development in a mouse-specic way.
However, many challenges still remain when performing mouse-specic CFD
simulations.e aforementioned small animal imaging techniques are not yet
widely available, and it remains cost - and time consuming to perform these
simulations in a mouse-specic way, especially when a large number of ani-
mals is needed to reach statistically signicant conclusions. For these reasons
(or simply because the necessary imaging techniques are not available), it is
common practice to make certain assumptions when setting up CFD simula-
tions, e.g. when studying aortic ow dynamics in themouse. In this chapter, we
have quantied the inuence of assumptions regarding (i) the applied boundary
conditions (BCs) and (ii) the geometry dening the boundaries of the compu-
tational domain.
Appropriate boundary conditions are indispensable to set up a trustworthy
CFD-simulation.e strategy that is followedmost oen is to estimate the ow
split rate towards each branch based on data from literature [88, 175, 176], as was
also done in chapter 5. However, literature data are scarce and oen limited to a
specic part of the aorta [140]. A second strategy is to prescribe a xed volumet-
ric ow rate such that the wall shear stress (based on fully developed laminar
Poiseuille ow) is equal for each outlet, a method oen referred to as Murray’s
law [185]. is method has been introduced in section 2.2.2 and was used to
estimate ow fractions in chapter 6. Despite the fact that this approach is oen
used in both a human [251, 252] and a small animal setting [179] it has never
been validated in the latter, mainly due to a lack of adequate reference data.
In this chapter, we present a reference data set containing ow splits towards
all major branches of the entire murine aorta, based on in vivo measurements
in a complete dataset of 10 male C57Bl/6 ApoE -/- mice. Furthermore, we use
this data set to quantify the eect of the imposed BC scheme on the results of
the CFD simulations: for each animal 3 dierent simulations were set up in the
complete aorta with outlet boundary conditions based on
1. mouse-specic in vivo measurements.
2. mouse-specic ow splits calculated using Murray’s law.
3. average ow splits from the measured dataset in 10 animals.
Apart from the boundary conditions, one also needs a geometrical model of the
aorta to set up a CFD simulation. Most studies restrict their geometry to the
part that is of interest for the study, e.g. the aortic arch as in chapters 5 and 6 and
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[140, 175, 176, 178, 251] or the abdominal aorta as in chapter 7 and [88, 253], but
it is unclear if and to what extent such restrictions inuences the outcome of the
CFD simulations. As a second part of this study, we therefore investigated the
eect of these geometrical restrictions: for each animal two simulationswere set
upwith boundary conditions based onmouse-specic in vivomeasurements in
which
1. the entire aorta was included into the computation, but only the abdom-
inal part was considered.
2. only the abdominal aorta was included into the computation.
8.2 Methods
8.2.1 Mice
Ten in-house bred male ApoE -/- mice on a C57Bl/6 background (data: see
Table 8.1) were used in this study.ey were housed in separate cages and wa-
ter and regular mouse diet were available ad libitum. All experiments were in
accordance with ethical committee guidelines for animal research and were ap-
proved by the animal ethics committee of the Ghent University.
8.2.2 Measurements
Micro-CT
Animals were anesthetizedwith 1.5% isourane and, once anesthetized, injected
intravenously in the lateral tail vein with 150 microliter/25 gram body weight of
Aurovist (Nanoprobes, Yaphank, NY, USA). As the contrast is maximal imme-
diately aer injection, the animals were subsequently scanned in supine posi-
tion in a GE FLEX Triumph CT scanner (Gamma Medica-Ideas, Northridge,
CA, USA).e acquisition parameters were the following: 50 m focal spot, 2 x
2 detector binning, 1024 projections over 360○, 3.5 times magnication, and 70
kVp tube voltage. Using a blank air scan, the ideal tube current was determined
by increasing the current until the detector response saturated.is ideal tube
current was determined at 180 A for a 70 kVp tube voltage.e gantry rotated
continuously, providing faster acquisition compared to step-and-shoot mode.
is resulted in a 33.81 mm transverse eld of view, a theoretical spatial resolu-
tion of 46m and a scanning time of 4.26min.e continuous data were binned
into 1024 projections and reconstructed with a proprietary soware (Cobra
EXXIM, EXXIM Computing corp., Livermore, USA) using a Feldkamp-type
algorithm with Parker’s weighting function in a 512 x 512 x 512 matrix with a 75
m voxel size.
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Figure 8.1: Pulsed Doppler ultrasound ow velocity measurements as they were acquired
throughout the arterial tree. On the le hand side - indicated with white dots and dotted lines
- are the measurements performed in all 7 side branches of the aorta. On the right hand side -
indicated with black dots and dashed lines - are the measurements performed at 8 dierent loca-
tions throughout the aorta itself. Mind that the shown images represent ow velocity waveforms
as they were measured, which implies that the scale is dierent for each measurement location.
Ultrasound
Aer the micro-CT scan, anesthesia was maintained and mice immediately
underwent an ultrasound scan. Ultrasound data were obtained with a high-
frequency ultrasound apparatus (Vevo 2100, VisualSonics, Toronto, Canada)
equippedwith a linear array probe (MS 550D, frequency 22-55MHz) andmouse
handling table. All measurements were performed by one single operator.e
animal was secured on the table in supine position and ECG and respiratory
rate were monitored via four electrodes connected to the paws of the animal
while body temperature was monitored via a rectal probe.e ultrasound pro-
tocol was restricted to 1 hour per mouse. First, B-mode imaging was used fol-
lowed by Color Doppler imaging to locate side branches, and pulsed Doppler
to assess ow velocities.e latter were measured in the aortic arch (ascending
aorta proximal to brachiocephalic trunk; aortic arch proximal to le common
carotid; descending aorta distal to le subclavian), brachiocephalic trunk, le
common carotid artery, le subclavian artery, thoracic aorta, abdominal aorta
(proximal to the celiac artery; between celiac and mesenteric arteries, and dis-
tal to the mesenteric artery), celiac artery, mesenteric artery, le and right renal
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arteries and nally the distal abdominal aorta (see Figure 8.1). To enable cor-
relation of ow velocity measurements with diameters obtained in micro-CT,
the distance from the location of each aortic ow velocity measurement to the
nearest bifurcation was measured along the aorta. Where possible, each ow
velocity measurement in the side branches was performed at two locations: the
rst one immediately aer branching, and the second one more distally in the
branched artery.
8.2.3 Geometry
e reconstructed images were converted into DICOM standard format, and
imported into the 3D segmentation soware packageMimics (Materialise, Leu-
ven, Belgium).e aorta was then semi-automatically segmented to select the
contrast-enhanced lumen, requiringmanual intervention to separate aortic and
venous segments. e resulting mask was then wrapped and smoothed while
care was being taken not to cause any shrinkage. is resulted in a 3D recon-
struction of the complete aorta, including 7 side branches.e outer surface of
the lumen, represented as a triangular grid aer segmentation, was processed in
pyFormex (www.pyFormex.org) to generate a structured and conformal fully
hexahedral mesh inside the aortic lumen [16]. A block-structured grid for the
uid domain consisting of hexahedral cells was chosen instead of an unstruc-
tured grid consisting of tetrahedral cells, allowing for a higher accuracy in the
CFD simulations when using same amount of cells due to a lower numerical
diusion error [135, 254]. Briey, the mesh was generated using a multi-block
approach, in which hexahedral cells were aligned longitudinally along the ves-
sel centerlines and combined together in a conformal fashion at locations of
branching, both for bi- and trifurcations [134, 135]. For each meshed geometry,
a secondmesh was created containing a copy of the abdominal part of the com-
plete aortic mesh.e copy is identical (in the nodal coordinates) to avoid the
eect of a dierent mesh when comparing the numerical results of the abdom-
inal part.
8.2.4 Boundary conditions
Measured (redistributed) outow velocities
Doppler ow velocity spectra were automatically traced using the built-in anal-
ysis tools of the VisualSonics soware and subsequently exported for further
analysis in Matlab (Natick, MA).ese time-series, containing multiple beats,
were rst converted into an averaged ow velocity waveform. To do so, the R-
peak of the ECG signal was used to mark the start and end of a cardiac cycle. A
minimum of three cycles was selected, and one representative of average ow
velocity waveform was obtained.is procedure is similar to the one described
in chapter 7, but instead of studying the abdominal aorta we now focus on the
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complete aorta. However, in the current geometrical setting there is an addi-
tional problem since the velocity waveforms in the abdominal aorta arrive later
in the cardiac cycle than thosemeasured in e.g. the aortic arch, due to the inter-
action between the uid and the arterial wall. In our CFD simulations, which
neglect the uid structure interaction, the instantaneous mass balance needs to
be correct at all timepoints, so one needs to correct for this time lag in order
to obtain a set of compatible CFD boundary conditions. erefore the transit
time from the R-top of the ECG signal to the foot of the ow velocity wave-
form was determined for each waveform. All waveforms were then shied in
time tomake sure that the foot concurred, using the ascending aortic waveform
as a reference. Furthermore, since the ow velocity measurements in dierent
branches were not obtained simultaneously, small dierences in heart rate oc-
curred for all volumetric ow ratewaveforms.erefore, the average heart cycle
duration over all waveforms was calculated and all waveforms were resampled
in time to match this heart cycle duration.
As alreadymentioned in section 7.4.4, ow velocity is not constant through-
out an arterial segment (due to the tapering of the aorta) and the boundary
conditions in the CFD model are not always applied at the exact same location
where ow velocity was measured. erefore a conversion to volumetric ow
rate is mandatory. For this purpose the diameter at the location of the ow ve-
locity measurement was measured in the reconstructed 3D model of the artery
(based on the micro-CT scans). To determine the location of the ow veloc-
ity measurement on the 3D model, the distance along the aorta to the near-
est branch (recorded during the ultrasound measurement protocol) was used.
Volumetric ow rate was then obtained by multiplying ow velocity with the
local cross-sectional area and dividing by 2, assuming that velocity proles are
parabolic and that pulsed wave Doppler measures the peak of parabolic ow
prole. e average between the proximal and distal measurement was used
when both were available. ese calculations lead to one volumetric ow rate
waveform (the proximal aorta) used as input, and eight volumetric ow rate
waveforms that could potentially be used as output boundary conditions.
As already mentioned the uid domain is assumed to be bounded by rigid
walls, and it is therefore essential that at any time point, the input equals the
sum of the output volumetric ow rates to balance the conservation of mass. To
ensure that this was eectively the case, the dierence between the measured
volumetric outow rate (in the distal aorta) and the computed theoretical volu-
metric outow rate (obtained by subtracting themeasured ow towards all side
branches from the measured inow) was redistributed over all in- and outlets.
is redistribution was imposed according to a weighting scheme: the amount
of redistribution assigned to each in- or outlet was proportional to the ratio of
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Figure 8.2: Redistribution scheme for 2 typical cases (top: AA2 , bottom: AA6). Solid lines
represent original (measured) volumetric ow waveforms (averaged over 3 cardiac cycles and
corrected for the time lag present in the measurements). Dashed lines represent redistributed
volumetric ow waveforms. As described in the Methods section, redistribution is split into
2 dierent parts (proximal and distal aorta). Volumetric ow in the thoracic aorta is xed in
the abdominal part to guarantee a correct mass balance using exactly the same outlet boundary
conditions in those simulations in which only the abdominal aorta is considered. Mind that the
scale is dierent for proximal (le) and distal (right) parts of the gure.
its local area over the total area of all in- and outlets, assuming that the largest
boundary (usually the proximal aorta) is also subject to the largest measure-
ment error. Unlike in chapter 7, where only the abdominal aorta was studied,
the redistribution is now performed in two dierent phases: in a rst step the
average thoracic ow waveform was calculated over three dierent measure-
ments (descending aorta distal to le subclavian aorta, thoracic aorta, abdom-
inal aorta proximal to coeliac artery). en a redistribution was performed in
the proximal part of the geometry (the aortic arch), considering the ascending
aorta as input signal, the brachiocephalic trunk, le common carotid and le
subclavian arteries as side branches and the thoracic signal as the outlet signal
(Figure 8.2, le panels). e obtained, redistributed thoracic volumetric ow
waveformwas then used as an input in a second redistribution (Figure 8.2, right
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panels), similar to the one in chapter 7. Using this approach the mass balance
is not only correct in the complete aorta, but also in the simulations that are re-
stricted to the abdominal aorta, while the exact same waveforms can be used as
boundary conditions in both simulations.e nal volumetric ow rate curves
were then divided by the cross-sectional area at the respective in- or outlets of
the model, to nally obtain ow velocities that could be imposed as parabolic
velocity proles in the CFD model.
Murray’s law outow ratios
In a second part of the study, outow ratios were based on Murray’s law [185]
as in equation 2.21.e ratio of the ow going to a specic branch over the ow
in the mother branch was assumed to be proportional to the third power of the
diameter ratio of both branches. Aortic diameters were measured in Mimics,
using the 3D representation of the aorta based on the micro-CT images. A ow
of 100 % was assumed at the ascending aorta and the ow ratio towards each
side branch was calculated until the distal aorta was reached. However, when
the ow towards the distal aorta is also calculated usingMurray’s law (thus con-
sidering the distal aorta as a side branch instead of just assigning all leover ow
to the distal aorta) the necessary condition of conservation of mass is usually
not fullled, as in the case of the measured ows. We thus redistributed all ow
ratios again in two dierent phases (rst the branches in the aortic arch, then
the abdominal part), using the exact same technique as for the measured ow
rates in order tominimize its inuence on the results. In literature, there is some
discussion whether the exponential factor 3 that is used in Murray’s law is cor-
rect, and some authors have proposed an exponential factor 2 instead [219, 220].
Since we have access to all necessary data to assess this assumption, we calcu-
lated an additional set of outow ratios. Resulting Murray outow ratios can
be found in Table 8.1.
Average outow ratios
As a third part of the study, outow ratios were averaged over the complete
dataset of 10 animals.e ow split towards a given branchwas calculated as the
average fraction of redistributed volumetric ow fractions going to that branch
and applied as an outow boundary condition. Resulting average outow ratios
can be found in Table 8.1 (in bold), and may also serve as a reference for future
studies.
8.2.5 CFD Simulations
All numerical simulations of the ow eld were performed with Fluent 12.0
(Ansys, Canonsburg, PA), commercially available CFD soware. Blood den-
sity was taken to be 1060 kg/m3 and at the high shear rates appropriate for the
murine arterial system the dynamic blood viscosity was assumed to remain at a
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constant asymptotic value of 3.5 mPas [140]. In all simulations a (parabolic) in-
let velocity prole was imposed based on the measured (redistributed) velocity
waveform. To avoid numerical instabilities by imposing ow boundary condi-
tions at all in- and outlets the distal abdominal aorta was always modeled as a
traction-free outlet, while other outlet boundary conditions depended on the
chosen outlet scheme, as described above. For each simulation, three cardiac
cycles were simulated and all results were obtained from the third cycle, when
cycle-to-cycle variability had ceased. e hexahedral mesh of the entire aorta
consisted of about 1,000,000 cells and 1,100,00 nodeswhile the abdominal aorta
typically consisted of about 500,000 cells. A mesh-sensitivity analysis was car-
ried out for one example case, increasing the number of cells up to 1,500,000
to ascertain that a further increase of the number of cells did not inuence the
results.
8.2.6 Post-processing
Statistical distribution
Derived CFD data consisted of time-varying 3-dimensional vector elds of the
ow velocity in the abdominal aorta and side-branches, and these data were
further processed using PyFormex 1. Time-averaged wall shear stress (TAWSS,
equation 2.18), oscillatory shear index (OSI, equation 2.19) and relative resi-
dence time (RRT, equation 2.20), which have previously been suggested asmea-
sures of disturbed aortic ow [246] (see section 2.1.3), were calculated as in sec-
tion 2.1.3. In order to quantify the inuence of dierent boundary conditions
on the CFD results, these shear stress based descriptors were analyzed statis-
tically. For each model and hemodynamic parameter, the area-averaged mean
value and standard deviation were computed using the following equations:
µ = ∑Nj=1 A j ⋅ ψ j∑Nj=1 A j (8.1)
σ =
¿ÁÁÁÀ∑Nj=1 [A j ⋅ (ψ j − µ)2]∑Nj=1 A j (8.2)
with ψ j is the face-averaged hemodynamic parameter at the face j, A j is the
surface area at that face, and N is the number of faces contained in the surface
mesh of the aortic wall [255]. In order to quantify the inuence of the dierent
BC schemes and the inuence of the dierent geometrical settings on the CFD
results, the distributions were compared for each hemodynamic parameter us-
ing the Cohen’s distance [30]. Comparing methods A and B, Cohen’s distance
1B. Verhegghe, www.pyformex.org
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d is calculated as:
d = µ¯A − µ¯B√ (n−1)(σ 2A+σ 2B)
2n
(8.3)
In this equation σ and µ are the mean and standard deviation while n repre-
sents the number of faces. Since we compare 2 dierent methods on the same
geometry the number of faces is equal for both methods (nA = nB = n). e
Cohen’s distance d can thus be considered as a maximum likelihood estima-
tor [256], allowing for a comparison of the statistical distribution of 2 dierent
methods using just one number. Furthermore the 5th , 10th , 25th , 50th , 75th , 90th
and 95th percentile of the nodal distribution of all hemodynamic parameters
were visualized using box plots.
Spatial distribution
Even if the statistical distribution of a hemodynamic parameter over a surface
is very similar in two dierent settings, the spatial distribution (i.e the physical
location of areas experiencing low and/or high values) may still be dierent.
erefore the spatial distribution over the surface was compared for all dierent
BC schemes and for each hemodynamic parameter (TAWSS, OSI and RRT).
e same was done to compare both geometrical settings. In the latter case
the lambda-2 vortex core was plotted as well. is isosurface was calculated
during the deceleration phase of the aortic cycle according to Jeong et al. [257]
and allows us to visualize the location of vortex cores in the model. All post-
processing was done in Tecplot (Tecplot Inc., Bellevue, WA).
8.3 Results
8.3.1 Flow measurements
In Table 8.1 the mouse-specic ow fractions as obtained from the measured
(redistributed) volumetric ow waveforms towards each branch can be com-
pared with the average ow fractions over all 10 cases (in bold). ere is sig-
nicant variation between dierent animals, as indicated by the relatively high
standard deviations. For example, themeasured ow fraction to themesenteric
artery is 18.3 ± 5.8%, ranging from 11.3% (in AA3) to 29.7% (in AA5). On the
other hand, the standard deviation on the ow fractions towards the right re-
nal artery is much smaller, with an average fraction 8.3 ± 1.0%, ranging from
6.8% (in AA5) to 9.5% (in AA3). Table 8.1 also shows the mouse-specic ow
fractions as calculated using Murray’s law for each animal, using both 2 and 3
as exponential factors. When comparing the average fractions over all 10 ani-
mals obtained using the original version of Murray’s law (exponential factor 3)
to those obtained using the measured ow fractions, the dierence is smaller
than or equal to 3.1% in almost all side branches. However, the ow going to the
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brachiocephalic trunk is signicantly smaller (13 ± 3% in Murray’s law, 23 ± 5%
measured) and the ow going to the distal aorta is higher (29 ± 6% in Murray’s
law, 15± 3% measured). When the adapted exponential factor 2 is used to apply
Murray’s law the mean dierences with the measured ow fractions are smaller
than or equal to 4.4% in all side branches, including the brachiocephalic trunk
and the distal aorta.
8.3.2 e inuence of boundary conditions
Figure 8.3: Boxplots showing the nodal distribution of TAWSS, OSI and RRT, visualizing the
25th , 50th and 75th percentile (box) as well as the 10th and 90th percentile (whiskers) and the
5th and 95th percentile (outliers). A.e nodal distribution is compared over the entire aorta
for three dierent BC schemes: white boxes (le) show the golden standard, i.e. the distribution
when the measured outow velocity waveforms are imposed. Light gray boxes (middle) show
the distribution when the average ow ratios over all 10 animals are imposed, and dark gray
boxes (right) show the distribution when Murray’s law (using an exponential factor 3) is used
to determine the outow ratios towards the branches. B.e nodal distribution is compared
over the abdominal aorta for 2 dierent geometrical settings: white boxes (le) show the golden
standard, i.e. the distribution over the abdominal aorta when the entire aorta is included into the
numerical model. Dark gray boxes (right) show the distribution when the proximal and thoracic
aorta are omitted from the model, thus imposing a ow velocity waveform directly at the inlet
of the abdominal model (see also Figure 7). Measured outow velocity waveforms were used as
boundary conditions in both cases.
For each animal 3 CFD simulations were performed in which 3 dierent
outlet BC schemes were imposed:
1. the time-dependent measured (redistributed) ow velocity waveforms.
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2. the mouse-specic (redistributed) ow fractions calculated by Murray’s
law (exponential factor 3) as indicated in Table .
3. the average measured (redistributed) ow fractions over all 10 animals
(indicated in bold in Table 8.1).
e inuence of the dierent BC outlet schemes on the statistical distribution
of TAWSS, OSI and RRT is shown qualitatively in Figure 8.3 A, while the quan-
titative dierences are reected by the Cohen’s distances in Table 8.2. For each
hemodynamic parameter, Figures 8.4, 8.5 and 8.6 depict the spatial distribution
over the surface for the case with highest (top panels) and lowest (bottom pan-
els) value of the average of the Cohen’s distances between results obtained with
(i) measured and Murray’s law BCs and (ii) measured and averaged BCs. e
statistical distribution of the dierent hemodynamic parameters is dierent for
eachBC setting but also diers between hemodynamic parameters.e TAWSS
Cohen’s distance between average ow fractions andmeasured ow waveforms
is −0.019 ± 0.201. TAWSS is thus practically equal but slightly lower when av-
erage ow fractions are imposed. However, the large standard deviations in-
dicate that there is some variation from case to case, which is also reected in
the box plots in Figure 8.3 A (top le). e good agreement with the refer-
ence cases (i.e. when measured waveforms were imposed) is also reected in
the spatial distribution of TAWSS over the surface (Figure 8.4, middle panels),
which is comparable to the one obtained using measured ow waveforms.e
dierences are mostly located in the side branches (e.g. mesenteric artery, bra-
chiocephalic trunk) but the zones of high and low TAWSS on the aorta itself
are very similar, even for the case with highest Cohen’s distance (AA2). On the
other hand, the TAWSS Cohen’s distance between Murray’s law and measured
ow waveforms is 0.123 ± 0.228.us, TAWSS is slightly higher than the refer-
ence case when Murray’s law is used (but again, not in all cases). As shown in
Figure 8.4(right panels), the dierences no longer appear on the side branches
alone but also on the aortic surface itself: both the thoracic and the distal ab-
dominal aorta experience much higher TAWSS than the reference, even in the
case with lowest Cohen’s distance (AA8). is is also reected in the statisti-
cal distribution since the dierence between both methods is mostly located in
the highest quartiles: for Murray’s law, the dierence with the reference case in
face-averaged mean TAWSS per quartile is 13.6± 10.5% for Q1 and 21.9± 25.3%
for Q4, while for average ow fractions this dierence is similar in all quartiles
(Q1 ∶ 11.3±7.2%;Q4 ∶ 12.2±8.1%).e OSI Cohen’s distances are dierent: both
for Murray’s law (−0.460 ± 0.161) and average ow fractions (−0.443 ± 0.170)
OSI is lower than the reference case, which is again reected in the box plots
(Figure 8.3 A, middle panel). In Figure 8.5, the spatial distribution of OSI over
the surface reveals that the dierence is located in the distal aorta: both in the
case with highest and the case with lowest Cohen’s distance the distal aortic OSI
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Figure 8.4: Spatial TAWSS distribution compared for three dierent outlet BC schemes. In each
panel the aorta is depicted both from a right lateral view (le part) and a le lateral view (right
part).e le panels show the TAWSS distribution when measured outow velocity waveforms
are imposed, middle panels when the average ow ratios over all 10 animals are imposed, and
right panels whenMurray’s law (using an exponential factor 3) is used to determine the imposed
outow ratios. Top: Inuence of BC outlet scheme on TAWSS distribution for maximal Cohen’s
distance (AA2). Bottom: Inuence of BC outlet scheme on TAWSS distribution for minimal
Cohen’s distance (AA8).
is much higher when measured ow waveforms are imposed. Finally, the RRT
Cohen’s distances combine both eects. RRT is slightly lower than the reference
for Murray’s law (−0.162 ± 0.212) and slightly higher for average ow fractions
(0.003 ± 0.270), but in both cases the high standard deviations indicate that
it is dierent for each animal, which is also indicated in the box plots. Figure
8.6 conrms these small dierences: the spatial distribution over the surface is
similar in both cases and zones experiencing high and low RRT can be found
at the same locations for all 3 BC outow schemes, with some small dierences
in magnitude.
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Figure 8.5: Spatial OSI distribution compared for three dierent outlet BC schemes. In each
panel the aorta is depicted both from a right lateral view (le part) and a le lateral view (right
part). e le panels show the OSI distribution when measured outow velocity waveforms
are imposed, middle panels when the average ow ratios over all 10 animals are imposed, and
right panels whenMurray’s law (using an exponential factor 3) is used to determine the imposed
outow ratios. Top: Inuence of BC outlet scheme on OSI distribution for maximal Cohen’s
distance (AA3). Bottom: inuence of BC outlet scheme onOSI distribution forminimal Cohen’s
distance (AA1).
8.3.3 e inuence of geometrical restrictions
Two dierent geometrical settings were compared: in the rst case the entire
aorta was included into the geometrical model but TAWSS, OSI and RRT were
only calculated over the abdominal part. In the second case, the geometri-
cal model was restricted to the abdominal aorta. e Cohen’s distances be-
tween both settings are much lower than when boundary conditions were var-
ied: TAWSS (−0.016± 0.019) and OSI (−0.019± 0.033) are slightly lower when
only the abdominal aorta is used while RRT (0.034 ± 0.042) is slightly higher.
e good agreement is also reected in the box plots (Figure 8.3B) and in the
spatial distribution over the surface (Figure 8.7). Figure 8.7 clearly shows that
the inclusion of the aortic arch and thoracic aorta does not aect the spatial
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Figure 8.6: Spatial RRT distribution compared for three dierent outlet BC schemes. In each
panel the aorta is depicted both from a right lateral view (le part) and a le lateral view (right
part). e le panels show the RRT distribution when measured outow velocity waveforms
are imposed, middle panels when the average ow ratios over all 10 animals are imposed, and
right panels whenMurray’s law (using an exponential factor 3) is used to determine the imposed
outow ratios. Top: Inuence of BC outlet scheme onRRT distribution formaximal Cohen’s dis-
tance (AA9). Bottom: Inuence of BC outlet scheme on RRT distribution for minimal Cohen’s
distance (AA8).
distribution of any hemodynamic parameter, even for the case with highest Co-
hen’s distance (AA5). Also, the specic curvature in the thoracic aorta does not
aect the location of the vortex cores, as can be seen in the lambda-2 isosurface
depicted in Figure 8.8 (le panels). Furthermore, Figure 8.8 also shows that the
velocity prole proximal to the coeliac artery is practically equal in both cases,
but a more skewed velocity prole enters the abdominal aorta when the entire
aorta is included into the model (Figure 8.8, top right panel) as compared to
the parabolic velocity prole that is imposed when the model is restricted to
the abdominal aorta (Figure 8.8, bottom right panel).
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Figure 8.7: Spatial TAWSS, OSI and RRT distribution with and without aortic arch inclusion.
In each panel the aorta is depicted both from a right lateral view (le part) and a le lateral view
(right part). Distributions are shown for the case with highest Cohen’s distance (AA5). Top: CFD
results over the abdominal aorta when the entire aorta is included into the geometrical model.
Bottom: CFD results when the geometrical model is restricted to the abdominal aorta, imposing
a (measured) parabolic ow velocity waveform at the inlet of the model.
8.4 Discussion
8.4.1 e need for reference ow data
In literature, few studies have actually performed CFD simulations in a murine
setting using entirely mouse-specic boundary conditions: to our knowledge
this was only done by Feintuch et al. [140], who restricted their model to the
aortic arch, and our previous described in chapter 7, that was restricted to the
abdominal aorta. When no mouse-specic boundary conditions are available
(which is oen the case), dierent strategies can be followed. In some cases the
most ecient strategy is to ignore all side branches [178], thus assuming that
ow to those branches will not inuence the general ow eld being studied.
In most cases however, the side branches are incorporated into the model since
disturbed ow patterns oen occur in the proximity of the branches, and out-
ow boundary conditions need to be prescribed at the outlet of these branches.
e strategy that is followedmost oen is to estimate the ow split towards each
branch based on data from literature [88, 175, 176]. However, this method is not
mouse-specic and one therefore risks to impose ow conditions that - even if
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Figure 8.8: Lambda-2 isosurfaces (indicating the location of vortex cores) and velocity vector
proles shown at the aortic deceleration phase for the case with highest Cohen’s distance (AA5).
Top:e entire aorta is included into the geometrical model. Vortex cores are located at the arch
and in the curvature of the thoracic aorta and a skewed velocity prole enters the abdominal
aorta. Bottom: e geometrical model is restricted to the abdominal aorta. Vortex cores are
located near the side branches, at the same locations as when the entire aorta was included into
the aorta. A (measured) parabolic ow velocity waveform is imposed at the inlet of the model
but proximal to the rst branch (coeliac artery) the velocity prole is no longer dierent from
the one that is obtained when the entire aorta is included into the model.
they are representative for the average animal - do not match the specic ge-
ometry one is studying. Furthermore, literature data on these ow splits in the
murine aorta are scarce, usually based on a very limited number of measure-
ments and in almost all cases limited to a specic part of the aorta. In this chap-
ter, we therefore attempted to provide a reference dataset on the ow eld in the
mouse aorta. Volumetric ow waveforms towards the branches were measured
for 10 animals and the average ow fractions going to each branch (bold values
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in Table 8.1) are presented as a reference dataset that can be used in future stu-
dies, e.g. when it is impossible tomeasuremouse-specic boundary conditions.
8.4.2 Average ow fractions
Imposing the average ow fractions over all animals (bold values in Table 8.1) as
generic boundary conditions in the CFD simulations results in a much smaller
dierence of the hemodynamic parameters with the mouse-specic situation
than what could be expected from the dierences observed in the actual ow
splits (Table 8.1).e statistical (Figure 8.3A) and spatial distributions of TAWSS
(Figure 8.4, middle panels) and RRT (Figure 8.6, middle panels) are similar
for both BC schemes. However, the OSI distribution is dierent: the statistical
(Figure 8.3A, middle panel) as well as the spatial distribution (Figure 8.5, mid-
dle panels) show that OSI is much higher in the distal aorta when the measured
waveforms are imposed.is is probably caused by the fact that the ow is uni-
directional when ow ratios are imposed to the branches - also during diastole.
In the reference case, however, time-dependent ow velocity waveforms are im-
posed at all outlets, and the interaction between these dierent waveforms may
cause retrograde ow during diastole, thus causing higher OSI values. How-
ever, the numerical OSI values are still very low, as can be observed in the box
plots in Figure 8.2 A, which is why they only have a moderate eect on the RRT
distribution.
One might be tempted to conclude that - especially when one is interested
in the distribution of TAWSS and/or RRT - time-consuming measurements of
the actual ow waveforms towards the side branches are in fact not needed to
obtain realistic CFD results since one could simply use the ow fractions pre-
sented in Table 8.1. However, it is important to keep in mind that the presented
ow fractions represent a very homogeneous dataset, which is a subsample of
the actual mouse population. All animals are relatively old (34 ± 5 weeks), all
are male and have the same strain (C57Bl/6). Still, there is signicant variation
in the ow fractions between the dierent animals (which is reected by the
relatively high standard deviations in Table 8.1, e.g. for the mesenteric artery).
It is also important to keep in mind that ow splits taken from literature - as
the ones presented in this chapter - represent the average situation in normal,
healthy animals. During follow-up studies the animals usually develop cardio-
vascular disease such as an aneurysm or a stenosis, which might drastically al-
ter the blood ow, hereby also aecting the boundary conditions that need to
be applied in order to reect reality in the CFD simulations. Furthermore, it is
important to notice that in this study the time-dependent, mouse-specicmea-
sured blood velocity prole that was applied at the inlet was the same for all sets
of three paired simulations, thus what is studied here is solely the inuence of
outow boundary conditions.
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8.4.3 Flow fractions based on Murray’s law
Murray stated that the volumetric blood ow at a certain location is at all times
proportional to the third power of the radius of the blood vessel at that location,
commonly referred to as Murray’s law [185]. Much later, Kassab and Fung [258]
showed that - in stationary ow circumstances- scaling of the radius of blood
vessels is actually described by Murray’s law if one assumes that the shear force
at the inner wall of vessels should be maintained constant. is is an interest-
ing hypothesis since it is in line with the theory that shear force sensed by the
endothelial cells may trigger circumferential growth [259, 260], as was already
mentioned in chapter 5. Furthermore, if one has a realistic waveform to im-
pose at the inlet, Murray’s law allows us to compute ow fractions towards all
aortic branches using only geometrical information.e method can therefore
be very attractive in some circumstances, e.g. when mouse-specic boundary
conditions are not possible due to a lack of the necessary imaging techniques
or simply due to time and / or cost constraints.
Despite the fact that Murray’s law is oen used [179, 251, 252], this method
has not been validated with in vivo data in a murine setting. We therefore in-
vestigated to what extent the ow splits generated by Murray’s law compare to
the actual in vivo measured ow rates. Taking a closer look at the ow splits to
all side branches - as presented in Table 8.1 - we see that there are some remark-
able dierences between the measured ow splits and those based on Murray’s
law.e ow split towards the brachiocephalic trunk and the distal abdominal
aorta diers signicantly from the measurements when Murray’s law is used.
Moreover the error in the ow balance when using Murray’s law (before redis-
tribution) was 19 ± 6% (data not shown).ese discrepancies are also reected
in the outcome of the CFD results: since the distal aorta gets too much ow, it
experiences an articially high level of TAWSS that is not present when mea-
sured ow waveforms or average ow fractions are imposed (Figure 8.4). e
distal aorta in Murray’s law also experiences lower OSI than the reference case,
but this is probably due to the fact that fractions are imposed instead of actual
ow waveforms, since this is also the case when average ow fractions are im-
posed.
e validity of Murray’s law in the setting of the aorta has previously been
questioned. West et al. [261] extended the original theories of Kassab and Fung,
using allometric scaling laws to show that - in pulsatile ow circumstances - the
relation between ow and aortic diameter is dependent on theWomersley num-
berWo (equation 5.3).is was conrmed by in vivo shear stressmeasurements
performed by Reneman andHoeks [220], who claimed that the exponent in the
power law is likely varying along the arterial system from 2 in large arteries near
the heart to 3 in arterioles. Cheng et al. [219] conrmed this, claiming that the
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variation of WSS among dierent species was not in line with Murray’s third
power law. Interestingly, our data seem to conrm this hypothesis: changing
the exponent in Murray’s law from 3 to 2 yields much better results: not only
does the average dierence with the reference case drop to a value ≤ 5% in all
branches (including the distal aorta), the average error in the ow balance also
drops to only 3±2% (data not shown). We did not perform anyCFD simulations
imposing these adapted ow fractions, but since they are close to the average
fractions (e.g. the fraction going to the distal aorta is exactly the same in both
cases, see Table 8.1) we can reasonably assume that the outcome of the CFD
simulations would be similar as well. Our data therefore strongly suggest that
- in a murine setting - Murray’s law is a much better approximation of reality
when an exponential factor 2 is used.
On the other hand, it may be important to notice that the work of Cheng
et al. was challenged by Friedman [262] who stated that Murray’s law was only
meant to be applied within a single species (i.e. human). Painter et al. [263]
brought the discussion back to a theoretical level: they revisited some of the as-
sumptions made by West et al., and used an elegant set of mathematical equa-
tions to show that Murray’s law does represent a good estimation of reality in
pulsatile circumstances, yet only in conditions where the Womersley number
is smaller than α = 2.5. In a human setting, Painter et al.’s work implies that
Murray’s law is only applicable for smaller arteries. However, even though the
frequency (i.e. the heart rate) is generally 10 times higher in mice, the radius
of most murine arteries is about 10 times smaller than the human counterpart
while blood viscosity and density can be assumed to be similar. erefore the
Womersley number as computed in equation 5.3 is on average roughly 3 times
smaller in mice when compared to the human setting. In our dataset theWom-
ersley number is 3.32 ± 0.19 in the aortic arch but only 0.55 ± 0.22 in the the
thoracic aorta and 0.39± 0.04 in the distal abdominal aorta. Following Painter
et al.’s theory,Murray’s law should therefore be applicable throughout the entire
murine arterial tree, which is not consistent with our current ndings.
8.4.4 Geometrical restrictions
Apart from making assumptions with respect to the imposed boundary condi-
tions, most CFD studies on the murine aorta also restrict their geometry to the
part that is of interest for the study, e.g. the aortic arch [140, 175, 176, 178, 251]
or the abdominal aorta [88, 253]. is approach allows us to save computa-
tional time and restricts the number of assumptions that need to be made, but
it is unclear if and to what extent this simplication of the problem inuences
the calculated ow eld. In chapter 4 we showed that the murine aortic arch is
curved in a dierent way than the human aorta, reporting an out-of-plane an-
gle of 45 degrees between ascending and descending aorta.is was conrmed
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in the current data, in which we observe a signicant curvature of the thoracic
aorta that is not observed in a human setting (see e.g. Figures 8.4, 8.5 and 8.6).
Vincent et al. [179] recently showed that the curvature in the rabbit aortic
arch gives rise to Dean vortices in the arch. We therefore investigated whether
these vortices are also present in amurine setting and if yes, whether they inu-
ence the ow eld in the abdominal aorta. Our results clearly show that these
vortical structures also arise in the mouse aortic arch and in the curved tho-
racic aorta (Figure 8.8, top le panel). However, the inclusion of the proximal
aorta into the computational model does not seem to inuence the outcome of
the CFD simulations in the abdominal aorta. In both simulations (Figure 8.8,
top and bottom right panel), the vortices in the abdominal aorta are located at
the exact same location, except for some minor dierences near the inlet of the
(abdominal) model. Also, the statistical (Figure 8.3 B) and spatial (Figure 8.7)
distributions of all hemodynamic parameters are practically equal in both sim-
ulations, which is another indication that (in healthy mice) the ow eld in the
abdominal aorta is not inuenced by the ow eld in the proximal aorta. Fig-
ure 8.8 clearly indicates the reason why this is the case: the velocity proles in
both simulations are dierent at the inlet of the abdominal aorta (a skewed pro-
le enters the aorta when the entire aorta is included, while a parabolic prole
is imposed in the other case) but little more distal they already resemble each
other much better and just proximal to the coeliac artery they are practically
the same. Due to the low Reynolds number (mean Re = 59 ± 11 in the aortic
arch and 48± 7 in the thoracic aorta ) the entrance length of the velocity prole
is only around 3-4, i.e. when a at prole would be imposed it would take a
length of 4 times the diameter to reach fully developed ow. In our case, the
ow entering the abdominal aorta is not a at but a skewed parabolic prole,
which is why it takes even less time for the proles to become the same. It is,
however, important to notice that this observation is only valid for mice, as in
a human setting the Reynolds number as well as the entrance length would be
a factor 10 higher, and aortic arch inclusion would probably have an eect on
abdominal hemodynamics.
8.4.5 Methodological issues on the ow redistribution
It is important to take into account that the reported reference data were ob-
tained aer redistributing the error in the mass balance at the outlet, resulting
from the direct measurements, over all branches.e inuence of this redistri-
bution on the resulting waveforms is shown for 2 typical cases (AA2 and AA6)
in Figure 8.2.e redistribution aects the nal waveforms in two dierent as-
pects: their magnitude and their behavior over time.e dierence in magni-
tude betweenmeasured and redistributedwaveforms is caused by the dierence
between total measured out- and inux (e.g. total measured outux amounts
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to 74 % of total inux in AA2, but only 60 % in AA6).
Part of the error in the ow balance is caused by the fact that not all side
branches have been taken into account. Several smaller branches such as all
thoracic arteries, middle suprarenal arteries, inferior phrenic artery, gonadal
artery, and spinal branches were neglected since measuring ow velocities in
each of these arteries would be too time-consuming and they were too small
to be segmented with sucient accuracy. An additional error in ow magni-
tude is likely caused by the assumption that all velocity waveforms measured
using Pulsed Doppler represent the maximal velocity over time of a perfectly
parabolic velocity prole. Some measurements may, however, not have been
taken in the exact center of the artery and the actual velocity proles may in
some cases have been skewed due to local bending of the aorta (as indicated
in Figure 8.8), both of which would cause the measured velocity to be lower
than the actual one.e latter is especially true for side branches. In addition,
although we tried to take care of appropriate angle correction of the Doppler
measurements, errors in angle correction may also contribute to the observed
error. A nal source of error in volumetric ow magnitude may be in a mis-
match between local aortic areas (obtained frommicro-CT) and velocities (ob-
tained from ultrasound). Within this dissertation, the geometry obtained from
micro-CT is assumed to represent an average between the systolic and diastolic
state. In reality however, the aortic diameter changes over time, especially in
the proximal part of the aorta, as it is most elastic. Moreover, the local diameter
also changes along the centerline due to tapering, which can also cause a mis-
match between the used aortic cross-sectional area and velocity. Once again,
the latter error is most likely to occur in the proximal part of the aorta, as this
is also the part with the largest aortic cross-sectional area.
In some cases there is also a small dierence in behavior over time be-
tween measured and redistributed waveforms. In the abdominal redistribution
of AA2 (Figure 8.2, top right panel) the moment of maximal velocity in the
distal aorta and mesenteric artery shis to the right upon redistribution. In
AA6 (Figure 8.2, bottom panels) this time shi is not present. e underlying
reason lies in the fact that the actual aorta has a buer capacity allowing it to
distend over time, which results in a time lag between distal and proximal ve-
locity measurements. However, since our present CFD simulations have rigid
walls the total mass balance needs to be correct at all timepoints, so the time
lag was removed (as described in the methods section). A small residual eect
of this correction inuences the redistribution scheme in some cases: the shape
of the most distal waveforms may be altered if their peak value does not concur
with the peak in the error waveform, which is the case in AA2.
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8.5 Conclusions
In this chapter we present a reference data set of ow fractions going to 7 major
side branches in the mouse aorta, based on in vivo measurements in 10 male
ApoE −/− mice. Furthermore, we have assessed the inuence of dierent as-
sumptions that are oen made in literature when performing CFD simulations
in the mouse aorta. We found that imposing the presented average ow frac-
tions as boundary conditions - instead of the measured, mouse-specic ow
velocity waveforms - does not inuence the outcome of TAWSS and RRT dis-
tributions signicantly, whileOSI distribution can be slightly dierent.e pre-
sented dataset can therefore be used in future studies, keeping in mind that it
represents a subsample of the total population, i.e. relatively old, non-diseased,
male C57Bl/6 mice. We also found that some ow fractions calculated using
Murray’s law (brachiocephalic trunk, distal abdominal aorta) dier signicantly
from the measured ones, inuencing the outcome of the CFD results signi-
cantly. Changing the exponential factor in Murray’s law from 3 to 2 (as sug-
gested by several authors in literature) yields results that correspond much bet-
ter to the measured ow fractions. Finally, we found that - even if the remark-
able curvature in the aortic arch and thoracic aorta gives rise to local vortical
structures - their eect on the abdominal hemodynamics is negligible and they
should therefore not be incorporated into themodel when one is only interested
in the abdominal part.
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Table 8.1: Basal data, diameters and ow fractions going to each branch for the dierent BC
outow schemes. Diameters are reported at the location of the ultrasound measurement, and
not at the border of the geometrical model. Measured volumetric ow waveforms were rst
averaged over a cardiac cycle and for each outlet the (redistributed) fraction relative to the inlet
ow is indicated in the table in terms of percentage. CFD simulations were performed using (i)
fractions calculated by Murray’s law using exponential factor 3 and (ii) mean fractions over all
10 animals (indicated in bold). CFD simulations for the measured case were performed using
mouse-specic waveforms and not by imposing a fraction of the inow.
AA1 AA2 AA3 AA4 AA5 AA6 AA7 AA8 AA9 AA10 Mean Stdev
Basal data
HR (bpm) 467 417 367 430 400 382 368 378 407 377 399 32
Age(weeks) 37 37 37 37 37 37 37 27 27 27 34 5
BW (g) 31.2 30.2 29.5 30.8 29.8 28.7 30.6 27.8 29.0 30.1 29.8 1.0
Brachiocephalic trunk
Diameter (mm) 0.64 0.72 0.60 0.60 0.44 0.70 0.67 0.68 0.67 0.66 0.64 0.08
Measured (%) 22.8 32.3 27.9 21.3 13.8 25.2 21.2 18.2 23.2 19.3 22.5 5.2
Murray’s law 3 (%) 11.7 16.8 11.6 11.4 7.0 15.3 15.5 14.6 14.4 15.3 13.4 2.9
Murray’s law 2 (%) 19.3 25.7 19.5 19.7 12.5 23.8 22.6 21.4 23.2 23.7 21.1 3.7
Le common carotid artery
Diameter (mm) 0.58 0.50 0.42 0.41 0.42 0.54 0.47 0.47 0.50 0.32 0.46 0.07
Measured (%) 17.4 11.3 10.6 12.1 10.8 12.3 10.0 9.0 12.0 6.5 11.2 2.8
Murray’s law 3 (%) 13.7 11.1 8.4 8.5 8.0 12.1 10.9 11.6 10.8 7.0 10.2 2.1
Murray’s law 2 (%) 19.4 15.7 13.6 13.8 13.1 17.0 15.2 16.3 15.8 11.5 15.1 2.2
Le subclavian artery
Diameter (mm) 0.45 0.55 0.30 0.51 0.38 0.60 0.36 0.53 0.51 0.41 0.46 0.10
Measured (%) 13.5 12.4 9.6 15.0 9.8 13.7 7.6 10.2 12.4 9.0 11.3 2.4
Murray’s law 3 (%) 10.8 15.6 7.1 14.5 10.5 15.3 9.5 15.7 13.9 11.0 12.4 3.0
Murray’s law 2 (%) 13.7 17.3 11.0 17.7 15.1 17.2 12.5 17.8 16.3 14.4 15.3 2.4
Celiac artery
Diameter (mm) 0.21 0.11 0.34 0.13 0.35 0.22 0.16 0.14 0.20 0.12 0.20 0.09
Measured (%) 4.6 3.1 13.6 4.1 9.4 7.3 7.2 7.7 8.8 7.5 7.3 3.0
Murray’s law 3 (%) 4.2 2.8 14.5 2.6 10.6 7.5 5.6 4.9 7.1 3.7 6.3 3.8
Murray’s law 2 (%) 7.0 4.2 16.4 5.1 14.1 8.8 7.5 6.4 8.2 5.0 8.3 4.0
Mesenteric artery
Diameter (mm) 0.36 0.28 0.28 0.35 0.51 0.26 0.40 0.28 0.32 0.30 0.33 0.08
Measured (%) 15.6 12.0 11.3 18.2 29.7 15.2 25.9 17.9 16.2 21.1 18.3 5.8
Murray’s law 3 (%) 11.5 11.6 10.3 14.1 25.4 13.0 23.9 12.5 16.0 13.7 15.2 5.2
Murray’s law 2 (%) 12.1 11.2 10.2 14.4 21.8 11.4 20.0 11.6 13.5 13.0 13.9 3.9
Right renal artery
Diameter (mm) 0.25 0.20 0.25 0.22 0.33 0.23 0.20 0.14 0.19 0.14 0.22 0.06
Measured (%) 7.0 7.4 9.5 9.2 6.8 7.9 8.7 8.9 8.8 8.8 8.3 1.0
Murray’s law 3 (%) 5.5 6.5 7.9 5.6 9.6 9.3 7.3 4.5 6.8 5.0 6.8 1.7
Murray’s law 2 (%) 5.7 6.0 6.9 6.0 7.7 7.0 6.1 4.4 5.6 5.1 6.0 1.0
Le renal artery
Diameter (mm) 0.22 0.12 0.22 0.15 0.18 0.21 0.10 0.14 0.14 0.17 0.17 0.04
Measured (%) 5.1 7.0 6.9 6.2 5.4 6.5 4.7 9.5 5.3 5.7 6.2 1.4
Murray’s law 3 (%) 9.4 4.1 9.5 6.8 6.4 7.4 4.2 7.0 6.0 7.9 6.9 1.8
Murray’s law 2 (%) 6.9 3.8 6.8 5.7 4.6 4.8 3.7 5.9 4.6 6.7 5.4 1.2
Distal abdominal aorta
Diameter (mm) 0.51 0.51 0.50 0.46 0.43 0.43 0.3 0.39 0.39 0.52 0.45 0.06
Measured (%) 13.9 14.4 10.5 13.9 14.3 12.0 14.8 18.6 13.4 22.1 14.8 3.3
Murray’s law 3 (%) 33.3 31.5 30.7 36.5 22.5 20.3 23.1 29.3 25.0 36.3 28.9 5.8
Murray’s law 2 (%) 16.0 16.1 15.5 17.5 11.1 9.9 12.5 16.3 12.8 20.6 14.8 3.2
oracic aorta
Diameter (mm) 1.56 1.32 1.51 1.42 1.49 1.45 1.40 1.31 1.41 1.44 1.43 0.08
Measured (%) 46.3 43.9 51.9 51.7 65.6 48.9 61.2 62.6 52.5 65.2 55.0 8.0
Murray’s law 3 (%) 63.9 56.5 72.9 65.6 74.5 57.3 64.1 58.2 60.9 66.6 64.1 6.2
Murray’s law2 (%) 47.6 41.3 55.9 48.7 59.3 42.0 49.7 44.5 44.8 50.4 48.4 5.8
HR=Heart Rate, bpm=beats per minute, BW=Body Weight, g=gram, stdev=standard deviation.
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Table 8.2: Cohen’s distance comparing the statistical dierence in the distribution of TAWSS,
OSI and RRT in all simulated cases.e top 3 sections show the Cohen’s distance comparing the
outcome of CFD simulations whenmeasured outow velocity waveforms are imposed, when the
average ow ratios over all 10 animals are imposed, andwhenMurray’s law (using an exponential
factor 3) is used to determine the outow ratios towards the branches.e bottom section shows
the Cohen’s distance comparing the outcome of CFD simulations when the geometrical model
is restricted to the abdominal aorta to the outcome of simulations in which the entire aorta was
included into the model (but only the abdominal part was used in the comparison).
AA1 AA2 AA3 AA4 AA5 AA6 AA7 AA8 AA9 AA10 Mean Stdev
Cohen’s distance Murray vs Measured
TAWSS 0.301 0.409 0.335 0.353 -0.174 0.098 0.092 -0.066 -0.237 0.103 0.123 0.228
OSI -0.174 -0.385 -0.646 -0.448 -0.583 -0.590 -0.403 -0.269 -0.638 -0.359 -0.460 0.161
RRT -0.280 -0.376 -0.370 -0.299 0.077 -0.339 -0.116 0.002 0.243 -0.112 -0.162 0.212
Cohen’s distance Average vs Measured
TAWSS 0.226 0.238 0.032 0.055 -0.215 0.073 -0.113 -0.094 -0.372 -0.240 0.019 0.201
OSI -0.150 -0.439 -0.644 -0.428 -0.566 -0.563 -0.361 -0.221 -0.618 -0.305 -0.443 0.170
RRT -0.192 -0.281 -0.144 -0.092 0.216 -0.209 0.088 0.121 0.521 0.381 0.003 0.270
Cohen’s distance Average vs Murray
TAWSS -0.028 -0.260 -0.281 -0.303 -0.066 -0.010 -0.213 -0.043 -0.157 -0.344 -0.151 0.126
OSI 0.022 -0.024 0.020 0.042 0.022 0.035 0.037 0.038 0.039 0.061 0.026 0.022
RRT 0.082 0.186 0.264 0.223 0.142 0.127 0.204 0.120 0.271 -0.047 0.180 0.095
Cohen’s distance Abdominal vs Entire aorta
TAWSS -0.005 0.005 -0.017 -0.012 -0.056 0.003 -0.021 -0.014 -0.030 -0.038 -0.016 0.019
OSI -0.089 -0.031 -0.001 -0.023 0.025 -0.051 -0.016 0.005 0.006 0.002 -0.019 0.033
RRT 0.005 -0.005 0.037 0.056 0.095 -0.041 0.063 0.034 0.058 0.086 0.034 0.042
stdev=standard deviation.
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Location and evolution of aortic
aneurysm: the role of disturbed
hemodynamics
9.1 Introduction
Aortic aneurysm, a focal dilatation of the aortic diameter larger than 1.5 times
the original size [264], is a complex cardiovascular disease. Aneurysm rupture
causes 1-2 % of all deaths in the industrial world [11]. Current therapy is re-
stricted to surgery or endovascular treatment due to a lack of eectivemedicinal
approaches, which in turn is caused by a lack of knowledge on its initial patho-
physiology [10, 37, 265]. Although aortic aneurysm can occur throughout the
entire aorta there is a predisposition for vascular sites such as the ascending and
the abdominal aorta [61]. However, etiology, natural history, and treatment are
dierent for both kinds of aortic aneurysms [243]. In order to provide mecha-
nistic insight into the initiating and propagating factors, several mouse models
have been developed. For example, abdominal aortic aneurysms (AAAs) have
been induced by calcium chloride [110], elastase [108] or angiotensin II [111] and
ascending aortic aneurysms have been observed in genetically modied mice
that are hypomorphic for brillin-1 [213, 266], a mouse model of Marfan syn-
drome [64].
Recent work revealed that one of the most commonly used mouse models
of AAA, in which ApoE −/− mice are infused with angiotensin II [111], showed
to develop aneurysm of the ascending aorta as well [112]. is model is thus
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one of the fewmodels in literature known to develop aneurysms at two entirely
dierent locations in the arterial tree. As the ascending aortic aneurysm forma-
tion went unnoticed for a long time, histological [124] as well as observational
ultrasonographic [181], biomechanical [183, 184] and hemodynamic (e.g. chap-
ter 8) studies all have investigated the initial disease stages in this mouse model
focusing on the abdominal aorta. e exact working mechanisms of neither
abdominal nor ascending aortic aneurysm formation in this mouse model are
fully understood. While low andoscillatory values of hemodynamic shear stress
(the viscous stress exerted by the blood on the endothelial cells) are known to
be an important factor in the pathogenesis of atherosclerosis [217, 267], the role
of disturbed shear stress in the initial phase of aneurysm formation is still de-
bated [37, 268].
We assessed the potential of several new emerging imaging and computa-
tional biomechanics techniques to predict the location of the aneurysm before
it is actually present. is was studied in ten angiotensin II - infused ApoE−/− mice. Several time points were investigated in the complete aorta, which
allowed us to evaluate aneurysm development over time and compare abdom-
inal with ascending aortic aneurysm formation. We computed the ow eld at
baseline (before aneurysm induction) using CFD simulations based onmouse-
specic measurements (including in vivo micro-CT and pulsed Doppler blood
velocities). Predictions based on these CFD simulations as well as in vivo mo-
lecular imaging techniques (Positron Emission Tomography (PET), measured
at days 7 and 14 aer aneurysm induction) were compared to intermediate and
end-stage disease stadia.e latter were characterized by ultrasound imaging,
in vivo micro-CT and post mortem histological tissue inspection. Due to the
relatively low number of imaged animals the present work should be consid-
ered as a proof of concept, in which the usefulness of several in vivo techniques
for aneurysm prediction in mice was tested.
9.2 Methods
9.2.1 Mice
Ten in-house bred male ApoE −/− mice on a C57Bl/6 background were used
in this study. All mice were implanted an osmotic pump (model Alzet 2004;
Durect Corp, Cupertino, CA), lled with angiotensin II (Bachem, Bubendorf,
Switzerland). Pumps were implanted subcutaneously on the right ank via an
incision in the scapular region. To avoid interference with the micro-CT im-
ages, the metal ow divider inside the pump was replaced by a PEEK alterna-
tive (Durect Corp, Cupertino, CA) as previously described in chapter 7. Each
pump released its content over a period of 28 days, at an infusion rate of 1000 ng
kg−1 min−1. Mice were housed in separate cages, water and regular mouse diet
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were available ad libitum and they were observed daily aer the implantation
of pumps. All experiments were in accordance with EC guidelines for animal
research and were approved by the animal ethics committee of the Ghent Uni-
versity.
9.2.2 In vivo imaging
e animals were imaged before pump implantation (day 0, n=10) and at days
2 (n=4), 7 (n=4), 14 (n=6) and 49 (n=5).ree animals (AA3 and AA5 at day 2,
AA1 at day 14, all from the same litter) did not wake up from anesthesia in the
initial week of the experiment, and no further datasets were obtained in these
animals. One animal (AA4) died in its cage at day 17. Detailed procedures for
micro-CT and ultrasound imaging and post-processing were the same as in
chapters 7 and 8. Briey, the mice were anesthetized with 1.5% isourane and,
once anesthetized, injected intravenously in the lateral tail vein with 150 micro-
liter/25 grambodyweight of Aurovist (Nanoprobes, Yaphank, NY).e animals
were subsequently scanned in supine position in a GE FLEX Triumph CT scan-
ner (Gamma Medica-Ideas, Northridge, CA, USA). Several animals were not
scanned at intermediate timepoints for ethical reasons, as their lateral tail vein
did not tolerate the high number of contrast agent injections. Ultrasound data
were obtained in all (surviving) animals at all timepoints with a high-frequency
ultrasound apparatus (Vevo 2100, VisualSonics, Toronto, Canada) and Pulsed
Doppler was used to assess ow velocities at ascending and distal abdominal
aorta, in 7 additional locations throughout the descending and abdominal aorta
as well as in the 7 major side branches (brachiocephalic trunk, le common
carotid, le subclavian, celiac, mesenteric, right and le renal arteries). All ul-
trasound measurements were performed by a single operator.
9.2.3 Molecular imaging
At days 7 and 14, those animals that tolerated the increased load on the lateral
tail vein (AA2, AA7, AA9 and AA10) were injected with a cocktail of 150 micro-
liter/25 gram body weight of Aurovist (micro-CT contrast agent) and 0.5 mCi
18F-FDG (PET tracer). A PET scan was taken 40 minutes aer injection on
the same GE FLEX Triumph scanner (Gamma Medica-Ideas, Northridge, CA,
USA) that was used for the micro-CT images.e aorta was subdivided into 4
dierent zones (see data analysis). For each zone a volume of interest (VOI) was
dened and the average number of PET counts in that VOI was normalized by
the average number of counts in the liver and the amount of injected activity.
9.2.4 Histology
At the end of the study, aortas were isolated, xated in 4% formaldehyde (pH
7.4) for 24 hours, dehydrated overnight and embedded in paran. Serial cross
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sections (5 µm) were prepared for histological analysis. Morphologic appear-
ance of the aorta was evaluated on orcein stained slides collected serially from
the proximal to the distal aorta (every 2.5 mm).
9.2.5 Assessment of disturbed ow via CFD
All numerical simulations of the ow eld were performed with Fluent 12.0
(Ansys, Canonsburg, PA). Blood density was taken to be 1060 kg/m3 and blood
viscosity was assumed constant (3.5 mPas) [140]. Reconstructed micro-CT im-
ageswere converted intoDICOMstandard format, and semi-automatically seg-
mented into a 3D model of the complete aorta using Mimics (Materialise, Leu-
ven, Belgium). PyFormex was then used to create a structured and conformal
fully hexahedral mesh [254], typically consisting of about 1,000,000 cells and
1,100,000 nodes, dening the geometry in the CFD simulations. Doppler ow
velocity spectra were post-processed inMatlab (Mathworks, Natick, MA) using
the methodology described in chapter 7, providing a set of mouse-specic ow
velocity waveforms that can be imposed as boundary conditions in the CFD
simulation. One ow velocity waveform (the ascending aorta) was imposed at
the inlet, and seven ow velocity waveforms were imposed at the side branches.
e output of CFD simulations was post-processed in both Paraview and Tec-
plot (Tecplot inc, Bellevue, WA).e degree of disturbed ow along the aorta
was quantied by the Relative Residence Time (RRT, see section 2.1.3), an indi-
cator for low and oscillatory wall shear stress.
9.2.6 Data analysis
e location of the aneurysm was quantied as described in chapter 7, using
the Vascular Modeling ToolKit (VMTK) to project the intermediate and end
stage geometries onto the baseline geometry and to compute a distance map
between both. High distance values can then be used to identify the (at that
stage yet to be developed) aneurysm location on the baseline geometry. For
the global data analysis the aorta of each animal was divided into 4 zones: as-
cending aorta, thoracic aorta, proximal abdominal aorta and distal abdominal
aorta. e transition point between dierent zones was determined in an au-
tomated way, using the bifurcations of side branches (brachiocephalic trunk,
celiac artery and mesenteric artery respectively) as landmarks. Box plots were
used to compare the distribution of RRT, PET and distance metrics over each
zone. For one specic case the baseline geometry was divided into a structured
set of patches, to study the relationship between local RRT and distancemetrics
both qualitatively (via a color map) and quantitatively (via a scatter plot).
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Figure 9.1: Detailed hemodynamics in the aortic arch and abdominal aorta of AA7. A. Baseline
RRT in the aortic arch shows a relatively large zone of increased RRT in the ascending aorta, and
focal spots of increased RRT near the bifurcations of le common carotid and le subclavian
arteries. B. Baseline RRT in the abdominal aorta shows a focal spot of increased RRT near the
trifurcation of mesenteric and right renal artery. C. Streamlines in the aortic arch for dierent
time points throughout the cardiac cycle. At systole, ow is very organized. At (late) systolic
deceleration, secondary ow patterns occur in the ascending aorta, the inner part of the arch
and near bifurcations. D. Streamlines in the abdominal aorta. Streamlines are very organized
throughout the cardiac cycle, and only a limited amount of secondary ow occurs near bi-and
trifurcations during (late) systolic deceleration.
9.3 Results
9.3.1 Natural history
An overview of the scanned time points and the observed aneurysms for all
animals is given in Table 9.1. Of the 6 animals surviving the complete proce-
dure, 2 animals did not develop any aneurysm (AA6 and AA10), 1 animal only
developed an ascending aortic aneurysm (AA2), and 3 animals developed both
ascending and abdominal aortic aneurysms (AA7, AA8 and AA9).
9.3.2 Hemodynamics and aneurysm location
Detailed baseline owpatterns in the ascending and abdominal aorta ofAA7, an
animal that developed both ascending and abdominal aneurysm at a later stage,
are shown in Figure 9.1. RRTwas increased in the ascending aorta (panelA), but
not as much in the abdominal aorta (panel B). While secondary ow occurred
in the proximal part of the ascending aorta and the inner curvature of the aor-
tic arch (panel C, particularly during systolic deceleration), the streamlines in
the abdominal aorta were much better organized throughout the cardiac cycle
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Table 9.1: Scanned time points and end stage aneurysm location in all animals.
AA1 AA2 AA3 AA4 AA5 AA6 AA7 AA8 AA9 AA10
Micro-CT scan at baseline + + + + + + + + + +
Micro-CT scan at day 2 + + x + x + - + + -
Micro-CT scan at day 7 - + + - + - + +
PET scan at day 7 - + + - + - + +
Micro-CT scan at day 14 x + - - + - + +
PET scan at day 14 + - - + - + +
Micro-CT scan at day 49 + x + + + + +
Ascending aneurysm at day 49 + - + + + -
Abdominal aneurysm at day 49 - - + - + -
x: animal had died before or during the scan, + : scan obtained / aneurysm observed,
- : no scan obtained / no aneurysm observed.
Figure 9.2:e relationship between baseline hemodynamics and aneurysm evolution in AA7.
A. Baseline RRT distribution over the entire aorta. B. e baseline surface is divided into a
structured set of patches. For each patch, the average baseline RRT is computed and plotted. C.
Morphological evolution of the aorta at 3 dierent time points. D. Each intermediate or end-
stage geometry is projected onto the baseline geometry. A distance map indicating the local
dierence between both geometries is computed in all nodes of the baseline geometry. High
distance values to identify aneurysm location (at a later time point) on the baseline geometry.
e baseline surface is then divided into the same structured set of patches as in panel B. For
each patch, the average distance is computed and plotted. E. Scatter plots relate the baseline RRT
to the distance metric at each time point. Each data point represents 1 patch (as calculated in
panels B and D).e scatter plots indicate that within the ascending aorta, patches with most
disturbed baseline ow do not necessarily develop into the most dilated part of the aneurysm.
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Figure 9.3: Box plots showing the distribution along the aorta of baseline RRT and end-stage
distance.e data were pooled into two dierent groups: animals that developed both ascending
and abdominal aneurysm (n=3) and animals that did not develop any aneurysm (n=2). All box
plots are colored according to their aortic zone, as indicated in the legend on top: red=ascending
aorta, dark blue= thoracic aorta, pink=proximal abdominal aorta, light blue=distal abdominal
aorta. A. Ascending aortic RRT is elevated in all animals, also for those not developing aortic
aneurysm. B. Distance to day 49 is elevated in the ascending and abdominal aorta for animals
that developed aortic aneurysm.
(panel D). Disturbed ow in the abdominal aorta was present but was localized
at a focal spot near the trifurcation of mesenteric and right renal artery (panel
B). Such focal spots also existed near bifurcations in the aortic arch (panel A).
In Figure 9.2 these hemodynamic results are linked to aneurysm growth in
the same animal, at dierent time points. e scatter plots in Figure 9.2 E re-
late the RRT at baseline to the distance metric that quanties aortic dilatation,
for each intermediate or end-stage time point and in each aortic zone. Baseline
RRT was clearly highest in the ascending aorta (colored in red), which was also
the zone in which aortic aneurysm developed. Baseline RRT in the abdominal
patches (colored in pink) was, however, not elevated.
Figure 9.3 extends these ndings to the other animals. Panel A shows the
box plots of baseline RRT distribution for each aortic zone while panel B shows
the end-stage distances.e data were pooled for aneurysmatic (in both the as-
cending and abdominal aorta) and non-aneurysmatic animals. RRT was con-
sistently highest in the ascending aorta (red boxes), which was also the zone
where an aneurysm develops. However, ascending aortic baseline RRTwas also
elevated in animals not developing an ascending aortic aneurysm, and in all an-
imals that died at an early stage of the experiment (data not shown). Baseline
RRT in the proximal abdominal aorta (pink boxes) was not dierent from other
zones. Nevertheless, abdominal aortic aneurysm was observed in 3 animals at
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end-stage (AA7, AA8 and AA9).
9.3.3 Hemodynamics and aneurysm evolution
From a longitudinal point of view, the scatter plots in Figure 9.2 E contain more
detailed information than the box plots in Figure 9.3. Despite the fact that
baseline RRT was generally increased in ascending aortic patches (colored in
red), those patches in which RRTwas the highest were not necessarily the same
patches in which the nal distance (i.e. the distance to the geometry at day 49)
was the largest. In other words, within an aneurysmatic zone local baseline RRT
was not predictive for the local amount of end-stage diameter increase.
Intermediate scans were obtained to investigate a potential change of hemo-
Figure 9.4: Qualitative evolution of RRT over time in the initial week aer angiotensin II-
infusion. AA2 developed only ascending aortic aneurysm, AA9 developed both ascending and
abdominal aortic aneurysm, and AA6 and AA10 did not develop any aneurysm. In all animals,
ascending aortic RRT increases from baseline (A) to days 2 (B) and 7 (C). Abdominal aortic RRT
is not generally elevated but increases at some focal spots (see Figure 9.1). Available intermediate
data are limited as not all animals could be scanned at all timepoints.
dynamics in the initial days aer angiotensin II infusion, and to assess whether
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hemodynamics may play a role in the initial remodeling phase of the aneu-
rysm. In those aneurysmatic animals in which scans were taken at both day 2
and 7 (AA2 and AA9), RRT increased over time (Figure 9.4).is was the case
in the ascending aorta (where RRT is the highest) but also in the descending
and abdominal aorta. However, an overall increase in RRT over time was also
observed in non-aneurysmatic animals that were scanned at one intermediate
time point (AA6 and AA10).
Doppler measurements at intermediate time points revealed that ascending
Figure 9.5: Ascending aortic ow velocities at dierent time points. In animals that don’t de-
velop ascending aortic aneurysm (such as AA6), no diastolic backow occurs at any time point.
In animals that do develop ascending aortic aneurysm (such as AA9), diastolic backow occurs
from day 7 on, and is increasingly severe at later time points. e shown waveforms are repre-
sentative for all animals in both groups.
aortic aneurysm formation was associated with aortic valve insuciency. All
animals that developed an ascending aortic aneurysm (AA2, AA7, AA8, AA9)
185
9. The role of hemodynamics in aortic aneurysm formation
showed diastolic backow in their ascending aorta fromday 7 on, in various de-
grees of severity. Animals not developing an ascending aortic aneurysm (AA6
and AA10) did not show any diastolic backow. Representative examples for
both cases are shown in Figure 9.5.
9.3.4 PET and aneurysm formation
Figure 9.6: PET imaging 7 and 14 days aer angiotensin II-infusion in 4 animals. Histograms
are colored according to their volume of interest (VOI). VOIs are dened in the same aortic zones
as for the hemodynamic analysis in Figure 9.3, as indicated in the legend on top: red=ascending
aorta, dark blue= thoracic aorta, pink=proximal abdominal aorta, light blue=distal abdominal
aorta. 18F−FDG uptake is quantied as the average number of counts in theVOI, andnormalized
by the average number of counts in the liver and the amount of injected activity. A. PET does not
predict aneurysm formation at day 7.ere is no dierence between animals that later on develop
aortic aneurysmand animals that don’t. B. PET conrms aneurysmpresence at day 14. 18F−FDG
uptake is markedly increased in the ascending aorta for those animals developing ascending
aortic aneurysm (AA2, AA7 and AA9) and in the abdominal aorta for those animals developing
AAA (AA7 and AA9). In these animals, 18F-FDG uptake is also increased in neighboring zones.
In animals that don’t develop aortic aneurysm (AA10 and the abdominal part of AA2) no such
increased uptake was found.
Figure 9.6 shows the results of a preliminary PET study that was conducted
in 4 animals at 2 dierent timepoints. At day 14, an increased ascending aor-
tic 18F-FDG uptake is found in all animals developing ascending aortic aneu-
rysm (AA2: +25% , AA7: +136% and AA9: +93%) while no such increase could
be detected in the only scanned animal not developing ascending aortic aneu-
rysm (AA10: -33%). In the abdominal aorta the same holds: aneurysmatic ani-
mals show an increased 18F-FDG uptake (AA7: + 90% and AA9: + 110%) while
non-aneurysmatic animals do not (AA2: -9%, AA10: -1%). In all aneurysmatic
animals, the increase in 18F-FDG uptake is not restricted to the aneurysmatic
zone, but is also found in neighboring thoracic (AA2:+17%, AA7: +135%, AA9:
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+216%) or distal aortic zones (AA7: +58%, AA9: +57%). PET does, however,
not have a prognostic value at day 7.e ascending aortic 18F-FDG uptake (red
histograms in Figure 9.6 A) at day 7 is slightly elevated in AA2 but not in AA7,
AA9 and AA10.e abdominal 18F-FDG uptake (pink histograms in Figure 9.6
A) at day 7 is similar for all 4 imaged animals.
9.3.5 Ascending versus abdominal aneurysm
Figure 9.7: Box plots showing the dierent evolution over time of ascending and abdominal
aortic aneurysm based on distance maps from micro-CT images. AA7: the ascending aortic
aneurysm grows gradually over time while the abdominal aortic aneurysm appears in between
scan times. AA9: the ascending aortic aneurysm grows gradually over time while the abdominal
aortic aneurysm cannot be deduced from micro-CT images.
Box plots in Figure 9.7 show the local distance evolution in two animals
developing aortic aneurysm in both the ascending and the abdominal aorta.
e ascending aortic aneurysm gradually increased in size, while the abdom-
inal aneurysm either appeared in between scan times at day 14 (AA7) or was
not associated with an increased lumen diameter at all (AA9). is dierence
between both aneurysm types is further elucidated in the histological stain-
ings in Figure 9.8. A clear dierence in the morphological appearance of the
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Figure 9.8: Histological orcein stainings and segmented micro-CT geometries in the ascending
aorta (le panels) and abdominal (right panels) aorta. A. AA6: In animals that do not develop
aortic aneurysm, no lumen dilatation is observed and the media is clearly delineated. B. AA7.
e ascending aortic aneurysm shows a dilated aortic lumen. In the abdominal aorta, a false
lumen appears and extensive wall remodeling occurs C. AA9. e ascending aortic aneurysm
shows a dilated aortic lumen. In the abdominal aorta, wall remodeling occurs but the aortic
lumen is not aected.
vessel wall can be observed between aneurysmatic and non-aneurysmatic an-
imals, and between the ascending and abdominal aneurysmatic wall. In non-
aneurysmatic animals, the aortic lumen was not enlarged and the outer wall
was clearly delineated in both the ascending and the abdominal aorta. In the
ascending aneurysms, histological stainings revealed a good qualitative agree-
ment with reconstructed micro-CT (lumen) geometries: an enlarged (lumen)
vessel diameter could be observed in both. In aneurysms the medial thickness
was slightly higher: 100 µm inAA7 and 175 µm inAA9, but only 65 µm inAA6.
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In the abdominal aneurysms, the dierence between the reconstructed micro-
CT (lumen) geometry and histological stainings wasmore prominent. In AA7 a
false lumen appeared, which was also detected on reconstructed micro-CT ge-
ometries, and the aneurysm was associated with extensive aortic wall remod-
eling. For example, at the level of the mesenteric artery (the lowest of three
abdominal stainings shown for each panel in Figure 9.8) an outer wall circum-
ference of 8370 µm was measured, compared to 1125 µm at the same level in
AA6. In AA9 wall remodeling also occurred, but as already indicated in Figure
9.7 the aortic lumen diameter was not aected as much by the aneurysm. For
example, proximal to the celiac artery (the highest of three abdominal stainings
shown for each panel in Figure 9.8) a lumen circumference of 1780 µm and an
outer wall circumference of 4100 µm were measured, compared to values of
1695 µm (lumen) and 1750 µm (outer wall) at the same level in AA6.
9.4 Discussion
9.4.1 Ascending versus abdominal aortic aneurysm
is is the rst study in which the initial stages of ascending as well as abdom-
inal aortic aneurysms are followed up closely within the same animal model.
Our data suggest that a dierent mechanism is driving both aneurysm types.
e potential initiating hemodynamic factors are already dierent at baseline:
ascending aortic aneurysms develop at the region experiencing highest baseline
RRT whereas AAAs do not. Furthermore, the ascending aortic aneurysm is as-
sociated with aortic valve insuciency at later time points (Figure 9.5), whereas
no backow is detected in the abdominal aorta (data not shown). Moreover
the increase in lumen diameter over time detected on micro-CT images and
the aortic wall properties observed from histological stainings are dierent at
both locations. ese ndings are consistent with the observations of Daugh-
erty et al [112], who described ‘highly contrasting pathologies’ between both
aneurysm types in the angiotensin II-infused model.ey reported that while
AAAs are caused by a highly localized transmural elastin disruption combined
with a highly focal medial macrophage accumulation, their ascending aortic
counterparts exhibit extensive (non-transmural) elastin fragmentation, com-
bined with (non-focal) macrophage accumulation throughout the medial lay-
ers.
Interestingly, dierences between ascending and abdominal aneurysmhave
also been reported in a human setting. For example, thrombus formation oc-
curs in abdominal but not in ascending aneurysms in human patients [10, 70,
269], and smoking and atherosclerotic plaque are correlated with dilatation of
the thoracic aorta starting from the arch, but not of the ascending aorta [37].
On the other hand, we observed that 18F-FDG uptake is increased at day 14
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in both aneurysmatic zones, indicating that inammation is likely involved in
ascending as well as abdominal aneurysm formation.
9.4.2 Hemodynamics and aneurysm location
Many dierent hypotheses have been postulated to clarify the predisposition of
aneurysm development to a limited number of vascular sites (see section 1.2.4),
but a particularly interesting hypothesis focuses on the role that (disturbed) lo-
cal hemodynamics might play [126, 147, 150, 165, 168, 169, 268, 270]. Anecdotal
evidence exists for a relationship between disturbed ow and AAA formation
in patients with spinal cord injury [86, 87] and patients with one amputated
leg [85].is has given rise to the theory that biomechanical factors related to
the forces induced by the blood ow on the endothelium (low shear stress lev-
els and/or oscillatory blood ow patterns) interplay with vascular biology, thus
creating aneurysm-prone regions analogous to what has already been shown to
be true for atherosclerotic lesions [60, 141].
For the ascending aorta our data seem to support a relationship between
low and oscillatory shear levels (reected by high RRT) and aneurysm forma-
tion. ere is, however, no dierence in baseline RRT between animals that
develop an ascending aortic aneurysm and animals that don’t. Yet, recent stu-
dies have shown that if these mice are fed on a Western-type diet to promote
a hypercholesterolaemic state, the incidence rate goes up to nearly 100 % [112],
indicating that all male ApoE −/− mice will eventually develop ascending aor-
tic aneurysm if certain conditions (angiotension II infusion,Western-type diet)
are fullled. Keeping this - and the limitations mentioned in section 9.4.5 - in
mind, our data suggest that high baseline RRT might be an early indicator for
aneurysm location, rather than aneurysm incidence.
In chapter 7, focusing on the abdominal aorta in the same mouse model,
we could not identify any overt relation between disturbed ow patterns and
aneurysm formation. Our current data support this observation for the ab-
dominal aorta. We furthermore hypothesized that AAA may occur proximal
to the (focal) locations experiencing increased RRT (usually at bi-or trifurca-
tions). Figure 9.1B shows that focally increased RRT is again present near the
trifurcation of mesenteric and right renal arteries. However, this focal increase
in RRT is too small to aect the value of the entire (proximal) abdominal aorta,
which is why there is no inuence visible in the box plots in Figure 9.3A.is
focally elevated RRT is typically caused by local recirculation at the trifurca-
tion and is also present at other bifurcations, e.g. in the aortic arch (Figure 9.1
A).is is also why proximal abdominal patches in the scatter plots in Figure
9.2 E are not markedly dierent from most patches in the thoracic aorta. Our
(abdominal) data did not allow us to conrm or deny our previous hypothesis
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that AAA develops proximal to the (trifurcation) zone that experiences a fo-
cally increased RRT, as the onset of abdominal aneurysm was either not clearly
detectable on micro-CT scans or happened in between scan times.
9.4.3 Hemodynamics and aneurysm evolution
While the intermediate data are limited by the absence of scans at several time
points, they do seem to suggest an interaction between hemodynamics and aor-
tic remodeling in the ascending aorta. Indeed, if local high RRT values give
rise to a small increase in aortic diameter this will result in an even greater in-
crease in RRT (driven by a lower near-wall velocity), thus creating a vicious
circle. However, in both aneurysmatic animals, RRT seems to increase over
time throughout the aorta, and not just at aneurysmatic locations. Moreover,
intermediate RRT is also increased in animals not developing aortic aneurysm
(AA6 and AA10). e increased RRT at intermediate time points might thus
be driven by other factors than aneurysm formation alone.
In this respect, the observed pulsed Doppler measurements in Figure 9.5
may be very important. ese are, to the best of our knowledge, the rst data
to show that, in the angiotensin II-infused ApoE −/− mouse model, ascending
aortic aneurysm formation is associated with aortic valve insuciency. Both
diastolic backow and ascending aortic aneurysm are noticeable from day 7 on
and evolve to a more severe stage over time. Unfortunately, we did not obtain
data at sucient time points to determine whether diastolic backow is occur-
ring rst and aneurysm is a consequence of it, or vice versa.
9.4.4 PET and aneurysm formation
Positron Emission Tomography (PET) is a functional imaging technique that
is used in a clinical setting to detect biological processes such as inammation
at an early stage. In human aortic aneurysms, an increased PET uptake of 18F-
FDG, an analogue of glucose, is associated with increased inammation and
wall instability [271, 272]. In small animals, this techniquemight therefore allow
for the detection of aneurysmatic activity before it can be observedmacroscop-
ically on ultrasound or micro-CT images. Our preliminary PET study, limited
by a small number of imaged subjects, did not have prognostic value at day 7.
e ascending aortic PET signal was elevated in one animal developing aneu-
rysm (AA2) but not in two others (AA7 and AA9). However, PET conrmed
aneurysm presence at day 14 with a high specicity, discriminating between
aneurysmatic (increased uptake) and non-aneurysmatic (no increased uptake)
animals in both the ascending and the abdominal aorta.
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As ascending aortic aneurysm development is a gradual process that is not
very prominent at day 14 (see Figures 9.2 and 9.7) and abdominal aortic aneu-
rysm cannot always be detected from contrast-enhanced micro-CT alone (see
section 9.4.5), the increased signal at day 14 may still have some prognostic
value. Additional scanning at earlier timepoints (between days 7 and 14) might
increase the prognostic value for ascending aortic aneurysms. In the abdomi-
nal aorta, this might be more challenging since the onset of AAA appears to be
more sudden than the ascending aorta (see Figure 9.2) and one risks scanning
too early or too late. PET analysis was performed in VOIs that matched the aor-
tic zones used in the hemodynamic analysis, for reasons of uniformity. Quali-
tative evaluation of the original PET images revealed that the increased uptake
of 18F-FDG in non-aneurysmatic zones of aneurysmatic animals is most likely
related to a general increase in inammation over the entire aorta (data not
shown). e ascending aortic PET signal may also experience some inuence
of the vicinity of the heart.
9.4.5 Limitations
As the study was set up as a proof of concept to test dierent assumptions, the
interpretation of our results is hampered by an important limitation: the rel-
atively low number of imaged animals. Due to the relatively high drop-out in
the initial week of the experiment, it is dicult to draw any statistically relevant
conclusions. Nevertheless, the presented data are very specic: PET images
discriminate between aneurysmatic and non-aneurysmatic animals at day 14,
and aortic valve insuciency was only found in (ascending) aneurysmatic ani-
mals from day 7 on. At baseline however, none of the proposed methods (RRT,
pulsed Doppler, PET at day 7) could discriminate between aneurysmatic and
non-aneurysmatic animals.
At the inlet of our CFDmodel a parabolic ow velocity prole was imposed,
thus assuming that the (1D)measured pulsed Doppler velocity waveform in the
ascending aorta is the maximal value of a parabolic prole. However, the actual
ow prole in the ascending aorta is very dicult to assess. While parabolic
(i.e., fully developed) ow seems to be a reasonable assumption at all other aor-
tic locations given the low eective length in themouse aorta (see section 8.4.4),
the ascending aorta is located just distal to the le ventricle. Blood that is ejected
out of the ventricle and enters the ascending aorta is most likely not fully devel-
oped yet, and could also be skewed due to the torsion of the le ventricle [231].
Moreover, we do not take the eect of the aortic heart valves on the ow into
account. Since the RRT values at the ascending aorta depend heavily on the
used inlet boundary condition (see Figure 9.1), the obtained results should be
regarded with the necessary reservations. In the future, uid-structure interac-
tion (FSI) simulations could be used to implement both le ventricle contrac-
tion and (at a later stage) aortic valve movement into the model. is would
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allow us to assess the inuence of the currently assumed parabolic velocity pro-
le on the outcome of the simulations.
No CFD simulations were performed at day 14 and day 49.e reasons for
this are twofold. First, our main interest was to elucidate the role of hemody-
namics in the initial stages of aneurysm development.e added value of small
animal research is exactly in the access to data on the initial stages of aneurysm
formation, unavailable in a human setting. A detailed analysis of the ow eld
in existing aneurysms has already been studied extensively in (human) litera-
ture (see the overview in section 2.2.1). A second reason was the diastolic back-
ow that was present in the ascending aorta of aneurysmatic animals from day
7 on (Figure 9.5).is inlet backow is not easily accounted for in the setting of
a CFD simulation with rigid walls, as the ow balance in the imposed boundary
conditions should be correct at all times. For the intermediate CFD simulations
performed at day 7, the small amount of measured diastolic backow in AA2
and AA9 was ignored (i.e., ow was assumed to be zero during diastole). For
later timepoints however, backow is more severe and this assumption would
signicantly aect the outcome of the simulation. A simple application of our
current methodology would imply that the negative inlet ow would be redis-
tributed over all outlets (see chapters 7 and 8). Diastolic backow would thus
also be introduced in the abdominal aorta, while this is not observed in the
abdominal pulsed Doppler measurements (data not shown). Furthermore the
dilated ascending aortic morphology is probably associated with complicated
ow patterns in the ascending aorta during ultrasound measurements as well,
and the assumption of a parabolic velocity prole would no longer be justied.
As the used inlet boundary condition is vital for the outcome for the simula-
tions, we opted not to perform any simulations at days 14 and 49, rather than
to perform simulations that would not reect the actual ow situation. In the
future, a detailed analysis of the ow eld in the presence of inlet diastolic back-
owmay shed further light on the inuence of aortic valve insuciency on an-
eurysm formation. However, a dierent simulation approach might be needed.
FSI simulations using impedance outlet boundary conditions would e.g. allow
for more exibility andmight thus result in more realistic boundary conditions
for these non-standard situations.
Within this chapter, the presence of aortic aneurysm was based on B-Mode
ultrasound images and on a macroscopic evaluation of the aorta just aer au-
topsy. InAA8 andAA9, the endstage abdominal aneurysm (present on B-Mode
ultrasound (not shown), post-mortem and PET images) is hardly detectable on
the 3D volume segmented from the micro-CT images. While indispensable to
follow-up on aneurysm morphology at intermediate stages in vivo, micro-CT
only visualizes the aortic lumen and does not allow us to assess wall proper-
ties. It is known that medial and adventitial remodeling occur in the abdominal
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aorta of this mouse model [124], which may in some cases cause signicant dif-
ferences between the circumferential shape of interior and exterior AAA wall.
Most likely the AAA in these subjects consists predominantly of thrombus, and
unlike in AA7 no blood is entering the aneurysmal lumen. Consequently, the
calculated distance map in these particular cases may not correspond entirely
to the actual aneurysmatic region. We conclude that contrast-enhanced micro-
CT is better suited to follow-up on ascending aortic aneurysm than AAA, a
nding that should be kept in mind for future studies.
9.5 Conclusion
We used the angiotensin II - infused ApoE −/− mouse model to investigate
whether new emerging imaging and computational biomechanics techniques
can be used to predict the location of the aneurysm before it is actually present.
Our data did not allow us to relate focally elevated abdominal aortic baseline
values of residual residence time (RRT, an indicator for disturbed ow) to the
AAA location. In the ascending aorta, aneurysm formation was associated
with an increased RRT at baseline. Baseline RRT could, however, not discrimi-
nate between animals that do and animals that don’t develop aortic aneurysm.
Pulsed Doppler imaging revealed that ascending aortic aneurysm formation
was associated with diastolic backow from day 7 on. Whether aortic valve in-
suciency precedes aneurysm formation remains to be elucidated. PET imag-
ing conrmed aneurysm presence at day 14, but was not predictive at day 7.
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Conclusions and future prospects
10.1 Mice as a model for human disease
e main goal of this dissertation was to increase the understanding of aortic
aneurysm formation, and more specically to elucidate if and to what extent
hemodynamics have a role to play in the initial stages of this disease. Despite
the fact that - for obvious reasons - our main interest was and still is in human
disease, all research presented in this dissertation was performed onmice.is
choice was primarily made out of practical considerations, as these animals of-
fer tremendous research possibilities that are simply not possible to achieve in
a human setting. Not only can we induce aneurysm in mice, the disease also
develops within a time period that is manageable in a research setting and one
keeps at all times access to both the pre-diseased and post mortem data. How-
ever, as for most things in life the path of least resistance is not necessarily the
right one. It is therefore important to keep the most important assumption of
this dissertation in mind at all times : we are using mice as a model for humans,
and as for all models there are some dierences with the original.
From a clinical point of view, important dierences may exist between an-
eurysm formation in humans and mice as the aortic dilatation grows naturally
in the rst and is provoked by a combination of genetic modications and an-
giotensin II-infusion in the latter. From a hemodynamic point of view, themost
important dierences between both species are the increased heart rate and de-
creased size of these animals, giving rise to a much more laminar, streamlined
ow than in a human setting. While it was dicult to evaluate clinical dier-
ences between murine and human aortic aneurysms (as the lack of knowledge
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on human disease was the main reason to develop mouse models in the rst
place), we did assess the inuence of anatomical and hemodynamic dierences
between both species in the rst part of this dissertation.
10.2 Anatomical and hemodynamic aspects of the mouse aorta
In the rst research chapter of this dissertation a purely anatomical comparative
study of the thoracic aorta in mice and younger and older men was presented.
Several agreements were found between mice and men: the initial segment of
the aorta, comprising the ascending aorta, the aortic arch and the superior part
of the descending aorta, was sigmoidally curved in both species. Although
some analogy between the intrathoracic position of the murine and human
heart was observed, the murine heart manifestly deviated more ventrally. e
major conclusion of this rst study was that, in bothmice andmen, the ascend-
ing and descending aorta do not lie in a single vertical plane (non-planar aortic
geometry), with a more prominent non-planar angle in the murine case. is
contrasts clearly with most other domestic mammals in which a planar aortic
pattern is present. As the vascular branching pattern of the aortic arch was also
found to be similar in mice and men we concluded that, from an anatomical
point of view, the thoracic aorta of the mouse seems a valuable model to study
human vascular diseases.
e subsequent study extended this purely anatomical comparison to the
eld of hemodynamics. e Reynolds number, an indication for the amount
of turbulence the blood ow experiences, and theWomersley number, an indi-
cation for the amount of pulsatility the blood ow experiences, were reported
to be much lower in mice. is results not only in a well organized, laminar
ow eld, but is also associated with an elevated level of wall shear stress.is
viscous stress, that is believed to be an important biomechanical stimulus in
the initial stages of cardiovascular disease, was conrmed to be higher for mice
both from a theoretical (idealizedWSS based on Poiseuille’s law) and a numer-
ical (detailed WSS calculated using CFD techniques) point of view. Scaling the
original geometry to dierent sizes showed that WSS decreases rapidly in early
life stages and reaches a plateau in adulthood, thus supporting a mediating role
for WSS in arterial growth. Most importantly however, these initial CFD data
show that calculatedWSS values formice should be interpreted very cautiously,
and if possible an animal-specic geometrywith animal-specic boundary con-
ditions should be used.
10.3 A methodology for mouse specific CFD simulations
In order to study the potential inuence of hemodynamics on the initial stages
of aortic aneurysm (or any other cardiovascular disease), one ideally wants to
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follow-up the same animal at several timepoints. To do so it is necessary to
be able to obtain the arterial geometry in vivo using micro-CT. As the standard
method to construct a 3Dmodel of themurine aorta (vascular casting) required
to sacrice the animals, new contrast agents for micro-CT had to be evaluated.
A study was set up in which 3D models based on scanned vascular casts were
compared to models that were obtained in the same animals in vivo, aer in-
jection of the newly developed contrast agent Fenestra VC-131. While a good
qualitative agreementwas found between bothmethods, the in vivomodels had
systematically higher aortic diameters, and consequentlyWSS values calculated
based on these models were systematically lower. In vivo micro-CT showed to
be a possible alternative for vascular casting, but still some shortcomings were
reported as Fenestra-VC 131 was not well tolerated by the animals due to the
high volumes of contrast agent that had to be injected.e latter problem was
solved by the introduction of Aurovist, a gold particle based contrast agent that
required much less injected volumes for the same amount of contrast. At the
same time a high-frequency ultrasound apparatus was purchased, allowing to
measure blood velocities with Pulsed Doppler.
us disposing of a unique setting inwhich both aortic diameters and blood
velocities could be measured in vivo in the same animals, a novel methodol-
ogy was developed to set up entirely mouse-specic CFD simulations. Veloci-
ties were rst converted to volumetric ows and the error in the ow balance
was redistributed over all ow waveforms, which eventually resulted in a set of
ow waveforms that could be imposed as mouse-specic, measurement-based
boundary conditions in the CFD simulations. is methodology was rst ap-
plied in the abdominal aorta. In a next study, it was extended to the complete
aorta, extending from the heart to the iliac bifurcation and including 7 side
branches.e developedmethodology has shown to be robust, and can be used
to obtain a detailed insight in the normal and pathophysiological behavior of
blood velocity in the murine aorta, as well as the shear stress patterns that are
associated with it. Moreover, it is tailored to the specic conditions of each an-
imal, and it can be used to compare dierent time points in the onset of any
cardiovascular disease as all measurements are obtained in vivo.
10.4 The flow field in the mouse aorta
In rst instance, the developed methodology was applied to study the ow eld
in the abdominal aorta. Flow and diameter values were reported in the 4 ab-
dominal branches, resulting in some interesting ndings such as a signicant
dierence in ow assigned to the le and right renal arteries. is was al-
ready an improvement to the (very limited) data available data in literature,
but the subsequent study went one step further. e complete aorta was now
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measured in vivo, which allowed to characterize the typical murine aorta from
both an anatomical and hemodynamic point of view in a dataset of 10 male
ApoE -/- mice. Aortic diameters were reported for 9 locations throughout the
aorta, as well as the percentage of ow going to each branch. Mean diame-
ters and ow fractions of this large dataset can be used to serve as a reference
for future studies. It is, aer all, not always necessary to dispose of entirely
mouse-specic boundary conditions. Within the setting of a follow-up study
they are indispensable as onewants to identify exactly those hemodynamic con-
ditions that deviate from the normal situation. In other research applications
however, one might only need to visualize the general ow eld in a typical
mouse, and mouse-specic boundary conditions can be replaced by meaning-
ful population-averaged data.
e obtained reference dataset provided uswith a unique opportunity to as-
sess the inuence of such averaged boundary conditions on the outcomemurine
CFD simulations. When imposing the reported mean ow fractions from our
dataset as a xed boundary condition in each of the ten mouse-specic aortic
geometries did not cause signicant dierences in the spatial or statistical shear
stress distribution. As the necessary imaging techniques to obtain in vivo ge-
ometries and boundary conditions are not always available, we conclude that
the reported dataset can be used to serve as a reference for other researchers.
Yet, it is important to keep inmind that the dataset was tested on the same pop-
ulation it was based upon, i.e. 10 relatively old, male ApoE -/- mice. As already
indicated previously, caution is neededwhen extrapolating these results tomice
of another strain or age.
10.5 The influence of common assumptions in small animal CFD
e reference dataset was also used to assess the inuence of Murray’s law, stat-
ing that ow is proportional to the third power of the arterial diameter through-
out the arterial tree. Murray’s law is oen used in literature to estimate ow frac-
tions to the side branches if ony only disposes of amouse-specic aortic geome-
try, as was also done in the rst part of this dissertation to compare CFD results
in in vivo and in vitro geometries. It has, however, never been validated in a
murine setting. Moreover, some authors have suggested that the third power
that is used to estimate the ow fractions should be replaced by a second power
law in a small animal setting.e latter hypothesis was conrmed in our study,
as it resulted in a decreased error in the ow balance and a better agreement of
obtained ow fractions with the measured ones compared to the original third
power law. e original version of Murray’s law resulted in signicant dier-
ences in ow assigned to the brachiocephalic trunk and the distal abdominal
aorta. We conclude that Murray’s law should be applied with caution in mice.
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e inuence of geometrical restrictions was assessed in a separate study.
For each case in the reference dataset, a CFD simulation in which the proxi-
mal part of the abdominal aorta was considered as the inlet of the model, was
compared to a CFD simulation of the same geometry in which the entire aorta
was included. Statistical and spatial abdominal shear stress distributions were
found to be very similar in both cases, clearly demonstrating that the aortic arch
is not needed if one is only interested in the abdominal ow situation.is con-
clusion is related to the specic murine conditions that were already discussed
previously: due to their low Reynolds andWomersley number, mice experience
a very laminar ow eld with velocity proles that evolve into fully developed
ow very rapidly. e fact that a skewed prole leaves the thoracic aorta and
enters the abdominal aorta thus only has a limited inuence on the abdominal
hemodynamics.
10.6 Hemodynamics and aneurysm formation
Having overcome most of the limitations that were previously hampering lon-
gitudinal CFD research in mice, the last part of this dissertation was dedicated
to the main research question that was posed at its very beginning:
Why do aortic aneurysms have a predisposition to develop at some very dis-
tinct aortic locations, and what is the role of local hemodynamics herein?
A rst study was limited to the abdominal aorta. Shear stress distributions
based on mouse-specic CFD simulations at baseline (before any aneurysm is
present) were compared to AAA location based on endstage micro-CT scans.
We did not nd an apparent relationship between aortic hemodynamics and
AAA location in the four animals that were found to develop an AAA. In most
cases however, AAAs seemed to occur proximal to the regions experiencing low
and oscillatory shear stress. Intermediate data that would allow to elucidate if
there was a causal eect were lacking. erefore an additional study was set
up, in which additional scans were performed 2, 7 and 14 days aer aneurysm
formation.
e second study allowed to assess the rst part of our research question, i.e.
the distinct aortic locations, as the entire aorta was now included into themodel
and aneurysms were detected in both the ascending and the abdominal aorta.
For the rst time, two dierent aneurysm locations could thus be compared in a
longitudinal study. Both aneurysm types were found to evolve dierently over
time: while the abdominal aneurysm appears abruptly in between scans, the
ascending aneurysm grows gradually. Several measurements were performed
in an attempt to elucidate some of the working mechanisms driving aneurysm
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formation at these aortic locations. Positron emission tomography (PET) mo-
lecular imaging could not predict aneurysm formation at day 7, but showed an
increased uptake of 18F-FDG in both the ascending and the abdominal aorta
at day 14. is indicates that inammation is involved at both aneurysm loca-
tions. Another interesting observation was made via Pulsed Doppler velocity
measurements. Ascending aortic aneurysm was found to be associated with
aortic valve insuciency, as diastolic backow occurred from day 7 on. At the
abdominal aorta no such backow was present. We were not able to determine
whether diastolic backow precedes ascending aortic aneurysm formation, or
if it is a consequence of ascending aortic dilatation. Whereas these data indicate
that some important dierences exist between ascending and abdominal aneu-
rysms, they do not allow to explain the specic locations of the disease entirely.
e second part of our research question, i.e. the role of hemodynamics,
was addressed in the same study. Baseline CFD simulations were compared to
both ascending and abdominal aneurysm growth following the methodology
that was developed earlier. Interestingly, baseline RRT (a combined descriptor
for low and oscillatory shear) was found to be markedly elevated in the ascend-
ing aorta, at the very same location where ascending aortic aneurysm develops
later on. Baseline RRT was, however, not predictive for aneurysm development
since it was also elevated in the ascending aorta of animals that did not develop
any ascending aortic aneurysm at a later stage. Moreover RRT could not predict
which part of the ascending aorta would dilate most either. We conclude that
disturbed hemodynamics seem to be related to the onset of aortic aneurysm in
the ascending aorta, but not unambiguously.
e abdominal RRT distribution on the other hand did not show an overt
relationship with the location at which AAAwas the largest, which was also the
case in the rst study in chapter 7. In both chapters, focal spots of increased
RRT could be observed near the bi-and trifurcations of abdominal branches,
albeit more prominently in chapter 7. In chapter 9 we could not deny or con-
rm the validity of the assumption put forward in chapter 7, that abdominal
aneurysm develops proximal to these zones of focally disturbed ow.e AAA
location could not unequivocally be detected from the obtained (lumen)micro-
CT scans and the CFD simulations at intermediate time points (2 and 7 days
aer pump implantation) were still hampered by a limited number of measure-
ments. e available intermediate data did not reveal a dierence in hemody-
namic behavior between aneurysmatic and non-aneurysmatic animals: RRT
consistently increased over time, in aneurysmatic as well as non-aneurysmatic
animals, and in the ascending aorta as well as the abdominal aorta. Even though
these data might support a role for RRT in aneurysm growth, they do not allow
to explain unambiguously if and to what extent hemodynamics are involved in
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the early disease stages.
e reader who managed to work his way through this entire dissertation
is at this stage probably completely overwhelmed by a pressing need to know:
What is the nal answer to the research question? Did we manage to explain
why aneurysm so oen develops in the ascending or the abdominal aorta, and
are disturbed hemodynamics part of that explanation? As usual in research,
the answer is not simple nor straightforward. Yet, if one poses clear questions
at the beginning one should provide clear answers at the end. So yes, we found
some interesting dierences between ascending and abdominal aneurysm. And
yes, baseline hemodynamics seem to play an important role, especially in the
ascending aorta. But no, we did not come up with one comprehensive expla-
nation that would make all other aneurysm research superuous. We conclude
that further research is needed to fully elucidate the role of disturbed ow pat-
terns in the initial stages of ascending as well as abdominal aneurysm, and that
- as formost travels - the road towards our goal has been as instructive as reach-
ing the goal itself.
10.7 Limitations
Despite their conclusive tone, most statements in the previous sections do not
represent the absolute truth. ey are the results of models, and as already
stated in the beginning of this chapter, models inherently have limitations. In
this dissertation the word model is to be interpreted in two dierent ways: we
use mice to model human aneurysm, and within that setting we use CFD to
model the actual ow eld of blood in the mouse aorta. Both mice and CFD
models have their own specic limitations. As most technical challenges and
shortcomings of the usedmethodology have already been discussed thoroughly
within the respective chapters, I will limit the limitations in this section to those
that may have inuenced our answer to the research question.
10.7.1 Mouse model limitations
e main limitation of the used angiotensin II-infused ApoE -/- mouse model
is that it remains unclear to what extent ndings obtained in these animals can
be extrapolated to a human setting. While many of the observed characteristics
of disease development are similar in both species, some important dierences
exist.e most prominent dierences are found in the abdominal aorta: AAA
formation in mice is associated with intimal dissection followed by a rapid di-
latation around the 10th day aer pump implantation, whereas in humans the
dilatation probably occursmore gradually. AAA also developsmore proximally
in mice than in humans (suprarenally instead of infrarenally), a nding that we
could not entirely explain from a hemodynamic point of view (as explained
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above). In a way such dierences are not entirely unexpected, since in mice the
onset of the disease is provoked by a combination of genetic (ApoE knockout)
and chemical (angiotensin II-infusion) techniques, whereas in humans the dis-
ease usually develops naturally. Nevertheless, it is important to keep them in
mind when extrapolating our results to a human setting.
Another important limitation is the limited number of animals that was
studied. From a clinical point of view, these small groups are far too low to draw
any statistically relevant conclusions. One should, however, keep in mind that
the presented CFD simulations require an extensive amount of manual inter-
vention, both in pre- and post-processing and for each investigated time point.
It is therefore not straightforward to repeat the (CFD part of these) follow-up
studies in a larger population, simply because it would be too time-consuming.
Despite the small sample sizes, we were able to nd some consistent dierences
between dierent aortic locations at baseline (RRT) and between aneurysmatic
and non-aneurysmatic animals from day 14 on (PET, pulsed Doppler). e
power of this study lies in its versatility, and from a clinical point of view it
should be considered as a proof of concept for future studies. If the pre- and
post-processing time of the entire procedure can be reduced, much more ani-
mals can be included to reach statistically signicant conclusions.
10.7.2 CFD limitations
Boundary conditions
e applied inlet boundary condition may have inuenced the outcome of as-
cending aortic CFD results. By imposing a parabolic velocity prole, we implic-
itly assumed that the (1D) pulsedDoppler velocity waveform that wasmeasured
in the ascending aorta is the maximal value of a parabolic prole. In chapter 8,
the assumption of a parabolic inlet ow prole was shown to have only a mi-
nor inuence on the ow eld in the abdominal aorta. In the ascending aorta,
however, it is not as straightforward to assess the validity of the imposed inlet
boundary condition. e ascending aorta is located just distal to the le ven-
tricle, and the velocity prole of the blood that is ejected out of the ventricle is
most likely not fully developed and could also be skewed due to the torsion of
the le ventricle. Since the RRT values at the ascending aorta depend heavily
on the used inlet boundary condition, the obtained results relating ascending
aortic RRT to aneurysm formation should be regardedwith the necessary reser-
vations.
e applied outlet boundary conditions may have inuenced the outcome
of abdominal aortic CFD results. e pros and cons of dierent approaches
that are followed in literature to estimate outlet boundary conditions formurine
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CFD applications have been studied extensively in chapter 8.e followed ap-
proach in this dissertation has improved on what previously existed in litera-
ture, as it allows to impose time-dependent ow velocitywaveforms throughout
the cardiac cycle, compatible with each other and based on in vivo measure-
ments. However, these boundary conditions are hard-coded, and each branch
gets a xed amount of ow throughout the cardiac cycle since the redistribution
algorithm (needed to fulll the conservation of mass) is performed before the
simulation is actually started. is means that the outcome of the simulations
depends on a goodmatch between dierent (redistributed)measurements with
reality.
Geometry
Geometrical simplications of the model might also have aected the outcome
of ascending aortic CFD results. We did not include the aortic valves into the
model, nor the aortic bulb and the coronary arteries that branch o just distal
to it. Image quality did not allow to segment these structures. However, their
incorporation into the model might aect the ow eld signicantly, especially
during diastole. Furthermore ourmodel does not take the buering function of
the ascending aorta into account, as it has rigid walls. In the abdominal aorta
some smaller side branches were neglected as well, but we believe these only
have a minor inuence on the computed ow eld.e fact that our model has
rigid walls does, however, also aect the abdominal ow eld since it implies
that we cannot take into account the windkessel eect.
10.8 What’s next?
One thing that this dissertation has clearly demonstrated, is that many of the
obtained results rely heavily on the fast progression of small animal imaging
techniques. We live in a technology-based society in which things only get bet-
ter, faster and stronger over time. ere is therefore no reason to assume that
this evolution will stop as soon as this dissertation has appeared in print. Better
micro-CT contrast agents will be developed, higher micro-CT and micro-MRI
resolutions will be achieved and more accurate methods to measure murine
blood velocities will be engineered. As more accurate measurements imply
more reliable results, many of the obtained data within this dissertation will be
evaluated in the (near) future, just like we have evaluated some of the assump-
tions and simplications that weremade in the (recent) past. Small animalMRI
already allows tomeasure both arterial geometries and blood owproles in 3D
in vivo. As soon as a sucient resolution can be reached, this technique will be
used to evaluate the accuracy of our methodology.
In the near future, dierent improvements of the currently used CFDmod-
els might solve some of the limitations mentioned in section 10.7.2.e use of
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uid-structure interaction (FSI) simulations would allow us to include distensi-
ble aortic walls into themodel. On a longer term, the le ventricle and the heart
valves may be incorporated, which would lead to a better estimate of the ow
eld entering the ascending aorta. Furthermore impedance boundary condi-
tions may be used to model the vasculature downstream of the outlet, instead
of imposing the ow prole itself. Such impedances allow to take into account
the eect of both pressures and ows, which will lead to a more realistic dis-
tribution of the ows towards dierent branches during the simulation. is
is particularly important when performing FSI simulations, as it is not pos-
sible to obtain a perfect match between (i) the time-shi that exists between
the dierent measured velocity waveforms that are imposed as outlet boundary
conditions and (ii) the aortic wall stiness that accounts for this time-shi via
the windkessel eect.e wall stiness is imposed in the FSI simulation as the
aortic wall material property (see below).
is PhD has focused on the role of hemodynamics in the initial stages of
aneurysm formation in mice. However, hemodynamics are only part of the
story: aortic aneurysm is essentially a disease of the aortic wall. Much (if not
all) of the biomechanical research on human aortic aneurysm is focused on a
better prediction of wall rupture in existing aneurysms. Mouse models can be
important in this research aspect as well, as they provide access to post-mortem
tissue to validate the location of rupture that is predicted by these biomechanical
simulations. Current and future research in our lab therefore aims to develop
an improved methodology for CSM (computational solid mechanics, focusing
only on the structural problem) and FSI simulations in (aneurysmatic) mice. A
rst attemptwas already taken in the context of the study presented in chapter 9:
aneurysmatic mice were monitored closely with a webcam for several months
to await aneurysm rupture.e animals were euthanized and histological stain-
ings were obtained aer 4 months, but none of the aneurysms had ruptured by
that time. In the future, more rupture-prone mouse models might be needed
for this purpose.
One of the major current limitations to perform mouse-specic CSM as
well as FSI simulations is the inability to obtain aortic wall material properties
and blood pressures (needed to dene boundary conditions for these models)
in vivo.e challenge thus remains to extend the possibilities of in vivo (small
animal) imaging, just like during the initial phase of this PhD, when mouse-
specic CFD simulations were hampered by the inability to obtain the aortic
lumen (needed to dene the geometry) and blood velocities (needed to dene
the boundary conditions) in vivo. While all in vivo measurements that were
presented and discussed within this dissertation served to improve our CFD
simulations, additional data have been obtained in an attempt to estimate aor-
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tic wall properties. M-Mode ultrasound was measured at several aortic loca-
tions and at all time points. As M-Mode shows the aortic wall distention over
time, we intend to process these measurements in the near future to obtain a
surrogate measure for local wall distensibility. A second in vivo assessment of
aortic wall properties was obtained from themeasured time lag in the owmea-
surements along the aorta. Combined with distance information derived from
the 3D models, transit times between dierent velocity measurements allow to
calculate the aortic pulse wave velocity (PWV), a measure for aortic stiness
that is oen used in clinical practice. As a third material parameter, the ma-
terial properties of aneurysmatic and non-aneurysmatic aortic tissue were de-
termined post mortem.e dissected aorta was inated and the inherent rela-
tionship between internal ination pressure, axial force and aortic diameter was
measured. In the near future, these in vivo and postmortemmaterial properties
will be processed and validated against each other, in order to estimate mouse-
specic aortic wall properties that will allow to increase the reliability of CSM
and FSI models. In vivo pressure waveforms to provide boundary conditions
for these models in longitudinal studies might be more challenging to obtain,
as the current state of the art only allows to obtain non-invasive pressure mea-
surements in the tail.
Finally, I would like to remark that the developedmethodology (or an ame-
liorated version of it) can be applied in many dierent settings.e most obvi-
ous example would be to study the role of hemodynamics in a dierent mouse
model for aortic aneurysm formation, but mice are (and will probably con-
tinue to be) the animal model of choice for many other diseases. We are cur-
rently planning to apply the developed methodology to study hemodynamics
in mouse models of vulnerable atherosclerotic plaque, and I hope that this dis-
sertation can be helpful for researchers who plan to study aortic hemodynamics
in existing (or yet to be developed) mouse models of cardiovascular disease.
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